No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1rkrB, 0.8061, 1.79, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
2, 1azcA, 0.8061, 1.74, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
3, 1azbA, 0.8060, 1.74, 0.177, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
4, 1rkrD, 0.8058, 1.80, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
5, 1rkrA, 0.8055, 1.80, 0.169, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
6, 1cuoA, 0.8053, 1.70, 0.185, 129, 124, CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J
7, 1uriA, 0.8051, 1.62, 0.163, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
8, 1aizA, 0.8047, 1.78, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
9, 4hz1D, 0.8043, 1.59, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
10, 1rkrC, 0.8041, 1.82, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
11, 2azaA, 0.8040, 1.85, 0.169, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
12, 1jziA, 0.8039, 1.70, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
13, 1a4aA, 0.8038, 1.86, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
14, 2tsbA, 0.8037, 1.53, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
15, 3azuA, 0.8036, 1.54, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
16, 2tsbD, 0.8036, 1.52, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
17, 2tsaD, 0.8030, 1.53, 0.131, 128, 122, AZURIN MUTANT M121A
18, 4ko5B, 0.8029, 1.63, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
19, 2tsaA, 0.8029, 1.54, 0.131, 128, 122, AZURIN MUTANT M121A
20, 1azbB, 0.8029, 1.77, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
21, 1jzgA, 0.8028, 1.70, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83)
22, 1jzeA, 0.8028, 1.70, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83)
23, 1azcB, 0.8027, 1.78, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
24, 3azuD, 0.8026, 1.53, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
25, 1vlxC, 0.8024, 1.78, 0.146, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
26, 1jzfA, 0.8020, 1.71, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83)
27, 1a4bA, 0.8020, 1.83, 0.169, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
28, 1dz0A, 0.8019, 1.67, 0.154, 129, 123, REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
29, 1dyzA, 0.8019, 1.67, 0.154, 129, 123, OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
30, 5azuC, 0.8018, 1.76, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
31, 2xv3A, 0.8017, 1.74, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
32, 1aizB, 0.8016, 1.80, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
33, 1jziB, 0.8015, 1.72, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
34, 1e5zC, 0.8015, 1.76, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
35, 2oj1B, 0.8014, 1.66, 0.146, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
36, 1jzhA, 0.8014, 1.71, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83)
37, 2azaB, 0.8013, 1.85, 0.177, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
38, 1e65C, 0.8013, 1.77, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
39, 1a4cB, 0.8013, 1.75, 0.169, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
40, 1jzjA, 0.8011, 1.68, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
41, 3ugeD, 0.8009, 1.55, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
42, 3ugeC, 0.8008, 1.78, 0.146, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
43, 1e65D, 0.8007, 1.56, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
44, 1e5zD, 0.8007, 1.56, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
45, 5azuD, 0.8006, 1.55, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
46, 2azuC, 0.8006, 1.58, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
47, 1a4cD, 0.8006, 1.88, 0.169, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
48, 4qlwA, 0.8004, 1.56, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
49, 4azuC, 0.8004, 1.79, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
50, 2azuD, 0.8003, 1.56, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
51, 2xv3B, 0.8002, 1.76, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
52, 1uriB, 0.8002, 1.76, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
53, 1gr7A, 0.8002, 1.63, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
54, 1e67C, 0.8002, 1.79, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
55, 6gyiC, 0.8000, 1.80, 0.154, 128, 123, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
56, 1e5yD, 0.8000, 1.56, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
57, 1ilsD, 0.7999, 1.56, 0.131, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
58, 1gr7D, 0.7999, 1.64, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
59, 1e5yC, 0.7999, 1.81, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
60, 1a4cA, 0.7999, 1.86, 0.169, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
61, 4azuD, 0.7998, 1.56, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
62, 4hz1A, 0.7997, 1.60, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
63, 2oj1A, 0.7997, 1.69, 0.146, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
64, 4ko6B, 0.7996, 1.69, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
65, 3azuC, 0.7996, 1.58, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
66, 2azuA, 0.7996, 1.57, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
67, 1nzrC, 0.7996, 1.80, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
68, 1ilsC, 0.7996, 1.80, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
69, 1gr7B, 0.7996, 1.47, 0.157, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
70, 4ko6A, 0.7995, 1.67, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
71, 3fswB, 0.7995, 1.58, 0.139, 128, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
72, 1jzjB, 0.7995, 1.79, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
73, 4ko7C, 0.7993, 1.73, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
74, 4ko6C, 0.7993, 1.70, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
75, 2gi0A, 0.7993, 1.73, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
76, 1xb3A, 0.7993, 1.69, 0.146, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
77, 1azrC, 0.7993, 1.79, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
78, 5azuA, 0.7992, 1.58, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
79, 4ko5A, 0.7992, 1.69, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
80, 4jknC, 0.7992, 1.83, 0.146, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
81, 1e5zA, 0.7992, 1.57, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
82, 2ghzA, 0.7991, 1.74, 0.146, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
83, 1vlxD, 0.7991, 1.57, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
84, 1jvoD, 0.7991, 1.59, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
85, 4mfhB, 0.7990, 1.72, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
86, 1gr7C, 0.7990, 1.47, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
87, 1e5zB, 0.7990, 1.62, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
88, 3fszA, 0.7989, 1.77, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
89, 1jvoC, 0.7989, 1.59, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
90, 2azuB, 0.7988, 1.59, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
91, 1jvoE, 0.7986, 1.59, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
92, 2idfB, 0.7985, 1.72, 0.146, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
93, 2idfA, 0.7985, 1.72, 0.154, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
94, 2ccwA, 0.7985, 1.72, 0.146, 129, 123, CRYSTAL STRUCTURE OF AZURIN II AT ATOMIC RESOLUTION (1.13 ANGSTROM)
95, 6iavA, 0.7984, 1.57, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
96, 4kobD, 0.7984, 1.72, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
97, 3u25B, 0.7984, 1.59, 0.156, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
98, 1jvoH, 0.7984, 1.59, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
99, 1jvoA, 0.7984, 1.60, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
100, 4ko7A, 0.7983, 1.74, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
101, 2tsaB, 0.7983, 1.60, 0.139, 128, 122, AZURIN MUTANT M121A
102, 1nzrD, 0.7983, 1.57, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
103, 6iavC, 0.7982, 1.58, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
104, 4ko6D, 0.7982, 1.72, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
105, 3azuB, 0.7982, 1.59, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
106, 2tsbC, 0.7982, 1.59, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
107, 4kobA, 0.7981, 1.71, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
108, 2tsaC, 0.7981, 1.60, 0.139, 128, 122, AZURIN MUTANT M121A
109, 1jvoI, 0.7981, 1.60, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
110, 1jvoB, 0.7981, 1.59, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
111, 1etjB, 0.7981, 1.59, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
112, 5azuB, 0.7980, 1.62, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
113, 3ft0B, 0.7980, 1.78, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
114, 2gi0B, 0.7980, 1.76, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
115, 1jvoL, 0.7980, 1.60, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
116, 1jvoJ, 0.7980, 1.59, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
117, 1e67D, 0.7980, 1.58, 0.139, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
118, 4mfhC, 0.7979, 1.73, 0.146, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
119, 4ko9D, 0.7979, 1.72, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
120, 3ugeA, 0.7979, 1.58, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
121, 3jtbD, 0.7979, 1.55, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
122, 1jvoG, 0.7979, 1.60, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
123, 4ko9A, 0.7978, 1.72, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
124, 4ko7B, 0.7978, 1.72, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
125, 1jvlB, 0.7978, 1.74, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
126, 1jvlA, 0.7978, 1.74, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
127, 1e65A, 0.7978, 1.58, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
128, 1e5yA, 0.7978, 1.59, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
129, 6gyiB, 0.7977, 1.60, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
130, 2tsbB, 0.7977, 1.59, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
131, 6mjtB, 0.7976, 1.58, 0.164, 128, 122, AZURIN 122F/124W/126RE 
132, 1jvoF, 0.7976, 1.60, 0.139, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
133, 4azuA, 0.7975, 1.58, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
134, 2ghzB, 0.7975, 1.77, 0.146, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
135, 1azrD, 0.7975, 1.58, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
136, 3iboB, 0.7974, 1.73, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
137, 1i53A, 0.7974, 1.77, 0.146, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
138, 6mjrA, 0.7973, 1.81, 0.163, 128, 123, AZURIN 122W/124F/126RE 
139, 3iboC, 0.7973, 1.70, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
140, 3ft0A, 0.7973, 1.78, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
141, 3fszB, 0.7973, 1.78, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
142, 1nzrA, 0.7973, 1.59, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
143, 1ezlA, 0.7972, 1.58, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
144, 1ag0B, 0.7972, 1.72, 0.138, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
145, 1ag0A, 0.7972, 1.72, 0.138, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
146, 1etjC, 0.7971, 1.60, 0.131, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
147, 4jknA, 0.7970, 1.58, 0.148, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
148, 4azuB, 0.7969, 1.62, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
149, 1jvoK, 0.7969, 1.61, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
150, 1ilsA, 0.7969, 1.60, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
151, 1e5yB, 0.7969, 1.63, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
152, 1a4cC, 0.7969, 1.77, 0.171, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
153, 2i7sD, 0.7968, 1.73, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
154, 1vlxB, 0.7968, 1.62, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
155, 1uatA, 0.7968, 1.86, 0.194, 129, 124, THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ-ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J
156, 1a4aB, 0.7968, 1.84, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
157, 6mjsA, 0.7967, 1.71, 0.163, 128, 123, AZURIN 122W/124W/126RE 
158, 4ko7D, 0.7967, 1.69, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
159, 3u25A, 0.7967, 1.61, 0.148, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
160, 1iluI, 0.7967, 1.62, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
161, 1iluD, 0.7967, 1.62, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
162, 1ilsB, 0.7967, 1.62, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
163, 1e67A, 0.7967, 1.60, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
164, 6mjrC, 0.7965, 1.62, 0.156, 128, 122, AZURIN 122W/124F/126RE 
165, 2i7sC, 0.7965, 1.73, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
166, 4qlwB, 0.7964, 1.82, 0.138, 128, 123, AZURIN MUTANT M121E WITH IRON
167, 4hz1C, 0.7964, 1.63, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
168, 3fpyA, 0.7963, 1.73, 0.122, 128, 123, AZURIN C112D/M121L
169, 1vlxA, 0.7963, 1.59, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
170, 5i28J, 0.7962, 1.74, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
171, 4jknB, 0.7962, 1.83, 0.146, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
172, 3fq1A, 0.7962, 1.74, 0.130, 128, 123, AZURIN C112D/M121I
173, 1bexB, 0.7962, 1.83, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
174, 6gyiD, 0.7961, 1.59, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
175, 5i28H, 0.7961, 1.76, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
176, 4kobC, 0.7961, 1.72, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
177, 4ko9C, 0.7961, 1.74, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
178, 1xb8C, 0.7961, 1.51, 0.140, 126, 121, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
179, 1xb6A, 0.7961, 1.73, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
180, 1etjA, 0.7961, 1.61, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
181, 1e67B, 0.7961, 1.63, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
182, 1bexA, 0.7960, 1.84, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
183, 4qlwC, 0.7959, 1.60, 0.148, 128, 122, AZURIN MUTANT M121E WITH IRON
184, 3jt2B, 0.7959, 1.60, 0.131, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
185, 1ezlB, 0.7959, 1.64, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
186, 3ugeB, 0.7958, 1.63, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
187, 5i28G, 0.7957, 1.74, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
188, 4kobB, 0.7957, 1.74, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
189, 4jknD, 0.7957, 1.61, 0.148, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
190, 1iluB, 0.7957, 1.62, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
191, 3iboD, 0.7956, 1.75, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
192, 5i28P, 0.7955, 1.77, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
193, 5i26A, 0.7955, 1.74, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM I
194, 1iluE, 0.7955, 1.62, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
195, 1xb8A, 0.7954, 1.64, 0.148, 127, 122, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
196, 1iluK, 0.7954, 1.65, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
197, 1e65B, 0.7954, 1.64, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
198, 3jt2A, 0.7953, 1.61, 0.148, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
199, 3fswD, 0.7953, 1.60, 0.148, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
200, 4mfhA, 0.7952, 1.74, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
201, 3iboA, 0.7952, 1.73, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
202, 1nzrB, 0.7952, 1.65, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
203, 1a4bB, 0.7952, 1.85, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
204, 2i7sB, 0.7951, 1.72, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
205, 1iluM, 0.7951, 1.63, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
206, 1etjD, 0.7951, 1.62, 0.131, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
207, 1azrA, 0.7950, 1.60, 0.148, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
208, 1aznA, 0.7949, 1.62, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
209, 4ko9B, 0.7948, 1.74, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
210, 1i53B, 0.7948, 1.76, 0.146, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
211, 1aznC, 0.7946, 1.61, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
212, 5i28A, 0.7944, 1.77, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
213, 4kocA, 0.7944, 1.77, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I/Y108F)
214, 1joiA, 0.7944, 1.87, 0.138, 128, 123, STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN
215, 1ezlD, 0.7942, 1.69, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
216, 1azrB, 0.7942, 1.64, 0.148, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
217, 1iluF, 0.7940, 1.63, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
218, 5i28I, 0.7939, 1.80, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
219, 5i28E, 0.7939, 1.77, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
220, 6mjsB, 0.7937, 1.52, 0.165, 126, 121, AZURIN 122W/124W/126RE 
221, 4k9jA, 0.7937, 1.62, 0.156, 127, 122, STRUCTURE OF RE(CO)3(47-DIMETHYL-PHEN)(THR126HIS)(LYS122TRP) (HIS83GLU)(TRP48PHE)(TYR72PHE)(TYR108PHE)AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
222, 3np3A, 0.7937, 1.77, 0.138, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
223, 1aznB, 0.7937, 1.63, 0.156, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
224, 5i28D, 0.7936, 1.79, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
225, 1iluH, 0.7936, 1.66, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
226, 1iluC, 0.7935, 1.66, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
227, 5i28N, 0.7933, 1.79, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
228, 4bwwC, 0.7933, 1.81, 0.148, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
229, 5i28K, 0.7932, 1.80, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
230, 5i26B, 0.7932, 1.74, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM I
231, 3fqyA, 0.7932, 1.78, 0.138, 128, 123, AZURIN C112D
232, 6gyiA, 0.7931, 1.63, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
233, 5i28C, 0.7931, 1.81, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
234, 1r1cA, 0.7931, 1.65, 0.172, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
235, 4bwwB, 0.7930, 1.57, 0.140, 127, 121, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
236, 2fnwA, 0.7930, 1.76, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
237, 6iavB, 0.7929, 1.63, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
238, 3jtbC, 0.7928, 1.65, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
239, 4bwwA, 0.7927, 1.80, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
240, 2i7oA, 0.7925, 1.76, 0.146, 128, 123, STRUCTURE OF RE(47-DIMETHYL-PHEN)(THR124HIS)(LYS122TRP)(HIS83GLN) AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
241, 1iluA, 0.7925, 1.66, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
242, 5i28O, 0.7924, 1.80, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
243, 5i28B, 0.7924, 1.81, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
244, 1nwoB, 0.7924, 1.75, 0.146, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
245, 6mjsD, 0.7923, 1.54, 0.165, 126, 121, AZURIN 122W/124W/126RE 
246, 2i7sA, 0.7923, 1.76, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
247, 3jtbB, 0.7922, 1.62, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
248, 1nwpA, 0.7921, 1.72, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
249, 5i28M, 0.7919, 1.81, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
250, 2hxaB, 0.7919, 1.73, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
251, 1r1cD, 0.7918, 1.75, 0.171, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
252, 5i28F, 0.7917, 1.79, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
253, 1nwoA, 0.7917, 1.75, 0.146, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
254, 6iavD, 0.7915, 1.62, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
255, 3in0C, 0.7915, 1.66, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
256, 5i28L, 0.7914, 1.80, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
257, 1xb6B, 0.7914, 1.79, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
258, 3jtbA, 0.7913, 1.66, 0.139, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
259, 2iweA, 0.7913, 1.91, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
260, 1xb3B, 0.7913, 1.79, 0.146, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
261, 1nwpB, 0.7913, 1.73, 0.138, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
262, 1iluG, 0.7913, 1.68, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
263, 1iluL, 0.7911, 1.69, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
264, 3n2jL, 0.7910, 1.75, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
265, 2iweG, 0.7910, 1.90, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
266, 4bwwD, 0.7907, 1.58, 0.140, 127, 121, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
267, 3np4A, 0.7907, 1.79, 0.130, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
268, 4hz1B, 0.7906, 1.76, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
269, 3fswA, 0.7905, 1.65, 0.148, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
270, 2h47C, 0.7904, 1.82, 0.130, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 1)
271, 1ezlC, 0.7904, 1.98, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
272, 3n2jK, 0.7902, 1.74, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
273, 3fq2A, 0.7901, 1.80, 0.130, 128, 123, AZURIN C112D/M121F
274, 2iweD, 0.7901, 1.91, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
275, 2iweJ, 0.7900, 1.91, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
276, 1aznD, 0.7899, 1.68, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
277, 6mjtA, 0.7898, 1.68, 0.164, 128, 122, AZURIN 122F/124W/126RE 
278, 3n2jG, 0.7898, 1.74, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
279, 3n2jE, 0.7897, 1.76, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
280, 6mjrB, 0.7895, 1.73, 0.164, 128, 122, AZURIN 122W/124F/126RE 
281, 1azuA, 0.7895, 1.59, 0.149, 126, 121, STRUCTURAL FEATURES OF AZURIN AT 2.7 ANGSTROMS RESOLUTION
282, 4wkxB, 0.7894, 1.80, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
283, 4qlwD, 0.7894, 1.70, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
284, 2iaaC, 0.7889, 1.85, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 2)
285, 2h3xC, 0.7889, 1.84, 0.122, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
286, 2h3xF, 0.7888, 1.85, 0.130, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
287, 6mjrD, 0.7886, 1.71, 0.164, 128, 122, AZURIN 122W/124F/126RE 
288, 1r1cB, 0.7884, 1.70, 0.172, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
289, 3n2jJ, 0.7883, 1.97, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
290, 3in0A, 0.7882, 1.71, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
291, 3in0D, 0.7877, 1.69, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
292, 3n2jB, 0.7875, 1.97, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
293, 2fnwB, 0.7875, 1.68, 0.148, 128, 122, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
294, 3n2jC, 0.7873, 1.98, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
295, 6mjsC, 0.7871, 1.54, 0.167, 125, 120, AZURIN 122W/124W/126RE 
296, 3n2jD, 0.7871, 1.78, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
297, 4hhgA, 0.7870, 1.74, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN RUH107NO YOH109
298, 3n2jH, 0.7868, 1.76, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
299, 2hx8B, 0.7867, 1.78, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
300, 3n2jF, 0.7866, 1.78, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
301, 1cc3B, 0.7864, 2.06, 0.136, 130, 125, PURPLE CUA CENTER
302, 3n2jI, 0.7862, 1.97, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
303, 1r1cC, 0.7862, 1.77, 0.164, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
304, 2hxaA, 0.7861, 1.54, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
305, 2hx9A, 0.7860, 1.54, 0.158, 124, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
306, 3n2jA, 0.7858, 1.79, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
307, 3in0B, 0.7858, 1.70, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
308, 2hx7B, 0.7856, 1.79, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
309, 5i26D, 0.7852, 1.94, 0.139, 126, 122, AZURIN T30R1 CRYSTAL FORM I
310, 4hhwB, 0.7851, 1.79, 0.164, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
311, 1ov8C, 0.7849, 1.80, 0.187, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
312, 1ov8A, 0.7848, 1.80, 0.187, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
313, 3in2A, 0.7847, 1.71, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
314, 1ov8B, 0.7845, 1.80, 0.195, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
315, 2hx8A, 0.7842, 1.56, 0.158, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
316, 1ov8D, 0.7839, 1.81, 0.195, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
317, 1qhqA, 0.7838, 1.82, 0.187, 139, 123, AURACYANIN A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS
318, 2aanA, 0.7834, 1.60, 0.192, 123, 120, AURACYANIN A: A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUMCHLOROFLEXUS AURANTIACUS
319, 4hipB, 0.7833, 1.84, 0.164, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
320, 2hx9B, 0.7833, 1.86, 0.139, 125, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
321, 4hhwA, 0.7829, 1.70, 0.157, 127, 121, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
322, 4hipA, 0.7828, 1.80, 0.164, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
323, 5i26C, 0.7824, 1.52, 0.151, 124, 119, AZURIN T30R1 CRYSTAL FORM I
324, 3ay2B, 0.7822, 1.80, 0.123, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
325, 1cc3A, 0.7819, 2.19, 0.136, 130, 125, PURPLE CUA CENTER
326, 2hx7A, 0.7813, 1.59, 0.158, 125, 120, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
327, 3ay2A, 0.7807, 1.82, 0.123, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
328, 4wkxA, 0.7806, 1.90, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
329, 4qktB, 0.7791, 1.79, 0.140, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
330, 4qktA, 0.7769, 1.80, 0.140, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
331, 2n0mA, 0.7762, 1.97, 0.122, 130, 123, THE SOLUTION STRUCTURE OF THE SOLUBLE FORM OF THE LIPID-MODIFIED AZURIN FROM NEISSERIA GONORRHOEAE
332, 2ftaC, 0.7754, 1.64, 0.151, 124, 119, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
333, 3fswC, 0.7714, 1.64, 0.151, 124, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
334, 2ftaD, 0.7712, 1.48, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
335, 2ftaB, 0.7709, 1.61, 0.153, 123, 118, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
336, 2ftaA, 0.7689, 1.53, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
337, 3oqrA, 0.7683, 1.76, 0.134, 123, 119, C112D/M121E AZURIN PH 10.0
338, 2xv0A, 0.7677, 1.82, 0.142, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.8
339, 2xv2A, 0.7615, 1.91, 0.142, 124, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.2
340, 2ft7A, 0.7598, 1.64, 0.154, 122, 117, STRUCTURE OF CU(I)AZURIN AT PH 6 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
341, 2ft8A, 0.7595, 1.64, 0.154, 122, 117, STRUCTURE OF CU(I)AZURIN PH8 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
342, 2ft6A, 0.7595, 1.64, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
343, 3fs9A, 0.7585, 1.95, 0.133, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM)
344, 3fsaA, 0.7562, 1.92, 0.134, 122, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM); CHEMICALLY REDUCED.
345, 5yt7B, 0.7105, 1.65, 0.138, 132, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
346, 5yt7A, 0.7094, 1.73, 0.128, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
347, 5yt7C, 0.7090, 1.77, 0.128, 130, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
348, 5yt7D, 0.7083, 1.80, 0.119, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
349, 3fsvA, 0.6663, 2.24, 0.103, 118, 107, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAHAAAM)
350, 2avfE, 0.6478, 2.24, 0.233, 315, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
351, 2avfC, 0.6477, 2.23, 0.233, 316, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
352, 1ntdA, 0.6477, 2.23, 0.223, 336, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC
353, 5oboA, 0.6475, 2.25, 0.204, 456, 103, CRYSTAL STRUCTURE OF NITRITE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
354, 3zbmA, 0.6475, 2.26, 0.204, 455, 103, STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII
355, 1j9rB, 0.6475, 2.22, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
356, 6fjaA, 0.6474, 2.26, 0.204, 455, 103, CRYSTAL STRUCTURE OF T2D THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
357, 5ocbA, 0.6474, 2.24, 0.204, 453, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
358, 2yqbA, 0.6474, 2.25, 0.214, 454, 103, STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION
359, 1ndrB, 0.6474, 2.22, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
360, 1ndrA, 0.6474, 2.22, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
361, 1et7A, 0.6474, 2.24, 0.233, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6
362, 5ocfA, 0.6473, 2.24, 0.204, 455, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND TO THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
363, 1ndsA, 0.6473, 2.23, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
364, 1ndrC, 0.6473, 2.23, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
365, 1et8A, 0.6473, 2.24, 0.233, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS
366, 2b08B, 0.6472, 2.22, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
367, 2afnC, 0.6471, 2.24, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
368, 1ndsB, 0.6471, 2.23, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
369, 1j9tB, 0.6471, 2.23, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
370, 1j9rC, 0.6471, 2.23, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
371, 2afnA, 0.6470, 2.24, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
372, 1nibB, 0.6470, 2.24, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
373, 1ndsC, 0.6470, 2.23, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
374, 1mzzC, 0.6470, 2.24, 0.204, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
375, 1as8B, 0.6470, 2.23, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
376, 5d4iA, 0.6469, 2.24, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
377, 3ziyA, 0.6469, 2.26, 0.204, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE  FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION
378, 2ppaB, 0.6469, 2.23, 0.233, 337, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
379, 1npjB, 0.6469, 2.23, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
380, 1kcbA, 0.6469, 2.24, 0.233, 333, 103, CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION
381, 1l9oB, 0.6468, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
382, 1j9sB, 0.6468, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
383, 5f7bA, 0.6467, 2.24, 0.233, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
384, 3h56A, 0.6467, 2.24, 0.223, 335, 103, MET150LEU/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
385, 2nrdA, 0.6467, 2.24, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
386, 2afnB, 0.6467, 2.24, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
387, 1rzqB, 0.6467, 2.25, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
388, 1npnB, 0.6467, 2.23, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
389, 1l9rB, 0.6467, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
390, 1l9qB, 0.6467, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
391, 1l9pB, 0.6467, 2.23, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
392, 2ppdB, 0.6466, 2.23, 0.223, 337, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
393, 2fjsB, 0.6466, 2.23, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
394, 2ppaC, 0.6465, 2.23, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
395, 2pp9B, 0.6465, 2.23, 0.233, 337, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
396, 1nieA, 0.6465, 2.25, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
397, 1nicA, 0.6465, 2.25, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
398, 1nibC, 0.6465, 2.25, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
399, 1niaC, 0.6465, 2.25, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
400, 1j9tC, 0.6465, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
401, 5ue6F, 0.6464, 2.24, 0.214, 307, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
402, 5n8hA, 0.6464, 2.25, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 3.
403, 3h4hB, 0.6464, 2.24, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
404, 3h4fB, 0.6464, 2.23, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
405, 2vw6B, 0.6464, 2.24, 0.233, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
406, 2pp8B, 0.6464, 2.24, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
407, 2fjsC, 0.6464, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
408, 1aq8B, 0.6464, 2.24, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
409, 6f1qA, 0.6463, 2.27, 0.204, 456, 103, CRYSTAL STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII IN I213 SPACE GROUP 
410, 5ue6C, 0.6463, 2.24, 0.214, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
411, 5f7aA, 0.6463, 2.24, 0.233, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
412, 2vm4A, 0.6463, 2.25, 0.233, 334, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE IN SPACE GROUP R3 - 2 OF 2
413, 2ppfB, 0.6463, 2.24, 0.233, 337, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
414, 2e86B, 0.6463, 2.24, 0.233, 337, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
415, 1wa1X, 0.6463, 2.25, 0.233, 335, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
416, 1npjC, 0.6463, 2.23, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
417, 1nidA, 0.6463, 2.25, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
418, 1l9pC, 0.6463, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
419, 1l9oC, 0.6463, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
420, 1gs6X, 0.6463, 2.25, 0.223, 336, 103, CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
421, 5og6A, 0.6462, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.24MGY 
422, 5og3A, 0.6462, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
423, 5ofhA, 0.6462, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
424, 5i6pA, 0.6462, 2.25, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 27.60 MGY
425, 5f7bB, 0.6462, 2.24, 0.233, 337, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
426, 5f7aB, 0.6462, 2.24, 0.233, 337, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
427, 2vw4B, 0.6462, 2.24, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
428, 2vm3A, 0.6462, 2.25, 0.233, 333, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS IN SPACE GROUP R3 - 1 OF 2
429, 1snrC, 0.6462, 2.24, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
430, 1snrB, 0.6462, 2.24, 0.233, 337, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
431, 1rzqC, 0.6462, 2.25, 0.233, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
432, 1niaB, 0.6462, 2.25, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
433, 1l9tB, 0.6462, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
434, 1l9sB, 0.6462, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
435, 1l9rC, 0.6462, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
436, 1j9sC, 0.6462, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
437, 1hauA, 0.6462, 2.25, 0.233, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9 A RESOLUTION
438, 1as7B, 0.6462, 2.24, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
439, 6gcgA, 0.6461, 2.26, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE POLYMORPH DATASET 15 
440, 6gbbA, 0.6461, 2.25, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE CELL POLYMORPH DATASET 1 
441, 6gb8A, 0.6461, 2.25, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: SMALL CELL POLYMORPH DATASET 1 
442, 5onyA, 0.6461, 2.25, 0.233, 335, 103, AS-ISOLATED RESTING STATE COPPER NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
443, 5oggA, 0.6461, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.30MGY 
444, 5og5A, 0.6461, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.21MGY 
445, 5og4A, 0.6461, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.18MGY 
446, 5ofgA, 0.6461, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.06MGY 
447, 5n8gA, 0.6461, 2.25, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 2.
448, 5n8fA, 0.6461, 2.25, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 1.
449, 5d4jB, 0.6461, 2.25, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
450, 5d4iC, 0.6461, 2.25, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
451, 5d4iB, 0.6461, 2.24, 0.233, 341, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
452, 4ax3C, 0.6461, 2.27, 0.204, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
453, 2vw7A, 0.6461, 2.24, 0.233, 335, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
454, 2ppfC, 0.6461, 2.24, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
455, 2pp7B, 0.6461, 2.24, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
456, 1wa0X, 0.6461, 2.25, 0.233, 335, 103, CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
457, 1npnC, 0.6461, 2.24, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
458, 1l9sC, 0.6461, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
459, 1hawA, 0.6461, 2.25, 0.233, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION
460, 5ogfA, 0.6460, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.27MGY 
461, 5og2A, 0.6460, 2.25, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.09MGY 
462, 5d4hB, 0.6460, 2.25, 0.233, 341, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
463, 4ax3D, 0.6460, 2.27, 0.204, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
464, 2xwzA, 0.6460, 2.26, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
465, 2ppeB, 0.6460, 2.24, 0.223, 337, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
466, 2ppdC, 0.6460, 2.24, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
467, 2ppcC, 0.6460, 2.24, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
468, 2ppcB, 0.6460, 2.24, 0.233, 337, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
469, 2pp7C, 0.6460, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
470, 2jfcA, 0.6460, 2.26, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
471, 1sjmB, 0.6460, 2.24, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
472, 1l9qC, 0.6460, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
473, 1j9qB, 0.6460, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
474, 1gs8A, 0.6460, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF  MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
475, 1gs7A, 0.6460, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
476, 1as6B, 0.6460, 2.24, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
477, 5i6oA, 0.6459, 2.25, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 20.70 MGY
478, 4cszA, 0.6459, 2.26, 0.233, 335, 103, STRUCTURE OF F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS WITH NITRITE BOUND
479, 4cspF, 0.6459, 2.25, 0.233, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
480, 2xxfA, 0.6459, 2.25, 0.233, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
481, 2vw6A, 0.6459, 2.25, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
482, 2pp9C, 0.6459, 2.23, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
483, 2pp8C, 0.6459, 2.24, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
484, 2jfcF, 0.6459, 2.26, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
485, 2dv6D, 0.6459, 2.25, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
486, 2b08C, 0.6459, 2.24, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
487, 1rzpC, 0.6459, 2.26, 0.233, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
488, 1oe1A, 0.6459, 2.25, 0.233, 335, 103, ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
489, 1j9qC, 0.6459, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
490, 1et5A, 0.6459, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6
491, 1as8C, 0.6459, 2.24, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
492, 6gtjA, 0.6458, 2.25, 0.233, 333, 103, NEUTRON CRYSTAL STRUCTURE FOR COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.8 A RESOLUTION 
493, 5onxA, 0.6458, 2.25, 0.233, 335, 103, RESTING STATE COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY
494, 5f7bC, 0.6458, 2.25, 0.233, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
495, 2xxfB, 0.6458, 2.26, 0.233, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
496, 2xwzF, 0.6458, 2.26, 0.233, 334, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
497, 2ppeC, 0.6458, 2.24, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
498, 2p80B, 0.6458, 2.24, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
499, 1zdsC, 0.6458, 2.25, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
500, 1sjmC, 0.6458, 2.25, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
501, 1nifA, 0.6458, 2.26, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
502, 1nibA, 0.6458, 2.26, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
503, 1l9tC, 0.6458, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
504, 1kbvA, 0.6458, 2.23, 0.214, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
505, 1as6C, 0.6458, 2.24, 0.233, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
506, 6gtiA, 0.6457, 2.25, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.0 
507, 5ue6I, 0.6457, 2.24, 0.214, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
508, 5offA, 0.6457, 2.26, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.03MGY 
509, 5f7aC, 0.6457, 2.25, 0.233, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
510, 4yscB, 0.6457, 2.25, 0.233, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
511, 4cspA, 0.6457, 2.26, 0.233, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
512, 2zooA, 0.6457, 2.28, 0.214, 438, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM PSEUDOALTEROMONAS HALOPLANKTIS TAC125
513, 2xx1A, 0.6457, 2.25, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
514, 2vw4A, 0.6457, 2.25, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
515, 2e86C, 0.6457, 2.25, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
516, 1zdsB, 0.6457, 2.25, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
517, 1ndtA, 0.6457, 2.25, 0.233, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
518, 1n70A, 0.6457, 2.26, 0.214, 334, 103, THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES
519, 1j9tA, 0.6457, 2.24, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
520, 1as8A, 0.6457, 2.25, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
521, 1as7C, 0.6457, 2.24, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
522, 5i6nA, 0.6456, 2.25, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 11.73 MGY
523, 4yseB, 0.6456, 2.25, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
524, 4yscA, 0.6456, 2.25, 0.233, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
525, 2zonB, 0.6456, 2.25, 0.233, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
526, 2fjsA, 0.6456, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
527, 1waeA, 0.6456, 2.25, 0.233, 334, 103, CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
528, 1rzpB, 0.6456, 2.26, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
529, 1kbwC, 0.6456, 2.24, 0.214, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
530, 6gtlA, 0.6455, 2.25, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.0 
531, 6gtkA, 0.6455, 2.25, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.5 
532, 6gbyA, 0.6455, 2.26, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: NON- POLYMORPH SEPARATED DATASET 1 
533, 5tb7C, 0.6455, 2.25, 0.214, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
534, 5tb7B, 0.6455, 2.24, 0.214, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
535, 5tb7A, 0.6455, 2.24, 0.214, 312, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
536, 5d4hC, 0.6455, 2.25, 0.233, 339, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
537, 5b1kA, 0.6455, 2.26, 0.233, 334, 103, CRYSTAL STRUCTURE OF THE CHLORIDE-BOUND FORM OF BLUE COPPER NITRITE REDUCTASE
538, 2zonC, 0.6455, 2.26, 0.233, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
539, 2xwzD, 0.6455, 2.26, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
540, 2vw7B, 0.6455, 2.25, 0.233, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
541, 2p80C, 0.6455, 2.25, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
542, 2dv6F, 0.6455, 2.26, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
543, 1wa2X, 0.6455, 2.25, 0.233, 334, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND
544, 1oe2A, 0.6455, 2.25, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
545, 1kbwB, 0.6455, 2.24, 0.214, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
546, 6gtnA, 0.6454, 2.26, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.5 
547, 5i6lA, 0.6454, 2.26, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 2.76 MGY
548, 5i6kA, 0.6454, 2.25, 0.233, 334, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 0.69 MGY
549, 5d4hA, 0.6454, 2.26, 0.233, 337, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
550, 2xx1F, 0.6454, 2.25, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
551, 2xx0A, 0.6454, 2.26, 0.233, 335, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
552, 2jfcD, 0.6454, 2.26, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
553, 2bwdA, 0.6454, 2.26, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO
554, 2bw5A, 0.6454, 2.26, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
555, 1kbwA, 0.6454, 2.24, 0.214, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
556, 1bq5A, 0.6454, 2.26, 0.233, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051
557, 1aq8C, 0.6454, 2.24, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
558, 5ue6H, 0.6453, 2.25, 0.214, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
559, 5i6mA, 0.6453, 2.26, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 7.59 MGY
560, 5d4jC, 0.6453, 2.25, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
561, 5d4jA, 0.6453, 2.25, 0.233, 335, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
562, 4yscC, 0.6453, 2.26, 0.233, 335, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
563, 3h4fC, 0.6453, 2.25, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
564, 2xxgC, 0.6453, 2.25, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
565, 2xx0B, 0.6453, 2.26, 0.233, 336, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
566, 2ppeA, 0.6453, 2.25, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
567, 2bp0B, 0.6453, 2.25, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
568, 1rzqA, 0.6453, 2.26, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
569, 1oe3A, 0.6453, 2.27, 0.233, 335, 103, ATOMIC RESOLUTION STRUCTURE OF  HALF APO  NIR
570, 1kbwF, 0.6453, 2.24, 0.214, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
571, 1as7A, 0.6453, 2.25, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
572, 6gsqA, 0.6452, 2.26, 0.233, 333, 103, OXIDISED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
573, 5ue6E, 0.6452, 2.25, 0.214, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
574, 4ax3A, 0.6452, 2.27, 0.204, 456, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
575, 2y1aA, 0.6452, 2.26, 0.233, 332, 103, CRYSTAL STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH BOUND NO
576, 2ppdA, 0.6452, 2.25, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
577, 2ppaA, 0.6452, 2.24, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
578, 2pp8A, 0.6452, 2.25, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
579, 2dv6B, 0.6452, 2.27, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
580, 2dv6A, 0.6452, 2.26, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
581, 2a3tA, 0.6452, 2.26, 0.214, 328, 103, CU-CONTAINING NITRITE REDUCTASE
582, 1niaA, 0.6452, 2.27, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
583, 1mzzB, 0.6452, 2.27, 0.204, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
584, 1mzzA, 0.6452, 2.26, 0.204, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
585, 1kbwE, 0.6452, 2.24, 0.214, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
586, 5b1jA, 0.6451, 2.27, 0.233, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
587, 4ax3B, 0.6451, 2.28, 0.204, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
588, 2b08A, 0.6451, 2.25, 0.223, 335, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
589, 1npjA, 0.6451, 2.24, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
590, 1l9rA, 0.6451, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
591, 5ue6B, 0.6450, 2.25, 0.214, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
592, 3h4hC, 0.6450, 2.25, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
593, 2ppfA, 0.6450, 2.25, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
594, 2pp9A, 0.6450, 2.24, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
595, 1mzyA, 0.6450, 2.27, 0.214, 331, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE
596, 1l9pA, 0.6450, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
597, 1kbwD, 0.6450, 2.24, 0.214, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
598, 1kbvE, 0.6450, 2.24, 0.214, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
599, 1j9sA, 0.6450, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
600, 1j9rA, 0.6450, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
601, 1as6A, 0.6450, 2.25, 0.233, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
602, 4yseA, 0.6449, 2.26, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
603, 2dv6C, 0.6449, 2.26, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
604, 1kbvD, 0.6449, 2.24, 0.214, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
605, 6gt2A, 0.6448, 2.26, 0.233, 333, 103, REDUCED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
606, 6gt0A, 0.6448, 2.26, 0.233, 333, 103, NITRITE-BOUND COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
607, 3h4fA, 0.6448, 2.25, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
608, 2ppcA, 0.6448, 2.25, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
609, 2pp7A, 0.6448, 2.26, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
610, 2dwtA, 0.6448, 2.27, 0.214, 329, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 6.0 WITH BOUND NITRITE
611, 2dv6E, 0.6448, 2.26, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
612, 1snrA, 0.6448, 2.26, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
613, 1l9oA, 0.6448, 2.26, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
614, 1j9qA, 0.6448, 2.25, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
615, 2bp8B, 0.6447, 2.26, 0.223, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
616, 1zdqB, 0.6447, 2.26, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
617, 1npnA, 0.6447, 2.25, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
618, 1l9tA, 0.6447, 2.26, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
619, 1l9sA, 0.6447, 2.26, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
620, 5ofdA, 0.6446, 2.27, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
621, 5ofcA, 0.6446, 2.27, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 21.65MGY 
622, 2zonA, 0.6446, 2.26, 0.233, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
623, 2xxgA, 0.6446, 2.26, 0.233, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
624, 2xwzE, 0.6446, 2.26, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
625, 2vn3A, 0.6446, 2.26, 0.233, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
626, 2bw4A, 0.6446, 2.26, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
627, 2bo0A, 0.6446, 2.28, 0.223, 335, 103, CRYSTAL STRUCTURE OF THE C130A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
628, 1sjmA, 0.6446, 2.26, 0.233, 335, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
629, 1kbvB, 0.6446, 2.24, 0.214, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
630, 2e86A, 0.6445, 2.26, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
631, 1zdqC, 0.6445, 2.26, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
632, 1rzpA, 0.6445, 2.27, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
633, 1l9qA, 0.6445, 2.26, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
634, 1kbvF, 0.6445, 2.25, 0.214, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
635, 1kbvC, 0.6445, 2.25, 0.214, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
636, 1e30A, 0.6445, 2.22, 0.152, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
637, 1aq8A, 0.6445, 2.25, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
638, 5of8A, 0.6444, 2.27, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
639, 3h4hA, 0.6444, 2.26, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
640, 2p80A, 0.6444, 2.26, 0.233, 335, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
641, 5of7A, 0.6443, 2.27, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
642, 5b1jB, 0.6443, 2.26, 0.233, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
643, 2xwzB, 0.6443, 2.28, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
644, 2dwsA, 0.6443, 2.27, 0.214, 328, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 8.4 WITH BOUND NITRITE
645, 2bp0A, 0.6443, 2.27, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
646, 2dy2A, 0.6442, 2.28, 0.214, 329, 103, NITRITE REDUCTASE PH 6.0
647, 1zv2A, 0.6442, 2.27, 0.214, 328, 103, CU-CONTAINING NITRITE REDUCTASE
648, 5ofeA, 0.6441, 2.28, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
649, 5akrA, 0.6441, 2.27, 0.233, 337, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE BOUND STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE AT 0.87 A RESOLUTION
650, 2jfcB, 0.6441, 2.27, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
651, 5ue6D, 0.6440, 2.26, 0.214, 309, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
652, 5of6A, 0.6440, 2.27, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
653, 2jfcE, 0.6440, 2.27, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
654, 2bp8A, 0.6440, 2.27, 0.223, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
655, 2bwiA, 0.6439, 2.27, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
656, 5n8iA, 0.6438, 2.27, 0.233, 334, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 100K REFERENCE DATASET.
657, 1zdsA, 0.6438, 2.27, 0.223, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
658, 5ue6G, 0.6437, 2.26, 0.214, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
659, 4knsB, 0.6437, 2.13, 0.206, 285, 102, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
660, 2jfcC, 0.6437, 2.27, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
661, 4knuD, 0.6436, 2.13, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
662, 2xwzC, 0.6433, 2.28, 0.233, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
663, 1zdqA, 0.6433, 2.27, 0.223, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
664, 4knsC, 0.6432, 2.13, 0.206, 285, 102, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
665, 5ue6A, 0.6430, 2.26, 0.214, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
666, 4yseC, 0.6429, 2.27, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
667, 4knuB, 0.6429, 2.14, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
668, 5zl1D, 0.6428, 1.81, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
669, 5zl1C, 0.6428, 1.82, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
670, 5zl1A, 0.6428, 1.82, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
671, 4knuC, 0.6428, 2.13, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
672, 4knsD, 0.6428, 2.14, 0.206, 285, 102, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
673, 5zl1B, 0.6425, 1.82, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
674, 4knuF, 0.6425, 2.14, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
675, 4knuA, 0.6425, 2.13, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
676, 4knsF, 0.6421, 2.15, 0.206, 285, 102, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
677, 4knsA, 0.6421, 2.14, 0.206, 285, 102, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
678, 2avfF, 0.6420, 2.56, 0.231, 323, 104, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
679, 4knuE, 0.6418, 2.15, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
680, 4kntA, 0.6418, 2.14, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
681, 2avfB, 0.6418, 2.16, 0.245, 316, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
682, 4kntC, 0.6417, 2.14, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
683, 4kntB, 0.6416, 2.14, 0.206, 285, 102, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
684, 4knsE, 0.6416, 2.16, 0.206, 285, 102, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
685, 2xx1D, 0.6416, 2.33, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
686, 5of5A, 0.6413, 2.30, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 
687, 1a8zA, 0.6406, 2.28, 0.173, 153, 104, STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS
688, 1a3zA, 0.6404, 2.31, 0.163, 150, 104, REDUCED RUSTICYANIN AT 1.9 ANGSTROMS
689, 1e30B, 0.6402, 2.36, 0.163, 153, 104, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
690, 2xx1E, 0.6400, 2.35, 0.233, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
691, 2cakA, 0.6399, 2.29, 0.173, 154, 104, 1.27ANGSTROM STRUCTURE OF RUSTICYANIN FROM THIOBACILLUS FERROOXIDANS
692, 1gy2B, 0.6399, 2.28, 0.163, 155, 104, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
693, 1rcyA, 0.6396, 2.31, 0.163, 151, 104, RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS
694, 1gy1B, 0.6396, 2.37, 0.163, 154, 104, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
695, 2calA, 0.6393, 2.34, 0.154, 153, 104, CRYSTAL STRUCTURE OF HIS143MET RUSTICYANIN
696, 1gy1A, 0.6390, 2.30, 0.163, 154, 104, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
697, 2xx1B, 0.6389, 2.13, 0.235, 335, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
698, 2avfD, 0.6389, 2.26, 0.245, 320, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
699, 2xx1C, 0.6388, 2.13, 0.235, 334, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
700, 1gy2A, 0.6388, 2.35, 0.163, 155, 104, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
701, 4q89A, 0.6384, 2.76, 0.113, 501, 106, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
702, 4q8bA, 0.6377, 2.77, 0.113, 499, 106, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
703, 2bhfA, 0.6370, 2.77, 0.113, 504, 106, 3D STRUCTURE OF THE REDUCED FORM OF COTA
704, 1gskA, 0.6365, 2.78, 0.113, 502, 106, CRYSTAL STRUCTURE OF COTA AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS
705, 2x87A, 0.6364, 2.77, 0.113, 504, 106, CRYSTAL STRUCTURE OF THE RECONSTITUTED COTA
706, 1w6wA, 0.6363, 2.77, 0.113, 502, 106, 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE
707, 1of0A, 0.6362, 2.77, 0.113, 502, 106, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS
708, 2x88A, 0.6361, 2.78, 0.113, 504, 106, CRYSTAL STRUCTURE OF HOLOCOTA
709, 1w8eA, 0.6361, 2.78, 0.113, 505, 106, 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE
710, 4akqA, 0.6360, 2.78, 0.113, 505, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498D MUTANT
711, 4a67A, 0.6360, 2.79, 0.113, 504, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116E MUTANT
712, 4akpA, 0.6359, 2.78, 0.113, 504, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE:E498T MUTANT
713, 4akoA, 0.6359, 2.78, 0.113, 505, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498L MUTANT
714, 4a68A, 0.6359, 2.79, 0.113, 502, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116N MUTANT
715, 1w6lA, 0.6359, 2.78, 0.113, 503, 106, 3D STRUCTURE OF COTA INCUBATED WITH CUCL2
716, 5zlmA, 0.6358, 2.78, 0.113, 502, 106, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H491C MUTANT; PH 8.0 
717, 4yvuA, 0.6358, 2.78, 0.113, 506, 106, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME IN THE ACID CONDITION PH5.6
718, 5zljA, 0.6357, 2.78, 0.113, 503, 106, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME; PH8.0 
719, 4yvnA, 0.6357, 2.78, 0.113, 505, 106, CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH ABTS AT A NOVEL BINDING SITE
720, 5zllA, 0.6356, 2.77, 0.113, 503, 106, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493C MUTANT; PH 8.0 
721, 3zdwA, 0.6356, 2.78, 0.113, 502, 106, SUBSTRATE AND DIOXYGEN BINDING TO THE ENDOSPORE COAT LACCASE COTA FROM BACILLUS SUBTILIS
722, 2wsdA, 0.6355, 2.79, 0.113, 504, 106, PROXIMAL MUTATIONS AT THE TYPE 1 CU SITE OF COTA-LACCASE: I494A MUTANT
723, 2avfA, 0.6355, 2.20, 0.248, 314, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
724, 4q8bB, 0.6348, 2.80, 0.113, 499, 106, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
725, 3wiaG, 0.6347, 2.38, 0.196, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
726, 4a66A, 0.6345, 2.62, 0.124, 501, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116A MUTANT
727, 5zlkA, 0.6342, 2.79, 0.113, 506, 106, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493A MUTANT; PH 8.0 
728, 4q89B, 0.6342, 2.80, 0.104, 499, 106, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
729, 3wiaA, 0.6339, 2.39, 0.196, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
730, 3wiaD, 0.6334, 2.18, 0.198, 273, 101, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
731, 3wiaB, 0.6331, 2.40, 0.196, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
732, 1qniE, 0.6331, 1.74, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
733, 1qniA, 0.6329, 1.74, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
734, 3x1gA, 0.6325, 2.40, 0.206, 296, 102, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS SHOWING TWO COORDINATION GEOMETRIES AT THE T2CU SITE
735, 1qniB, 0.6324, 1.75, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
736, 3x1fA, 0.6320, 2.41, 0.206, 296, 102, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
737, 1qniF, 0.6320, 1.76, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
738, 3wiaC, 0.6319, 2.20, 0.198, 273, 101, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
739, 3wiaF, 0.6318, 2.21, 0.198, 273, 101, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
740, 1qniD, 0.6318, 1.76, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
741, 1qniC, 0.6318, 1.76, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
742, 3x1nA, 0.6315, 2.41, 0.186, 298, 102, NITRITE-BOUND THERMOSTABLE COPPER NITRITE REDUCTASE AT 320 K
743, 3wiaH, 0.6314, 2.20, 0.198, 273, 101, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
744, 6iqzA, 0.6313, 2.53, 0.088, 535, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
745, 5zd6A, 0.6313, 2.53, 0.088, 535, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
746, 4ysrA, 0.6311, 2.41, 0.206, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.6 MGY
747, 4ystA, 0.6310, 2.42, 0.196, 294, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 24.9 MGY
748, 4yspA, 0.6310, 2.41, 0.206, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.32 MGY
749, 3wkqA, 0.6310, 2.41, 0.196, 299, 102, COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH FORMATE
750, 6iqyB, 0.6309, 2.51, 0.088, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
751, 5zd7B, 0.6309, 2.51, 0.088, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
752, 4yssA, 0.6309, 2.42, 0.196, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.7 MGY
753, 4ysqA, 0.6309, 2.41, 0.206, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.38 MGY
754, 4ysaA, 0.6309, 2.19, 0.198, 294, 101, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
755, 3wiaE, 0.6309, 2.21, 0.198, 273, 101, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
756, 4ysuA, 0.6308, 2.41, 0.206, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 25.0 MGY
757, 5ytnA, 0.6307, 2.42, 0.186, 298, 102, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH PEROXIDE 
758, 3x1eA, 0.6306, 2.41, 0.206, 295, 102, STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS WITHOUT CHLORIDE
759, 3wniA, 0.6305, 2.42, 0.206, 298, 102, 1.50 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
760, 5ytmA, 0.6304, 2.43, 0.196, 298, 102, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS DETERMINED BY IN-OUSE SOURCE 
761, 4ysoA, 0.6304, 2.41, 0.206, 295, 102, COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 0.064 MGY
762, 6iqxB, 0.6303, 2.52, 0.088, 535, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
763, 2xllD, 0.6303, 2.52, 0.088, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
764, 2xllC, 0.6303, 2.52, 0.088, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
765, 2xllB, 0.6303, 2.52, 0.088, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
766, 2xllA, 0.6303, 2.52, 0.088, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
767, 6iqyA, 0.6302, 2.52, 0.088, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
768, 6iqxA, 0.6302, 2.52, 0.088, 535, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
769, 5zd7A, 0.6302, 2.52, 0.088, 536, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
770, 5ytlA, 0.6302, 2.21, 0.198, 294, 101, CRYSTAL STRUCTURE OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE DETERMINED WITH AN ANAEROBICALLY MANIPULATED CRYSTAL 
771, 3wnjA, 0.6302, 2.42, 0.206, 298, 102, 1.20 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
772, 4zk8A, 0.6299, 2.21, 0.198, 294, 101, COPPER-CONTAINING NITRITE REDUCTASE FROM THERMOPHILIC BACTERIUM GEOBACILLUS THERMODENITRIFICANS (RE-REFINED)
773, 3wkpA, 0.6299, 2.42, 0.196, 295, 102, C135A MUTANT OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE IN COMPLEX WITH NITRITE
774, 3gdcB, 0.6291, 2.05, 0.172, 285, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
775, 6rkzB, 0.6289, 1.84, 0.235, 586, 98, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
776, 3gdcC, 0.6289, 2.04, 0.172, 286, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
777, 1fwxC, 0.6287, 1.81, 0.175, 590, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
778, 3gyrL, 0.6286, 2.74, 0.143, 587, 105, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
779, 3gdcA, 0.6284, 2.09, 0.172, 288, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
780, 1fwxA, 0.6282, 1.82, 0.175, 591, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
781, 5i5mA, 0.6281, 1.80, 0.155, 575, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
782, 3wiaI, 0.6278, 2.40, 0.198, 272, 101, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
783, 3gyrD, 0.6278, 2.75, 0.143, 587, 105, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
784, 5i5mB, 0.6276, 1.81, 0.155, 576, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
785, 1sddA, 0.6276, 2.69, 0.144, 268, 104, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
786, 3gyrJ, 0.6275, 2.74, 0.143, 587, 105, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
787, 3tasA, 0.6269, 2.31, 0.119, 300, 101, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
788, 2iwfA, 0.6268, 1.75, 0.187, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
789, 2iwfB, 0.6266, 1.74, 0.187, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
790, 2iwkA, 0.6264, 1.76, 0.187, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
791, 3tasC, 0.6262, 2.31, 0.119, 300, 101, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
792, 6rl0C, 0.6261, 1.83, 0.237, 582, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
793, 2iwkB, 0.6259, 1.76, 0.187, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
794, 4enzA, 0.6258, 2.76, 0.163, 1029, 104, STRUCTURE OF HUMAN CERULOPLASMIN AT 2.6 A RESOLUTION
795, 6rl0D, 0.6257, 1.83, 0.237, 581, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
796, 3tbbB, 0.6255, 2.31, 0.119, 278, 101, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
797, 6fc7C, 0.6252, 2.34, 0.139, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
798, 6rl0A, 0.6251, 1.84, 0.237, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
799, 6rl0B, 0.6248, 1.83, 0.237, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
800, 3kw8A, 0.6248, 2.33, 0.139, 273, 101, TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR AT 2.3 A RESOLUTION
801, 1fwxB, 0.6248, 1.78, 0.177, 589, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
802, 6rhqF, 0.6246, 2.34, 0.129, 276, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
803, 6fc7F, 0.6246, 2.33, 0.129, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
804, 5mkmC, 0.6245, 2.34, 0.129, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
805, 3tbbC, 0.6245, 2.33, 0.119, 277, 101, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
806, 3sbpF, 0.6244, 1.84, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
807, 3cg8B, 0.6244, 2.33, 0.139, 272, 101, LACCASE FROM STREPTOMYCES COELICOLOR
808, 6fc7J, 0.6243, 2.33, 0.129, 281, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
809, 3cg8C, 0.6243, 2.34, 0.139, 272, 101, LACCASE FROM STREPTOMYCES COELICOLOR
810, 1fwxD, 0.6242, 1.79, 0.177, 588, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
811, 4uahB, 0.6241, 2.32, 0.109, 271, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
812, 5lhlD, 0.6239, 2.35, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
813, 5lhlC, 0.6239, 2.36, 0.129, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
814, 6s0oB, 0.6238, 2.35, 0.129, 280, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
815, 5o4iA, 0.6238, 2.35, 0.139, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
816, 3sbpG, 0.6237, 1.85, 0.237, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
817, 6rhqB, 0.6236, 2.35, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
818, 5o4qA, 0.6236, 2.34, 0.139, 281, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
819, 5o4iG, 0.6236, 2.35, 0.129, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
820, 5mkmD, 0.6236, 2.35, 0.129, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
821, 3sbrE, 0.6236, 1.84, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
822, 3cg8A, 0.6236, 2.36, 0.139, 270, 101, LACCASE FROM STREPTOMYCES COELICOLOR
823, 3sbqA, 0.6235, 1.85, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
824, 5o4qD, 0.6234, 2.35, 0.139, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
825, 3sbrF, 0.6234, 1.86, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
826, 6s0oD, 0.6233, 2.35, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
827, 6s0oC, 0.6233, 2.34, 0.129, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
828, 6fdjD, 0.6233, 2.33, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
829, 3sbpE, 0.6233, 1.85, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
830, 6rkzA, 0.6232, 1.84, 0.237, 586, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
831, 5o4iL, 0.6232, 2.35, 0.139, 280, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
832, 5o4iK, 0.6231, 2.35, 0.139, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
833, 3sbqB, 0.6231, 1.85, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
834, 6rhqA, 0.6230, 2.36, 0.129, 282, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
835, 5mkmA, 0.6230, 2.36, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
836, 3sbpH, 0.6230, 1.85, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
837, 6fdjJ, 0.6229, 2.35, 0.129, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
838, 5o4qC, 0.6229, 2.37, 0.139, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
839, 4uanC, 0.6229, 2.34, 0.119, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
840, 4wtqB, 0.6228, 2.34, 0.119, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
841, 4wtqA, 0.6228, 2.34, 0.119, 270, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
842, 5o4iF, 0.6227, 2.35, 0.129, 277, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
843, 4w1tB, 0.6227, 2.34, 0.119, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
844, 3sbpD, 0.6227, 1.86, 0.237, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
845, 4nb7A, 0.6226, 2.35, 0.139, 280, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 180 MIN SOAKING
846, 3sbrD, 0.6226, 1.86, 0.237, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
847, 4uahA, 0.6225, 2.33, 0.119, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
848, 4bdvA, 0.6225, 2.65, 0.135, 612, 104, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
849, 3sbrA, 0.6225, 1.89, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
850, 6fdjA, 0.6224, 2.35, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
851, 5o4qF, 0.6224, 2.36, 0.139, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
852, 3sbrG, 0.6224, 1.87, 0.237, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
853, 3sbpA, 0.6222, 1.88, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
854, 5o4qL, 0.6221, 2.37, 0.139, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
855, 5o4iI, 0.6221, 2.37, 0.129, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
856, 5o4iD, 0.6221, 2.37, 0.129, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
857, 6rh9C, 0.6219, 2.35, 0.139, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
858, 5mkmE, 0.6219, 2.36, 0.129, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
859, 3sbpB, 0.6219, 1.88, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
860, 5lhlE, 0.6218, 2.37, 0.129, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
861, 4w1tA, 0.6218, 2.35, 0.119, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
862, 5o3kH, 0.6217, 2.35, 0.139, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
863, 1curA, 0.6217, 2.51, 0.171, 155, 105, REDUCED RUSTICYANIN NMR
864, 5o4iH, 0.6216, 2.37, 0.139, 277, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
865, 5o3kC, 0.6216, 2.35, 0.129, 277, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
866, 5lhlA, 0.6216, 2.37, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
867, 4wtqC, 0.6216, 2.34, 0.119, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
868, 3sbpC, 0.6214, 1.87, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
869, 3sbrH, 0.6213, 1.86, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
870, 4m3hA, 0.6212, 2.36, 0.119, 269, 101, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
871, 6rhqC, 0.6211, 2.37, 0.129, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
872, 3sbrC, 0.6210, 1.88, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
873, 6fc7K, 0.6209, 2.38, 0.129, 282, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
874, 3tbcA, 0.6208, 2.36, 0.129, 279, 101, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
875, 3t9wA, 0.6208, 2.36, 0.149, 270, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116
876, 6rh9A, 0.6207, 2.37, 0.139, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
877, 3ta4D, 0.6207, 2.36, 0.149, 273, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
878, 2fqdA, 0.6206, 2.73, 0.118, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
879, 5lhlF, 0.6205, 2.39, 0.129, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
880, 4e9xC, 0.6203, 2.49, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA3)
881, 3sbrB, 0.6203, 1.88, 0.237, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
882, 6fdjE, 0.6202, 2.37, 0.129, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
883, 4uahC, 0.6202, 2.35, 0.109, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
884, 4m3hB, 0.6202, 2.37, 0.119, 269, 101, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
885, 4e9yC, 0.6202, 2.49, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA4)
886, 4e9wC, 0.6202, 2.48, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA2)
887, 4w1tC, 0.6201, 2.36, 0.119, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
888, 4uanA, 0.6200, 2.36, 0.119, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
889, 4e9vC, 0.6199, 2.48, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA1)
890, 2zwnC, 0.6198, 2.49, 0.188, 316, 101, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
891, 2fqfA, 0.6197, 2.72, 0.118, 465, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
892, 2r7eA, 0.6196, 2.74, 0.135, 693, 104, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
893, 2fqgA, 0.6196, 2.72, 0.118, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
894, 5b7mC, 0.6195, 2.74, 0.118, 462, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
895, 4uanB, 0.6195, 2.79, 0.117, 270, 103, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
896, 2zwnA, 0.6195, 2.51, 0.188, 317, 101, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
897, 6fdjL, 0.6194, 2.37, 0.139, 276, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
898, 5b7mB, 0.6194, 2.74, 0.118, 464, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
899, 4e9yA, 0.6194, 2.52, 0.188, 317, 101, MULTICOPPER OXIDASE MGLAC (DATA4)
900, 4e9xA, 0.6194, 2.52, 0.188, 317, 101, MULTICOPPER OXIDASE MGLAC (DATA3)
901, 3pauA, 0.6194, 2.72, 0.118, 464, 102, CUEO IN THE RESTING OXIDIZED STATE
902, 2fqeA, 0.6194, 2.74, 0.118, 463, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
903, 5mkmB, 0.6193, 2.39, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
904, 5lhlB, 0.6193, 2.39, 0.129, 278, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
905, 4e9wA, 0.6193, 2.52, 0.188, 317, 101, MULTICOPPER OXIDASE MGLAC (DATA2)
906, 4e9vA, 0.6193, 2.53, 0.188, 317, 101, MULTICOPPER OXIDASE MGLAC (DATA1)
907, 5b7eA, 0.6190, 2.74, 0.118, 477, 102, STRUCTURE OF PERDEUTERATED CUEO
908, 4n8uC, 0.6190, 2.38, 0.129, 275, 101, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
909, 5o3kL, 0.6189, 2.38, 0.129, 276, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
910, 3ta4E, 0.6188, 2.39, 0.149, 267, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
911, 3pavA, 0.6188, 2.93, 0.117, 466, 103, THE REDUCED FORM OF CUEO
912, 3nscA, 0.6188, 2.90, 0.117, 470, 103, C500S MUTANT OF CUEO BOUND TO CU(II)
913, 1n68A, 0.6188, 2.75, 0.118, 464, 102, COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO
914, 6hbeC, 0.6187, 2.41, 0.230, 427, 100, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
915, 5n0kA, 0.6186, 2.40, 0.190, 1034, 100, RAT CERULOPLASMIN ORTHORHOMBIC FORM
916, 6rh9L, 0.6185, 2.39, 0.139, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
917, 3g5wA, 0.6185, 2.50, 0.158, 318, 101, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
918, 4hakA, 0.6184, 2.91, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO MUTANT E506A
919, 2uxtA, 0.6183, 2.63, 0.098, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
920, 6hbeA, 0.6182, 2.42, 0.230, 425, 100, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
921, 6hbeB, 0.6181, 2.42, 0.230, 425, 100, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
922, 3nsfA, 0.6181, 2.74, 0.118, 480, 102, APO FORM OF THE MULTICOPPER OXIDASE CUEO
923, 5b7mA, 0.6180, 2.93, 0.117, 463, 103, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
924, 4halA, 0.6180, 2.92, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO MUTANT E506I
925, 4e9tA, 0.6180, 2.92, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO (DATA6)
926, 2yxwA, 0.6180, 2.91, 0.117, 440, 103, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
927, 4e9rA, 0.6179, 2.92, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO (DATA4)
928, 4nerA, 0.6178, 2.92, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO (DATA1)
929, 4e9sA, 0.6178, 2.92, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO (DATA5)
930, 4e9qA, 0.6178, 2.92, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO (DATA2)
931, 3uaeA, 0.6178, 2.91, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA6)
932, 3od3A, 0.6178, 2.91, 0.117, 488, 103, CUEO AT 1.1 A RESOLUTION INCLUDING RESIDUES IN PREVIOUSLY DISORDERED REGION
933, 3g5wE, 0.6178, 2.51, 0.158, 318, 101, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
934, 1pf3A, 0.6178, 2.91, 0.117, 463, 103, CRYSTAL STRUCTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO
935, 5ys5A, 0.6177, 2.79, 0.118, 457, 102, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT WITH SEVEN COPPER IONS 
936, 3uadA, 0.6177, 2.90, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA5)
937, 3uacA, 0.6177, 2.91, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA4)
938, 3uabA, 0.6175, 2.91, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA2)
939, 3uaaA, 0.6175, 2.91, 0.117, 476, 103, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA1)
940, 3qqxA, 0.6175, 2.92, 0.117, 474, 103, REDUCED NATIVE INTERMEDIATE OF THE MULTICOPPER OXIDASE CUEO
941, 1kv7A, 0.6175, 2.76, 0.118, 463, 102, CRYSTAL STRUCTURE OF CUEO A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS
942, 5ys1A, 0.6174, 2.79, 0.118, 461, 102, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT 
943, 3nt0A, 0.6174, 2.92, 0.117, 468, 103, C500S (T1D) MUTANT OF CUEO SOAKED IN AND BOUND TO CU(I)
944, 1kcwA, 0.6174, 2.41, 0.180, 1017, 100, X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS
945, 6rh9E, 0.6173, 2.40, 0.139, 277, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
946, 3t6zC, 0.6171, 3.01, 0.135, 495, 104, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
947, 3nsyA, 0.6170, 2.76, 0.118, 465, 102, THE MULTI-COPPER OXIDASE CUEO WITH SIX MET TO SER MUTATIONS (M358S M361SM362SM364SM366SM368S)
948, 3t6xA, 0.6169, 3.01, 0.144, 495, 104, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
949, 3t6wA, 0.6169, 3.01, 0.144, 495, 104, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
950, 1aspA, 0.6169, 2.59, 0.178, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
951, 1asoA, 0.6169, 2.25, 0.182, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
952, 1asqA, 0.6168, 2.25, 0.182, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
953, 5n4lA, 0.6167, 2.49, 0.178, 1034, 101, RAT CERULOPLASMIN TRIGONAL FORM
954, 3nsdA, 0.6167, 2.93, 0.117, 462, 103, SILVER BOUND TO THE MULTICOPPER OXIDASE CUEO (UNTAGGED)
955, 3g5wC, 0.6167, 2.52, 0.158, 318, 101, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
956, 6im8A, 0.6166, 2.77, 0.118, 469, 102, CUEO-PM2 MULTICOPPER OXIDASE 
957, 3g5wF, 0.6166, 2.52, 0.158, 318, 101, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
958, 3g5wD, 0.6166, 2.52, 0.158, 318, 101, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
959, 2zwnB, 0.6166, 2.56, 0.188, 316, 101, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
960, 1aspB, 0.6166, 2.59, 0.178, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
961, 5gnoA, 0.6165, 2.78, 0.118, 463, 102, STRUCTURE OF MULTICOPPER OXIDASE CUEO - SIGNAL PEPTIDE-FREE
962, 5b7fA, 0.6165, 2.78, 0.118, 463, 102, STRUCTURE OF CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
963, 2j5wA, 0.6163, 2.41, 0.180, 1029, 100, CERULOPLASMIN REVISITED: STRUCTURAL AND FUNCTIONAL ROLES OF VARIOUS METAL CATION BINDING SITES
964, 1aozB, 0.6163, 2.03, 0.184, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
965, 3abgA, 0.6162, 2.67, 0.078, 508, 102, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
966, 3kw7A, 0.6161, 2.97, 0.135, 502, 104, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
967, 3g5wB, 0.6161, 2.52, 0.158, 318, 101, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
968, 1asqB, 0.6161, 2.03, 0.184, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
969, 1asoB, 0.6161, 2.03, 0.184, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
970, 4e9xB, 0.6160, 2.56, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA3)
971, 4ef3A, 0.6159, 2.97, 0.117, 466, 103, MULTICOPPER OXIDASE CUEO (CITRATE BUFFER)
972, 4e9yB, 0.6159, 2.56, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA4)
973, 5i5iB, 0.6158, 1.44, 0.161, 537, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
974, 4n8uB, 0.6158, 2.41, 0.129, 276, 101, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
975, 5z1xA, 0.6157, 2.85, 0.146, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
976, 5o4iJ, 0.6157, 2.82, 0.126, 279, 103, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
977, 2uxtB, 0.6157, 2.76, 0.098, 420, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
978, 3kw7B, 0.6156, 2.99, 0.135, 502, 104, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
979, 1aozA, 0.6156, 2.04, 0.184, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
980, 6rilA, 0.6155, 2.73, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTEENTH STRUCTURE OF THE SERIES WITH 5600 KGY DOSE (DATA WAS COLLECTED AFTER REFREEZING). 
981, 4e9wB, 0.6155, 2.56, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA2)
982, 4e9vB, 0.6155, 2.56, 0.188, 316, 101, MULTICOPPER OXIDASE MGLAC (DATA1)
983, 2yxwB, 0.6155, 2.76, 0.118, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
984, 2yxvA, 0.6155, 2.78, 0.118, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
985, 4m3hC, 0.6154, 2.83, 0.117, 270, 103, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
986, 6rhrA, 0.6153, 2.73, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
987, 2yxvB, 0.6153, 2.76, 0.118, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
988, 6rghA, 0.6152, 2.73, 0.137, 499, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
989, 5mhyA, 0.6151, 2.73, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SEVENTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 183 MIN.
990, 3j2qA, 0.6151, 2.86, 0.143, 630, 105, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
991, 3cdzA, 0.6151, 2.86, 0.143, 630, 105, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
992, 1v10A, 0.6151, 2.87, 0.126, 487, 103, STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS
993, 5mejA, 0.6150, 2.73, 0.137, 499, 102, STRUCTURAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. FIRST STRUCTURE OF THE SERIES WITH 3 MIN TOTAL X-RAY EXPOSITION TIME.
994, 4ejxA, 0.6150, 2.27, 0.170, 1034, 100, STRUCTURE OF CERULOPLASMIN-MYELOPEROXIDASE COMPLEX
995, 3t6zA, 0.6150, 2.74, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
996, 6s0oE, 0.6149, 2.83, 0.126, 278, 103, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
997, 6im9A, 0.6149, 2.48, 0.130, 490, 100, MDM2 BOUND CUEO-PM2 SENSOR 
998, 5mhuA, 0.6149, 2.73, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE THIRD STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 63 MIN.
999, 5mewA, 0.6149, 2.73, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. SECOND STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 33 MIN.
1000, 3t6vA, 0.6149, 2.73, 0.137, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1001, 6rikA, 0.6147, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRTEENTH STRUCTURE OF THE SERIES WITH 5200 KGY DOSE. 
1002, 3t6xC, 0.6146, 2.75, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1003, 6ri2A, 0.6144, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
1004, 6rhpA, 0.6144, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTY FIRST STRUCTURE OF THE SERIES WITH 4415 KGY DOSE (COLLECTED AFTER REFREEZING). 
1005, 6rhoA, 0.6144, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
1006, 3t71A, 0.6144, 2.74, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1007, 6riiA, 0.6143, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTH STRUCTURE OF THE SERIES WITH 1200 KGY DOSE. 
1008, 6ri4A, 0.6143, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 13 KGY DOSE. 
1009, 6evgA, 0.6143, 2.61, 0.109, 444, 101, STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF A BACTERIAL LACCASE-LIKE MULTI-COPPER OXIDASE CUEO FROM LIGNIN-DEGRADING BACTERIUM OCHROBACTRUM SP. WITH OXIDASE ACTIVITY TOWARDS LIGNIN MODEL COMPOUNDS AND LIGNOSULFONATE 
1010, 6ri8A, 0.6142, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 800 KGY DOSE. 
1011, 6ri6A, 0.6142, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 400 KGY DOSE. 
1012, 6ri0A, 0.6142, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
1013, 6rhuA, 0.6142, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
1014, 6rhiA, 0.6142, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
1015, 6rhhA, 0.6142, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
1016, 6rgpA, 0.6142, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
1017, 5micA, 0.6142, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 13-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 363 MIN.
1018, 6rhxA, 0.6141, 2.55, 0.139, 497, 101, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
1019, 5migA, 0.6141, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 16-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 453 MIN. THE CRYSTAL WAS QUICK REFREEZING BEFORE THIS DATA COLLECTION.
1020, 5mieA, 0.6141, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 15-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 423 MIN.
1021, 5midA, 0.6141, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 14-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 393 MIN.
1022, 5miaA, 0.6140, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 11-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 303 MIN.
1023, 5mi2A, 0.6140, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 10-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 273 MIN.
1024, 5mi1A, 0.6140, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 9-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 243 MIN.
1025, 5mhxA, 0.6140, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SIXTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 153 MIN.
1026, 1kyaC, 0.6140, 2.85, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1027, 1kyaA, 0.6140, 2.85, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1028, 5mibA, 0.6139, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 12-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 333 MIN.
1029, 5mhzA, 0.6139, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 8-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 213 MIN.
1030, 5mhwA, 0.6139, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FIFTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 123 MIN.
1031, 5mhvA, 0.6139, 2.55, 0.139, 499, 101, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FOURTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 93 MIN.
1032, 2uxvB, 0.6139, 2.67, 0.098, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
1033, 1kyaD, 0.6139, 2.85, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1034, 1kyaB, 0.6139, 2.85, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1035, 3t6vB, 0.6138, 2.58, 0.139, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1036, 3abgB, 0.6138, 2.69, 0.078, 518, 102, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1037, 5i5iA, 0.6137, 1.50, 0.161, 539, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
1038, 3t6vC, 0.6137, 2.57, 0.139, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1039, 5e9nA, 0.6136, 2.55, 0.139, 495, 101, STECCHERINUM MURASHKINSKYI LACCASE AT 0.95 RESOLUTION
1040, 3t6wC, 0.6135, 2.57, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1041, 3t6wB, 0.6135, 2.57, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1042, 5z22A, 0.6134, 2.56, 0.149, 494, 101, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
1043, 5z1xB, 0.6134, 2.56, 0.149, 495, 101, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
1044, 5n4lB, 0.6133, 2.45, 0.190, 1034, 100, RAT CERULOPLASMIN TRIGONAL FORM
1045, 3t6zB, 0.6132, 2.58, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
1046, 3zx1A, 0.6131, 2.38, 0.188, 471, 101, MULTICOPPER OXIDASE FROM CAMPYLOBACTER JEJUNI: A METALLO-OXIDASE
1047, 3t71B, 0.6131, 2.58, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1048, 3t71C, 0.6130, 2.58, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1049, 3t6xB, 0.6130, 2.58, 0.139, 495, 101, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1050, 3v9cA, 0.6127, 2.87, 0.107, 499, 103, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION
1051, 3pxlA, 0.6126, 2.88, 0.107, 499, 103, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA
1052, 5ehfA, 0.6125, 2.56, 0.119, 497, 101, LACCASE FROM ANTRODIELLA FAGINEA
1053, 3divA, 0.6125, 2.90, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.76A RESOLUTION
1054, 3ppsD, 0.6124, 2.75, 0.139, 564, 101, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1055, 3ppsA, 0.6124, 2.74, 0.139, 564, 101, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1056, 2r7eB, 0.6123, 2.18, 0.162, 644, 99, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1057, 2h5uA, 0.6122, 2.88, 0.126, 497, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION
1058, 3x1bB, 0.6121, 3.03, 0.096, 500, 104, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
1059, 3x1bA, 0.6119, 3.03, 0.096, 500, 104, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
1060, 3fpxA, 0.6117, 2.90, 0.107, 499, 103, NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA
1061, 4bdvB, 0.6115, 2.31, 0.162, 606, 99, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
1062, 4x4kA, 0.6109, 2.71, 0.140, 525, 100, STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT
1063, 2qt6B, 0.6105, 2.90, 0.136, 498, 103, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1064, 5k8dB, 0.6104, 2.33, 0.152, 619, 99, CRYSTAL STRUCTURE OF RFVIIIFC
1065, 2hzhA, 0.6100, 3.04, 0.135, 499, 104, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLUS ZONATUS AT 2.6 A RESOLUTION
1066, 1gycA, 0.6098, 2.91, 0.126, 499, 103, CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS
1067, 6im7A, 0.6097, 2.42, 0.121, 461, 99, CUEO-12.1 MULTICOPPER OXIDASE 
1068, 2uxvA, 0.6097, 2.64, 0.109, 422, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
1069, 2xybA, 0.6093, 2.60, 0.129, 497, 101, CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS
1070, 3fu9B, 0.6090, 2.86, 0.139, 559, 101, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1071, 5lduA, 0.6089, 2.60, 0.109, 499, 101, RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA
1072, 5lwxA, 0.6086, 2.23, 0.165, 554, 97, CRYSTAL STRUCTURE OF THE H253D MUTANT OF MCOG FROM ASPERGILLUS NIGER
1073, 5k5kA, 0.6085, 2.90, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASSE FROM THERMUS THERMOPHILUS HB27 (ASCORBIC ACID 10 MIN)
1074, 5jx9A, 0.6084, 2.91, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 5 MIN)
1075, 2qt6A, 0.6084, 2.61, 0.139, 498, 101, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1076, 5k84A, 0.6083, 2.91, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 10 MIN)
1077, 2yaoA, 0.6082, 2.91, 0.184, 437, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (50.0-62.5 PERCENT DOSE)
1078, 5jrrA, 0.6081, 2.89, 0.184, 439, 103, CRYSTAL STRUCTURE OF NATIVE LACCASE FROM THERMUS THERMOPHILUS HB27
1079, 5lm8A, 0.6080, 2.53, 0.152, 549, 99, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER
1080, 5k15A, 0.6080, 2.91, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU2PO 8 MIN)
1081, 5nq9A, 0.6079, 2.61, 0.119, 497, 101, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1082, 2yarA, 0.6079, 2.91, 0.184, 436, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (87.5-100.0 PERCENT DOSE)
1083, 2yapA, 0.6079, 2.91, 0.184, 437, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (62.5-75.0 PERCENT DOSE)
1084, 2yaeA, 0.6079, 2.91, 0.184, 438, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27(0.0-12.5 PERCENT DOSE)
1085, 5k7aA, 0.6078, 2.91, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FRON THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 1.5 MIN)
1086, 5k0dA, 0.6078, 2.92, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 3 MIN)
1087, 4jhvA, 0.6078, 2.94, 0.126, 496, 103, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA
1088, 4jhuA, 0.6077, 2.95, 0.126, 496, 103, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA SOAKED WITH CUCL
1089, 4a2dA, 0.6077, 2.95, 0.126, 495, 103, CORIOLOPSIS GALLICA LACCASE T2 COPPER DEPLETED AT PH  4.5
1090, 3fu8A, 0.6077, 2.69, 0.140, 558, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1091, 2yafA, 0.6077, 2.91, 0.184, 438, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (12.5-25.0 PERCENT DOSE)
1092, 2xu9A, 0.6077, 2.91, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27
1093, 5k3kA, 0.6076, 2.92, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CUSO4 20 MIN)
1094, 5g3dA, 0.6076, 2.92, 0.184, 438, 103, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CCASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1095, 5g3cA, 0.6076, 2.92, 0.184, 435, 103, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS TERMOPHILUS MULTICOPPER OXIDASE
1096, 4a2fA, 0.6076, 2.96, 0.126, 495, 103, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 12.65 KEV
1097, 2yaqA, 0.6076, 2.92, 0.184, 436, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (75.0-87.5 PERCENT DOSE)
1098, 2yahA, 0.6076, 2.91, 0.184, 436, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (25.0-37.5 PERCENT DOSE)
1099, 5g3eA, 0.6075, 2.92, 0.184, 437, 103, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1100, 5afaA, 0.6074, 2.90, 0.184, 439, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH AG CRYSTAL OF THE HOLOENZYME SOAKED FOR 30 M IN 5 MM AGNO3 AT 278 K.
1101, 4a2hA, 0.6074, 2.96, 0.126, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLOPSIS GALLICA PH 7.0
1102, 2yamA, 0.6072, 2.91, 0.184, 436, 103, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (37.5-50.0 PERCENT DOSE)
1103, 4a2gA, 0.6071, 2.96, 0.126, 495, 103, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 8.98 KEV
1104, 2hrgA, 0.6071, 2.95, 0.136, 496, 103, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE
1105, 2vmjA, 0.6070, 2.30, 0.227, 326, 97, TYPE 1 COPPER-BINDING LOOP OF NITRITE REDUCTASE MUTANT: 130- CAPEGMVPWHVVSGM-144 TO 130-CTPHPFM-136
1106, 5g3hA, 0.6069, 2.92, 0.184, 438, 103, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1107, 3qpkA, 0.6068, 2.80, 0.139, 559, 101, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1108, 2ih9A, 0.6068, 2.81, 0.139, 559, 101, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1109, 5nq9C, 0.6067, 3.09, 0.125, 497, 104, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1110, 5nq8A, 0.6067, 2.64, 0.119, 497, 101, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II
1111, 5anhA, 0.6067, 2.98, 0.136, 496, 103, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1112, 4a2eA, 0.6066, 2.97, 0.126, 495, 103, CRYSTAL STRUCTURE OF A CORIOLOPSIS GALLICA LACCASE AT 1.7 A RESOLUTION PH 5.5
1113, 5anhC, 0.6065, 2.99, 0.136, 496, 103, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1114, 2xuwA, 0.6064, 2.92, 0.184, 437, 103, CRYSTAL STRUCTURE OF APOLACCASE FROM THERMUS THERMOPHILUS HB27
1115, 1gw0A, 0.6063, 2.82, 0.139, 559, 101, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1116, 3cdzB, 0.6060, 2.76, 0.139, 631, 101, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
1117, 1gw0B, 0.6060, 2.82, 0.139, 559, 101, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1118, 5nq7A, 0.6057, 3.08, 0.115, 497, 104, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM I
1119, 3gyrE, 0.6052, 2.81, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1120, 1sddB, 0.6052, 1.82, 0.147, 601, 95, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
1121, 3gyrG, 0.6051, 2.82, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1122, 3gyrK, 0.6050, 2.82, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1123, 2hrhA, 0.6048, 2.67, 0.139, 496, 101, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII
1124, 5a7eA, 0.6044, 2.92, 0.127, 495, 102, CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION
1125, 3gyrB, 0.6044, 2.82, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1126, 3gyrF, 0.6042, 2.83, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1127, 3gyrA, 0.6042, 2.83, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1128, 5anhB, 0.6035, 2.69, 0.139, 496, 101, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1129, 3gyrC, 0.6033, 2.84, 0.056, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1130, 3gyrH, 0.6028, 2.82, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1131, 3gyrI, 0.6026, 2.84, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1132, 3j2qB, 0.6019, 2.86, 0.139, 631, 101, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
1133, 3j2sB, 0.6018, 2.24, 0.155, 631, 97, MEMBRANE-BOUND FACTOR VIII LIGHT CHAIN
1134, 1hfuA, 0.6018, 3.02, 0.117, 500, 103, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION
1135, 3ta4F, 0.6012, 2.67, 0.220, 282, 100, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1136, 1a65A, 0.6011, 3.18, 0.115, 504, 104, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS
1137, 5g3bA, 0.6009, 2.93, 0.186, 437, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE: THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1138, 5g3gA, 0.6007, 2.93, 0.186, 437, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1139, 5g3fA, 0.6007, 2.93, 0.186, 437, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1140, 5k8dA, 0.6003, 2.16, 0.103, 611, 97, CRYSTAL STRUCTURE OF RFVIIIFC
1141, 4bxsV, 0.6000, 2.11, 0.134, 1262, 97, CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS
1142, 4ai7A, 0.5997, 2.99, 0.184, 437, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 2 H IN 5 MM HGCL2 AT 278 K.
1143, 2xvbA, 0.5987, 3.01, 0.184, 438, 103, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 5 MIN. IN 5 MM HGCL2 AT 278 K.
1144, 4ysdA, 0.5967, 1.95, 0.189, 299, 95, ROOM TEMPERATURE STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
1145, 6s0oA, 0.5964, 2.71, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1146, 6fc7L, 0.5959, 2.73, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1147, 6rh9F, 0.5957, 2.73, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1148, 6rh9J, 0.5952, 2.73, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1149, 6rh9I, 0.5952, 2.75, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1150, 5o3kA, 0.5952, 2.70, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1151, 6fc7D, 0.5951, 2.72, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1152, 5o3kB, 0.5951, 2.72, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1153, 5o3kI, 0.5950, 2.74, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1154, 6fc7I, 0.5949, 2.72, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1155, 6fdjB, 0.5948, 2.73, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1156, 6rh9D, 0.5946, 2.73, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1157, 5o3kJ, 0.5946, 2.73, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1158, 6rh9K, 0.5945, 2.76, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1159, 6rh9G, 0.5945, 2.74, 0.170, 279, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1160, 5o4iC, 0.5945, 2.73, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1161, 6fc7G, 0.5944, 2.72, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1162, 6fc7H, 0.5943, 2.74, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1163, 5o4qG, 0.5943, 2.74, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1164, 5o4iE, 0.5943, 2.75, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1165, 6rh9B, 0.5942, 2.75, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1166, 5o3kD, 0.5941, 2.54, 0.172, 281, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1167, 6fdjF, 0.5940, 2.74, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1168, 6s0oF, 0.5939, 2.73, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1169, 3aw5A, 0.5938, 2.78, 0.170, 438, 100, STRUCTURE OF A MULTICOPPER OXIDASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROBACULUM AEROPHILUM
1170, 6rh9H, 0.5936, 2.76, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1171, 6fdjI, 0.5936, 2.72, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1172, 5o4qE, 0.5936, 2.75, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1173, 5o3kG, 0.5936, 2.73, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1174, 5o3kE, 0.5936, 2.76, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1175, 5o4qJ, 0.5935, 2.74, 0.170, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1176, 5o4iB, 0.5935, 2.75, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1177, 6rhqD, 0.5934, 2.74, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1178, 5o4qB, 0.5933, 2.74, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1179, 6fc7E, 0.5932, 2.74, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1180, 6fc7A, 0.5932, 2.74, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1181, 5o4qI, 0.5932, 2.74, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1182, 5o4qH, 0.5931, 2.78, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1183, 6fdjG, 0.5930, 2.75, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1184, 5o3kF, 0.5930, 2.76, 0.170, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1185, 6rhqE, 0.5929, 2.77, 0.170, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1186, 6fdjC, 0.5927, 2.74, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1187, 5o3kK, 0.5927, 2.75, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1188, 6fdjH, 0.5925, 2.74, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1189, 6fc7B, 0.5924, 2.78, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1190, 5o4qK, 0.5923, 2.75, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1191, 5mkmF, 0.5923, 2.74, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1192, 6fdjK, 0.5922, 2.73, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1193, 4n8uA, 0.5918, 2.76, 0.170, 275, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1194, 3wi9A, 0.5918, 1.86, 0.191, 303, 94, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS KAUSTOPHILUS
1195, 4gybA, 0.5914, 2.78, 0.170, 279, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AT 2.4 A RESOLUTION AC1709
1196, 4najA, 0.5911, 2.78, 0.170, 279, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 90 MIN SOAKING
1197, 4gxfB, 0.5907, 2.77, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1198, 4gy4B, 0.5906, 2.78, 0.170, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1199, 4gxfC, 0.5904, 2.78, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1200, 4gxfA, 0.5904, 2.78, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1201, 3tbcC, 0.5904, 2.78, 0.170, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1202, 4gy4C, 0.5903, 2.79, 0.170, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1203, 4gy4A, 0.5901, 2.79, 0.170, 276, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1204, 1zpuB, 0.5901, 2.77, 0.149, 529, 101, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1205, 1zpuA, 0.5898, 2.77, 0.149, 529, 101, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1206, 3tbcB, 0.5896, 2.77, 0.170, 278, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1207, 1zpuF, 0.5896, 2.77, 0.149, 529, 101, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1208, 1zpuC, 0.5896, 2.78, 0.149, 529, 101, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1209, 1zpuD, 0.5895, 2.78, 0.149, 529, 101, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1210, 1zpuE, 0.5894, 2.78, 0.149, 529, 101, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1211, 3tasB, 0.5890, 2.78, 0.170, 301, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1212, 3tbbA, 0.5887, 2.77, 0.170, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1213, 3pnrB, 0.5886, 3.83, 0.034, 129, 116, STRUCTURE OF PBICP-C IN COMPLEX WITH FALCIPAIN-2
1214, 5lwwA, 0.5834, 2.78, 0.143, 550, 98, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC
1215, 3v9eA, 0.5809, 2.83, 0.143, 539, 98, STRUCTURE OF THE L499M MUTANT OF THE LACCASE FROM B.ACLADA
1216, 3sqrA, 0.5806, 2.82, 0.133, 539, 98, CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION
1217, 1ibzA, 0.5760, 1.62, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1218, 1ic0E, 0.5753, 1.62, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1219, 1ibzB, 0.5751, 1.91, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1220, 1ic0C, 0.5750, 1.64, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1221, 1ic0D, 0.5748, 1.69, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1222, 1ibyA, 0.5746, 1.82, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1223, 6f5kA, 0.5739, 2.90, 0.163, 557, 98, CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA 
1224, 1ibyB, 0.5739, 1.88, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1225, 1ibyC, 0.5732, 1.88, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1226, 1ic0B, 0.5726, 1.70, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1227, 1ibzC, 0.5725, 1.56, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1228, 1ic0F, 0.5716, 1.58, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1229, 5i5jB, 0.5713, 1.26, 0.153, 529, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1230, 5i5jA, 0.5712, 1.26, 0.153, 531, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1231, 1ibzD, 0.5707, 1.77, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1232, 1ibyD, 0.5699, 1.75, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1233, 2ih8A, 0.5694, 3.12, 0.143, 559, 98, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1234, 5sydB, 0.5693, 1.81, 0.180, 131, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1235, 4m4rF, 0.5693, 3.38, 0.027, 138, 112, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1236, 3dkhA, 0.5693, 3.16, 0.143, 558, 98, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1237, 2q9oB, 0.5693, 3.13, 0.143, 558, 98, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1238, 2q9oA, 0.5692, 3.12, 0.143, 558, 98, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1239, 2ih8B, 0.5692, 3.12, 0.143, 559, 98, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1240, 3dkhB, 0.5691, 3.17, 0.143, 558, 98, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1241, 3fu7A, 0.5690, 3.13, 0.143, 558, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1242, 2ih9B, 0.5689, 3.14, 0.143, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1243, 3fu7B, 0.5687, 3.14, 0.143, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1244, 3fu8B, 0.5683, 3.15, 0.143, 558, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1245, 2wo3B, 0.5681, 3.31, 0.055, 142, 109, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINA2 COMPLEX
1246, 1ic0A, 0.5675, 1.68, 0.216, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1247, 3qpkB, 0.5674, 3.18, 0.143, 559, 98, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1248, 6ci0D, 0.5672, 2.37, 0.117, 257, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1249, 3ehbB, 0.5672, 2.33, 0.160, 252, 94, A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT CONSERVED GLUTAMATE
1250, 1ar1B, 0.5669, 2.36, 0.160, 252, 94, STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1251, 4l0pB, 0.5666, 3.43, 0.036, 139, 112, STRUCTURE OF THE HUMAN EPHA3 RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH EPHRIN-A5
1252, 3hb3B, 0.5664, 2.36, 0.160, 252, 94, HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE
1253, 2gsmB, 0.5663, 2.39, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1254, 3omiD, 0.5661, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1255, 3fyeD, 0.5661, 2.39, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1256, 2gsmD, 0.5661, 2.39, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1257, 3omnD, 0.5660, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1258, 3om3B, 0.5660, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1259, 3omiB, 0.5659, 2.39, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1260, 3omaD, 0.5658, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1261, 3om3D, 0.5657, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1262, 3dtuD, 0.5657, 2.39, 0.117, 258, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1263, 3fu9A, 0.5656, 3.35, 0.152, 559, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1264, 3omnB, 0.5655, 2.39, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1265, 3omaB, 0.5655, 2.39, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1266, 3fyiD, 0.5655, 2.38, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1267, 1qleB, 0.5655, 2.34, 0.160, 252, 94, CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1268, 6ci0B, 0.5654, 2.39, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1269, 3fyeB, 0.5654, 2.39, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1270, 3fyiB, 0.5653, 2.40, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1271, 4m4rD, 0.5652, 3.43, 0.027, 140, 112, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1272, 1m56B, 0.5648, 2.40, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1273, 5wehB, 0.5647, 2.41, 0.117, 254, 94, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1274, 3ppsB, 0.5646, 3.13, 0.143, 564, 98, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1275, 3ppsC, 0.5645, 3.13, 0.143, 564, 98, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1276, 5sydA, 0.5644, 2.09, 0.180, 130, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1277, 3dtuB, 0.5644, 2.40, 0.117, 259, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1278, 1ikoP, 0.5644, 3.09, 0.056, 141, 108, CRYSTAL STRUCTURE OF THE MURINE EPHRIN-B2 ECTODOMAIN
1279, 1m56H, 0.5642, 2.41, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1280, 5wehH, 0.5628, 2.43, 0.117, 253, 94, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1281, 1m57B, 0.5619, 2.41, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1282, 3d12E, 0.5617, 3.18, 0.065, 141, 107, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1283, 1m57H, 0.5616, 2.42, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1284, 4m4rB, 0.5615, 3.33, 0.027, 141, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1285, 4f2fA, 0.5605, 1.82, 0.148, 100, 88, CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)
1286, 6hu9b, 0.5604, 2.44, 0.149, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1287, 4bkfD, 0.5604, 3.19, 0.065, 141, 107, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1288, 4bkfC, 0.5604, 3.19, 0.065, 141, 107, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1289, 3d12B, 0.5604, 3.19, 0.065, 141, 107, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1290, 4w9zA, 0.5603, 2.43, 0.128, 138, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC DOMAIN OF SUBUNIT II OF CYTOCHROME OXIDASE (COXB) OF BRADYRHIZOBIUM JAPONICUM
1291, 4m4rH, 0.5595, 3.49, 0.036, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1292, 3mx0D, 0.5591, 3.52, 0.027, 138, 111, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1293, 5z62B, 0.5589, 2.41, 0.128, 227, 94, STRUCTURE OF HUMAN CYTOCHROME C OXIDASE 
1294, 6hu9n, 0.5577, 2.45, 0.149, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1295, 1shwA, 0.5570, 3.42, 0.027, 138, 110, EPHB2 / EPHRINA5 COMPLEX STRUCTURE
1296, 5x1bO, 0.5559, 2.45, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1297, 5b1bO, 0.5556, 2.45, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1298, 3abkO, 0.5556, 2.44, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1299, 1shxB, 0.5553, 3.54, 0.045, 138, 110, EPHRIN A5 LIGAND STRUCTURE
1300, 3mx0B, 0.5551, 3.53, 0.027, 138, 111, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1301, 6j8mO, 0.5549, 2.47, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1302, 3heiB, 0.5549, 3.04, 0.057, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1303, 3ag4O, 0.5549, 2.46, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1304, 3ag3O, 0.5549, 2.46, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1305, 5zcqO, 0.5548, 2.48, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1306, 5b3sO, 0.5548, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1307, 3ag2O, 0.5548, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1308, 5zcpO, 0.5545, 2.48, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1309, 2x11B, 0.5545, 3.60, 0.036, 138, 111, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
1310, 5z86O, 0.5544, 2.47, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1311, 5z85O, 0.5544, 2.48, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1312, 5x1fO, 0.5544, 2.47, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1313, 5b1aO, 0.5544, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1314, 5zcoO, 0.5543, 2.48, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1315, 5waub, 0.5542, 2.47, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1316, 5z84O, 0.5541, 2.48, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1317, 5x19O, 0.5541, 2.47, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1318, 2y69O, 0.5541, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1319, 2eikB, 0.5541, 2.48, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1320, 6nmfO, 0.5540, 2.50, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1321, 3wg7O, 0.5540, 2.48, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1322, 3asoO, 0.5540, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1323, 2eikO, 0.5540, 2.48, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1324, 3abmO, 0.5539, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1325, 2einB, 0.5539, 2.49, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1326, 1v55O, 0.5539, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1327, 1v54O, 0.5538, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1328, 1ocrO, 0.5538, 2.49, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1329, 5xdxO, 0.5537, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1330, 5w97b, 0.5537, 2.49, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1331, 3asnO, 0.5537, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1332, 1ocrB, 0.5537, 2.50, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1333, 5xdqO, 0.5536, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1334, 5wauB, 0.5536, 2.50, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1335, 3ag3B, 0.5536, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1336, 3abkB, 0.5536, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1337, 3x2qO, 0.5535, 2.49, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1338, 3ag1O, 0.5535, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1339, 3ag1B, 0.5535, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1340, 2zxwO, 0.5535, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1341, 2eijO, 0.5535, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1342, 1v55B, 0.5535, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1343, 1v54B, 0.5535, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1344, 2einO, 0.5534, 2.50, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1345, 5x1bB, 0.5533, 2.49, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1346, 3heiL, 0.5533, 3.11, 0.048, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1347, 3ablO, 0.5533, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1348, 2eijB, 0.5533, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1349, 2dyrO, 0.5533, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1350, 6j8mB, 0.5532, 2.52, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1351, 3wg7B, 0.5532, 2.52, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1352, 3ag4B, 0.5532, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1353, 2dysO, 0.5532, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1354, 2dysB, 0.5532, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1355, 5zcpB, 0.5531, 2.52, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1356, 5z86B, 0.5531, 2.52, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1357, 5iy5O, 0.5531, 2.49, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1358, 2vsmB, 0.5531, 3.46, 0.073, 137, 109, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1359, 2dyrB, 0.5531, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1360, 3ag2B, 0.5530, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1361, 3abmB, 0.5530, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1362, 2wo2B, 0.5530, 3.26, 0.064, 136, 110, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINB2 COMPLEX
1363, 2eimO, 0.5530, 2.49, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1364, 2eilB, 0.5530, 2.51, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1365, 2eimB, 0.5529, 2.50, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1366, 2eilO, 0.5529, 2.50, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1367, 6nknO, 0.5528, 2.51, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1368, 5z85B, 0.5528, 2.52, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1369, 5iy5B, 0.5528, 2.53, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1370, 5b1bB, 0.5528, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1371, 3x2qB, 0.5528, 2.52, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1372, 6nmpO, 0.5527, 2.50, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1373, 5z84B, 0.5527, 2.52, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1374, 4uf7C, 0.5527, 3.32, 0.055, 138, 109, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1375, 6nmfB, 0.5526, 2.52, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1376, 5zcoB, 0.5526, 2.52, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1377, 5xdxB, 0.5526, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1378, 5x1fB, 0.5526, 2.50, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1379, 5b3sB, 0.5526, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1380, 2occO, 0.5526, 2.52, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1381, 5zcqB, 0.5525, 2.52, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1382, 5xtiWD, 0.5525, 2.53, 0.117, 227, 94, struct.pdbx_descriptor              
1383, 5xtiUA, 0.5525, 2.53, 0.117, 227, 94, struct.pdbx_descriptor              
1384, 5xthUA, 0.5525, 2.53, 0.117, 227, 94, struct.pdbx_descriptor              
1385, 5lufy, 0.5525, 2.53, 0.117, 227, 94, CRYO-EM OF BOVINE RESPIRASOME
1386, 5gupVB, 0.5525, 2.53, 0.117, 227, 94, 
1387, 5gpnIB, 0.5525, 2.53, 0.117, 227, 94, 
1388, 5b1aB, 0.5525, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1389, 2ybbM, 0.5525, 2.53, 0.117, 227, 94, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
1390, 2y69B, 0.5525, 2.52, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1391, 1occO, 0.5525, 2.53, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1392, 1occB, 0.5525, 2.53, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1393, 5xdqB, 0.5524, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1394, 5x19B, 0.5523, 2.51, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1395, 3asoB, 0.5523, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1396, 2occB, 0.5523, 2.52, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1397, 2zxwB, 0.5522, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1398, 5w97B, 0.5520, 2.52, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1399, 3heiJ, 0.5520, 3.07, 0.067, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1400, 3asnB, 0.5520, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1401, 6nknB, 0.5515, 2.54, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1402, 3ablB, 0.5514, 2.54, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1403, 1ocoO, 0.5514, 2.53, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1404, 1ocoB, 0.5514, 2.53, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1405, 4uf7E, 0.5512, 3.21, 0.056, 139, 108, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1406, 1oczO, 0.5512, 2.53, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1407, 1oczB, 0.5511, 2.54, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1408, 3heiP, 0.5510, 3.12, 0.057, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1409, 6nmpB, 0.5509, 2.55, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1410, 3heiH, 0.5504, 3.15, 0.048, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1411, 1shxA, 0.5499, 3.73, 0.035, 138, 113, EPHRIN A5 LIGAND STRUCTURE
1412, 4f2eA, 0.5487, 1.88, 0.172, 98, 87, CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE D39 COPPER CHAPERONE CUPA WITH CU(I)
1413, 3gxuB, 0.5487, 3.15, 0.065, 138, 107, CRYSTAL STRUCTURE OF EPH RECEPTOR AND EPHRIN COMPLEX
1414, 4txvB, 0.5486, 2.68, 0.128, 142, 94, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1415, 3heiN, 0.5486, 3.39, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1416, 4bkaC, 0.5483, 3.86, 0.018, 136, 112, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
1417, 4bk5C, 0.5479, 3.86, 0.018, 136, 112, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
1418, 3czuB, 0.5475, 3.24, 0.057, 130, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2- EPHRIN A1 COMPLEX
1419, 4txvD, 0.5472, 2.50, 0.140, 133, 93, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1420, 3heiD, 0.5467, 3.20, 0.048, 132, 105, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1421, 1kgyH, 0.5462, 3.10, 0.057, 138, 106, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1422, 3mbwB, 0.5455, 3.07, 0.039, 127, 103, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1
1423, 6giqb, 0.5452, 2.59, 0.149, 235, 94, SACCHAROMYCES CEREVISIAE RESPIRATORY SUPERCOMPLEX III2IV 
1424, 1kgyF, 0.5449, 3.14, 0.075, 138, 106, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1425, 1kgyE, 0.5441, 3.22, 0.083, 138, 108, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1426, 2mryA, 0.5437, 2.01, 0.172, 98, 87, NMR SOLUTION STRUCTURE OF COPPER BINDING PROTEIN IN THE APO FORM
1427, 2hb0B, 0.5436, 3.87, 0.071, 355, 113, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1428, 1kgyG, 0.5427, 3.30, 0.083, 138, 108, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1429, 3heiF, 0.5423, 3.13, 0.058, 132, 104, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1430, 1ayrA, 0.5381, 3.53, 0.029, 368, 105, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1431, 2vskB, 0.5369, 3.20, 0.076, 131, 105, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1432, 1ayrC, 0.5366, 3.41, 0.029, 368, 104, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1433, 3q48A, 0.5364, 2.78, 0.124, 194, 97, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
1434, 2vskD, 0.5356, 3.17, 0.057, 131, 105, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1435, 2hleB, 0.5347, 3.15, 0.067, 133, 104, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE EPHB4-EPHRINB2 PROTEIN PROTEIN INTERACTION AND RECEPTOR SPECIFICITY.
1436, 3p2dB, 0.5340, 3.48, 0.049, 352, 103, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1437, 3m4eD, 0.5328, 4.01, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1438, 3m4eG, 0.5321, 4.12, 0.080, 293, 113, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1439, 3m4eE, 0.5320, 4.00, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1440, 3m4eB, 0.5320, 4.01, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1441, 3m4eC, 0.5318, 4.00, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1442, 3m4dB, 0.5318, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1443, 3m3rG, 0.5318, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1444, 1g4rA, 0.5317, 3.74, 0.066, 353, 106, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1445, 3m3rB, 0.5314, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1446, 3m4dD, 0.5312, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1447, 3f83A, 0.5312, 4.08, 0.077, 508, 117, STRUCTURE OF FUSION COMPLEX OF THE MINOR PILIN CFAE AND MAJOR PILIN CFAB OF CFA/I PILI FROM ETEC E. COLI
1448, 3m4eF, 0.5311, 4.01, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1449, 3m4dF, 0.5310, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1450, 3m4dE, 0.5310, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1451, 3m2lD, 0.5310, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1452, 3m4dG, 0.5309, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1453, 3m2lE, 0.5309, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1454, 3m4eA, 0.5308, 4.00, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1455, 3m4dC, 0.5308, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1456, 3m3rE, 0.5308, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1457, 3m2lA, 0.5308, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1458, 3m4dA, 0.5307, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1459, 3m2lG, 0.5307, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1460, 3m3rC, 0.5305, 4.02, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1461, 3m3rA, 0.5304, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1462, 3m2lB, 0.5303, 4.04, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1463, 7ahlA, 0.5302, 4.03, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1464, 3d34B, 0.5299, 3.38, 0.076, 215, 105, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1465, 3m3rF, 0.5298, 4.04, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1466, 3m3rD, 0.5298, 4.03, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1467, 3m2lC, 0.5298, 4.03, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1468, 7ahlD, 0.5297, 4.02, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1469, 7ahlB, 0.5297, 4.03, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1470, 4p24B, 0.5297, 4.01, 0.080, 291, 112, PORE FORMING TOXIN
1471, 3d34A, 0.5296, 3.38, 0.067, 211, 105, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1472, 7ahlF, 0.5294, 4.00, 0.089, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1473, 3m2lF, 0.5294, 4.04, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1474, 7ahlG, 0.5293, 4.03, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1475, 7ahlE, 0.5293, 4.04, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1476, 4yhdG, 0.5292, 4.05, 0.080, 281, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1477, 4p24E, 0.5292, 4.03, 0.080, 291, 112, PORE FORMING TOXIN
1478, 2wtrB, 0.5292, 3.78, 0.076, 367, 105, FULL LENGTH ARRESTIN2
1479, 4p24D, 0.5290, 4.01, 0.089, 292, 112, PORE FORMING TOXIN
1480, 7ahlC, 0.5289, 4.04, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1481, 3anzG, 0.5286, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1482, 6d49B, 0.5284, 3.84, 0.081, 126, 111, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1483, 4p24F, 0.5284, 4.00, 0.089, 290, 112, PORE FORMING TOXIN
1484, 3gd1C, 0.5283, 3.76, 0.067, 345, 105, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
1485, 3anzY, 0.5283, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1486, 3anzK, 0.5283, 4.04, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1487, 3q13A, 0.5281, 3.29, 0.096, 235, 104, THE STRUCTURE OF THE CA2+-BINDING GLYCOSYLATED F-SPONDIN DOMAIN OF F- SPONDIN A C2-DOMAIN VARIANT FROM EXTRACELLULAR MATRIX
1488, 1al0F, 0.5279, 4.40, 0.087, 418, 115, PROCAPSID OF BACTERIOPHAGE PHIX174
1489, 3anzO, 0.5278, 4.05, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1490, 1kiuO, 0.5278, 2.83, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1491, 1kiuM, 0.5278, 2.83, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1492, 1kiuK, 0.5278, 2.83, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1493, 1kiuI, 0.5278, 2.83, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1494, 5j7yZB, 0.5277, 2.67, 0.118, 227, 93, 
1495, 5j4zZB, 0.5277, 2.67, 0.118, 227, 93, 
1496, 4p24G, 0.5277, 4.03, 0.080, 292, 112, PORE FORMING TOXIN
1497, 3ugxC, 0.5277, 3.52, 0.029, 358, 102, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1498, 7pcyA, 0.5276, 2.49, 0.156, 98, 90, THE CRYSTAL STRUCTURE OF PLASTOCYANIN FROM A GREEN ALGA ENTEROMORPHA PROLIFERA
1499, 3anzW, 0.5276, 4.04, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1500, 3anzF, 0.5276, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1501, 3ugxA, 0.5275, 3.73, 0.047, 369, 106, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1502, 3anzU, 0.5275, 4.05, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1503, 3anzD, 0.5275, 4.05, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1504, 3anzA, 0.5274, 4.05, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1505, 3anzV, 0.5273, 4.05, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1506, 3anzL, 0.5273, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1507, 3anzB, 0.5273, 4.05, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1508, 3anzT, 0.5271, 4.06, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1509, 3anzQ, 0.5271, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1510, 3anzJ, 0.5271, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1511, 3anzI, 0.5271, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1512, 1g4mB, 0.5271, 3.50, 0.069, 357, 102, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1513, 4p24C, 0.5270, 4.01, 0.089, 291, 112, PORE FORMING TOXIN
1514, 3anza, 0.5270, 4.06, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1515, 3anzX, 0.5270, 4.06, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1516, 1hxmC, 0.5270, 3.77, 0.110, 206, 109, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1517, 3anzN, 0.5269, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1518, 3anzH, 0.5269, 4.06, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1519, 3anzE, 0.5269, 4.06, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1520, 3anzR, 0.5268, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1521, 3anzP, 0.5268, 4.06, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1522, 3anzC, 0.5268, 4.05, 0.080, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1523, 1cf1A, 0.5267, 3.78, 0.029, 373, 105, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1524, 3anzS, 0.5265, 4.05, 0.080, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1525, 6d49A, 0.5262, 3.73, 0.082, 126, 110, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1526, 5k93A, 0.5260, 2.91, 0.124, 210, 97, PAPD WILD-TYPE CHAPERONE
1527, 1hxmE, 0.5260, 3.81, 0.110, 206, 109, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1528, 1ayrD, 0.5259, 3.44, 0.030, 363, 101, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1529, 4bcuA, 0.5258, 4.48, 0.052, 188, 116, SATELLITE TOBACCO NECROSIS VIRUS (STNV) VIRUS LIKE PARTICLE IN COMPLEX WITH THE B3 APTAMER
1530, 1hxmG, 0.5258, 3.80, 0.110, 206, 109, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1531, 1hxmA, 0.5258, 3.80, 0.110, 206, 109, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1532, 1ayrB, 0.5258, 3.44, 0.030, 363, 101, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1533, 3vacA, 0.5257, 4.09, 0.078, 356, 116, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1534, 2hb0A, 0.5257, 4.26, 0.085, 356, 118, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1535, 4v4mL, 0.5256, 4.49, 0.052, 184, 116, 
1536, 4v4mB, 0.5254, 4.69, 0.034, 184, 119, 
1537, 5k93B, 0.5253, 4.49, 0.052, 184, 116, PAPD WILD-TYPE CHAPERONE
1538, 4v4mS, 0.5252, 4.49, 0.052, 184, 116, 
1539, 4v4mP, 0.5252, 4.70, 0.034, 184, 119, 
1540, 4v4mMA, 0.5252, 2.92, 0.124, 210, 97, 
1541, 4v4mHA, 0.5252, 4.49, 0.052, 184, 116, 
1542, 4v4mF, 0.5252, 4.70, 0.034, 184, 119, 
1543, 4v4mWA, 0.5251, 4.49, 0.052, 184, 116, 
1544, 4v4mPA, 0.5251, 4.48, 0.052, 184, 116, 
1545, 4v4mNA, 0.5251, 4.49, 0.052, 184, 116, 
1546, 4v4mH, 0.5251, 4.49, 0.052, 184, 116, 
1547, 4v4mEB, 0.5251, 4.49, 0.052, 184, 116, 
1548, 6dzrL, 0.5250, 4.42, 0.043, 184, 116, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
1549, 4v4mE, 0.5250, 4.70, 0.034, 184, 119, 
1550, 3vacB, 0.5250, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1551, 2j7lA, 0.5250, 4.48, 0.052, 184, 116, E.COLI P PILUS CHAPERONE PAPD IN COMPLEX WITH A PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1552, 4v4mYA, 0.5249, 4.49, 0.052, 184, 116, 
1553, 4v4mR, 0.5249, 4.49, 0.052, 184, 116, 
1554, 4v4mI, 0.5249, 4.49, 0.052, 184, 116, 
1555, 4v4mCA, 0.5249, 4.49, 0.052, 184, 116, 
1556, 4v4mA, 0.5249, 4.48, 0.052, 184, 116, 
1557, 1gff1, 0.5249, 3.97, 0.110, 218, 109, THE ATOMIC STRUCTURE OF THE DEGRADED PROCAPSID PARTICLE OF THE BACTERIOPHAGE G4: INDUCED STRUCTURAL CHANGES IN THE PRESENCE OF CALCIUM IONS AND FUNCTIONAL IMPLICATIONS
1558, 4v4mY, 0.5248, 4.48, 0.052, 184, 116, 
1559, 4v4mU, 0.5248, 4.49, 0.052, 184, 116, 
1560, 4v4mTA, 0.5248, 4.42, 0.043, 184, 116, 
1561, 4v4mBB, 0.5248, 4.07, 0.078, 356, 115, 
1562, 4u6vA, 0.5248, 2.87, 0.124, 210, 97, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
1563, 3q48B, 0.5248, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
1564, 5yu5B, 0.5247, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF SHAFT PILIN SPAD FROM LACTOBACILLUS RHAMNOSUS GG 
1565, 4v4mKA, 0.5247, 4.70, 0.034, 184, 119, 
1566, 4v4mZ, 0.5246, 4.49, 0.052, 184, 116, 
1567, 4v4mHB, 0.5246, 4.50, 0.052, 184, 116, 
1568, 4v4mCB, 0.5246, 4.49, 0.052, 184, 116, 
1569, 4v4mIA, 0.5245, 4.49, 0.052, 184, 116, 
1570, 4v4mAB, 0.5245, 4.50, 0.052, 184, 116, 
1571, 3p2dA, 0.5245, 4.77, 0.033, 184, 120, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1572, 6d4aA, 0.5244, 4.63, 0.077, 417, 117, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1573, 4zrgA, 0.5244, 4.49, 0.052, 184, 116, VISUAL ARRESTIN MUTANT - R175E
1574, 4u6vB, 0.5244, 4.49, 0.052, 184, 116, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
1575, 4m62M, 0.5243, 4.49, 0.052, 184, 116, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
1576, 4ydjH, 0.5241, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1577, 3dpaA, 0.5240, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF CHAPERONE PROTEIN PAPD REVEALS AN IMMUNOGLOBULIN FOLD
1578, 3anzb, 0.5240, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1579, 3anzZ, 0.5240, 4.09, 0.071, 272, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1580, 3njhD, 0.5239, 2.82, 0.105, 186, 95, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1581, 6dc9L, 0.5238, 3.90, 0.036, 448, 110, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1582, 4jqiA, 0.5238, 4.49, 0.052, 184, 116, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1583, 3jwnI, 0.5238, 4.49, 0.052, 184, 116, COMPLEX OF FIMC FIMF FIMG AND FIMH
1584, 1cf1B, 0.5238, 4.67, 0.042, 184, 119, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1585, 3anzM, 0.5237, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1586, 2d7tL, 0.5237, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
1587, 1zshA, 0.5237, 4.50, 0.052, 184, 116, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1588, 5ihbB, 0.5236, 4.50, 0.052, 184, 116, STRUCTURE OF THE IMMUNE RECEPTOR CD33
1589, 6cjkA, 0.5235, 3.71, 0.047, 354, 106, ANTI HIV FAB 10A 
1590, 4v4mC, 0.5235, 3.73, 0.082, 123, 110, 
1591, 1qppA, 0.5234, 3.64, 0.029, 343, 103, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
1592, 1pdkA, 0.5233, 4.09, 0.071, 272, 112, PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX FROM E.COLI P PILUS
1593, 5yu5A, 0.5232, 3.91, 0.084, 113, 107, CRYSTAL STRUCTURE OF SHAFT PILIN SPAD FROM LACTOBACILLUS RHAMNOSUS GG 
1594, 4v4mFA, 0.5230, 4.05, 0.071, 238, 112, 
1595, 1jsyA, 0.5230, 2.98, 0.103, 218, 97, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1596, 1iuzA, 0.5230, 4.07, 0.088, 295, 113, PLASTOCYANIN
1597, 4v4mM, 0.5229, 4.07, 0.088, 294, 113, 
1598, 4v4mEA, 0.5229, 3.27, 0.111, 122, 99, 
1599, 3uguA, 0.5229, 3.88, 0.103, 215, 107, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
1600, 2xg4A, 0.5229, 3.83, 0.065, 353, 107, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1601, 6cd2A, 0.5228, 2.77, 0.105, 198, 95, CRYSTAL STRUCTURE OF THE PAPC USHER BOUND TO THE CHAPERONE-ADHESIN PAPD-PAPG 
1602, 5j0bB, 0.5228, 3.52, 0.030, 360, 101, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
1603, 2pltA, 0.5228, 4.07, 0.088, 295, 113, STRUCTURE DETERMINATION OF PLASTOCYANIN FROM A CRYSTAL SPECIMEN WITH HEMIHEDRAL TWINNING FRACTION OF ONE-HALF
1604, 1rb8F, 0.5228, 3.89, 0.112, 110, 107, THE PHIX174 DNA BINDING PROTEIN J IN TWO DIFFERENT CAPSID ENVIRONMENTS.
1605, 1m06F, 0.5228, 3.76, 0.065, 354, 107, STRUCTURAL STUDIES OF BACTERIOPHAGE ALPHA3 ASSEMBLY X-RAY CRYSTALLOGRAPHY
1606, 4yhdA, 0.5227, 3.78, 0.082, 214, 110, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1607, 6d48H, 0.5226, 3.86, 0.103, 216, 107, CELL SURFACE RECEPTOR 
1608, 2w07A, 0.5226, 4.49, 0.052, 184, 116, STRUCTURAL DETERMINANTS OF POLYMERIZATION REACTIVITY OF THE P PILUS ADAPTOR SUBUNIT PAPF
1609, 2uy7E, 0.5225, 4.49, 0.052, 184, 116, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1610, 2uy6A, 0.5225, 4.42, 0.043, 184, 116, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1611, 1g4mA, 0.5224, 3.00, 0.082, 207, 97, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1612, 6didH, 0.5223, 3.01, 0.122, 215, 98, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
1613, 6didE, 0.5223, 3.91, 0.045, 444, 110, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
1614, 6didC, 0.5223, 4.42, 0.043, 184, 116, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
1615, 4j3oC, 0.5223, 3.78, 0.065, 358, 107, CRYSTAL STRUCTURE OF THE FIMD USHER TRAVERSED BY THE PILUS TIP COMPLEX ASSEMBLY COMPOSED OF FIMC:FIMF:FIMG:FIMH
1616, 3jwnC, 0.5223, 2.52, 0.133, 98, 90, COMPLEX OF FIMC FIMF FIMG AND FIMH
1617, 1klfO, 0.5223, 4.49, 0.052, 184, 116, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1618, 1klfM, 0.5223, 4.42, 0.043, 184, 116, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1619, 1klfK, 0.5223, 4.42, 0.043, 184, 116, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1620, 1klfI, 0.5223, 3.49, 0.039, 345, 102, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1621, 6cjkC, 0.5222, 3.22, 0.141, 216, 99, ANTI HIV FAB 10A 
1622, 4idjA, 0.5222, 3.04, 0.122, 215, 98, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
1623, 3g6jE, 0.5222, 4.00, 0.071, 214, 112, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1624, 4v4mXA, 0.5221, 2.58, 0.167, 98, 90, 
1625, 3njmA, 0.5221, 4.32, 0.079, 422, 114, P117A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1626, 2xg5A, 0.5221, 4.33, 0.079, 422, 114, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 5D
1627, 2uy7A, 0.5221, 3.93, 0.073, 281, 110, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1628, 3g6jG, 0.5220, 3.73, 0.083, 124, 109, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1629, 3bwuC, 0.5220, 3.05, 0.122, 215, 98, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N-TERMINAL DOMAIN FIMDN) WITH FIMC AND THE N-TERMINALLY TRUNCATED PILUS SUBUNIT FIMF (FIMFT)
1630, 2j2zA, 0.5220, 3.09, 0.122, 216, 98, X-RAY STRUCTURE OF THE CHAPERONE PAPD IN COMPLEX WITH THE PILUS TERMINATOR SUBUNIT PAPH AT 2.3 ANGSTROM RESOLUTION
1631, 6d48F, 0.5219, 3.09, 0.122, 216, 98, CELL SURFACE RECEPTOR 
1632, 3sqbC, 0.5219, 3.74, 0.066, 356, 106, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1633, 1sujA, 0.5219, 3.88, 0.103, 217, 107, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1634, 1jerA, 0.5219, 3.88, 0.103, 217, 107, CUCUMBER STELLACYANIN CU2+ PH 7.0
1635, 5fc9A, 0.5218, 3.88, 0.103, 217, 107, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1636, 3sqbA, 0.5218, 2.83, 0.094, 199, 96, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1637, 3njkA, 0.5218, 2.87, 0.104, 199, 96, D116A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS AT PH5.5
1638, 1jxgA, 0.5218, 2.76, 0.095, 205, 95, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1639, 4yhdD, 0.5217, 2.76, 0.095, 205, 95, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1640, 2wtrA, 0.5217, 2.76, 0.095, 205, 95, FULL LENGTH ARRESTIN2
1641, 1ylbB, 0.5217, 2.76, 0.095, 205, 95, NMR SOLUTION STRUCTURE OF THE REDUCED SPINACH PLASTOCYANIN
1642, 1jxgB, 0.5217, 3.89, 0.103, 217, 107, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1643, 4dwhA, 0.5216, 4.07, 0.080, 276, 112, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1644, 2n7bA, 0.5216, 3.95, 0.093, 214, 107, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN IN COMPLEX WITH 6 SULFO SIALYL LEWISX
1645, 1uweU, 0.5216, 4.43, 0.043, 184, 116, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1646, 1qpxA, 0.5215, 3.22, 0.112, 122, 98, CRYSTAL STRUCTURES OF SELF-CAPPING PAPD CHAPERONE HOMODIMERS
1647, 6dc9M, 0.5214, 3.09, 0.122, 216, 98, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1648, 6d48E, 0.5213, 3.09, 0.122, 216, 98, CELL SURFACE RECEPTOR 
1649, 1i7zA, 0.5213, 3.93, 0.084, 214, 107, ANTIBODY GNC92H2 BOUND TO LIGAND
1650, 5j06B, 0.5212, 2.71, 0.106, 200, 94, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1651, 4dwhC, 0.5212, 3.08, 0.122, 216, 98, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1652, 6nz7L, 0.5211, 3.67, 0.083, 125, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
1653, 2uy7C, 0.5211, 2.80, 0.105, 200, 95, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1654, 1za3A, 0.5211, 3.47, 0.030, 363, 101, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1655, 1cf1D, 0.5211, 3.11, 0.125, 110, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1656, 4nobA, 0.5210, 2.17, 0.148, 95, 88, CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
1657, 1uweL, 0.5210, 2.81, 0.105, 191, 95, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1658, 2uy7G, 0.5208, 3.32, 0.121, 122, 99, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1659, 5j06A, 0.5207, 2.62, 0.135, 100, 89, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1660, 4yhdE, 0.5206, 4.05, 0.072, 282, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1661, 2zg2A, 0.5206, 3.73, 0.066, 356, 106, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5
1662, 5tv1A, 0.5205, 2.48, 0.136, 99, 88, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
1663, 4r7dN, 0.5205, 2.53, 0.122, 100, 90, FAB HU 15C1
1664, 5j0bA, 0.5204, 2.70, 0.106, 197, 94, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
1665, 5ihbA, 0.5204, 3.81, 0.108, 145, 111, STRUCTURE OF THE IMMUNE RECEPTOR CD33
1666, 4yhdB, 0.5204, 3.92, 0.131, 213, 107, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1667, 1qppB, 0.5204, 2.99, 0.103, 206, 97, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
1668, 1kiuE, 0.5204, 3.92, 0.103, 215, 107, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1669, 1kiuC, 0.5204, 3.68, 0.083, 125, 109, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1670, 4r7nD, 0.5203, 3.91, 0.103, 219, 107, FAB C2E3
1671, 4r7dB, 0.5203, 3.91, 0.072, 215, 111, FAB HU 15C1
1672, 4jo4M, 0.5203, 2.79, 0.105, 201, 95, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
1673, 1kiuA, 0.5203, 3.87, 0.093, 214, 107, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1674, 5j0bC, 0.5202, 3.09, 0.122, 216, 98, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
1675, 4kroC, 0.5202, 3.88, 0.093, 213, 107, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
1676, 4jo3L, 0.5202, 3.82, 0.038, 368, 106, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
1677, 1uweX, 0.5202, 3.66, 0.094, 112, 106, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1678, 1klfG, 0.5202, 3.93, 0.131, 213, 107, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1679, 1klfA, 0.5202, 3.10, 0.122, 216, 98, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1680, 6nz7I, 0.5201, 3.99, 0.071, 213, 112, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
1681, 4j2qA, 0.5201, 4.05, 0.072, 268, 111, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1682, 1klfE, 0.5201, 3.83, 0.082, 214, 110, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1683, 1klfC, 0.5201, 3.52, 0.049, 337, 102, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1684, 4r7nB, 0.5200, 3.99, 0.075, 211, 107, FAB C2E3
1685, 3l5wA, 0.5200, 3.89, 0.081, 213, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
1686, 5gzoL, 0.5199, 3.98, 0.080, 213, 112, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
1687, 1s5hB, 0.5199, 3.95, 0.073, 283, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
1688, 6bzuH, 0.5198, 3.03, 0.093, 212, 97, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1689, 6avuL, 0.5198, 2.78, 0.095, 205, 95, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
1690, 3ugxD, 0.5198, 2.78, 0.095, 205, 95, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1691, 6dwaA, 0.5197, 3.95, 0.084, 211, 107, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
1692, 6avrL, 0.5197, 3.95, 0.084, 211, 107, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
1693, 6avqL, 0.5197, 3.93, 0.093, 214, 107, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
1694, 4xhjC, 0.5197, 2.78, 0.095, 205, 95, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
1695, 4kq4L, 0.5197, 3.84, 0.073, 212, 110, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
1696, 3sqoL, 0.5197, 3.92, 0.093, 211, 107, PCSK9 J16 FAB COMPLEX
1697, 3idyL, 0.5197, 3.92, 0.093, 214, 107, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
1698, 3idyC, 0.5196, 3.94, 0.131, 213, 107, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
1699, 1kiuG, 0.5196, 2.89, 0.094, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1700, 6hkgB, 0.5195, 2.89, 0.094, 205, 96, STRUCTURE OF FISW84 FAB FRAGMENT 
1701, 5vkhA, 0.5195, 3.90, 0.093, 214, 107, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
1702, 5eblA, 0.5195, 3.99, 0.028, 340, 106, KCSA T75G IN THE CONDUCTIVE STATE
1703, 6r2sA, 0.5194, 2.89, 0.094, 205, 96, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
1704, 6i9iB, 0.5194, 2.89, 0.094, 205, 96, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
1705, 5xj4L, 0.5194, 3.97, 0.084, 211, 107, COMPLEX STRUCTURE OF DURVALUMAB-SCFV/PD-L1 
1706, 5w0kL, 0.5194, 3.94, 0.103, 213, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
1707, 5nyxN, 0.5194, 3.95, 0.093, 213, 107, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
1708, 4ztpL, 0.5194, 4.06, 0.089, 219, 112, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
1709, 4r7nJ, 0.5194, 4.00, 0.120, 215, 108, FAB C2E3
1710, 4r7nF, 0.5194, 3.98, 0.121, 211, 107, FAB C2E3
1711, 4j1uC, 0.5194, 3.42, 0.030, 348, 101, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
1712, 5ebmA, 0.5193, 4.00, 0.102, 217, 108, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
1713, 4x8jB, 0.5193, 3.98, 0.121, 211, 107, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
1714, 3vfgL, 0.5193, 3.98, 0.121, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
1715, 2xraL, 0.5193, 3.94, 0.093, 207, 107, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
1716, 6bzuB, 0.5192, 3.96, 0.140, 214, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1717, 5nhrB, 0.5192, 3.92, 0.112, 213, 107, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV CUBIC CRYSTAL FORM
1718, 5ec2A, 0.5192, 3.98, 0.083, 214, 108, KCSA WITH V76ESTER+G77DA MUTATIONS
1719, 5d6cA, 0.5192, 3.98, 0.083, 214, 108, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
1720, 4r7nT, 0.5192, 2.91, 0.094, 205, 96, FAB C2E3
1721, 4r7dJ, 0.5192, 3.95, 0.093, 214, 107, FAB HU 15C1
1722, 5sx4I, 0.5191, 4.08, 0.080, 219, 112, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
1723, 5lfuA, 0.5191, 4.08, 0.089, 219, 112, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN
1724, 5bzwA, 0.5191, 3.91, 0.093, 213, 107, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1725, 3stlA, 0.5191, 3.96, 0.102, 216, 108, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
1726, 3p11L, 0.5191, 4.01, 0.083, 113, 108, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION
1727, 1figL, 0.5191, 3.98, 0.121, 210, 107, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
1728, 6dwcA, 0.5190, 3.94, 0.112, 210, 107, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
1729, 4dp0X, 0.5190, 3.98, 0.112, 216, 107, THE 1.5 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 4.0
1730, 3fo1A, 0.5190, 3.97, 0.084, 211, 107, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
1731, 3fo0L, 0.5190, 3.96, 0.084, 211, 107, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
1732, 3fb8A, 0.5190, 4.00, 0.093, 213, 108, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
1733, 3fb6A, 0.5190, 4.08, 0.089, 218, 112, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
1734, 3f7yA, 0.5190, 3.96, 0.121, 214, 107, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
1735, 3f5wA, 0.5190, 3.87, 0.104, 211, 106, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
1736, 2wmpA, 0.5190, 3.94, 0.093, 215, 107, STRUCTURE OF THE E. COLI CHAPERONE PAPD IN COMPLEX WITH THE PILIN DOMAIN OF THE PAPGII ADHESIN
1737, 1k4cA, 0.5190, 4.00, 0.120, 216, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
1738, 1i7zC, 0.5190, 3.95, 0.093, 114, 108, ANTIBODY GNC92H2 BOUND TO LIGAND
1739, 1hxmF, 0.5190, 4.06, 0.089, 219, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1740, 3u9pL, 0.5189, 4.02, 0.102, 219, 108, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
1741, 3bn9C, 0.5189, 3.97, 0.075, 211, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
1742, 1t4wA, 0.5189, 3.98, 0.084, 212, 107, STRUCTURAL DIFFERENCES IN THE DNA BINDING DOMAINS OF HUMAN P53 AND ITS C. ELEGANS ORTHOLOG CEP-1: STRUCTURE OF C. ELEGANS CEP-1
1743, 6mefL, 0.5188, 3.95, 0.093, 213, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
1744, 6by3A, 0.5188, 3.90, 0.090, 487, 111, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
1745, 5t1kA, 0.5188, 4.02, 0.093, 213, 108, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
1746, 5sx4L, 0.5188, 4.08, 0.089, 219, 112, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
1747, 4xhjG, 0.5188, 3.94, 0.093, 211, 107, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
1748, 4r7dP, 0.5188, 3.99, 0.111, 215, 108, FAB HU 15C1
1749, 4dp1X, 0.5188, 4.02, 0.102, 217, 108, THE 1.35 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 4.0
1750, 4alaL, 0.5188, 2.50, 0.146, 99, 89, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
1751, 3njhB, 0.5188, 4.04, 0.111, 216, 108, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1752, 1l4iA, 0.5188, 4.04, 0.111, 216, 108, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
1753, 6bfsL, 0.5187, 4.07, 0.089, 219, 112, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
1754, 5eukA, 0.5187, 4.07, 0.089, 219, 112, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
1755, 5do2L, 0.5187, 4.07, 0.089, 219, 112, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
1756, 4r7dF, 0.5187, 4.07, 0.089, 219, 112, FAB HU 15C1
1757, 3lhpL, 0.5187, 3.09, 0.122, 215, 98, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
1758, 3fo2L, 0.5187, 4.07, 0.089, 219, 112, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
1759, 3fo2A, 0.5187, 3.91, 0.103, 219, 107, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
1760, 3bn9E, 0.5187, 4.17, 0.143, 230, 112, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
1761, 6idgL, 0.5186, 3.95, 0.112, 212, 107, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
1762, 6dfjL, 0.5186, 3.93, 0.084, 210, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO DENV-1 ENVELOPE PROTEIN DIII 
1763, 5ihbC, 0.5186, 3.80, 0.073, 196, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33
1764, 5dr5L, 0.5186, 3.97, 0.084, 212, 107, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
1765, 4r7nH, 0.5186, 4.06, 0.089, 219, 112, FAB C2E3
1766, 4laqL, 0.5186, 3.94, 0.103, 213, 107, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
1767, 4j2qB, 0.5186, 3.93, 0.093, 213, 107, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1768, 4dp4X, 0.5186, 3.93, 0.075, 196, 107, THE 1.54 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 6.0
1769, 1r3jB, 0.5186, 3.97, 0.075, 211, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
1770, 1lcsA, 0.5186, 2.50, 0.146, 99, 89, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
1771, 6cdoB, 0.5185, 3.99, 0.112, 212, 107, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
1772, 5mvjB, 0.5185, 3.28, 0.112, 121, 98, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
1773, 5icxA, 0.5185, 2.74, 0.074, 189, 94, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
1774, 5gzoD, 0.5185, 3.97, 0.093, 212, 107, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
1775, 5bzdA, 0.5185, 3.95, 0.103, 212, 107, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1776, 4r7dH, 0.5185, 3.97, 0.093, 214, 107, FAB HU 15C1
1777, 4mswA, 0.5185, 3.99, 0.075, 211, 107, Y78 ESTER MUTANT OF KCSA IN HIGH K+
1778, 4m6nH, 0.5185, 3.99, 0.065, 111, 108, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
1779, 3fo1L, 0.5185, 4.04, 0.111, 216, 108, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
1780, 3cm9S, 0.5185, 4.03, 0.111, 216, 108, SOLUTION STRUCTURE OF HUMAN SIGA2
1781, 2n7aA, 0.5185, 3.92, 0.084, 211, 107, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN
1782, 2itcA, 0.5185, 3.99, 0.120, 217, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
1783, 2gcyA, 0.5185, 3.93, 0.084, 214, 107, HUMANIZED ANTIBODY C25 FAB FRAGMENT
1784, 1r3iH, 0.5185, 3.78, 0.073, 212, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
1785, 5opyL, 0.5184, 4.03, 0.083, 215, 108, CRYSTAL STRUCTURE OF ANTI-ALPHAVBETA3 INTEGRIN FAB LM609
1786, 5ff6A, 0.5184, 3.97, 0.084, 211, 107, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
1787, 5az2L, 0.5184, 4.08, 0.167, 118, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
1788, 4z8fL, 0.5184, 3.88, 0.048, 346, 105, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
1789, 4uujA, 0.5184, 2.50, 0.146, 99, 89, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
1790, 4mxvE, 0.5184, 4.08, 0.089, 219, 112, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
1791, 4am0D, 0.5184, 4.75, 0.066, 205, 122, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1792, 4am0B, 0.5184, 4.05, 0.111, 219, 108, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1793, 3stzA, 0.5184, 4.04, 0.157, 218, 108, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
1794, 3rfzC, 0.5184, 3.95, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
1795, 3or7A, 0.5184, 3.96, 0.093, 213, 107, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
1796, 3iu4L, 0.5184, 4.04, 0.083, 213, 108, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
1797, 2hfeA, 0.5184, 3.97, 0.084, 212, 107, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1798, 1k4dA, 0.5184, 4.08, 0.089, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
1799, 1fl5L, 0.5184, 3.99, 0.073, 213, 110, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
1800, 6bzuF, 0.5183, 4.04, 0.111, 216, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1801, 5ur8B, 0.5183, 3.81, 0.091, 585, 110, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
1802, 5ec1A, 0.5183, 3.80, 0.109, 145, 110, KCSA WITH V76ESTER MUTATION
1803, 5dtfL, 0.5183, 4.07, 0.089, 219, 112, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
1804, 4z95L, 0.5183, 4.01, 0.083, 216, 108, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
1805, 4jo4L, 0.5183, 4.08, 0.089, 219, 112, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
1806, 4dp5X, 0.5183, 4.00, 0.121, 212, 107, THE 1.88 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 8.0
1807, 3phqA, 0.5183, 3.95, 0.103, 213, 107, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
1808, 2oslH, 0.5183, 3.92, 0.103, 213, 107, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1809, 1nsnL, 0.5183, 3.95, 0.084, 214, 107, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
1810, 6c08B, 0.5182, 4.10, 0.089, 219, 112, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
1811, 5icyA, 0.5182, 3.91, 0.112, 211, 107, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
1812, 5hpmA, 0.5182, 3.97, 0.121, 212, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
1813, 3rfzF, 0.5182, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
1814, 3phoA, 0.5182, 4.08, 0.089, 219, 112, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
1815, 2oz4L, 0.5182, 2.98, 0.093, 201, 97, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
1816, 2ih1A, 0.5182, 4.06, 0.089, 219, 112, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
1817, 2b4cL, 0.5182, 3.96, 0.112, 213, 107, CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
1818, 1rmfH, 0.5182, 4.09, 0.089, 219, 112, STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1819, 1ngpH, 0.5182, 4.08, 0.089, 219, 112, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1820, 5yslA, 0.5181, 4.06, 0.111, 217, 108, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1821, 5vk6A, 0.5181, 4.02, 0.120, 214, 108, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
1822, 5j9pA, 0.5181, 3.94, 0.093, 215, 107, KCSA IN VITRO
1823, 5ezoL, 0.5181, 4.10, 0.080, 219, 112, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
1824, 4oiiI, 0.5181, 3.97, 0.093, 211, 107, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1825, 4oiiH, 0.5181, 3.95, 0.093, 214, 107, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1826, 4krpC, 0.5181, 3.95, 0.093, 214, 107, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
1827, 4dp6X, 0.5181, 2.51, 0.146, 99, 89, THE 1.67 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 8.0
1828, 4am0L, 0.5181, 4.00, 0.111, 216, 108, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1829, 2p7tA, 0.5181, 3.91, 0.118, 224, 110, CRYSTAL STRUCTURE OF KCSA MUTANT
1830, 2hvkA, 0.5181, 4.06, 0.111, 217, 108, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
1831, 1seqL, 0.5181, 4.01, 0.120, 215, 108, FAB MNAC13
1832, 1p2cD, 0.5181, 3.96, 0.103, 212, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
1833, 5x0tD, 0.5180, 3.95, 0.103, 213, 107, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
1834, 5v7rL, 0.5180, 3.00, 0.093, 201, 97, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-7.1 FAB
1835, 5th2C, 0.5180, 4.00, 0.111, 216, 108, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
1836, 5mp5F, 0.5180, 3.95, 0.121, 214, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
1837, 5mp5D, 0.5180, 4.08, 0.089, 219, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
1838, 5g64M, 0.5180, 4.03, 0.102, 215, 108, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
1839, 5fc9C, 0.5180, 4.11, 0.088, 216, 114, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1840, 4dp2X, 0.5180, 3.94, 0.109, 215, 110, THE 1.8 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 6.0
1841, 2qscL, 0.5180, 3.97, 0.082, 211, 110, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE
1842, 2jixL, 0.5180, 4.11, 0.080, 219, 112, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
1843, 1uwgX, 0.5180, 4.12, 0.080, 219, 112, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1844, 1riuL, 0.5180, 3.95, 0.103, 213, 107, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
1845, 1ahwD, 0.5180, 3.88, 0.109, 217, 110, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1846, 5t1mA, 0.5179, 3.88, 0.109, 217, 110, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
1847, 5etuA, 0.5179, 3.96, 0.093, 211, 107, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
1848, 4yhdC, 0.5179, 2.51, 0.146, 99, 89, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1849, 4ydjA, 0.5179, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1850, 4p3dB, 0.5179, 4.08, 0.089, 219, 112, MT1-MMP:FAB COMPLEX (FORM II)
1851, 4p3cL, 0.5179, 4.09, 0.089, 219, 112, MT1-MMP:FAB COMPLEX (FORM I)
1852, 4am0F, 0.5179, 3.89, 0.132, 208, 106, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1853, 2hg5A, 0.5179, 3.98, 0.131, 211, 107, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1854, 2h8pA, 0.5179, 3.98, 0.131, 213, 107, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1855, 1rfdL, 0.5179, 4.02, 0.102, 215, 108, ANTI-COCAINE ANTIBODY M82G2
1856, 1r3lB, 0.5179, 3.96, 0.103, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
1857, 1b6dA, 0.5179, 4.04, 0.130, 216, 108, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
1858, 6bftB, 0.5178, 4.03, 0.157, 218, 108, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
1859, 6attL, 0.5178, 3.93, 0.093, 214, 107, 39S FAB BOUND TO HER2 ECD 
1860, 5w0kF, 0.5178, 2.23, 0.148, 95, 88, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
1861, 5mvjD, 0.5178, 2.51, 0.146, 99, 89, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
1862, 5jhlL, 0.5178, 3.95, 0.084, 215, 107, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
1863, 5fc9B, 0.5178, 3.91, 0.093, 214, 107, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1864, 5dtfB, 0.5178, 3.94, 0.121, 213, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
1865, 4yhkH, 0.5178, 4.03, 0.120, 218, 108, REVERSAL AGENT FOR DABIGATRAN
1866, 4rgoL, 0.5178, 3.95, 0.112, 214, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
1867, 4odtL, 0.5178, 3.96, 0.103, 213, 107, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
1868, 3idxL, 0.5178, 3.96, 0.103, 213, 107, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C222
1869, 2itdA, 0.5178, 3.85, 0.074, 279, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
1870, 2ih3A, 0.5178, 4.05, 0.080, 238, 112, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
1871, 2dweA, 0.5178, 4.00, 0.120, 218, 108, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
1872, 1ze3C, 0.5178, 4.01, 0.120, 218, 108, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N- TERMINAL DOMAIN) WITH FIMC AND THE PILIN DOMAIN OF FIMH
1873, 1uwgL, 0.5178, 3.98, 0.121, 212, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1874, 1r3kB, 0.5178, 4.09, 0.089, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
1875, 1q72L, 0.5178, 4.09, 0.089, 219, 112, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
1876, 6d4aB, 0.5177, 4.02, 0.120, 218, 108, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1877, 6azkA, 0.5177, 4.09, 0.089, 219, 112, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
1878, 6aynA, 0.5177, 3.95, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
1879, 5yslC, 0.5177, 3.94, 0.093, 214, 107, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1880, 5sx5L, 0.5177, 4.04, 0.102, 220, 108, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
1881, 5o14L, 0.5177, 3.99, 0.121, 212, 107, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
1882, 5hyqA, 0.5177, 4.03, 0.157, 218, 108, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
1883, 5ebwA, 0.5177, 4.00, 0.121, 211, 107, KCSA WITH G77ESTER MUTATION
1884, 5dmiL, 0.5177, 2.24, 0.148, 95, 88, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
1885, 4p3dL, 0.5177, 3.98, 0.093, 214, 107, MT1-MMP:FAB COMPLEX (FORM II)
1886, 4oduB, 0.5177, 3.91, 0.082, 222, 110, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
1887, 4lu5L, 0.5177, 3.93, 0.112, 212, 107, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
1888, 4dp8X, 0.5177, 3.96, 0.093, 214, 107, THE 1.07 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 4.0
1889, 3u9pM, 0.5177, 4.01, 0.083, 214, 108, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
1890, 3o41B, 0.5177, 4.09, 0.089, 219, 112, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
1891, 1fl6A, 0.5177, 4.07, 0.089, 219, 112, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
1892, 6oc3D, 0.5176, 4.08, 0.089, 219, 112, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1893, 6ncpD, 0.5176, 2.85, 0.105, 205, 95, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
1894, 5l0qE, 0.5176, 3.94, 0.121, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
1895, 5ezjB, 0.5176, 4.09, 0.089, 219, 112, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
1896, 5eziL, 0.5176, 4.02, 0.120, 218, 108, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
1897, 4ywgM, 0.5176, 3.69, 0.073, 124, 109, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
1898, 3fzuL, 0.5176, 3.96, 0.103, 212, 107, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
1899, 3difC, 0.5176, 3.95, 0.103, 212, 107, CRYSTAL STRUCTURE OF FABOX117
1900, 2nr6E, 0.5176, 3.88, 0.083, 210, 108, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
1901, 1zglT, 0.5176, 3.94, 0.093, 212, 107, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1902, 1rhhA, 0.5176, 3.93, 0.093, 212, 107, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
1903, 1kcsL, 0.5176, 3.96, 0.103, 213, 107, CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
1904, 1fl6L, 0.5176, 4.11, 0.089, 218, 112, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
1905, 6oc3B, 0.5175, 3.96, 0.112, 213, 107, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1906, 6azlA, 0.5175, 4.00, 0.120, 218, 108, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
1907, 5x0tB, 0.5175, 3.96, 0.084, 212, 107, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
1908, 5trpL, 0.5175, 4.06, 0.111, 219, 108, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
1909, 5sx5K, 0.5175, 2.59, 0.148, 99, 88, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
1910, 5mp5L, 0.5175, 3.98, 0.112, 211, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
1911, 4r7nN, 0.5175, 4.00, 0.103, 217, 107, FAB C2E3
1912, 4mhhL, 0.5175, 4.02, 0.111, 217, 108, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
1913, 4lkcA, 0.5175, 3.92, 0.093, 213, 107, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
1914, 3njiA, 0.5175, 3.92, 0.084, 212, 107, S114A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1915, 3f7vA, 0.5175, 3.96, 0.121, 212, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
1916, 2hjfA, 0.5175, 3.94, 0.103, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
1917, 2dwdA, 0.5175, 3.96, 0.103, 214, 107, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
1918, 1qygL, 0.5175, 3.97, 0.093, 215, 107, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
1919, 6eynL, 0.5174, 3.95, 0.103, 213, 107, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
1920, 6c08E, 0.5174, 3.97, 0.140, 214, 107, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
1921, 5iv2A, 0.5174, 3.95, 0.140, 211, 107, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
1922, 5id0A, 0.5174, 3.98, 0.109, 226, 110, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
1923, 5ggqL, 0.5174, 4.00, 0.102, 215, 108, CRYSTAL STRUCTURE OF NIVOLUMAB FAB FRAGMENT
1924, 5cmaA, 0.5174, 4.00, 0.112, 214, 107, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
1925, 4x7tB, 0.5174, 4.05, 0.111, 217, 108, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
1926, 4r7nL, 0.5174, 3.93, 0.093, 213, 107, FAB C2E3
1927, 4i2xC, 0.5174, 3.95, 0.103, 212, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
1928, 4b0mM, 0.5174, 3.97, 0.131, 213, 107, COMPLEX OF THE CAF1AN USHER DOMAIN CAF1M CHAPERONE AND CAF1 SUBUNIT FROM YERSINIA PESTIS
1929, 3p0yL, 0.5174, 4.04, 0.102, 217, 108, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
1930, 3p0vM, 0.5174, 3.95, 0.093, 213, 107, ANTI-EGFR/HER3 FAB DL11 ALONE
1931, 3fb5A, 0.5174, 4.03, 0.157, 218, 108, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
1932, 2oslB, 0.5174, 3.98, 0.084, 211, 107, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1933, 2nr6C, 0.5174, 4.05, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
1934, 2gsiC, 0.5174, 3.97, 0.112, 213, 107, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
1935, 1l7iL, 0.5174, 3.22, 0.103, 119, 97, CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
1936, 6oe5C, 0.5173, 4.08, 0.089, 219, 112, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
1937, 6ocbL, 0.5173, 4.10, 0.080, 219, 112, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H3 (A/HONG KONG/1/1968) 
1938, 5vh4B, 0.5173, 4.10, 0.080, 219, 112, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
1939, 5mu0J, 0.5173, 4.04, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
1940, 4ncdA, 0.5173, 4.06, 0.102, 217, 108, CRYSTAL STRUCTURE OF CLASS 5 FIMBRIAE CHAPERONE CFAA
1941, 4m43H, 0.5173, 4.03, 0.111, 215, 108, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
1942, 4jo3M, 0.5173, 3.97, 0.103, 213, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
1943, 4hbcL, 0.5173, 3.97, 0.103, 212, 107, CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS
1944, 3hi6Y, 0.5173, 3.95, 0.084, 211, 107, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
1945, 3fb7A, 0.5173, 3.98, 0.103, 213, 107, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
1946, 3bj91, 0.5173, 4.02, 0.093, 218, 108, CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
1947, 1rhhC, 0.5173, 3.99, 0.084, 211, 107, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
1948, 6ncpB, 0.5172, 4.01, 0.140, 214, 107, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
1949, 6eynC, 0.5172, 3.15, 0.082, 212, 97, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
1950, 5xhvQ, 0.5172, 3.94, 0.084, 213, 107, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
1951, 5w0pC, 0.5172, 3.93, 0.084, 212, 107, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1952, 5uddT, 0.5172, 4.09, 0.089, 219, 112, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
1953, 5o4gA, 0.5172, 3.92, 0.132, 213, 106, HER2 IN COMPLEX WITH FAB MF3958 
1954, 5k9kB, 0.5172, 3.95, 0.131, 211, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
1955, 5j06C, 0.5172, 4.03, 0.102, 215, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1956, 3ulvF, 0.5172, 3.90, 0.093, 214, 107, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1957, 3qpqJ, 0.5172, 3.89, 0.113, 211, 106, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1958, 3ogcA, 0.5172, 3.94, 0.093, 213, 107, KCSA E71A VARIANT IN PRESENCE OF NA+
1959, 3gkwL, 0.5172, 3.98, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
1960, 3aazL, 0.5172, 4.05, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
1961, 2nljB, 0.5172, 3.37, 0.079, 211, 101, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
1962, 2jk5A, 0.5172, 4.07, 0.099, 219, 111, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
1963, 2jelH, 0.5172, 3.97, 0.093, 214, 107, JEL42 FAB/HPR COMPLEX
1964, 2atkA, 0.5172, 4.01, 0.103, 213, 107, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
1965, 1q9wA, 0.5172, 3.93, 0.093, 209, 107, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
1966, 1igfL, 0.5172, 4.09, 0.089, 219, 112, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
1967, 6foeL, 0.5171, 3.96, 0.156, 116, 109, BAXB01 FAB FRAGMENT
1968, 6csfB, 0.5171, 4.02, 0.102, 215, 108, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
1969, 5vh4L, 0.5171, 3.89, 0.084, 212, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
1970, 5mp1D, 0.5171, 4.05, 0.102, 207, 108, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
1971, 5ir1A, 0.5171, 3.96, 0.093, 214, 107, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
1972, 5i66B, 0.5171, 3.70, 0.038, 849, 104, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
1973, 5ebmB, 0.5171, 3.96, 0.093, 211, 107, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
1974, 5e1aB, 0.5171, 3.96, 0.103, 214, 107, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
1975, 5d4kB, 0.5171, 4.07, 0.093, 215, 108, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
1976, 4ztoL, 0.5171, 3.79, 0.073, 211, 109, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
1977, 4zsoB, 0.5171, 4.11, 0.099, 217, 111, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1978, 4dkfM, 0.5171, 4.02, 0.100, 216, 110, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
1979, 3v6oE, 0.5171, 4.14, 0.080, 219, 112, LEPTIN RECEPTOR-ANTIBODY COMPLEX
1980, 3pcyA, 0.5171, 4.03, 0.111, 199, 108, THE CRYSTAL STRUCTURE OF MERCURY-SUBSTITUTED POPLAR PLASTOCYANIN AT 1.9-ANGSTROMS RESOLUTION
1981, 3fzuD, 0.5171, 4.05, 0.130, 228, 108, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
1982, 1gpoM, 0.5171, 4.10, 0.089, 218, 112, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
1983, 1cz8L, 0.5171, 4.12, 0.080, 219, 112, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
1984, 1clzL, 0.5171, 3.80, 0.110, 218, 109, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
1985, 6f2sJ, 0.5170, 4.11, 0.089, 219, 112, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1986, 6f2sH, 0.5170, 4.04, 0.139, 219, 108, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1987, 6by2B, 0.5170, 4.04, 0.111, 219, 108, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
1988, 6by2A, 0.5170, 3.98, 0.112, 214, 107, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
1989, 6bfqB, 0.5170, 3.95, 0.140, 213, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
1990, 6au5A, 0.5170, 3.98, 0.093, 213, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
1991, 5o14D, 0.5170, 4.06, 0.157, 218, 108, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
1992, 5i2iA, 0.5170, 3.97, 0.103, 213, 107, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
1993, 5ezlL, 0.5170, 3.98, 0.121, 213, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
1994, 5dubB, 0.5170, 3.98, 0.121, 212, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
1995, 5bk3B, 0.5170, 3.98, 0.121, 212, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
1996, 4r7dD, 0.5170, 3.76, 0.093, 536, 108, FAB HU 15C1
1997, 4lcuA, 0.5170, 4.00, 0.121, 216, 107, STRUCTURE OF KCSA WITH E118A MUTATION
1998, 4lbeA, 0.5170, 3.96, 0.118, 218, 110, STRUCTURE OF KCSA WITH R122A MUTATION
1999, 4kphL, 0.5170, 3.99, 0.084, 207, 107, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
2000, 4jlrL, 0.5170, 4.04, 0.121, 213, 107, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
2001, 4jlrB, 0.5170, 2.55, 0.125, 99, 88, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
2002, 4gw1A, 0.5170, 3.96, 0.103, 213, 107, CQFD MEDITOPE
2003, 4g6jL, 0.5170, 4.03, 0.130, 218, 108, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
2004, 3i75A, 0.5170, 3.95, 0.093, 213, 107, ANTIBODY STRUCTURE
2005, 1zglP, 0.5170, 4.02, 0.120, 219, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2006, 1s3kL, 0.5170, 4.75, 0.076, 195, 118, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
2007, 1p2cA, 0.5170, 4.54, 0.069, 218, 116, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
2008, 1ncdL, 0.5170, 3.99, 0.121, 212, 107, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2009, 1jpsL, 0.5170, 4.11, 0.080, 219, 112, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
2010, 1ahwA, 0.5170, 3.97, 0.112, 212, 107, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2011, 6foeB, 0.5169, 3.97, 0.103, 212, 107, BAXB01 FAB FRAGMENT
2012, 6ellB, 0.5169, 3.94, 0.093, 215, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2013, 6cseB, 0.5169, 3.96, 0.103, 213, 107, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH L-ALANINE BOUND 
2014, 5wk3U, 0.5169, 3.96, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2015, 5t1kC, 0.5169, 4.00, 0.093, 214, 107, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
2016, 5mp5B, 0.5169, 4.01, 0.103, 217, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2017, 5i71C, 0.5169, 3.98, 0.084, 211, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
2018, 4yk4Y, 0.5169, 4.12, 0.089, 219, 112, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2019, 4x7sL, 0.5169, 4.13, 0.080, 219, 112, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
2020, 3hmwL, 0.5169, 3.89, 0.132, 209, 106, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
2021, 2cdeB, 0.5169, 3.89, 0.113, 210, 106, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2022, 6mi2D, 0.5168, 3.91, 0.113, 210, 106, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
2023, 6fg1L, 0.5168, 3.96, 0.103, 212, 107, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA32. 
2024, 6eljB, 0.5168, 3.99, 0.093, 212, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2025, 6bfqD, 0.5168, 3.98, 0.084, 212, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2026, 5t1mC, 0.5168, 3.99, 0.109, 242, 110, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
2027, 5t1lA, 0.5168, 4.01, 0.120, 216, 108, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
2028, 5n7wL, 0.5168, 3.99, 0.131, 212, 107, COMPUTATIONALLY DESIGNED FUNCTIONAL ANTIBODY 
2029, 5mvjF, 0.5168, 3.94, 0.140, 214, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2030, 5mu0N, 0.5168, 3.97, 0.084, 213, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2031, 5mu0F, 0.5168, 3.96, 0.112, 214, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2032, 5fuzL, 0.5168, 3.98, 0.112, 214, 107, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
2033, 4oqtL, 0.5168, 3.98, 0.103, 213, 107, LINGO-1/LI81 FAB COMPLEX
2034, 4lbeB, 0.5168, 3.97, 0.131, 213, 107, STRUCTURE OF KCSA WITH R122A MUTATION
2035, 4jo2L, 0.5168, 4.02, 0.073, 221, 109, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
2036, 4ffzL, 0.5168, 3.95, 0.103, 213, 107, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2037, 4dzbB, 0.5168, 4.04, 0.157, 217, 108, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
2038, 4dp7X, 0.5168, 3.99, 0.121, 214, 107, THE 1.08 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 4.0
2039, 3stzB, 0.5168, 3.96, 0.103, 211, 107, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
2040, 3ra7M, 0.5168, 4.01, 0.093, 218, 108, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
2041, 3qumC, 0.5168, 3.97, 0.093, 214, 107, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
2042, 3o41L, 0.5168, 4.11, 0.082, 244, 110, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
2043, 3l7fL, 0.5168, 4.09, 0.073, 210, 110, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2044, 3difA, 0.5168, 3.97, 0.103, 211, 107, CRYSTAL STRUCTURE OF FABOX117
2045, 2w0fA, 0.5168, 3.98, 0.103, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
2046, 2vl5B, 0.5168, 3.98, 0.112, 213, 107, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2047, 1qunO, 0.5168, 3.95, 0.103, 213, 107, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2048, 1qunK, 0.5168, 3.96, 0.103, 213, 107, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2049, 1ngxL, 0.5168, 3.93, 0.093, 211, 107, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
2050, 6f2sB, 0.5167, 4.04, 0.157, 218, 108, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2051, 6csfL, 0.5167, 4.05, 0.120, 215, 108, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
2052, 6bfqF, 0.5167, 4.06, 0.120, 216, 108, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2053, 5mp1K, 0.5167, 4.02, 0.093, 216, 108, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2054, 5iczA, 0.5167, 3.99, 0.093, 214, 107, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
2055, 5dfvF, 0.5167, 3.98, 0.121, 212, 107, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
2056, 4yzfL, 0.5167, 4.01, 0.102, 216, 108, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2057, 4xzuB, 0.5167, 4.03, 0.111, 216, 108, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2058, 4rgnC, 0.5167, 3.83, 0.112, 244, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2059, 4pozC, 0.5167, 2.60, 0.136, 99, 88, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
2060, 4plkK, 0.5167, 3.98, 0.121, 212, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2061, 4osuL, 0.5167, 4.00, 0.103, 211, 107, CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT
2062, 4mxvL, 0.5167, 4.06, 0.111, 218, 108, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2063, 4d3cL, 0.5167, 4.01, 0.103, 218, 107, CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68.
2064, 3l95L, 0.5167, 4.00, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
2065, 3igaA, 0.5167, 3.98, 0.150, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
2066, 2jixA, 0.5167, 4.12, 0.089, 218, 112, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2067, 2bobB, 0.5167, 4.03, 0.120, 217, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2068, 1xf5C, 0.5167, 2.81, 0.095, 198, 95, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
2069, 1ngxA, 0.5167, 2.81, 0.095, 198, 95, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
2070, 6f2sF, 0.5166, 3.97, 0.103, 213, 107, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2071, 6bjzL, 0.5166, 4.76, 0.076, 195, 118, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY CONTAINING THE FLUORESCENT NON-CANONICAL AMINO ACID L-(7- HYDROXYCOUMARIN-4-YL)ETHYLGLYCINE AT PH 5.5 
2072, 6bftL, 0.5166, 3.96, 0.140, 213, 107, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
2073, 6bfqL, 0.5166, 3.98, 0.103, 213, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2074, 5vkeB, 0.5166, 4.06, 0.157, 218, 108, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
2075, 5mu0P, 0.5166, 3.97, 0.103, 213, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2076, 5mu0D, 0.5166, 4.01, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2077, 5kanL, 0.5166, 3.97, 0.084, 218, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2078, 5f88A, 0.5166, 3.89, 0.142, 213, 106, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
2079, 5esqA, 0.5166, 3.94, 0.121, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
2080, 5bzdC, 0.5166, 3.97, 0.093, 211, 107, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2081, 4r97B, 0.5166, 3.99, 0.112, 208, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
2082, 4q6iA, 0.5166, 3.90, 0.093, 212, 107, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2083, 4p1xG, 0.5166, 3.95, 0.103, 211, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2084, 3k2uL, 0.5166, 3.97, 0.103, 209, 107, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
2085, 2v7hA, 0.5166, 3.96, 0.112, 212, 107, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
2086, 2o5yL, 0.5166, 4.13, 0.080, 219, 112, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
2087, 2bocA, 0.5166, 3.94, 0.093, 214, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2088, 1moeA, 0.5166, 3.99, 0.121, 212, 107, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
2089, 1iaiL, 0.5166, 4.07, 0.102, 220, 108, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2090, 1fj1A, 0.5166, 3.98, 0.103, 213, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2091, 1bj1J, 0.5166, 4.77, 0.076, 195, 118, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2092, 6flbL, 0.5165, 3.95, 0.103, 214, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
2093, 6bliK, 0.5165, 3.95, 0.093, 213, 107, RSV G PEPTIDE BOUND TO FAB CB002.5
2094, 5x2nL, 0.5165, 3.98, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2095, 5wuxD, 0.5165, 3.98, 0.121, 212, 107, TNFALPHA-CERTOLIZUMAB FAB
2096, 5mu2N, 0.5165, 4.06, 0.120, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2097, 5i1aA, 0.5165, 4.06, 0.120, 217, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
2098, 5fc9D, 0.5165, 4.01, 0.093, 214, 107, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
2099, 5d8jH, 0.5165, 3.96, 0.103, 213, 107, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
2100, 4yk4B, 0.5165, 3.97, 0.103, 213, 107, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2101, 4q6iL, 0.5165, 4.05, 0.083, 214, 108, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2102, 4q6iF, 0.5165, 3.98, 0.112, 214, 107, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2103, 4p1yA, 0.5165, 3.96, 0.121, 218, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2104, 4l5fL, 0.5165, 4.23, 0.106, 266, 113, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
2105, 4gw5A, 0.5165, 3.96, 0.103, 208, 107, CQYN MEDITOPE - CETUXIMAB FAB
2106, 4g3yL, 0.5165, 3.98, 0.084, 214, 107, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
2107, 4dpaX, 0.5165, 4.05, 0.130, 218, 108, THE 1.05 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 6.0
2108, 3stlB, 0.5165, 4.11, 0.080, 219, 112, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
2109, 3p0vL, 0.5165, 4.04, 0.111, 240, 108, ANTI-EGFR/HER3 FAB DL11 ALONE
2110, 3or6A, 0.5165, 3.99, 0.131, 214, 107, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
2111, 3hplA, 0.5165, 3.93, 0.103, 213, 107, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
2112, 3gb7A, 0.5165, 3.97, 0.093, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
2113, 2q8bL, 0.5165, 4.04, 0.093, 216, 108, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2114, 2ntfB, 0.5165, 3.98, 0.093, 214, 107, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
2115, 2ih1B, 0.5165, 4.04, 0.111, 216, 108, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2116, 2hjfB, 0.5165, 3.94, 0.084, 201, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
2117, 1rivL, 0.5165, 4.06, 0.120, 218, 108, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
2118, 6e4xY, 0.5164, 3.97, 0.084, 211, 107, HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2) 
2119, 6bliB, 0.5164, 2.27, 0.148, 95, 88, RSV G PEPTIDE BOUND TO FAB CB002.5
2120, 5mvjL, 0.5164, 4.10, 0.117, 216, 111, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2121, 5lfrB, 0.5164, 3.96, 0.103, 211, 107, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3
2122, 5ivzA, 0.5164, 3.97, 0.121, 218, 107, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
2123, 5iopA, 0.5164, 3.97, 0.121, 218, 107, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
2124, 5id1A, 0.5164, 4.23, 0.106, 267, 113, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
2125, 5gjtL, 0.5164, 3.97, 0.131, 213, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
2126, 4rgnL, 0.5164, 3.97, 0.103, 212, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2127, 4pljC, 0.5164, 3.98, 0.093, 214, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2128, 4nryL, 0.5164, 2.61, 0.136, 99, 88, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
2129, 4nrxL, 0.5164, 3.98, 0.121, 212, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2130, 4jo2M, 0.5164, 3.94, 0.093, 212, 107, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
2131, 4edwL, 0.5164, 4.09, 0.089, 219, 112, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
2132, 4a6yB, 0.5164, 4.10, 0.089, 219, 112, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
2133, 3iyoB, 0.5164, 4.10, 0.089, 219, 112, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
2134, 3gb7B, 0.5164, 3.95, 0.112, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
2135, 2jk5B, 0.5164, 4.07, 0.090, 222, 111, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
2136, 1xedF, 0.5164, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2137, 1hxmB, 0.5164, 3.97, 0.121, 212, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2138, 1cz8X, 0.5164, 4.04, 0.120, 218, 108, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2139, 6k7oC, 0.5163, 3.82, 0.114, 208, 105, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2140, 6eynA, 0.5163, 3.97, 0.093, 214, 107, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2141, 5x2pL, 0.5163, 4.04, 0.157, 219, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2142, 5vkhB, 0.5163, 3.88, 0.090, 312, 111, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
2143, 5nyxL, 0.5163, 3.97, 0.103, 213, 107, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2144, 5j0bD, 0.5163, 3.97, 0.103, 213, 107, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
2145, 5e1aA, 0.5163, 3.97, 0.103, 212, 107, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
2146, 5ds8L, 0.5163, 3.98, 0.093, 211, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE
2147, 4uujB, 0.5163, 3.95, 0.121, 213, 107, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
2148, 4nrxB, 0.5163, 3.98, 0.121, 201, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2149, 4nnpY, 0.5163, 3.97, 0.121, 207, 107, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
2150, 4nnpL, 0.5163, 3.96, 0.121, 213, 107, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
2151, 3zkmL, 0.5163, 4.03, 0.102, 216, 108, BACE2 FAB COMPLEX
2152, 3zkmD, 0.5163, 3.98, 0.103, 214, 107, BACE2 FAB COMPLEX
2153, 3ujjH, 0.5163, 3.84, 0.101, 214, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
2154, 3njhA, 0.5163, 4.10, 0.073, 468, 109, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
2155, 3iyoD, 0.5163, 3.98, 0.121, 212, 107, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
2156, 3f7vB, 0.5163, 3.99, 0.121, 212, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
2157, 3dggA, 0.5163, 3.63, 0.085, 111, 106, CRYSTAL STRUCTURE OF FABOX108
2158, 2o5zL, 0.5163, 4.30, 0.132, 230, 114, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
2159, 2ckbC, 0.5163, 3.95, 0.093, 213, 107, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
2160, 2ckbA, 0.5163, 4.06, 0.102, 218, 108, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
2161, 1ct8C, 0.5163, 4.07, 0.102, 214, 108, CATALYTIC ANTIBODY 7C8 COMPLEX
2162, 1bj1L, 0.5163, 4.05, 0.111, 217, 108, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2163, 6ol5B, 0.5162, 3.99, 0.121, 212, 107, STRUCTURE OF IGLB12 FAB IN COMPLEX WITH ANTI-IDIOTYPE IB3 FAB 
2164, 6nb8L, 0.5162, 3.96, 0.112, 211, 107, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
2165, 5x2oL, 0.5162, 3.68, 0.084, 209, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2166, 5wuvL, 0.5162, 4.15, 0.089, 219, 112, CRYSTAL STRUCTURE OF CERTOLIZUMAB FAB
2167, 5vkeA, 0.5162, 4.00, 0.084, 211, 107, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
2168, 5mu2B, 0.5162, 3.98, 0.121, 212, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2169, 5mhsG, 0.5162, 3.96, 0.121, 207, 107, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
2170, 5l0qB, 0.5162, 3.96, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
2171, 5k59L, 0.5162, 3.95, 0.093, 213, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2172, 5k59F, 0.5162, 4.06, 0.102, 217, 108, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2173, 5i6xC, 0.5162, 4.06, 0.102, 217, 108, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2174, 5i1gL, 0.5162, 4.11, 0.072, 230, 111, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11
2175, 5i1eL, 0.5162, 3.27, 0.112, 121, 98, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39
2176, 5i19L, 0.5162, 3.98, 0.046, 461, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39
2177, 5epmF, 0.5162, 3.98, 0.121, 212, 107, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
2178, 4gajL, 0.5162, 4.07, 0.102, 217, 108, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 411-424)
2179, 4dpbX, 0.5162, 4.06, 0.130, 218, 108, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 8.0
2180, 4dn3L, 0.5162, 3.95, 0.111, 202, 108, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
2181, 3sobL, 0.5162, 3.95, 0.111, 202, 108, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
2182, 3o2dL, 0.5162, 3.95, 0.103, 214, 107, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
2183, 3n9gL, 0.5162, 3.97, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354
2184, 3l7fD, 0.5162, 4.01, 0.112, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2185, 3jabQ, 0.5162, 4.05, 0.093, 219, 108, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
2186, 3jabH, 0.5162, 4.03, 0.111, 216, 108, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
2187, 3iywM, 0.5162, 3.96, 0.084, 213, 107, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
2188, 3iywL, 0.5162, 4.08, 0.089, 219, 112, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
2189, 3fb5B, 0.5162, 4.06, 0.120, 218, 108, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
2190, 3aazB, 0.5162, 4.09, 0.093, 205, 108, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
2191, 2oslL, 0.5162, 3.96, 0.121, 212, 107, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2192, 2dwdB, 0.5162, 3.97, 0.093, 212, 107, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
2193, 1ncbL, 0.5162, 3.96, 0.103, 212, 107, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2194, 1fptL, 0.5162, 3.99, 0.121, 214, 107, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
2195, 1fj1C, 0.5162, 3.97, 0.075, 211, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2196, 12e8H, 0.5162, 3.97, 0.093, 211, 107, 2E8 FAB FRAGMENT
2197, 6fn1C, 0.5161, 3.98, 0.084, 213, 107, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2198, 6flaB, 0.5161, 4.07, 0.120, 218, 108, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2199, 6f2sK, 0.5161, 4.07, 0.111, 215, 108, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2200, 6f2sI, 0.5161, 2.61, 0.136, 99, 88, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2201, 6apbL, 0.5161, 4.04, 0.093, 214, 108, CRYSTAL STRUCTURE OF NON-NEUTRALIZING INFANT ANTIBODY ADI-14359 IN COMPLEX WITH POSTFUSION RSV F GLYCOPROTEIN
2202, 5yxoA, 0.5161, 3.96, 0.103, 213, 107, CRYSTAL STRUCTURE OF SHAFT PILIN SPAD FROM LACTOBACILLUS RHAMNOSUS GG IN BENT CONFORMATION 
2203, 5yslG, 0.5161, 4.06, 0.120, 216, 108, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
2204, 5pcyA, 0.5161, 3.97, 0.121, 220, 107, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
2205, 5o1rL, 0.5161, 4.04, 0.093, 213, 107, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2206, 5mv4B, 0.5161, 4.01, 0.081, 221, 111, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2207, 5mu0L, 0.5161, 4.01, 0.081, 221, 111, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2208, 5itfA, 0.5161, 3.97, 0.121, 220, 107, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
2209, 5i1dA, 0.5161, 3.97, 0.121, 220, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
2210, 5drzL, 0.5161, 3.98, 0.121, 212, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
2211, 5do2D, 0.5161, 4.07, 0.130, 229, 108, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
2212, 5bo1L, 0.5161, 3.93, 0.132, 213, 106, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
2213, 5bk3F, 0.5161, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2214, 4zykL, 0.5161, 3.97, 0.140, 214, 107, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
2215, 4zykB, 0.5161, 4.06, 0.111, 219, 108, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
2216, 4zs6D, 0.5161, 3.93, 0.103, 213, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
2217, 4r7dL, 0.5161, 4.01, 0.081, 221, 111, FAB HU 15C1
2218, 4q6iD, 0.5161, 4.03, 0.099, 225, 111, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2219, 4pb9L, 0.5161, 4.06, 0.102, 216, 108, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
2220, 4njaL, 0.5161, 4.77, 0.076, 195, 118, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
2221, 4mwfL, 0.5161, 4.77, 0.076, 203, 118, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
2222, 4gw5C, 0.5161, 3.97, 0.093, 212, 107, CQYN MEDITOPE - CETUXIMAB FAB
2223, 4dpcX, 0.5161, 4.11, 0.063, 415, 111, THE 1.06 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 8.0
2224, 3o45L, 0.5161, 3.87, 0.083, 210, 108, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
2225, 3j3oL, 0.5161, 2.61, 0.136, 99, 88, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
2226, 3fb7B, 0.5161, 3.98, 0.112, 211, 107, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
2227, 3eoaL, 0.5161, 4.05, 0.120, 217, 108, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
2228, 2nljA, 0.5161, 4.06, 0.130, 217, 108, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2229, 2fjfW, 0.5161, 3.98, 0.103, 213, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2230, 1rz8A, 0.5161, 4.04, 0.111, 218, 108, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
2231, 1r3lA, 0.5161, 4.08, 0.102, 216, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
2232, 6pcyA, 0.5160, 4.00, 0.093, 214, 107, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
2233, 6eleL, 0.5160, 3.98, 0.112, 214, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2234, 6dw2A, 0.5160, 3.97, 0.103, 217, 107, STRUCTURE OF THE 6078 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2235, 6dcvA, 0.5160, 3.93, 0.084, 213, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2236, 5ye3A, 0.5160, 3.94, 0.084, 214, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 2A7D9 FAB FRAGMENT 
2237, 5xkuB, 0.5160, 3.96, 0.093, 210, 107, CRYSTAL STRUCTURE OF HEMAGGLUTININ GLOBULAR HEAD FROM AN H7N9 INFLUENZA VIRUS IN COMPLEX WITH A NEUTRALIZING ANTIBODY HNIGGA6
2238, 5x2qL, 0.5160, 3.99, 0.075, 211, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2239, 5x2mK, 0.5160, 3.96, 0.121, 218, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2240, 5w23M, 0.5160, 4.06, 0.102, 216, 108, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2241, 5vk6B, 0.5160, 4.04, 0.111, 217, 108, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
2242, 5tzuL, 0.5160, 3.99, 0.084, 212, 107, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2
2243, 5mu2L, 0.5160, 3.97, 0.103, 213, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2244, 5mu2J, 0.5160, 2.61, 0.136, 99, 88, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2245, 5mu2D, 0.5160, 4.01, 0.103, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2246, 5j9pB, 0.5160, 4.05, 0.111, 219, 108, KCSA IN VITRO
2247, 5ec1B, 0.5160, 3.98, 0.121, 212, 107, KCSA WITH V76ESTER MUTATION
2248, 4lmqL, 0.5160, 3.99, 0.103, 214, 107, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
2249, 4llyD, 0.5160, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
2250, 4jo1M, 0.5160, 3.96, 0.103, 211, 107, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
2251, 4i2xA, 0.5160, 4.00, 0.093, 214, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
2252, 4ffzY, 0.5160, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2253, 4dp9X, 0.5160, 2.39, 0.138, 99, 87, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 6.0
2254, 3igaB, 0.5160, 3.98, 0.103, 211, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
2255, 3hplB, 0.5160, 4.01, 0.093, 213, 107, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
2256, 3hfmL, 0.5160, 3.95, 0.103, 220, 107, STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
2257, 3eobL, 0.5160, 3.97, 0.103, 213, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
2258, 2xa8L, 0.5160, 3.99, 0.093, 211, 107, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2259, 2hvjB, 0.5160, 4.04, 0.111, 217, 108, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
2260, 2fjfC, 0.5160, 4.05, 0.111, 216, 108, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2261, 2arjL, 0.5160, 4.07, 0.111, 215, 108, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2262, 1q9wC, 0.5160, 3.99, 0.121, 212, 107, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2263, 1hxmH, 0.5160, 3.96, 0.112, 213, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2264, 1beyL, 0.5160, 4.06, 0.120, 218, 108, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
2265, 6mftB, 0.5159, 4.06, 0.130, 218, 108, CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN 
2266, 6mamB, 0.5159, 4.07, 0.130, 218, 108, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2267, 6fqaC, 0.5159, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
2268, 6ehwB, 0.5159, 3.99, 0.121, 209, 107, SCFV ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN DRUG DISCOVERY
2269, 5zs0A, 0.5159, 3.98, 0.112, 214, 107, STRUCTURE OF GLYCOPROTEIN B DOMAIN IV OF PSEUDORABIES VIRUS WITH 7B11 ANTIBODY 
2270, 5vshF, 0.5159, 3.96, 0.103, 209, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2271, 5v6lM, 0.5159, 4.02, 0.102, 216, 108, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A37 IN COMPLEX WITH V3 PEPTIDE JR-FL
2272, 5mv4V, 0.5159, 3.97, 0.140, 214, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2273, 5mv4J, 0.5159, 4.05, 0.111, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2274, 5mv4G, 0.5159, 2.62, 0.136, 99, 88, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2275, 5mv4D, 0.5159, 3.99, 0.121, 212, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2276, 5k9kL, 0.5159, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
2277, 5k9jL, 0.5159, 3.99, 0.121, 214, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
2278, 5f3bF, 0.5159, 3.98, 0.093, 214, 107, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
2279, 5ewiL, 0.5159, 4.03, 0.093, 218, 108, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90
2280, 5ec2B, 0.5159, 3.98, 0.121, 212, 107, KCSA WITH V76ESTER+G77DA MUTATIONS
2281, 5eblB, 0.5159, 3.96, 0.103, 211, 107, KCSA T75G IN THE CONDUCTIVE STATE
2282, 4yqxL, 0.5159, 3.99, 0.093, 211, 107, MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT
2283, 4mwfB, 0.5159, 4.06, 0.111, 219, 108, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
2284, 4k2uM, 0.5159, 4.29, 0.132, 230, 114, CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT
2285, 4jo1L, 0.5159, 3.95, 0.103, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
2286, 4g6mL, 0.5159, 3.83, 0.095, 209, 105, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
2287, 3t77A, 0.5159, 4.12, 0.083, 215, 109, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
2288, 3nzhL, 0.5159, 3.30, 0.071, 228, 98, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
2289, 3iyoA, 0.5159, 3.98, 0.103, 237, 107, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
2290, 2o5xL, 0.5159, 4.06, 0.121, 211, 107, CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
2291, 2itcB, 0.5159, 3.95, 0.112, 211, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
2292, 2gsiG, 0.5159, 4.04, 0.103, 215, 107, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2293, 1zwiA, 0.5159, 4.05, 0.120, 218, 108, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
2294, 1r3iL, 0.5159, 4.06, 0.120, 218, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
2295, 1pncA, 0.5159, 4.06, 0.120, 218, 108, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
2296, 1plcA, 0.5159, 4.05, 0.120, 217, 108, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN AT 1.33 ANGSTROMS RESOLUTION
2297, 1fskK, 0.5159, 4.08, 0.093, 215, 108, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2298, 1fskH, 0.5159, 3.96, 0.093, 212, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2299, 1fskE, 0.5159, 4.04, 0.112, 213, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2300, 1fskB, 0.5159, 4.02, 0.111, 217, 108, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2301, 6mamF, 0.5158, 3.99, 0.121, 212, 107, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2302, 6dcwL, 0.5158, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
2303, 6axpA, 0.5158, 3.92, 0.113, 117, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
2304, 5yupL, 0.5158, 3.92, 0.085, 211, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF FVIIA ANTIBODY MAB4F5 
2305, 5x2mL, 0.5158, 4.00, 0.084, 200, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2306, 5w23L, 0.5158, 4.02, 0.102, 216, 108, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2307, 5vshL, 0.5158, 3.97, 0.093, 213, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2308, 5mu2F, 0.5158, 4.05, 0.111, 219, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2309, 5mp1L, 0.5158, 3.98, 0.093, 214, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2310, 5lf5A, 0.5158, 4.10, 0.073, 468, 109, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) DEGLYCOSYLATED FULL EXTRACELLULAR DOMAIN WITH CO-PURIFIED LIGAND
2311, 4p1xC, 0.5158, 4.06, 0.130, 218, 108, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2312, 4m6mH, 0.5158, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
2313, 4llyB, 0.5158, 4.05, 0.102, 215, 108, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
2314, 4lluB, 0.5158, 4.11, 0.089, 219, 112, STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
2315, 4ki5D, 0.5158, 3.99, 0.121, 212, 107, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
2316, 4jreL, 0.5158, 2.61, 0.136, 99, 88, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2317, 4dvbL, 0.5158, 2.57, 0.125, 99, 88, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
2318, 3r1gL, 0.5158, 4.00, 0.140, 214, 107, STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY
2319, 3qpqH, 0.5158, 4.00, 0.140, 214, 107, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2320, 3or6B, 0.5158, 4.00, 0.140, 214, 107, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
2321, 2hfgL, 0.5158, 4.00, 0.140, 214, 107, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2322, 1uywN, 0.5158, 4.12, 0.092, 216, 109, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2323, 1k4dB, 0.5158, 3.96, 0.103, 219, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
2324, 1fl5A, 0.5158, 3.98, 0.103, 212, 107, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
2325, 6medD, 0.5157, 4.14, 0.120, 215, 108, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2326, 6f2sG, 0.5157, 4.04, 0.111, 217, 108, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2327, 6f2sE, 0.5157, 4.05, 0.111, 216, 108, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2328, 6eluC, 0.5157, 3.95, 0.112, 213, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2329, 6c5kL, 0.5157, 4.07, 0.120, 217, 108, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
2330, 6aynC, 0.5157, 4.07, 0.157, 218, 108, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
2331, 5yl1A, 0.5157, 3.90, 0.080, 484, 112, T=1 SUBVIRAL PARTICLE OF PENAEUS VANNAMEI NODAVIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-37  and 251-368) 
2332, 5x2pK, 0.5157, 4.23, 0.106, 267, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2333, 5vshD, 0.5157, 4.04, 0.072, 215, 111, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2334, 5uddR, 0.5157, 3.97, 0.103, 209, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2335, 5i8oL, 0.5157, 3.96, 0.103, 210, 107, HMM5 FAB IN COMPLEX WITH DISACCHARIDE
2336, 5i75C, 0.5157, 3.92, 0.142, 211, 106, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
2337, 5i73C, 0.5157, 3.97, 0.112, 211, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
2338, 5i1hL, 0.5157, 4.14, 0.120, 215, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20
2339, 5bk5G, 0.5157, 3.99, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2340, 4x7tL, 0.5157, 4.01, 0.100, 215, 110, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2341, 4p1xA, 0.5157, 3.98, 0.121, 212, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2342, 4ojfL, 0.5157, 3.98, 0.093, 213, 107, HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8
2343, 4nryB, 0.5157, 3.97, 0.121, 211, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
2344, 4j1uA, 0.5157, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2345, 4eowL, 0.5157, 4.08, 0.111, 217, 108, CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
2346, 3or7B, 0.5157, 3.99, 0.093, 212, 107, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
2347, 3hi1L, 0.5157, 4.78, 0.076, 195, 118, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
2348, 3d85A, 0.5157, 4.77, 0.076, 195, 118, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
2349, 3bszL, 0.5157, 4.07, 0.111, 217, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
2350, 2vxqL, 0.5157, 4.06, 0.111, 219, 108, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2351, 2hvkB, 0.5157, 3.95, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
2352, 1yuhH, 0.5157, 4.26, 0.081, 185, 111, FAB FRAGMENT
2353, 1mjjA, 0.5157, 4.05, 0.111, 216, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2354, 1egjL, 0.5157, 3.95, 0.112, 211, 107, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
2355, 1afvH, 0.5157, 3.96, 0.093, 211, 107, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2356, 6obzB, 0.5156, 4.03, 0.111, 217, 108, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2357, 6eljL, 0.5156, 4.00, 0.121, 214, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2358, 6azlC, 0.5156, 4.01, 0.121, 214, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
2359, 6azkC, 0.5156, 4.08, 0.083, 214, 108, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
2360, 5x2qK, 0.5156, 4.05, 0.102, 217, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2361, 5vshB, 0.5156, 3.94, 0.093, 218, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2362, 5mv4S, 0.5156, 4.23, 0.106, 265, 113, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2363, 5mv4P, 0.5156, 4.04, 0.102, 219, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2364, 5mv4M, 0.5156, 3.96, 0.121, 205, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2365, 5mu0H, 0.5156, 4.04, 0.093, 210, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2366, 5mp1G, 0.5156, 3.91, 0.113, 211, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2367, 5dubL, 0.5156, 4.00, 0.121, 212, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
2368, 5bk3L, 0.5156, 4.05, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2369, 4zs6L, 0.5156, 3.98, 0.112, 213, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
2370, 4yzfH, 0.5156, 4.09, 0.111, 215, 108, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2371, 4oduL, 0.5156, 3.92, 0.084, 213, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
2372, 4nylD, 0.5156, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
2373, 4ma3A, 0.5156, 4.05, 0.099, 218, 111, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
2374, 4m61C, 0.5156, 4.06, 0.093, 218, 108, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
2375, 4lu5M, 0.5156, 4.05, 0.093, 215, 108, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
2376, 4g6kL, 0.5156, 4.06, 0.108, 220, 111, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
2377, 4dvbB, 0.5156, 3.94, 0.093, 213, 107, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
2378, 3mxvL, 0.5156, 3.99, 0.103, 212, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
2379, 3hi1A, 0.5156, 3.97, 0.103, 212, 107, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
2380, 2r0kL, 0.5156, 3.96, 0.103, 212, 107, PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
2381, 2pcpA, 0.5156, 4.05, 0.111, 216, 108, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
2382, 2ntfH, 0.5156, 3.95, 0.112, 213, 107, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
2383, 2hvjA, 0.5156, 4.06, 0.120, 218, 108, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
2384, 2hfeB, 0.5156, 4.05, 0.120, 218, 108, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2385, 2aepL, 0.5156, 4.05, 0.120, 217, 108, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
2386, 1qunM, 0.5156, 4.06, 0.130, 217, 108, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2387, 1qunI, 0.5156, 4.08, 0.157, 218, 108, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2388, 1c5dA, 0.5156, 4.02, 0.093, 211, 107, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
2389, 1ai1L, 0.5156, 3.99, 0.103, 217, 107, HIV-1 V3 LOOP MIMIC
2390, 6mlkL, 0.5155, 3.98, 0.103, 210, 107, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
2391, 6i9iL, 0.5155, 3.98, 0.084, 218, 107, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
2392, 6gc2L, 0.5155, 3.98, 0.093, 212, 107, ABLIFT: ANTIBODY STABILITY AND AFFINITY OPTIMIZATION BY COMPUTATIONAL DESIGN OF THE VARIABLE LIGHT-HEAVY CHAIN INTERFACE 
2393, 6fg2M, 0.5155, 4.00, 0.093, 211, 107, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
2394, 6dfiL, 0.5155, 3.89, 0.103, 218, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII 
2395, 6dcaO, 0.5155, 4.04, 0.111, 219, 108, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
2396, 5x2oK, 0.5155, 4.06, 0.111, 219, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2397, 5wk3Q, 0.5155, 3.99, 0.093, 212, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2398, 5udcL, 0.5155, 4.14, 0.120, 215, 108, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2399, 5tkjJ, 0.5155, 3.98, 0.084, 212, 107, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2400, 5lfvB, 0.5155, 4.05, 0.102, 215, 108, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3 WITH SOAKED TRISACCHARIDE LIGAND
2401, 5f3bB, 0.5155, 3.97, 0.112, 214, 107, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
2402, 5ezlB, 0.5155, 4.05, 0.130, 216, 108, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
2403, 5ds8B, 0.5155, 4.09, 0.090, 222, 111, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE
2404, 5drnB, 0.5155, 4.05, 0.090, 218, 111, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
2405, 4p1xE, 0.5155, 4.00, 0.121, 211, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2406, 4mhhI, 0.5155, 4.02, 0.103, 129, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
2407, 3v0wL, 0.5155, 2.88, 0.094, 198, 96, CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
2408, 3qq9L, 0.5155, 2.88, 0.094, 198, 96, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
2409, 3o45B, 0.5155, 3.98, 0.112, 213, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
2410, 3ikcC, 0.5155, 4.05, 0.102, 215, 108, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2411, 2nyyC, 0.5155, 4.06, 0.093, 217, 108, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2412, 2itdB, 0.5155, 3.93, 0.103, 215, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
2413, 2ih3B, 0.5155, 3.95, 0.112, 214, 107, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
2414, 2g5bC, 0.5155, 3.97, 0.103, 211, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
2415, 2fjfE, 0.5155, 3.97, 0.084, 215, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2416, 2bobA, 0.5155, 4.08, 0.102, 215, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
2417, 1s5hA, 0.5155, 4.04, 0.111, 216, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
2418, 1a4kB, 0.5155, 4.05, 0.073, 221, 110, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
2419, 6obzL, 0.5154, 3.98, 0.093, 211, 107, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2420, 6c5kB, 0.5154, 3.83, 0.110, 211, 109, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
2421, 6au5C, 0.5154, 3.88, 0.099, 311, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
2422, 5x2nK, 0.5154, 4.04, 0.112, 213, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2423, 5vzxL, 0.5154, 3.98, 0.103, 213, 107, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2424, 5vr9L, 0.5154, 4.03, 0.093, 211, 107, CH1/CKAPPA FAB BASED ON MATUZUMAB
2425, 5tztB, 0.5154, 4.02, 0.083, 215, 108, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
2426, 5o1rM, 0.5154, 4.24, 0.106, 267, 113, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2427, 5mu2P, 0.5154, 4.08, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2428, 5mu2H, 0.5154, 3.99, 0.103, 211, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2429, 5mu0B, 0.5154, 4.09, 0.102, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2430, 5kmvL, 0.5154, 4.06, 0.111, 217, 108, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2431, 5gz0C, 0.5154, 4.03, 0.148, 217, 108, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
2432, 5f88C, 0.5154, 4.04, 0.074, 216, 108, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
2433, 5dgyB, 0.5154, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2434, 5bmfL, 0.5154, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
2435, 5b4mD, 0.5154, 4.04, 0.130, 217, 108, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2436, 4zwjB, 0.5154, 3.96, 0.103, 211, 107, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2437, 4zfgL, 0.5154, 4.11, 0.089, 219, 112, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
2438, 4p1yG, 0.5154, 4.00, 0.121, 211, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2439, 4o4yL, 0.5154, 4.01, 0.082, 219, 110, CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
2440, 4lcuB, 0.5154, 3.94, 0.093, 213, 107, STRUCTURE OF KCSA WITH E118A MUTATION
2441, 3zknL, 0.5154, 4.05, 0.111, 219, 108, BACE2 FAB INHIBITOR COMPLEX
2442, 3okmA, 0.5154, 3.97, 0.103, 213, 107, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
2443, 3i02C, 0.5154, 4.05, 0.111, 216, 108, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
2444, 3bszM, 0.5154, 4.04, 0.102, 218, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
2445, 2z4qA, 0.5154, 3.89, 0.104, 212, 106, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2446, 2qadD, 0.5154, 4.09, 0.102, 218, 108, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
2447, 2p7tB, 0.5154, 3.98, 0.112, 212, 107, CRYSTAL STRUCTURE OF KCSA MUTANT
2448, 2hg5B, 0.5154, 4.06, 0.120, 217, 108, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2449, 1uywL, 0.5154, 4.06, 0.130, 217, 108, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2450, 1h3pL, 0.5154, 4.06, 0.130, 217, 108, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
2451, 1ct8A, 0.5154, 4.04, 0.102, 218, 108, CATALYTIC ANTIBODY 7C8 COMPLEX
2452, 6medI, 0.5153, 3.97, 0.103, 213, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2453, 6flaL, 0.5153, 3.97, 0.103, 213, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2454, 6emjL, 0.5153, 3.94, 0.028, 673, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2455, 6d0uD, 0.5153, 4.03, 0.111, 216, 108, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2456, 5w42L, 0.5153, 4.08, 0.111, 218, 108, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2) 
2457, 5th2A, 0.5153, 3.94, 0.028, 673, 106, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
2458, 5mp3B, 0.5153, 4.05, 0.093, 213, 108, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
2459, 5j3dL, 0.5153, 4.24, 0.106, 266, 113, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
2460, 5hj3F, 0.5153, 3.91, 0.103, 218, 107, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
2461, 5drzA, 0.5153, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
2462, 4nkoA, 0.5153, 4.07, 0.111, 217, 108, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
2463, 4jhwL, 0.5153, 4.06, 0.120, 215, 108, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
2464, 4jhaL, 0.5153, 3.95, 0.112, 196, 107, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
2465, 4f8tA, 0.5153, 4.09, 0.111, 215, 108, CRYSTAL STRUCTURE OF THE HUMAN BTN3A3 ECTODOMAIN
2466, 4dkeM, 0.5153, 4.09, 0.120, 219, 108, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
2467, 3zknD, 0.5153, 4.33, 0.078, 229, 115, BACE2 FAB INHIBITOR COMPLEX
2468, 3qwoL, 0.5153, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
2469, 3mxwL, 0.5153, 3.99, 0.121, 212, 107, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
2470, 3ijhC, 0.5153, 3.97, 0.121, 212, 107, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2471, 2uylA, 0.5153, 4.09, 0.120, 219, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2472, 2dweB, 0.5153, 3.97, 0.112, 214, 107, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
2473, 2atkB, 0.5153, 4.00, 0.093, 213, 107, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
2474, 1yedA, 0.5153, 4.07, 0.102, 216, 108, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
2475, 1q9oC, 0.5153, 3.99, 0.103, 211, 107, S45-18 FAB UNLIGANDED
2476, 6fqaA, 0.5152, 4.01, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
2477, 6b5nL, 0.5152, 4.06, 0.093, 212, 108, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN PROTECTIVE ANTIBODY CIS43
2478, 5xrqB, 0.5152, 3.97, 0.103, 213, 107, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
2479, 5w1kN, 0.5152, 4.05, 0.157, 218, 108, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2480, 5w1kC, 0.5152, 3.99, 0.093, 215, 107, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2481, 5nb5M, 0.5152, 3.99, 0.093, 189, 107, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
2482, 5mv3J, 0.5152, 4.09, 0.102, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2483, 5kvfL, 0.5152, 4.07, 0.102, 115, 108, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
2484, 5hysD, 0.5152, 4.01, 0.093, 211, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2485, 5gjsL, 0.5152, 3.98, 0.093, 211, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
2486, 4rirA, 0.5152, 4.06, 0.110, 210, 109, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2487, 4p1yE, 0.5152, 3.97, 0.093, 212, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2488, 4mswB, 0.5152, 4.07, 0.111, 217, 108, Y78 ESTER MUTANT OF KCSA IN HIGH K+
2489, 4mhhK, 0.5152, 3.92, 0.113, 210, 106, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
2490, 3uluF, 0.5152, 3.98, 0.084, 212, 107, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2491, 3l7fA, 0.5152, 4.03, 0.148, 217, 108, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2492, 2qadH, 0.5152, 4.06, 0.120, 218, 108, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
2493, 2q8aL, 0.5152, 4.00, 0.121, 212, 107, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2494, 2oslA, 0.5152, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2495, 2op4H, 0.5152, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
2496, 1zwiB, 0.5152, 4.06, 0.120, 219, 108, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
2497, 1yedL, 0.5152, 3.31, 0.071, 229, 98, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
2498, 1jptL, 0.5152, 4.07, 0.102, 219, 108, CRYSTAL STRUCTURE OF FAB D3H44
2499, 1acyL, 0.5152, 4.07, 0.093, 212, 108, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
2500, 6mxsL, 0.5151, 4.07, 0.102, 211, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
2501, 6gk7L, 0.5151, 4.10, 0.102, 213, 108, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
2502, 6bzwB, 0.5151, 4.10, 0.102, 218, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
2503, 6by3B, 0.5151, 4.07, 0.130, 218, 108, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
2504, 6arpC, 0.5151, 3.96, 0.121, 220, 107, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
2505, 5wk3W, 0.5151, 4.06, 0.093, 217, 108, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2506, 5vebB, 0.5151, 4.00, 0.093, 207, 107, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
2507, 5t5fH, 0.5151, 4.17, 0.072, 219, 111, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
2508, 5mv3B, 0.5151, 4.24, 0.106, 265, 113, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2509, 5mubV, 0.5151, 4.00, 0.121, 212, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2510, 5mubM, 0.5151, 4.09, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2511, 5mubD, 0.5151, 4.14, 0.099, 217, 111, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2512, 5mhsD, 0.5151, 4.01, 0.103, 213, 107, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
2513, 5j06D, 0.5151, 4.33, 0.078, 229, 115, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
2514, 5ghuA, 0.5151, 3.97, 0.112, 214, 107, CRYSTAL STRUCTURE OF ECPD CHAPERONE AT 1.63 ANGSTROM
2515, 5eocL, 0.5151, 3.95, 0.118, 221, 110, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
2516, 5d1zC, 0.5151, 4.08, 0.090, 217, 111, ISDB NEAT1 BOUND BY CLONE D4-10
2517, 5b4mL, 0.5151, 3.98, 0.121, 212, 107, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2518, 4r7nR, 0.5151, 4.08, 0.120, 219, 108, FAB C2E3
2519, 4pj8D, 0.5151, 3.99, 0.084, 213, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
2520, 4m6oL, 0.5151, 4.05, 0.102, 215, 108, CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
2521, 4jr9L, 0.5151, 3.98, 0.092, 218, 109, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
2522, 4gayB, 0.5151, 4.07, 0.093, 216, 108, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
2523, 3qpqD, 0.5151, 4.08, 0.111, 217, 108, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2524, 3fb8B, 0.5151, 4.00, 0.121, 212, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
2525, 3fb6B, 0.5151, 3.98, 0.103, 213, 107, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
2526, 3f7yB, 0.5151, 4.04, 0.073, 221, 109, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
2527, 3f5wB, 0.5151, 3.98, 0.084, 215, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
2528, 3dggD, 0.5151, 4.10, 0.108, 212, 111, CRYSTAL STRUCTURE OF FABOX108
2529, 1r3jA, 0.5151, 4.08, 0.130, 218, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
2530, 1kcvL, 0.5151, 4.08, 0.120, 217, 108, CRYSTAL STRUCTURE OF ANTIBODY PC282
2531, 1k4cB, 0.5151, 4.07, 0.120, 217, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
2532, 6medB, 0.5150, 4.08, 0.120, 217, 108, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2533, 6k7oL, 0.5150, 4.11, 0.093, 214, 108, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2534, 6jfiI, 0.5150, 3.87, 0.046, 212, 108, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
2535, 6jfhI, 0.5150, 2.84, 0.097, 201, 93, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
2536, 6jepI, 0.5150, 4.10, 0.111, 216, 108, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
2537, 6idhL, 0.5150, 3.95, 0.093, 208, 107, ANTIBODY 64M-5 FAB IN LIGAND-FREE FORM 
2538, 6fbjL, 0.5150, 4.09, 0.111, 218, 108, MONOCLONAL ANTIBODY TARGETING MATRIX METALLOPROTEINASE 7 
2539, 6f2sA, 0.5150, 3.99, 0.084, 213, 107, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2540, 6eluI, 0.5150, 3.83, 0.103, 243, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2541, 6dcvL, 0.5150, 3.99, 0.103, 214, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2542, 6cseL, 0.5150, 3.98, 0.112, 211, 107, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH L-ALANINE BOUND 
2543, 6bzwF, 0.5150, 4.08, 0.111, 216, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
2544, 6axpC, 0.5150, 4.04, 0.100, 218, 110, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
2545, 5mv3M, 0.5150, 4.00, 0.121, 212, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2546, 5mv3G, 0.5150, 4.00, 0.121, 212, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2547, 5ebwB, 0.5150, 4.00, 0.121, 212, 107, KCSA WITH G77ESTER MUTATION
2548, 5dmgD, 0.5150, 4.00, 0.121, 212, 107, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
2549, 5cp3A, 0.5150, 4.08, 0.098, 215, 112, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
2550, 4zypG, 0.5150, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
2551, 4zsoD, 0.5150, 3.98, 0.112, 214, 107, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
2552, 4lexL, 0.5150, 4.00, 0.121, 212, 107, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
2553, 4hs6L, 0.5150, 4.00, 0.093, 213, 107, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
2554, 4hjjH, 0.5150, 4.06, 0.102, 218, 108, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
2555, 4dkfL, 0.5150, 3.88, 0.095, 214, 105, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
2556, 4a6yH, 0.5150, 3.88, 0.095, 214, 105, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
2557, 3t65A, 0.5150, 3.88, 0.095, 214, 105, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
2558, 3oklA, 0.5150, 4.08, 0.120, 217, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
2559, 3ojdA, 0.5150, 4.03, 0.112, 213, 107, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
2560, 3ijyC, 0.5150, 4.78, 0.076, 195, 118, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
2561, 2vl5C, 0.5150, 4.08, 0.111, 217, 108, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2562, 2uylM, 0.5150, 4.06, 0.102, 220, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2563, 2g60L, 0.5150, 3.97, 0.140, 213, 107, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
2564, 2g5bE, 0.5150, 4.09, 0.111, 217, 108, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
2565, 1yjdL, 0.5150, 3.97, 0.103, 212, 107, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
2566, 1xcqA, 0.5150, 4.07, 0.130, 218, 108, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2567, 1r3kA, 0.5150, 4.08, 0.120, 217, 108, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
2568, 1mlbA, 0.5150, 4.01, 0.121, 210, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
2569, 1i9jL, 0.5150, 4.05, 0.102, 217, 108, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
2570, 1ag6A, 0.5150, 4.04, 0.130, 218, 108, PLASTOCYANIN FROM SPINACH
2571, 6qkdT, 0.5149, 3.94, 0.084, 213, 107, CRYSTAL STRUCTURE OF VHH-BASED FAB-FRAGMENT OF ANTIBODY BCD-085 
2572, 6mqrL, 0.5149, 4.12, 0.117, 219, 111, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-A.01 IN COMPLEX WITH FP (RESIDUE 512-519) 
2573, 6k7oE, 0.5149, 4.05, 0.093, 217, 108, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2574, 6f2sD, 0.5149, 4.08, 0.093, 218, 108, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2575, 6emjB, 0.5149, 4.41, 0.087, 341, 115, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2576, 6dc8L, 0.5149, 3.98, 0.093, 212, 107, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
2577, 5yslE, 0.5149, 3.93, 0.099, 215, 111, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
2578, 5w23N, 0.5149, 4.04, 0.120, 219, 108, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2579, 5w1kM, 0.5149, 4.04, 0.148, 219, 108, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2580, 5vcoA, 0.5149, 3.99, 0.159, 214, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2581, 5tljG, 0.5149, 4.03, 0.148, 217, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
2582, 5otjL, 0.5149, 3.99, 0.118, 218, 110, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2583, 5mv3S, 0.5149, 4.07, 0.111, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2584, 5mv3D, 0.5149, 4.03, 0.130, 213, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2585, 5mhrG, 0.5149, 4.06, 0.111, 217, 108, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2586, 5gz0A, 0.5149, 4.01, 0.103, 212, 107, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
2587, 5ff6C, 0.5149, 4.03, 0.102, 220, 108, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
2588, 5epmA, 0.5149, 4.00, 0.121, 212, 107, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
2589, 5e2vL, 0.5149, 3.99, 0.121, 214, 107, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
2590, 5dgyD, 0.5149, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2591, 5bo1M, 0.5149, 2.52, 0.124, 99, 89, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
2592, 4zwjD, 0.5149, 4.06, 0.083, 213, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2593, 4pp2A, 0.5149, 3.98, 0.112, 213, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2594, 4j1uE, 0.5149, 4.09, 0.102, 218, 108, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2595, 4d9rL, 0.5149, 4.78, 0.076, 195, 118, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2596, 4bz1L, 0.5149, 4.00, 0.103, 213, 107, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
2597, 3uzqA, 0.5149, 4.07, 0.120, 218, 108, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2598, 3t4yA, 0.5149, 3.89, 0.083, 210, 108, S25-2- KDO MONOSACCHARIDE COMPLEX
2599, 3sgeI, 0.5149, 4.08, 0.111, 215, 108, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
2600, 3l7eA, 0.5149, 4.07, 0.102, 213, 108, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2601, 3ijsC, 0.5149, 4.02, 0.093, 211, 107, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
2602, 3cm9O, 0.5149, 3.98, 0.093, 215, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
2603, 3cm9N, 0.5149, 3.90, 0.112, 213, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
2604, 3cm9M, 0.5149, 4.06, 0.130, 218, 108, SOLUTION STRUCTURE OF HUMAN SIGA2
2605, 3cm9L, 0.5149, 4.06, 0.130, 217, 108, SOLUTION STRUCTURE OF HUMAN SIGA2
2606, 3bpcA, 0.5149, 3.99, 0.112, 211, 107, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
2607, 2y06H, 0.5149, 4.01, 0.103, 213, 107, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
2608, 2vq1A, 0.5149, 3.97, 0.103, 213, 107, ANTI TRIMERIC LEWIS X FAB54-5C10-A
2609, 2h8pB, 0.5149, 4.03, 0.100, 218, 110, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
2610, 2gjjA, 0.5149, 4.09, 0.083, 216, 108, CRYSTAL STRUCTURE OF A SINGLE CHAIN ANTIBODY SCA21 AGAINST HER2/ERBB2
2611, 2arjA, 0.5149, 3.94, 0.028, 833, 106, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2612, 1vpoL, 0.5149, 3.96, 0.112, 214, 107, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE
2613, 1afvK, 0.5149, 3.94, 0.028, 833, 106, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2614, 6fn4C, 0.5148, 4.02, 0.093, 211, 107, APO FORM OF UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2615, 6faxL, 0.5148, 3.97, 0.084, 214, 107, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
2616, 5yhlH, 0.5148, 4.00, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2617, 5w0pA, 0.5148, 4.07, 0.139, 218, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
2618, 5vjqF, 0.5148, 4.08, 0.073, 234, 110, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2619, 5vebL, 0.5148, 4.05, 0.120, 219, 108, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
2620, 5tztL, 0.5148, 4.09, 0.111, 219, 108, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
2621, 5iblH, 0.5148, 4.00, 0.093, 213, 107, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2622, 5etuC, 0.5148, 4.04, 0.148, 216, 108, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
2623, 5dqdL, 0.5148, 4.02, 0.093, 214, 107, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
2624, 5bk5A, 0.5148, 4.02, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2625, 5bk3D, 0.5148, 4.02, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2626, 4pljL, 0.5148, 4.02, 0.093, 214, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2627, 4nylF, 0.5148, 4.06, 0.111, 216, 108, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
2628, 4nylB, 0.5148, 4.04, 0.099, 215, 111, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
2629, 4jreC, 0.5148, 4.05, 0.111, 216, 108, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2630, 4hixL, 0.5148, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE
2631, 4g6aD, 0.5148, 4.04, 0.121, 236, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
2632, 4d9qL, 0.5148, 4.00, 0.093, 211, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2633, 3okkA, 0.5148, 4.07, 0.120, 219, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
2634, 2y07H, 0.5148, 4.06, 0.108, 220, 111, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
2635, 2uylX, 0.5148, 4.09, 0.099, 225, 111, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2636, 2r0lL, 0.5148, 4.00, 0.084, 211, 107, SHORT FORM HGFA WITH INHIBITORY FAB75
2637, 2g5bA, 0.5148, 4.29, 0.096, 223, 115, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
2638, 1yy8C, 0.5148, 3.89, 0.038, 847, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
2639, 1pndA, 0.5148, 3.98, 0.121, 212, 107, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
2640, 1n7mL, 0.5148, 4.00, 0.093, 215, 107, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
2641, 1f11C, 0.5148, 4.09, 0.102, 219, 108, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
2642, 6okqE, 0.5147, 3.92, 0.083, 216, 108, CRYSTAL STRUCTURE OF THE SF12 FAB 
2643, 6mi2A, 0.5147, 3.97, 0.103, 213, 107, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
2644, 6h3uL, 0.5147, 4.08, 0.120, 217, 108, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
2645, 6dwaL, 0.5147, 4.06, 0.102, 219, 108, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2646, 6bf4C, 0.5147, 3.99, 0.103, 217, 107, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
2647, 6awqC, 0.5147, 4.01, 0.131, 212, 107, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
2648, 6awoC, 0.5147, 3.94, 0.094, 124, 106, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
2649, 5x31A, 0.5147, 3.93, 0.103, 117, 107, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
2650, 5wuxB, 0.5147, 3.99, 0.112, 211, 107, TNFALPHA-CERTOLIZUMAB FAB
2651, 5mubB, 0.5147, 4.05, 0.102, 219, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2652, 5i76C, 0.5147, 4.08, 0.111, 218, 108, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
2653, 5i74C, 0.5147, 4.01, 0.093, 213, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
2654, 5d96I, 0.5147, 4.05, 0.120, 220, 108, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
2655, 4m61A, 0.5147, 4.06, 0.099, 215, 111, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
2656, 4kxzL, 0.5147, 4.06, 0.120, 216, 108, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
2657, 4jzjH, 0.5147, 3.99, 0.112, 214, 107, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
2658, 4fnlM, 0.5147, 4.05, 0.111, 217, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
2659, 3e8uL, 0.5147, 3.98, 0.103, 213, 107, CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
2660, 2y5tB, 0.5147, 2.42, 0.138, 99, 87, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
2661, 2w0fB, 0.5147, 3.96, 0.082, 216, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
2662, 2vl5A, 0.5147, 4.08, 0.102, 216, 108, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2663, 1q9lA, 0.5147, 3.98, 0.093, 210, 107, S25-2 FAB UNLIGANDED 2
2664, 1nakL, 0.5147, 4.15, 0.071, 209, 112, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
2665, 6eluF, 0.5146, 3.96, 0.075, 113, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2666, 5w24L, 0.5146, 4.06, 0.102, 219, 108, CRYSTAL STRUCTURE OF 5C4 FAB
2667, 5vjqD, 0.5146, 4.08, 0.102, 219, 108, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2668, 5vcoC, 0.5146, 4.01, 0.121, 214, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2669, 5th9M, 0.5146, 4.01, 0.121, 214, 107, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
2670, 5mubJ, 0.5146, 2.70, 0.148, 125, 88, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2671, 5mthB, 0.5146, 3.97, 0.093, 212, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
2672, 5mp3L, 0.5146, 4.08, 0.130, 217, 108, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
2673, 5i1aL, 0.5146, 3.98, 0.103, 213, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
2674, 5hyqC, 0.5146, 4.02, 0.121, 214, 107, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
2675, 5hpmC, 0.5146, 4.03, 0.112, 214, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
2676, 5bk5C, 0.5146, 4.02, 0.120, 219, 108, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2677, 4pp2C, 0.5146, 4.12, 0.093, 213, 108, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
2678, 4p1yC, 0.5146, 4.05, 0.090, 215, 111, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
2679, 4mauL, 0.5146, 3.98, 0.084, 213, 107, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
2680, 4k3jL, 0.5146, 4.08, 0.111, 216, 108, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
2681, 4fqrj, 0.5146, 4.05, 0.120, 218, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2682, 4fqrd, 0.5146, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2683, 4etqB, 0.5146, 4.16, 0.117, 218, 111, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
2684, 3mo1A, 0.5146, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
2685, 3hzkA, 0.5146, 3.98, 0.131, 217, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
2686, 3f8uB, 0.5146, 4.09, 0.111, 217, 108, TAPASIN/ERP57 HETERODIMER
2687, 2j5lB, 0.5146, 4.08, 0.111, 215, 108, STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2688, 2hffL, 0.5146, 4.01, 0.121, 213, 107, CRYSTAL STRUCTURE OF CB2 FAB
2689, 2gsiA, 0.5146, 4.01, 0.093, 211, 107, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2690, 2fjhL, 0.5146, 3.98, 0.103, 214, 107, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
2691, 1oowA, 0.5146, 4.08, 0.130, 217, 108, THE CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN DOUBLE MUTANT G8D/L12E GIVES INSIGHT INTO ITS LOW REACTIVITY TOWARDS PHOTOSYSTEM 1 AND CYTOCHROME F
2692, 1lo4L, 0.5146, 4.08, 0.120, 218, 108, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
2693, 6iuvL, 0.5145, 4.06, 0.157, 218, 108, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
2694, 6fg2L, 0.5145, 3.96, 0.075, 212, 107, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
2695, 6ellL, 0.5145, 3.97, 0.103, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2696, 6eleB, 0.5145, 3.97, 0.103, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2697, 6bf4L, 0.5145, 4.06, 0.102, 217, 108, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
2698, 5ywyH, 0.5145, 4.01, 0.093, 211, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2699, 5wuxL, 0.5145, 4.22, 0.115, 266, 113, TNFALPHA-CERTOLIZUMAB FAB
2700, 5w1kH, 0.5145, 4.07, 0.111, 216, 108, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2701, 5mubP, 0.5145, 4.05, 0.102, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2702, 5mubG, 0.5145, 3.99, 0.084, 213, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2703, 5id1C, 0.5145, 3.99, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
2704, 5e2tL, 0.5145, 3.92, 0.132, 212, 106, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB
2705, 4qxuL, 0.5145, 4.04, 0.102, 218, 108, NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY
2706, 3ulvH, 0.5145, 3.97, 0.103, 218, 107, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2707, 3oz9L, 0.5145, 4.40, 0.061, 361, 114, CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
2708, 3okoA, 0.5145, 3.95, 0.113, 212, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
2709, 3l7eL, 0.5145, 3.98, 0.112, 211, 107, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2710, 3ixtL, 0.5145, 4.06, 0.102, 215, 108, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
2711, 3ixtB, 0.5145, 3.97, 0.084, 214, 107, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
2712, 2r2bA, 0.5145, 2.37, 0.138, 99, 87, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2713, 2r1xA, 0.5145, 4.04, 0.111, 217, 108, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2714, 2qqkL, 0.5145, 4.01, 0.102, 215, 108, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2715, 1ngwL, 0.5145, 3.98, 0.103, 211, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2716, 1ngwA, 0.5145, 4.01, 0.103, 213, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2717, 1f11A, 0.5145, 4.00, 0.093, 213, 107, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
2718, 1byoA, 0.5145, 4.10, 0.102, 218, 108, WILD-TYPE PLASTOCYANIN FROM SILENE
2719, 6bzyL, 0.5144, 4.29, 0.096, 223, 115, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
2720, 5vxrL, 0.5144, 3.99, 0.093, 213, 107, THE ANTIGEN-BINDING FRAGMENT OF MAB24 IN COMPLEX WITH A PEPTIDE FROM HEPATITIS C VIRUS E2 EPITOPE I (412-423)
2721, 5vjoD, 0.5144, 4.12, 0.102, 213, 108, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2722, 5uddS, 0.5144, 4.08, 0.130, 217, 108, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2723, 5mv3V, 0.5144, 4.08, 0.130, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2724, 4z5rT, 0.5144, 3.97, 0.103, 212, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2725, 4of0A, 0.5144, 4.09, 0.102, 216, 108, CRYSTAL STRUCTURE OF SYG-1 D1-D2 REFOLDED
2726, 4ma3L, 0.5144, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
2727, 4hgwA, 0.5144, 4.03, 0.083, 225, 109, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
2728, 3wkmL, 0.5144, 3.87, 0.132, 211, 106, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
2729, 3b2vL, 0.5144, 4.06, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
2730, 2wucL, 0.5144, 4.01, 0.093, 213, 107, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON- INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
2731, 2uylV, 0.5144, 3.93, 0.104, 211, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2732, 2pcfA, 0.5144, 3.93, 0.104, 210, 106, THE COMPLEX OF CYTOCHROME F AND PLASTOCYANIN DETERMINED WITH PARAMAGNETIC NMR. BASED ON THE STRUCTURES OF CYTOCHROME F AND PLASTOCYANIN 10 STRUCTURES
2733, 2gk0L, 0.5144, 4.05, 0.120, 217, 108, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
2734, 1t4kC, 0.5144, 4.05, 0.120, 219, 108, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
2735, 1qunC, 0.5144, 4.00, 0.103, 211, 107, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2736, 1q9lC, 0.5144, 4.02, 0.093, 213, 107, S25-2 FAB UNLIGANDED 2
2737, 1gafH, 0.5144, 4.02, 0.093, 213, 107, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
2738, 6ogxD, 0.5143, 4.09, 0.102, 216, 108, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
2739, 6mxsB, 0.5143, 2.63, 0.135, 99, 89, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
2740, 6igwA, 0.5143, 4.06, 0.111, 215, 108, MPZL1 MUTANT - S86G; V145G; Q146K;P147T;G148S 
2741, 6bzwD, 0.5143, 4.05, 0.111, 217, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
2742, 6bpaC, 0.5143, 4.00, 0.112, 211, 107, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
2743, 6aniH, 0.5143, 3.99, 0.093, 211, 107, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
2744, 5mubS, 0.5143, 4.08, 0.130, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
2745, 5k59A, 0.5143, 4.00, 0.093, 217, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2746, 5iopC, 0.5143, 3.68, 0.067, 226, 105, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
2747, 5d96B, 0.5143, 3.92, 0.103, 218, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
2748, 4z5rV, 0.5143, 4.05, 0.120, 217, 108, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2749, 4z5rA, 0.5143, 4.14, 0.111, 215, 108, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2750, 4y2oA, 0.5143, 4.03, 0.084, 213, 107, STRUCTURE OF CFA/I PILI CHAPERONE-MAJOR SUBUNIT COMPLEX (CFAA-CFAB)
2751, 4otxL, 0.5143, 4.00, 0.103, 214, 107, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
2752, 3okdA, 0.5143, 4.06, 0.120, 216, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
2753, 3gi8L, 0.5143, 2.67, 0.135, 99, 89, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2754, 3cfeL, 0.5143, 4.10, 0.120, 217, 108, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
2755, 3cfeA, 0.5143, 4.09, 0.093, 217, 108, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
2756, 3cfdA, 0.5143, 2.95, 0.094, 200, 96, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
2757, 2xknC, 0.5143, 4.09, 0.111, 219, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
2758, 2nz9E, 0.5143, 4.02, 0.099, 217, 111, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2759, 2hffA, 0.5143, 4.00, 0.093, 213, 107, CRYSTAL STRUCTURE OF CB2 FAB
2760, 1yeeL, 0.5143, 4.01, 0.092, 217, 109, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.5)
2761, 1xedA, 0.5143, 4.03, 0.091, 119, 110, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2762, 1qunE, 0.5143, 4.09, 0.111, 216, 108, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2763, 1ngyA, 0.5143, 4.01, 0.103, 212, 107, CHIMERIC MATURE FAB 7G12-APO
2764, 1mjuL, 0.5143, 4.12, 0.108, 216, 111, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
2765, 1i9iL, 0.5143, 4.08, 0.130, 217, 108, NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
2766, 6o39A, 0.5142, 4.03, 0.081, 292, 111, CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH F2.I FAB 
2767, 6n81D, 0.5142, 3.99, 0.103, 213, 107, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
2768, 6azmA, 0.5142, 4.03, 0.121, 214, 107, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
2769, 6aq7L, 0.5142, 4.00, 0.093, 217, 107, STRUCTURE OF POM6 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC
2770, 5wk3S, 0.5142, 4.00, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2771, 5vzxI, 0.5142, 3.27, 0.070, 211, 100, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2772, 5tlkG, 0.5142, 4.07, 0.120, 211, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
2773, 5tlkA, 0.5142, 4.05, 0.148, 219, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
2774, 5mx3L, 0.5142, 4.06, 0.148, 220, 108, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
2775, 5lspT, 0.5142, 4.01, 0.093, 213, 107, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
2776, 5kmvI, 0.5142, 4.01, 0.093, 213, 107, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2777, 5itfC, 0.5142, 4.02, 0.093, 213, 107, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
2778, 5i15L, 0.5142, 3.96, 0.075, 213, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
2779, 5fb8A, 0.5142, 4.05, 0.074, 216, 108, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
2780, 5drnL, 0.5142, 3.98, 0.103, 213, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
2781, 5cp7E, 0.5142, 4.05, 0.120, 219, 108, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
2782, 5aumB, 0.5142, 3.35, 0.088, 111, 102, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
2783, 4z5rP, 0.5142, 2.95, 0.094, 200, 96, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2784, 4z5rJ, 0.5142, 3.99, 0.103, 213, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2785, 4wcyL, 0.5142, 4.12, 0.111, 219, 108, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
2786, 4otxM, 0.5142, 4.09, 0.120, 219, 108, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
2787, 4fqrp, 0.5142, 3.93, 0.103, 212, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2788, 4d9rD, 0.5142, 3.99, 0.093, 211, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2789, 3sy0A, 0.5142, 4.08, 0.111, 219, 108, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
2790, 3o2wL, 0.5142, 3.98, 0.112, 216, 107, CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
2791, 2r2hA, 0.5142, 4.03, 0.073, 221, 109, STRUCTURE OF S25-2 IN COMPLEX WITH KO
2792, 2b3iA, 0.5142, 4.06, 0.102, 219, 108, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (19 STRUCTURES)
2793, 1qunG, 0.5142, 4.09, 0.093, 215, 108, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2794, 1qunA, 0.5142, 4.09, 0.102, 215, 108, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
2795, 1nccL, 0.5142, 4.07, 0.148, 218, 108, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2796, 1nakM, 0.5142, 4.00, 0.103, 212, 107, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
2797, 1hxmD, 0.5142, 4.06, 0.102, 219, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2798, 1ejoL, 0.5142, 3.98, 0.103, 213, 107, FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
2799, 1a3rL, 0.5142, 4.01, 0.103, 214, 107, FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
2800, 6oknB, 0.5141, 4.10, 0.102, 218, 108, OX40R (TNFRSF4) BOUND TO FAB 1A7 
2801, 6my5L, 0.5141, 4.02, 0.093, 213, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
2802, 6d9gB, 0.5141, 4.06, 0.130, 218, 108, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
2803, 6d0uF, 0.5141, 4.08, 0.111, 216, 108, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2804, 6bzuD, 0.5141, 4.01, 0.093, 217, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2805, 5x4gB, 0.5141, 4.00, 0.093, 217, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD147 MONOCLONAL ANTIBODY 6H8
2806, 5iv2C, 0.5141, 4.06, 0.102, 217, 108, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
2807, 5a16D, 0.5141, 4.04, 0.120, 213, 108, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
2808, 4zffB, 0.5141, 3.99, 0.084, 213, 107, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
2809, 4nrxE, 0.5141, 4.00, 0.103, 213, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2810, 4fnlL, 0.5141, 4.04, 0.120, 219, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
2811, 4ebqL, 0.5141, 4.10, 0.111, 218, 108, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
2812, 3ulvL, 0.5141, 4.05, 0.120, 219, 108, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2813, 3uluH, 0.5141, 3.00, 0.152, 97, 92, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2814, 3hr5L, 0.5141, 2.96, 0.094, 200, 96, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2815, 3gnmL, 0.5141, 2.96, 0.094, 200, 96, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
2816, 3fctC, 0.5141, 3.98, 0.150, 214, 107, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
2817, 3eobA, 0.5141, 3.98, 0.131, 217, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
2818, 3cfdL, 0.5141, 4.33, 0.132, 230, 114, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
2819, 2vl5D, 0.5141, 4.06, 0.102, 216, 108, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2820, 2r2eA, 0.5141, 3.98, 0.112, 220, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2821, 2fjgL, 0.5141, 4.06, 0.084, 213, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
2822, 1ncaL, 0.5141, 4.03, 0.119, 218, 109, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2823, 1iqwL, 0.5141, 4.01, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
2824, 1cicA, 0.5141, 4.01, 0.093, 213, 107, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
2825, 6n81L, 0.5140, 4.01, 0.121, 214, 107, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
2826, 6jmqD, 0.5140, 4.06, 0.131, 213, 107, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
2827, 6f2sC, 0.5140, 3.99, 0.103, 213, 107, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2828, 6arpA, 0.5140, 4.01, 0.084, 218, 107, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
2829, 5y9cL, 0.5140, 4.09, 0.093, 210, 108, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
2830, 5uixL, 0.5140, 3.99, 0.121, 211, 107, CRYSTAL STRUCTURE OF THE DH576 CD4BS FAB (UNLIGANDED) FROM THE RV305 HIV VACCINE TRIAL
2831, 5tkjG, 0.5140, 3.99, 0.084, 213, 107, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2832, 5t1lC, 0.5140, 3.93, 0.132, 211, 106, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
2833, 5icyC, 0.5140, 3.95, 0.084, 214, 107, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
2834, 5e94C, 0.5140, 4.06, 0.082, 225, 110, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
2835, 5dwuL, 0.5140, 4.05, 0.102, 219, 108, BETA COMMON RECEPTOR IN COMPLEX WITH A FAB
2836, 5dlmL, 0.5140, 4.07, 0.120, 217, 108, COMPLEX OF INFLUENZA M2E AND ANTIBODY
2837, 5cusO, 0.5140, 3.99, 0.093, 213, 107, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
2838, 5a16F, 0.5140, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
2839, 4zypE, 0.5140, 4.02, 0.093, 213, 107, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
2840, 4z5rL, 0.5140, 4.07, 0.120, 216, 108, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2841, 4m7kL, 0.5140, 4.09, 0.111, 219, 108, CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
2842, 4kuzL, 0.5140, 4.00, 0.093, 211, 107, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
2843, 4f8qA, 0.5140, 3.98, 0.140, 214, 107, CRYSTAL STRUCTURE OF THE HUMAN BTN3A2 ECTODOMAIN
2844, 4dtgL, 0.5140, 4.10, 0.111, 215, 108, HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
2845, 3oknA, 0.5140, 4.02, 0.150, 214, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
2846, 3mlwH, 0.5140, 4.01, 0.093, 211, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
2847, 3j3pL, 0.5140, 4.03, 0.102, 219, 108, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
2848, 3hr5Q, 0.5140, 4.80, 0.076, 195, 118, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2849, 2qr0S, 0.5140, 3.99, 0.103, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
2850, 2cdeD, 0.5140, 4.00, 0.112, 203, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2851, 2bocB, 0.5140, 3.98, 0.103, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
2852, 1lcsB, 0.5140, 3.91, 0.118, 208, 110, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
2853, 1l4iB, 0.5140, 3.99, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
2854, 1ibgL, 0.5140, 3.98, 0.103, 212, 107, STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
2855, 1bbdL, 0.5140, 3.98, 0.075, 214, 107, THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
2856, 6qexC, 0.5139, 4.04, 0.103, 207, 107, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
2857, 6mqmE, 0.5139, 4.09, 0.120, 217, 108, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
2858, 6i04D, 0.5139, 3.86, 0.113, 200, 106, CRYSTAL STRUCTURE OF SEMA DOMAIN OF THE MET RECEPTOR IN COMPLEX WITH FAB 
2859, 6ddmA, 0.5139, 3.99, 0.084, 218, 107, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2860, 6dcaM, 0.5139, 3.94, 0.103, 213, 107, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
2861, 6cezL, 0.5139, 4.01, 0.093, 217, 107, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V2 FAB 16C2 IN COMPLEX WITH V2 PEPTIDE CONB 
2862, 6anaL, 0.5139, 4.09, 0.102, 220, 108, LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
2863, 5mv3P, 0.5139, 4.06, 0.111, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2864, 5mo3L, 0.5139, 4.07, 0.110, 208, 109, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
2865, 5hysL, 0.5139, 4.08, 0.102, 219, 108, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2866, 5hysB, 0.5139, 4.06, 0.120, 218, 108, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2867, 5dgyA, 0.5139, 4.03, 0.073, 228, 109, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2868, 4zwjA, 0.5139, 4.08, 0.111, 219, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2869, 4plkL, 0.5139, 4.04, 0.102, 219, 108, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2870, 4kxzM, 0.5139, 3.97, 0.093, 213, 107, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
2871, 4jzjA, 0.5139, 4.08, 0.091, 244, 110, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
2872, 4fqrt, 0.5139, 4.02, 0.121, 212, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2873, 3wkmM, 0.5139, 4.75, 0.066, 205, 122, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
2874, 2y36H, 0.5139, 2.76, 0.085, 189, 94, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
2875, 2xqyK, 0.5139, 4.07, 0.111, 217, 108, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
2876, 2r23A, 0.5139, 3.96, 0.112, 219, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2877, 2q76A, 0.5139, 4.06, 0.099, 225, 111, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
2878, 1sbsL, 0.5139, 4.05, 0.093, 217, 108, CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
2879, 1f5wA, 0.5139, 4.02, 0.103, 212, 107, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
2880, 6oknD, 0.5138, 4.02, 0.112, 215, 107, OX40R (TNFRSF4) BOUND TO FAB 1A7 
2881, 6ml8L, 0.5138, 4.11, 0.102, 215, 108, CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM H1N1 INFLUENZA A VIRUS A/DENVER/57 BOUND TO THE C05 ANTIBODY 
2882, 6dg2A, 0.5138, 4.06, 0.093, 212, 108, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
2883, 6d0uI, 0.5138, 4.06, 0.102, 217, 108, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2884, 5th9L, 0.5138, 4.08, 0.120, 215, 108, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
2885, 5t78C, 0.5138, 4.08, 0.120, 218, 108, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
2886, 5m63N, 0.5138, 4.07, 0.093, 217, 108, CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5
2887, 5m63L, 0.5138, 4.06, 0.093, 217, 108, CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5
2888, 5iblC, 0.5138, 4.08, 0.028, 833, 107, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2889, 5i76A, 0.5138, 4.08, 0.028, 833, 107, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
2890, 5hj3N, 0.5138, 4.05, 0.111, 208, 108, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
2891, 5eukC, 0.5138, 4.12, 0.083, 213, 108, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
2892, 5esqC, 0.5138, 3.94, 0.092, 214, 109, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
2893, 4ubdX, 0.5138, 4.01, 0.084, 213, 107, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2894, 4ubdP, 0.5138, 4.13, 0.111, 214, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2895, 4ubdD, 0.5138, 4.07, 0.108, 215, 111, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2896, 4r7nP, 0.5138, 4.10, 0.102, 218, 108, FAB C2E3
2897, 4nkoC, 0.5138, 4.06, 0.120, 217, 108, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
2898, 4hs8L, 0.5138, 4.00, 0.121, 212, 107, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3
2899, 4fqrf, 0.5138, 4.10, 0.130, 220, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2900, 4aehH, 0.5138, 4.10, 0.071, 124, 112, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
2901, 3v4vM, 0.5138, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2902, 3ogcB, 0.5138, 4.02, 0.093, 212, 107, KCSA E71A VARIANT IN PRESENCE OF NA+
2903, 3mbxL, 0.5138, 4.10, 0.108, 217, 111, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
2904, 3hr5P, 0.5138, 4.03, 0.093, 213, 107, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2905, 3eoaA, 0.5138, 4.01, 0.103, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
2906, 2z4qB, 0.5138, 4.09, 0.120, 216, 108, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2907, 2xknA, 0.5138, 4.11, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
2908, 2r1wA, 0.5138, 4.11, 0.120, 215, 108, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2909, 2qr0Q, 0.5138, 3.85, 0.084, 216, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
2910, 1yy8A, 0.5138, 4.02, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
2911, 1r70A, 0.5138, 4.01, 0.093, 203, 107, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
2912, 1jnnL, 0.5138, 3.98, 0.103, 213, 107, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
2913, 6d0uL, 0.5137, 3.98, 0.103, 213, 107, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2914, 5vjqH, 0.5137, 4.11, 0.083, 213, 108, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2915, 5n09L, 0.5137, 4.11, 0.083, 213, 108, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
2916, 5mjvC, 0.5137, 4.12, 0.083, 213, 108, REBUILD AND RE-REFINED MODEL FOR HUMAN PARECHOVIRUS 1
2917, 5lxaH, 0.5137, 4.02, 0.084, 211, 107, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
2918, 5k8aL, 0.5137, 4.09, 0.102, 115, 108, NIST FAB
2919, 5iczC, 0.5137, 4.06, 0.093, 218, 108, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
2920, 4ubdL, 0.5137, 4.00, 0.084, 213, 107, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2921, 4r0lB, 0.5137, 4.11, 0.108, 219, 111, ANTI-CANINE CD28 ANTIBODY 1C6 BOUND CANINE CD28
2922, 4kphM, 0.5137, 4.11, 0.099, 213, 111, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
2923, 4k7pX, 0.5137, 4.02, 0.121, 212, 107, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
2924, 4fqrn, 0.5137, 4.08, 0.130, 220, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2925, 4fqrl, 0.5137, 4.03, 0.102, 219, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2926, 4fp8L, 0.5137, 4.00, 0.103, 214, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2927, 4dkeL, 0.5137, 4.14, 0.090, 218, 111, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
2928, 3tpuA, 0.5137, 3.99, 0.075, 213, 107, 42F3 P5E8/H2-LD COMPLEX
2929, 3iy3A, 0.5137, 4.05, 0.148, 216, 108, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 8 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 8 COMPLEX
2930, 3hzmA, 0.5137, 3.97, 0.093, 213, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
2931, 3chnN, 0.5137, 3.99, 0.103, 213, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
2932, 2xzqH, 0.5137, 4.05, 0.093, 214, 107, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF
2933, 2qtjN, 0.5137, 3.99, 0.150, 211, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
2934, 2qr0K, 0.5137, 4.03, 0.093, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
2935, 2jixG, 0.5137, 4.02, 0.121, 212, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2936, 2bz7A, 0.5137, 3.98, 0.074, 213, 108, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
2937, 1yuhB, 0.5137, 3.85, 0.087, 257, 104, FAB FRAGMENT
2938, 1xctC, 0.5137, 3.99, 0.082, 238, 110, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
2939, 1r70C, 0.5137, 3.93, 0.113, 213, 106, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
2940, 1gpoL, 0.5137, 3.99, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
2941, 6o3aA, 0.5136, 4.11, 0.083, 213, 108, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F7.B FAB 
2942, 6mxrL, 0.5136, 4.07, 0.103, 114, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
2943, 6azxB, 0.5136, 3.93, 0.132, 195, 106, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
2944, 5v52D, 0.5136, 3.82, 0.086, 213, 105, STRUCTURE OF TIGIT BOUND TO NECTIN-2 (CD112)
2945, 5umnD, 0.5136, 4.00, 0.084, 213, 107, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2946, 5otjA, 0.5136, 3.99, 0.084, 213, 107, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2947, 5nivA, 0.5136, 4.00, 0.093, 213, 107, CRYSTAL STRUCTURE OF 5D3 FAB
2948, 5epmE, 0.5136, 3.99, 0.093, 214, 107, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
2949, 5dk3A, 0.5136, 3.95, 0.111, 205, 108, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
2950, 4z5rR, 0.5136, 4.07, 0.103, 113, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2951, 4ubdT, 0.5136, 4.05, 0.111, 218, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2952, 4ubdH, 0.5136, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2953, 4nylL, 0.5136, 3.96, 0.109, 215, 110, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
2954, 4jm0A, 0.5136, 4.02, 0.103, 214, 107, STRUCTURE OF HUMAN CYTOMEGALOVIRUS IMMUNE MODULATOR UL141
2955, 4guqA, 0.5136, 3.97, 0.093, 213, 107, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
2956, 4g6aL, 0.5136, 3.93, 0.084, 214, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
2957, 4fqrv, 0.5136, 2.63, 0.157, 102, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2958, 3v4vH, 0.5136, 4.06, 0.099, 218, 111, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2959, 3sgdI, 0.5136, 4.10, 0.111, 220, 108, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
2960, 3nz8B, 0.5136, 4.05, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
2961, 3ncjH, 0.5136, 4.07, 0.139, 216, 108, CRYSTAL STRUCTURE OF FAB15 MUT8
2962, 3lizL, 0.5136, 3.95, 0.093, 212, 107, CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
2963, 3hzvA, 0.5136, 3.99, 0.092, 218, 109, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
2964, 3chnO, 0.5136, 4.09, 0.102, 211, 108, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
2965, 3chnM, 0.5136, 3.99, 0.144, 127, 111, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
2966, 3chnL, 0.5136, 4.03, 0.084, 213, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
2967, 2vweE, 0.5136, 3.91, 0.103, 213, 107, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2968, 2r1yA, 0.5136, 4.02, 0.112, 212, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2969, 2qtjO, 0.5136, 4.05, 0.100, 218, 110, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
2970, 2qtjM, 0.5136, 4.09, 0.083, 218, 108, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
2971, 2qtjL, 0.5136, 4.10, 0.093, 217, 108, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
2972, 2nz9C, 0.5136, 4.11, 0.083, 213, 108, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2973, 2i9lE, 0.5136, 4.11, 0.083, 213, 108, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
2974, 2fjfA, 0.5136, 4.00, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2975, 2esgM, 0.5136, 3.95, 0.126, 175, 111, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
2976, 2esgL, 0.5136, 3.99, 0.094, 200, 106, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
2977, 1vgeL, 0.5136, 4.08, 0.111, 218, 108, TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
2978, 1tetL, 0.5136, 4.01, 0.084, 213, 107, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
2979, 1igaD, 0.5136, 4.11, 0.099, 211, 111, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
2980, 1igaC, 0.5136, 4.09, 0.111, 218, 108, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
2981, 1ce1L, 0.5136, 4.04, 0.120, 217, 108, 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
2982, 1bfoC, 0.5136, 4.05, 0.091, 225, 110, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
2983, 6gfeL, 0.5135, 4.02, 0.103, 211, 107, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
2984, 6eayL, 0.5135, 3.99, 0.103, 218, 107, STRUCTURAL BASIS FOR BROAD NEUTRALIZATION OF EBOLAVIRUSES BY AN ANTIBODY TARGETING THE GLYCOPROTEIN FUSION LOOP 
2985, 6ddvA, 0.5135, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2986, 5yfiL, 0.5135, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
2987, 5wk2H, 0.5135, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
2988, 5uxqB, 0.5135, 4.10, 0.099, 219, 111, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
2989, 5tljC, 0.5135, 4.05, 0.148, 217, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
2990, 5lsfB, 0.5135, 4.02, 0.103, 214, 107, SACBROOD HONEYBEE VIRUS 
2991, 5id0C, 0.5135, 4.02, 0.103, 214, 107, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
2992, 5hysF, 0.5135, 4.02, 0.103, 214, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2993, 5dqjL, 0.5135, 4.04, 0.074, 216, 108, STRUCTURE OF UNLIGANDED S55-5 FAB
2994, 5dqjB, 0.5135, 3.98, 0.112, 219, 107, STRUCTURE OF UNLIGANDED S55-5 FAB
2995, 4zptL, 0.5135, 3.99, 0.103, 211, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
2996, 4u1gF, 0.5135, 4.02, 0.103, 214, 107, PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1
2997, 4rgnE, 0.5135, 4.02, 0.103, 214, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2998, 4oz4L, 0.5135, 4.02, 0.103, 214, 107, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
2999, 4oz4B, 0.5135, 4.08, 0.120, 216, 108, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3000, 4nwtL, 0.5135, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
3001, 4m7lL, 0.5135, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
3002, 3nacH, 0.5135, 4.04, 0.103, 211, 107, CRYSTAL STRUCTURE OF FAB15 MUT7
3003, 3na9H, 0.5135, 4.03, 0.121, 214, 107, CRYSTAL STRUCTURE OF FAB15
3004, 3gi9H, 0.5135, 3.99, 0.084, 215, 107, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3005, 3c09B, 0.5135, 4.03, 0.093, 211, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
3006, 2zpkI, 0.5135, 4.07, 0.111, 217, 108, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
3007, 2qr0W, 0.5135, 4.01, 0.112, 214, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3008, 2e27L, 0.5135, 4.09, 0.072, 217, 111, CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN
3009, 1t4kA, 0.5135, 4.10, 0.093, 217, 108, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3010, 1q9oA, 0.5135, 4.08, 0.102, 215, 108, S45-18 FAB UNLIGANDED
3011, 1mamL, 0.5135, 4.02, 0.087, 239, 104, CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
3012, 1igyC, 0.5135, 3.98, 0.103, 212, 107, STRUCTURE OF IMMUNOGLOBULIN
3013, 1eajA, 0.5135, 4.08, 0.093, 215, 108, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
3014, 6novB, 0.5134, 4.08, 0.120, 217, 108, A FAB DERIVED FROM IXEKIZUMAB 
3015, 6njmN, 0.5134, 4.08, 0.120, 217, 108, STRUCTURE OF A COMPLEX 
3016, 6mxrB, 0.5134, 4.00, 0.093, 212, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
3017, 6dg2D, 0.5134, 4.03, 0.112, 215, 107, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
3018, 5yxnB, 0.5134, 4.09, 0.111, 220, 108, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
3019, 5w0pD, 0.5134, 4.08, 0.157, 218, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
3020, 5swzT, 0.5134, 4.07, 0.148, 218, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
3021, 5nb5L, 0.5134, 4.09, 0.102, 220, 108, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
3022, 5myoA, 0.5134, 4.07, 0.102, 220, 108, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
3023, 5mhrH, 0.5134, 4.06, 0.091, 225, 110, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3024, 5ir1C, 0.5134, 4.05, 0.082, 225, 110, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
3025, 5i2iC, 0.5134, 4.10, 0.108, 217, 111, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
3026, 4yhoH, 0.5134, 3.91, 0.094, 175, 106, REVERSAL AGENT FOR DABIGATRAN
3027, 4rgnG, 0.5134, 3.93, 0.074, 207, 108, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3028, 4onfL, 0.5134, 3.97, 0.093, 213, 107, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7
3029, 4irzL, 0.5134, 3.79, 0.087, 107, 104, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
3030, 4g7yL, 0.5134, 4.10, 0.093, 217, 108, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
3031, 3tt1M, 0.5134, 4.08, 0.148, 219, 108, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3032, 3okeA, 0.5134, 4.03, 0.093, 214, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3033, 3o2vL, 0.5134, 4.08, 0.112, 213, 107, CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
3034, 3kykL, 0.5134, 4.01, 0.072, 124, 111, CRYSTAL STRUCTURE OF LI33 IGG1 FAB
3035, 2qr0M, 0.5134, 4.10, 0.111, 218, 108, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3036, 2qr0G, 0.5134, 4.00, 0.000, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3037, 2i9lG, 0.5134, 4.01, 0.101, 217, 109, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3038, 2i9lC, 0.5134, 4.09, 0.112, 211, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3039, 1xcqD, 0.5134, 3.96, 0.102, 241, 108, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3040, 1t66C, 0.5134, 3.89, 0.038, 773, 105, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
3041, 1rjlB, 0.5134, 4.04, 0.130, 239, 108, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
3042, 1n64L, 0.5134, 4.11, 0.111, 218, 108, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
3043, 1igyA, 0.5134, 4.09, 0.111, 219, 108, STRUCTURE OF IMMUNOGLOBULIN
3044, 6okqB, 0.5133, 4.00, 0.112, 205, 107, CRYSTAL STRUCTURE OF THE SF12 FAB 
3045, 6my4B, 0.5133, 4.00, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
3046, 6dwiI, 0.5133, 3.99, 0.103, 213, 107, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3047, 5vigL, 0.5133, 3.95, 0.082, 222, 110, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
3048, 5udcG, 0.5133, 4.09, 0.111, 220, 108, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3049, 5i1dL, 0.5133, 4.06, 0.111, 218, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
3050, 5cipL, 0.5133, 3.91, 0.094, 208, 106, CRYSTAL STRUCTURE OF UNBOUND 4E10
3051, 5bvjC, 0.5133, 3.97, 0.093, 211, 107, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
3052, 4plkC, 0.5133, 4.08, 0.102, 215, 108, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3053, 4mhjX, 0.5133, 4.07, 0.148, 217, 108, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
3054, 4mhjV, 0.5133, 4.09, 0.120, 218, 108, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
3055, 4mhjQ, 0.5133, 3.99, 0.075, 211, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
3056, 4mhjL, 0.5133, 3.97, 0.103, 213, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
3057, 4mhjJ, 0.5133, 3.97, 0.093, 213, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
3058, 4mhjE, 0.5133, 3.98, 0.112, 219, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
3059, 4gagL, 0.5133, 3.98, 0.112, 219, 107, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
3060, 4f9pA, 0.5133, 4.09, 0.072, 218, 111, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 103.2 SINGLE CHAIN ANTIBODY
3061, 3tt1L, 0.5133, 4.07, 0.120, 219, 108, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3062, 3so3B, 0.5133, 4.14, 0.099, 221, 111, STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON- CANONICAL MECHANISM OF INHIBITION.
3063, 3j7eL, 0.5133, 4.08, 0.130, 220, 108, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3064, 3j7eE, 0.5133, 4.07, 0.140, 213, 107, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3065, 3j7eC, 0.5133, 3.99, 0.093, 210, 107, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3066, 3j7eA, 0.5133, 4.03, 0.119, 217, 109, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3067, 3i02A, 0.5133, 4.07, 0.084, 211, 107, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3068, 2pcpC, 0.5133, 4.01, 0.093, 212, 107, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3069, 2or9M, 0.5133, 4.02, 0.093, 213, 107, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
3070, 6jmqC, 0.5132, 4.07, 0.093, 220, 108, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
3071, 6c5hL, 0.5132, 4.11, 0.065, 212, 108, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
3072, 5ye4D, 0.5132, 3.96, 0.094, 214, 106, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
3073, 5swzE, 0.5132, 4.04, 0.102, 198, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
3074, 5kqvC, 0.5132, 4.05, 0.112, 216, 107, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
3075, 5h35I, 0.5132, 4.05, 0.112, 214, 107, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3076, 5e2wL, 0.5132, 4.05, 0.112, 215, 107, ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE
3077, 5dmgF, 0.5132, 4.05, 0.112, 215, 107, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
3078, 4kq3L, 0.5132, 4.05, 0.112, 211, 107, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
3079, 4jn2L, 0.5132, 4.05, 0.112, 216, 107, AN ANTIDOTE FOR DABIGATRAN
3080, 4fp8M, 0.5132, 4.11, 0.111, 215, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3081, 3tt3L, 0.5132, 4.07, 0.110, 207, 109, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3082, 3kj4B, 0.5132, 4.08, 0.102, 215, 108, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3083, 3gi8H, 0.5132, 3.98, 0.103, 216, 107, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3084, 2qr0A, 0.5132, 4.02, 0.112, 115, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3085, 1tqbC, 0.5132, 4.02, 0.112, 115, 107, OVINE RECOMBINANT PRP(114-234) VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
3086, 1oayJ, 0.5132, 4.02, 0.112, 115, 107, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
3087, 1oayH, 0.5132, 4.02, 0.112, 115, 107, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
3088, 6okqC, 0.5131, 4.06, 0.148, 219, 108, CRYSTAL STRUCTURE OF THE SF12 FAB 
3089, 6njmJ, 0.5131, 4.08, 0.130, 216, 108, STRUCTURE OF A COMPLEX 
3090, 6dg2B, 0.5131, 4.09, 0.120, 218, 108, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
3091, 6b5mL, 0.5131, 4.03, 0.055, 214, 110, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3092, 6a77L, 0.5131, 4.06, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B5209B 
3093, 6a0zL, 0.5131, 3.98, 0.103, 212, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 BOUND TO H5N1 INFLUENZA HEMAGGLUTININ; HA HEAD REGION 
3094, 5vigB, 0.5131, 4.05, 0.130, 240, 108, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
3095, 5tlkC, 0.5131, 4.06, 0.083, 211, 109, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3096, 5t78A, 0.5131, 4.08, 0.120, 217, 108, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3097, 5mx3B, 0.5131, 4.08, 0.083, 216, 108, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3098, 5i1lH, 0.5131, 4.07, 0.102, 215, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
3099, 5d4kA, 0.5131, 4.03, 0.093, 211, 107, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
3100, 4xmlL, 0.5131, 4.09, 0.093, 219, 108, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424
3101, 4xc1L, 0.5131, 4.02, 0.093, 213, 107, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE
3102, 4gayL, 0.5131, 4.06, 0.111, 216, 108, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
3103, 4fqrx, 0.5131, 4.11, 0.111, 219, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3104, 4fqrh, 0.5131, 4.13, 0.108, 220, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3105, 4fp8N, 0.5131, 3.97, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3106, 4etqA, 0.5131, 4.14, 0.120, 219, 108, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
3107, 3wd5L, 0.5131, 3.96, 0.091, 121, 110, CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
3108, 3tpuC, 0.5131, 3.95, 0.100, 121, 110, 42F3 P5E8/H2-LD COMPLEX
3109, 3ietA, 0.5131, 3.98, 0.093, 210, 107, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3110, 3fo9A, 0.5131, 4.00, 0.000, 213, 107, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
3111, 3fctA, 0.5131, 4.10, 0.112, 212, 107, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3112, 2z91D, 0.5131, 3.98, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
3113, 2xqyL, 0.5131, 3.99, 0.150, 211, 107, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3114, 2qqlL, 0.5131, 4.08, 0.121, 212, 107, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
3115, 2g5bG, 0.5131, 4.02, 0.093, 212, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3116, 2fgwL, 0.5131, 4.10, 0.093, 215, 108, X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
3117, 2f58L, 0.5131, 4.10, 0.120, 216, 108, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
3118, 2bzcA, 0.5131, 4.07, 0.148, 218, 108, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
3119, 2bukA, 0.5131, 4.07, 0.073, 225, 109, SATELLITE TOBACCO NECROSIS VIRUS
3120, 1ymhA, 0.5131, 3.79, 0.093, 539, 108, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
3121, 1oazH, 0.5131, 4.05, 0.111, 215, 108, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
3122, 1mjjL, 0.5131, 4.13, 0.065, 214, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
3123, 1lk3M, 0.5131, 4.08, 0.111, 213, 108, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
3124, 1igtC, 0.5131, 4.00, 0.084, 213, 107, STRUCTURE OF IMMUNOGLOBULIN
3125, 1cu4L, 0.5131, 4.00, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
3126, 6qeeC, 0.5130, 4.04, 0.084, 213, 107, NANODISC RECONSTITUTED HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)-EQ MUTANT IN COMPLEX WITH UIC2 FAB AND ZOSUQUIDAR. 
3127, 6eluL, 0.5130, 4.03, 0.090, 217, 111, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
3128, 6dc7L, 0.5130, 3.98, 0.112, 213, 107, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
3129, 5ye4B, 0.5130, 3.95, 0.111, 204, 108, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
3130, 5vjoB, 0.5130, 4.07, 0.120, 215, 108, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3131, 5lx9H, 0.5130, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 2.4 ANGSTROM RESOLUTION
3132, 5k8aA, 0.5130, 4.04, 0.103, 213, 107, NIST FAB
3133, 5h2bB, 0.5130, 3.95, 0.113, 208, 106, STRUCTURE OF A NOVEL ANTIBODY G196
3134, 5bk5E, 0.5130, 4.11, 0.111, 218, 108, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
3135, 4yxlH, 0.5130, 4.00, 0.103, 214, 107, CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB
3136, 4wffF, 0.5130, 4.06, 0.139, 217, 108, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
3137, 4wfeF, 0.5130, 3.99, 0.103, 214, 107, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3138, 4qexM, 0.5130, 4.10, 0.111, 216, 108, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3139, 4qexL, 0.5130, 2.65, 0.157, 102, 89, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3140, 4ouuA, 0.5130, 4.79, 0.033, 184, 120, ANTI-MT1-MMP MONOCLONAL ANTIBODY
3141, 4mxwV, 0.5130, 4.08, 0.102, 220, 108, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
3142, 4lriB, 0.5130, 4.07, 0.090, 122, 111, ANTI CMV FAB FRAGMENT
3143, 4i9wF, 0.5130, 4.11, 0.093, 216, 108, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
3144, 4fqrr, 0.5130, 3.92, 0.113, 210, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3145, 4ffvC, 0.5130, 4.03, 0.103, 214, 107, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
3146, 4f9pB, 0.5130, 4.10, 0.111, 219, 108, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 103.2 SINGLE CHAIN ANTIBODY
3147, 4f80A, 0.5130, 4.08, 0.099, 225, 111, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN
3148, 3u79B, 0.5130, 4.10, 0.111, 217, 108, AL-103 Y32F Y96F
3149, 3qwoB, 0.5130, 4.04, 0.120, 218, 108, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3150, 3qpqE, 0.5130, 4.00, 0.112, 211, 107, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3151, 3mltH, 0.5130, 4.04, 0.121, 211, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3152, 3hzyA, 0.5130, 4.11, 0.081, 228, 111, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3153, 2vq1E, 0.5130, 3.93, 0.113, 213, 106, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3154, 2dtmL, 0.5130, 4.02, 0.131, 211, 107, THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
3155, 1nd0C, 0.5130, 4.09, 0.111, 217, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3156, 1mj8L, 0.5130, 4.12, 0.090, 218, 111, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
3157, 1fgnL, 0.5130, 3.96, 0.104, 211, 106, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
3158, 1afvM, 0.5130, 3.96, 0.104, 211, 106, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
3159, 6oe5L, 0.5129, 4.09, 0.111, 213, 108, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
3160, 6my5B, 0.5129, 4.09, 0.111, 212, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
3161, 6igtC, 0.5129, 4.08, 0.120, 217, 108, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
3162, 6b5oL, 0.5129, 3.98, 0.121, 211, 107, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3163, 6azzC, 0.5129, 3.99, 0.093, 217, 107, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
3164, 6axkB, 0.5129, 3.96, 0.104, 211, 106, CRYSTAL STRUCTURE OF FAB311 COMPLEX
3165, 6a9kL, 0.5129, 4.01, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 9C10 WITH A TRANSITION-STATE ANALOG 
3166, 5wkzL, 0.5129, 3.98, 0.170, 207, 106, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
3167, 5udcC, 0.5129, 4.06, 0.110, 208, 109, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3168, 5kvlL, 0.5129, 4.08, 0.101, 209, 109, HUMANIZED 10G4 ANTI-LEUKOTRIENE C4 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LEUKOTRIENE C4
3169, 5icxC, 0.5129, 3.89, 0.095, 111, 105, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
3170, 5cilL, 0.5129, 3.93, 0.113, 210, 106, CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (WDWD) WITH EPITOPE BOUND
3171, 5a16H, 0.5129, 4.00, 0.121, 215, 107, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
3172, 4ouuL, 0.5129, 4.09, 0.045, 215, 110, ANTI-MT1-MMP MONOCLONAL ANTIBODY
3173, 4hdiL, 0.5129, 4.06, 0.139, 215, 108, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
3174, 4hdiA, 0.5129, 4.09, 0.111, 216, 108, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
3175, 4g80B, 0.5129, 4.10, 0.120, 218, 108, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
3176, 4djmH, 0.5129, 4.11, 0.102, 219, 108, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3177, 3v6zD, 0.5129, 4.14, 0.111, 214, 108, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3178, 3jb4B, 0.5129, 4.02, 0.112, 214, 107, STRUCTURE OF LJUNGAN VIRUS: INSIGHT INTO PICORNAVIRUS PACKAGING
3179, 3cxdL, 0.5129, 4.07, 0.093, 217, 108, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
3180, 2i9lA, 0.5129, 4.03, 0.075, 212, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3181, 1nlbL, 0.5129, 4.03, 0.119, 218, 109, CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
3182, 1jnlL, 0.5129, 3.96, 0.100, 116, 110, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3183, 6o3bA, 0.5128, 4.10, 0.093, 219, 108, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
3184, 6novD, 0.5128, 4.04, 0.090, 217, 111, A FAB DERIVED FROM IXEKIZUMAB 
3185, 6mamD, 0.5128, 3.91, 0.103, 214, 107, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
3186, 6avnL, 0.5128, 4.07, 0.111, 219, 108, CRYSTAL STRUCTURE OF UNBOUND ANTI-HIV ANTIBODY FAB PGV19 AT 2.5 A 
3187, 5vplC, 0.5128, 3.87, 0.105, 212, 105, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
3188, 5vjqB, 0.5128, 4.02, 0.093, 211, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3189, 5tl5L, 0.5128, 3.98, 0.112, 214, 107, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
3190, 5ob5L, 0.5128, 3.99, 0.103, 212, 107, FAB COMPLEX WITH GROBETA. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
3191, 4zffL, 0.5128, 4.14, 0.065, 212, 108, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
3192, 4webL, 0.5128, 4.01, 0.084, 218, 107, STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2
3193, 4pb0L, 0.5128, 4.07, 0.120, 217, 108, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53
3194, 4hs6A, 0.5128, 4.09, 0.111, 219, 108, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
3195, 3v6fB, 0.5128, 4.09, 0.111, 217, 108, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3196, 3ra7L, 0.5128, 3.97, 0.093, 211, 107, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3197, 3qnxA, 0.5128, 3.07, 0.084, 201, 95, ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
3198, 3ld8B, 0.5128, 4.08, 0.111, 219, 108, STRUCTURE OF JMJD6 AND FAB FRAGMENTS
3199, 3ijhA, 0.5128, 3.84, 0.038, 222, 104, STRUCTURE OF S67-27 IN COMPLEX WITH KO
3200, 2orbL, 0.5128, 4.03, 0.121, 213, 107, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
3201, 2fjgA, 0.5128, 3.99, 0.140, 219, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3202, 2co7B, 0.5128, 4.11, 0.102, 220, 108, SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH THE SAFB CHAPERONE (TYPE II)
3203, 1nd0A, 0.5128, 3.99, 0.121, 211, 107, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3204, 1mrfL, 0.5128, 3.99, 0.093, 213, 107, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
3205, 1f90L, 0.5128, 4.11, 0.102, 219, 108, FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
3206, 1ck0L, 0.5128, 4.19, 0.083, 215, 109, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II UNLIGANDED FORM
3207, 1afvL, 0.5128, 3.86, 0.076, 205, 105, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
3208, 6eyoM, 0.5127, 4.03, 0.093, 211, 107, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
3209, 6dwiK, 0.5127, 4.04, 0.131, 212, 107, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3210, 5x31B, 0.5127, 4.09, 0.102, 217, 108, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
3211, 5tlkE, 0.5127, 4.03, 0.103, 213, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3212, 5myxA, 0.5127, 4.00, 0.093, 213, 107, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
3213, 5fuoL, 0.5127, 4.06, 0.130, 217, 108, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
3214, 5d06B, 0.5127, 4.09, 0.111, 216, 108, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME
3215, 4pcyA, 0.5127, 4.10, 0.102, 218, 108, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
3216, 4k8rC, 0.5127, 4.09, 0.120, 219, 108, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
3217, 4jn2A, 0.5127, 4.05, 0.103, 211, 107, AN ANTIDOTE FOR DABIGATRAN
3218, 4hxaL, 0.5127, 4.10, 0.120, 219, 108, CRYSTAL STRUCTURE OF 13D9 FAB
3219, 4g80F, 0.5127, 4.05, 0.148, 217, 108, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
3220, 4djmD, 0.5127, 4.08, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3221, 4cniL, 0.5127, 4.00, 0.121, 212, 107, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
3222, 3wihH, 0.5127, 4.01, 0.103, 211, 107, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
3223, 3v6zB, 0.5127, 3.17, 0.125, 197, 96, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3224, 3v4pM, 0.5127, 4.11, 0.102, 219, 108, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
3225, 3s4gA, 0.5127, 4.10, 0.111, 216, 108, LOW RESOLUTION STRUCTURE OF STNV COMPLEXED WITH RNA
3226, 3rvtC, 0.5127, 4.10, 0.120, 219, 108, STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
3227, 3qc6X, 0.5127, 3.98, 0.121, 216, 107, GSPB
3228, 3hujF, 0.5127, 4.07, 0.093, 217, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3229, 2uylB, 0.5127, 4.10, 0.102, 201, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3230, 2qr0E, 0.5127, 4.08, 0.084, 211, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3231, 2brrL, 0.5127, 2.72, 0.148, 125, 88, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
3232, 1zglR, 0.5127, 4.11, 0.102, 215, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
3233, 1tzgL, 0.5127, 4.07, 0.111, 219, 108, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
3234, 1otuF, 0.5127, 4.05, 0.093, 217, 108, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
3235, 6cw2B, 0.5126, 3.40, 0.059, 1506, 102, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 1 
3236, 6cdmE, 0.5126, 2.66, 0.157, 99, 89, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3237, 6cdmD, 0.5126, 4.06, 0.103, 213, 107, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3238, 6azzF, 0.5126, 4.06, 0.102, 219, 108, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
3239, 5vgjL, 0.5126, 3.95, 0.132, 213, 106, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90 BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN
3240, 5cipB, 0.5126, 3.97, 0.103, 211, 107, CRYSTAL STRUCTURE OF UNBOUND 4E10
3241, 5b3jF, 0.5126, 3.08, 0.084, 204, 95, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
3242, 4zxbB, 0.5126, 4.08, 0.121, 214, 107, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
3243, 4xxdA, 0.5126, 3.92, 0.118, 219, 110, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
3244, 4v4mAA, 0.5126, 4.08, 0.111, 219, 108, 
3245, 4rirH, 0.5126, 4.11, 0.099, 211, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
3246, 4n90I, 0.5126, 4.69, 0.034, 184, 119, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
3247, 4n5eC, 0.5126, 4.04, 0.093, 213, 107, 42F3 TCR PCPA12/H-2LD COMPLEX
3248, 4mxqC, 0.5126, 3.41, 0.119, 351, 101, 42F3 TCR PCPC5/H-2LD COMPLEX
3249, 4hc1L, 0.5126, 4.06, 0.111, 242, 108, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
3250, 4g7vL, 0.5126, 4.13, 0.099, 213, 111, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
3251, 4d9qD, 0.5126, 3.98, 0.093, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3252, 3eyvA, 0.5126, 4.04, 0.131, 215, 107, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
3253, 2z91B, 0.5126, 4.02, 0.118, 238, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
3254, 2vweL, 0.5126, 4.12, 0.065, 214, 108, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
3255, 2jelL, 0.5126, 3.95, 0.151, 211, 106, JEL42 FAB/HPR COMPLEX
3256, 2fx8M, 0.5126, 3.97, 0.103, 199, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3257, 2cdeF, 0.5126, 4.11, 0.111, 218, 108, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
3258, 1xcqG, 0.5126, 3.94, 0.091, 218, 110, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3259, 1tziA, 0.5126, 4.04, 0.090, 220, 111, CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
3260, 1moeB, 0.5126, 4.09, 0.111, 217, 108, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
3261, 1mhhC, 0.5126, 4.12, 0.065, 212, 108, ANTIBODY-ANTIGEN COMPLEX
3262, 1m7dA, 0.5126, 3.98, 0.112, 211, 107, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
3263, 1emtL, 0.5126, 4.07, 0.120, 218, 108, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
3264, 6mqmB, 0.5125, 4.06, 0.111, 218, 108, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3265, 6fq0C, 0.5125, 4.77, 0.033, 184, 120, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
3266, 6dg2C, 0.5125, 4.20, 0.072, 219, 111, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
3267, 6bzwH, 0.5125, 4.03, 0.084, 214, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3268, 5vphC, 0.5125, 4.03, 0.111, 199, 108, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
3269, 5tudE, 0.5125, 4.01, 0.111, 199, 108, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
3270, 5mthL, 0.5125, 4.06, 0.103, 213, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
3271, 5j3dD, 0.5125, 3.98, 0.093, 211, 107, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
3272, 5hd8F, 0.5125, 4.04, 0.103, 213, 107, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
3273, 5h35G, 0.5125, 4.10, 0.120, 219, 108, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3274, 5ea0L, 0.5125, 3.95, 0.142, 211, 106, STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE
3275, 5e08L, 0.5125, 4.11, 0.099, 219, 111, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
3276, 5cinL, 0.5125, 4.06, 0.120, 217, 108, CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (DELTALOOP) WITH EPITOPE BOUND
3277, 5b3jL, 0.5125, 4.12, 0.065, 214, 108, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
3278, 4yhoL, 0.5125, 4.12, 0.091, 244, 110, REVERSAL AGENT FOR DABIGATRAN
3279, 4xbeL, 0.5125, 3.97, 0.103, 219, 107, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).
3280, 4wfhF, 0.5125, 3.93, 0.103, 214, 107, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
3281, 4v4mGB, 0.5125, 4.18, 0.111, 240, 108, 
3282, 4q2zL, 0.5125, 4.11, 0.102, 219, 108, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
3283, 4mnqE, 0.5125, 4.09, 0.120, 215, 108, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
3284, 4gw1C, 0.5125, 4.03, 0.084, 214, 107, CQFD MEDITOPE
3285, 4fqrb, 0.5125, 4.06, 0.083, 217, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3286, 4fp8O, 0.5125, 3.33, 0.071, 207, 98, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3287, 4f9lB, 0.5125, 4.12, 0.108, 211, 111, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
3288, 4f9lA, 0.5125, 4.12, 0.111, 218, 108, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
3289, 3x2dO, 0.5125, 4.00, 0.093, 211, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3290, 3wihI, 0.5125, 3.97, 0.104, 211, 106, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
3291, 3v6fL, 0.5125, 4.07, 0.157, 219, 108, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3292, 3u30E, 0.5125, 4.02, 0.103, 215, 107, CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3293, 3s96B, 0.5125, 3.96, 0.142, 211, 106, CRYSTAL STRUCTURE OF 3B5H10
3294, 3rvxC, 0.5125, 4.11, 0.120, 217, 108, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
3295, 3rvvC, 0.5125, 3.99, 0.103, 219, 107, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
3296, 3qc5X, 0.5125, 4.01, 0.084, 215, 107, GSPB
3297, 3ijsA, 0.5125, 4.15, 0.065, 212, 108, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3298, 2zzqA, 0.5125, 3.99, 0.112, 212, 107, CRYSTAL STRUCTURE ANALYSIS OF THE HEV CAPSID PROTEIN PORF2
3299, 2eh8L, 0.5125, 4.11, 0.111, 219, 108, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE
3300, 1oazJ, 0.5125, 4.15, 0.065, 214, 108, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
3301, 1bfoE, 0.5125, 3.97, 0.104, 211, 106, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3302, 6jmrF, 0.5124, 4.69, 0.034, 184, 119, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3303, 6iuvD, 0.5124, 3.96, 0.094, 212, 106, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3304, 6i04L, 0.5124, 4.02, 0.093, 240, 108, CRYSTAL STRUCTURE OF SEMA DOMAIN OF THE MET RECEPTOR IN COMPLEX WITH FAB 
3305, 6cdmB, 0.5124, 3.99, 0.103, 213, 107, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3306, 6bzvD, 0.5124, 4.01, 0.084, 213, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3307, 5tkkL, 0.5124, 4.01, 0.093, 213, 107, STRUCTURE OF MOUSE VACCINATION-ELICITED HIV NEUTRALIZING ANTIBODY VFP5.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3308, 5lcvL, 0.5124, 4.08, 0.110, 213, 109, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
3309, 5kqvP, 0.5124, 4.08, 0.110, 214, 109, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
3310, 5i6zC, 0.5124, 3.99, 0.093, 211, 107, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
3311, 5aumL, 0.5124, 3.92, 0.118, 219, 110, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
3312, 4zd3H, 0.5124, 4.09, 0.111, 219, 108, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY FAB FRAGMENT
3313, 4z92C, 0.5124, 4.00, 0.112, 211, 107, CRYSTAL STRUCTURE OF PARECHOVIRUS-1 VIRION
3314, 4xxdD, 0.5124, 3.95, 0.120, 204, 108, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
3315, 4xawL, 0.5124, 4.00, 0.093, 211, 107, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA)
3316, 4uv4L, 0.5124, 4.03, 0.093, 211, 107, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
3317, 4okvB, 0.5124, 3.36, 0.150, 352, 100, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
3318, 4mvbC, 0.5124, 4.08, 0.148, 217, 108, 42F3 PCPB7/H-2LD COMPLEX
3319, 4amkH, 0.5124, 4.08, 0.064, 483, 109, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
3320, 3wsqL, 0.5124, 4.10, 0.102, 218, 108, STRUCTURE OF HER2 WITH AN FAB
3321, 3us2A, 0.5124, 4.06, 0.090, 122, 111, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
3322, 3tpuM, 0.5124, 4.03, 0.121, 214, 107, 42F3 P5E8/H2-LD COMPLEX
3323, 3qpxL, 0.5124, 4.07, 0.139, 218, 108, CRYSTAL STRUCTURE OF FAB C2507
3324, 3lh9B, 0.5124, 4.02, 0.102, 215, 108, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
3325, 3jbaL, 0.5124, 4.04, 0.103, 212, 107, THE U4 ANTIBODY EPITOPE ON HUMAN PAPILLOMAVIRUS 16 IDENTIFIED BY CRYO- EM
3326, 3cviH, 0.5124, 4.13, 0.111, 218, 108, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3327, 3ck0L, 0.5124, 4.10, 0.111, 215, 108, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH HUMAN ANGIOTENSIN II
3328, 3bkyL, 0.5124, 4.04, 0.103, 213, 107, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
3329, 2brrX, 0.5124, 4.02, 0.074, 212, 108, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
3330, 1yy9C, 0.5124, 4.10, 0.082, 220, 110, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225
3331, 1v7nN, 0.5124, 4.03, 0.121, 214, 107, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3332, 1mwaA, 0.5124, 4.10, 0.102, 216, 108, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
3333, 1mf2M, 0.5124, 4.18, 0.072, 199, 111, ANTI HIV1 PROTEASE FAB COMPLEX
3334, 1kdiA, 0.5124, 3.87, 0.087, 257, 104, REDUCED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
3335, 1h0dA, 0.5124, 4.07, 0.102, 217, 108, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F
3336, 1fskL, 0.5124, 4.15, 0.065, 214, 108, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3337, 1fskI, 0.5124, 4.00, 0.112, 217, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3338, 1fskF, 0.5124, 4.09, 0.120, 218, 108, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3339, 1fskC, 0.5124, 3.92, 0.112, 199, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3340, 1fgnH, 0.5124, 3.85, 0.111, 215, 108, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
3341, 1cr9L, 0.5124, 4.05, 0.047, 215, 107, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
3342, 1cloL, 0.5124, 3.91, 0.094, 193, 106, ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
3343, 1axsA, 0.5124, 3.97, 0.111, 204, 108, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
3344, 12e8P, 0.5124, 4.03, 0.112, 213, 107, 2E8 FAB FRAGMENT
3345, 6mqmK, 0.5123, 3.87, 0.097, 288, 103, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3346, 6jfiL, 0.5123, 4.04, 0.112, 115, 107, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3347, 6jfhN, 0.5123, 4.06, 0.100, 213, 110, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3348, 6jfhL, 0.5123, 3.97, 0.121, 216, 107, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3349, 6jepL, 0.5123, 3.94, 0.113, 213, 106, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
3350, 6fq0A, 0.5123, 4.04, 0.131, 214, 107, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
3351, 6awnC, 0.5123, 4.00, 0.103, 211, 107, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
3352, 5vicL, 0.5123, 3.95, 0.132, 212, 106, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z004 BOUND TO DENV-1 ENVELOPE PROTEIN DIII
3353, 5t6pC, 0.5123, 4.04, 0.111, 202, 108, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3354, 5t6pA, 0.5123, 4.09, 0.111, 215, 108, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3355, 5swzJ, 0.5123, 2.48, 0.159, 102, 88, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
3356, 5e8eB, 0.5123, 4.10, 0.102, 216, 108, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
3357, 4yhmL, 0.5123, 4.14, 0.126, 220, 111, REVERSAL AGENT FOR DABIGATRAN
3358, 4v4mSA, 0.5123, 4.14, 0.126, 220, 111, 
3359, 4v4mLA, 0.5123, 4.14, 0.126, 220, 111, 
3360, 4uimF, 0.5123, 4.14, 0.126, 220, 111, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
3361, 4qwwE, 0.5123, 4.13, 0.099, 214, 111, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
3362, 3x2dK, 0.5123, 4.09, 0.111, 219, 108, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3363, 3us2I, 0.5123, 3.95, 0.160, 213, 106, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
3364, 3ujtM, 0.5123, 4.04, 0.121, 211, 107, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
3365, 3rifJ, 0.5123, 4.05, 0.081, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
3366, 3rifH, 0.5123, 4.07, 0.093, 217, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
3367, 3j42L, 0.5123, 3.92, 0.095, 214, 105, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3368, 3j42J, 0.5123, 3.92, 0.095, 214, 105, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3369, 3j42H, 0.5123, 3.92, 0.095, 214, 105, OBSTRUCTION OF DENGUE VIRUS MATURATION BY FAB FRAGMENTS OF THE 2H2 ANTIBODY
3370, 3igkA, 0.5123, 3.92, 0.095, 214, 105, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 2)
3371, 3if1A, 0.5123, 3.20, 0.082, 206, 97, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
3372, 2fjhA, 0.5123, 4.05, 0.121, 214, 107, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3373, 1z9sA, 0.5123, 4.06, 0.093, 211, 107, CRYSTAL STRUCTURE OF THE NATIVE CHAPERONE:SUBUNIT:SUBUNIT CAF1M:CAF1:CAF1 COMPLEX
3374, 1z3gL, 0.5123, 4.10, 0.120, 216, 108, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
3375, 1tpxC, 0.5123, 4.09, 0.120, 216, 108, OVINE RECOMBINANT PRP(114-234) ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
3376, 1t66L, 0.5123, 4.06, 0.130, 240, 108, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
3377, 1sy6L, 0.5123, 4.16, 0.080, 228, 113, CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
3378, 1nd0E, 0.5123, 4.13, 0.111, 219, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3379, 1m71A, 0.5123, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
3380, 6cxyL, 0.5122, 4.69, 0.034, 184, 119, CRYSTAL STRUCTURE OF HUMAN E-CADHERIN BOUND BY MOUSE MONOCLONAL ANTIBODY FAB MAB-1_19A11 
3381, 5yfiH, 0.5122, 4.01, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
3382, 5wawL, 0.5122, 3.97, 0.142, 212, 106, FCABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY
3383, 5uqyG, 0.5122, 4.01, 0.093, 211, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3384, 5myxC, 0.5122, 3.91, 0.094, 193, 106, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
3385, 4xcfL, 0.5122, 4.10, 0.130, 217, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)
3386, 4wy7L, 0.5122, 3.98, 0.100, 200, 110, CRYSTAL STRUCTURE OF RECOMBINANT 4E10 EXPRESSED IN ESCHERICHIA COLI WITH EPITOPE BOUND
3387, 4v4mGA, 0.5122, 3.98, 0.100, 221, 110, 
3388, 4uokL, 0.5122, 4.02, 0.131, 212, 107, ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4
3389, 4odsL, 0.5122, 4.02, 0.131, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3
3390, 4nhuA, 0.5122, 4.02, 0.131, 212, 107, THE M33 TCR P3M33L/H-2 LD COMPLEX
3391, 4mzrB, 0.5122, 3.89, 0.067, 197, 105, CRYSTAL STRUCTURE OF A POLYPEPTIDE P53 MUTANT BOUND TO DNA
3392, 3us1A, 0.5122, 4.08, 0.120, 215, 108, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR RESPONSE ELEMENT CONTAINING A TWO BASE PAIR GC SPACER BETWEEN HALF SITES
3393, 3u0tC, 0.5122, 3.99, 0.093, 211, 107, FAB-ANTIBODY COMPLEX
3394, 3u0tA, 0.5122, 3.07, 0.095, 196, 95, FAB-ANTIBODY COMPLEX
3395, 3rifG, 0.5122, 3.96, 0.113, 213, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
3396, 3ldbB, 0.5122, 4.14, 0.120, 219, 108, STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.
3397, 3gi9L, 0.5122, 4.09, 0.120, 219, 108, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3398, 3b9kF, 0.5122, 3.97, 0.113, 213, 106, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
3399, 2w9eL, 0.5122, 4.11, 0.102, 219, 108, STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
3400, 2r56L, 0.5122, 4.09, 0.120, 215, 108, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
3401, 2fatL, 0.5122, 4.09, 0.139, 217, 108, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
3402, 2exyF, 0.5122, 3.89, 0.072, 221, 111, CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC FAB COMPLEXED IN ABSENCE OF BOUND IONS
3403, 1zeaL, 0.5122, 4.11, 0.102, 218, 108, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
3404, 1za6G, 0.5122, 4.01, 0.103, 210, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3405, 1q9kA, 0.5122, 4.12, 0.111, 218, 108, S25-2 FAB UNLIGANDED 1
3406, 1opgL, 0.5122, 4.13, 0.065, 214, 108, OPG2 FAB FRAGMENT
3407, 1mh5A, 0.5122, 4.15, 0.065, 212, 108, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
3408, 1cd3F, 0.5122, 4.70, 0.034, 184, 119, PROCAPSID OF BACTERIOPHAGE PHIX174
3409, 6gfeM, 0.5121, 4.12, 0.111, 215, 108, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
3410, 6b0hC, 0.5121, 4.08, 0.111, 218, 108, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1262
3411, 5yhlL, 0.5121, 3.87, 0.112, 197, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
3412, 5x08L, 0.5121, 4.00, 0.075, 234, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 4E10 MUTANT NPRO WITH PEPTIDE BOUND
3413, 5v6mL, 0.5121, 3.91, 0.094, 193, 106, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A3 IN COMPLEX WITH V3 PEPTIDE CONB
3414, 5mhsF, 0.5121, 4.10, 0.111, 219, 108, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3415, 5mg7A, 0.5121, 4.10, 0.111, 218, 108, P53-DNA COMPLEX 7 
3416, 5k8aM, 0.5121, 3.98, 0.100, 214, 110, NIST FAB
3417, 5ik3D, 0.5121, 4.04, 0.148, 217, 108, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
3418, 5i8kL, 0.5121, 4.09, 0.130, 219, 108, HHH1 FAB FRAGMENT
3419, 5d6cL, 0.5121, 4.02, 0.109, 117, 110, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
3420, 5a16B, 0.5121, 3.95, 0.123, 212, 106, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
3421, 4v4mX, 0.5121, 4.02, 0.093, 211, 107, 
3422, 4v4mW, 0.5121, 3.92, 0.123, 212, 106, 
3423, 4v4mV, 0.5121, 3.96, 0.170, 211, 106, 
3424, 4tnvW, 0.5121, 4.09, 0.120, 216, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3425, 4qwwC, 0.5121, 4.12, 0.102, 220, 108, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
3426, 4ma8H, 0.5121, 4.10, 0.120, 219, 108, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
3427, 4k23L, 0.5121, 4.10, 0.112, 214, 107, STRUCTURE OF ANTI-UPAR FAB ATN-658
3428, 3v4pH, 0.5121, 4.17, 0.111, 197, 108, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
3429, 3ulvE, 0.5121, 4.43, 0.087, 426, 115, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
3430, 3mlwI, 0.5121, 4.10, 0.083, 215, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3431, 3bdyL, 0.5121, 4.06, 0.103, 213, 107, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3432, 2ht2F, 0.5121, 4.01, 0.093, 214, 107, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX
3433, 2gk0A, 0.5121, 4.15, 0.065, 212, 108, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
3434, 2ez0F, 0.5121, 4.09, 0.111, 219, 108, CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC IN COMPLEX WITH A FAB FRAGMENT
3435, 1v7nL, 0.5121, 4.15, 0.093, 212, 108, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3436, 1oarJ, 0.5121, 3.89, 0.067, 199, 105, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
3437, 1oarH, 0.5121, 3.93, 0.113, 213, 106, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
3438, 1mexL, 0.5121, 4.07, 0.102, 218, 108, ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
3439, 1f8tL, 0.5121, 4.06, 0.093, 216, 108, FAB (LNKB-2) OF MONOCLONAL ANTIBODY CRYSTAL STRUCTURE
3440, 1d5bA, 0.5121, 4.11, 0.102, 219, 108, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
3441, 1cicC, 0.5121, 4.01, 0.093, 218, 107, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3442, 1a0qL, 0.5121, 4.43, 0.043, 184, 116, 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
3443, 6igtB, 0.5120, 4.69, 0.034, 184, 119, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
3444, 6eyoI, 0.5120, 4.49, 0.052, 184, 116, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
3445, 6egvB, 0.5120, 4.69, 0.034, 184, 119, SACBROOD VIRUS OF HONEYBEE 
3446, 6bj2E, 0.5120, 4.70, 0.034, 184, 119, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
3447, 6azxD, 0.5120, 4.68, 0.042, 184, 119, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
3448, 6a0xF, 0.5120, 4.00, 0.100, 224, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3449, 5weqA, 0.5120, 3.96, 0.142, 212, 106, THE CRYSTAL STRUCTURE OF A MR78 MUTANT 
3450, 5w0kE, 0.5120, 4.13, 0.090, 218, 111, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
3451, 5uqyK, 0.5120, 4.06, 0.111, 218, 108, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3452, 5umnF, 0.5120, 4.12, 0.099, 211, 111, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3453, 5uddP, 0.5120, 4.01, 0.131, 215, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3454, 5mv5B, 0.5120, 4.10, 0.073, 228, 109, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
3455, 5mg7B, 0.5120, 4.20, 0.119, 217, 109, P53-DNA COMPLEX 7 
3456, 5ivzC, 0.5120, 3.98, 0.142, 211, 106, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
3457, 5g64L, 0.5120, 4.11, 0.120, 217, 108, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
3458, 5fhxL, 0.5120, 3.97, 0.151, 211, 106, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
3459, 5dq9B, 0.5120, 3.97, 0.123, 213, 106, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
3460, 5d1zE, 0.5120, 4.05, 0.090, 122, 111, ISDB NEAT1 BOUND BY CLONE D4-10
3461, 5cp7G, 0.5120, 4.05, 0.090, 122, 111, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3462, 4zpvL, 0.5120, 4.05, 0.112, 213, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
3463, 4yxhH, 0.5120, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF DEER PRION PROTEIN COMPLEXED WITH POM1 FAB
3464, 4p59L, 0.5120, 4.03, 0.121, 211, 107, HER3 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT OF MOR09825
3465, 4nj9L, 0.5120, 4.05, 0.121, 214, 107, CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS
3466, 4n90E, 0.5120, 4.04, 0.112, 211, 107, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
3467, 4kvcL, 0.5120, 3.98, 0.100, 117, 110, 2H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
3468, 4ffwC, 0.5120, 3.63, 0.075, 208, 107, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
3469, 3ugxB, 0.5120, 4.05, 0.087, 239, 104, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
3470, 3sgeL, 0.5120, 3.98, 0.130, 241, 108, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
3471, 3qrgL, 0.5120, 4.10, 0.093, 215, 108, CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
3472, 3o6lL, 0.5120, 4.08, 0.112, 214, 107, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 15-MER TAT PEPTIDE
3473, 3inuL, 0.5120, 3.95, 0.093, 211, 107, CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
3474, 3dpbA, 0.5120, 4.12, 0.099, 214, 111, CRYSTAL STRUCTURE OF THE COMPLEX OF THE CAF1M CHAPERONE WITH THE MINI-FIBER OF TWO CAF1 SUBUNITS (CAF1:CAF1) CARRYING THE ALA9VAL ALA11VAL AND LEU13VAL MUTATIONS IN THE GD DONOR STRAND
3475, 1xedE, 0.5120, 4.00, 0.093, 210, 107, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
3476, 1ws7A, 0.5120, 4.02, 0.084, 213, 107, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
3477, 1mhhA, 0.5120, 4.01, 0.093, 212, 107, ANTIBODY-ANTIGEN COMPLEX
3478, 1mf2L, 0.5120, 4.05, 0.048, 250, 105, ANTI HIV1 PROTEASE FAB COMPLEX
3479, 1lkfA, 0.5120, 3.89, 0.067, 199, 105, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS
3480, 1kdjA, 0.5120, 4.01, 0.103, 213, 107, OXIDIZED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
3481, 1kcrL, 0.5120, 4.02, 0.084, 216, 107, CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
3482, 6dcaN, 0.5119, 4.09, 0.102, 334, 108, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3483, 6bzvB, 0.5119, 4.06, 0.111, 212, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3484, 5ywyL, 0.5119, 3.99, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
3485, 5xxyL, 0.5119, 4.08, 0.130, 218, 108, COMPLEX STRUCTURE OF PD-L1 WITH ATEZOLIZUMAB FAB
3486, 5vkkB, 0.5119, 3.98, 0.093, 212, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
3487, 5uxqL, 0.5119, 4.15, 0.090, 218, 111, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
3488, 5uqyO, 0.5119, 4.00, 0.093, 211, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3489, 5k8aE, 0.5119, 4.08, 0.111, 212, 108, NIST FAB
3490, 5hcgL, 0.5119, 4.05, 0.093, 214, 107, CRYSTAL STRUCTURE OF FREE-CODV.
3491, 5dq9L, 0.5119, 4.01, 0.121, 212, 107, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
3492, 5dq9D, 0.5119, 3.96, 0.142, 207, 106, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
3493, 4v4mUA, 0.5119, 3.74, 0.039, 352, 103, 
3494, 4v4mRA, 0.5119, 4.12, 0.111, 219, 108, 
3495, 4v4mJA, 0.5119, 4.11, 0.093, 217, 108, 
3496, 4v4mFB, 0.5119, 4.09, 0.111, 217, 108, 
3497, 4v4mD, 0.5119, 4.10, 0.093, 217, 108, 
3498, 4v4mBA, 0.5119, 3.09, 0.084, 196, 95, 
3499, 4jm4L, 0.5119, 3.80, 0.084, 111, 107, CRYSTAL STRUCTURE OF PGT 135 FAB
3500, 4grmD, 0.5119, 3.12, 0.083, 107, 96, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
3501, 4gq9L, 0.5119, 4.11, 0.111, 219, 108, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
3502, 3v4uL, 0.5119, 4.10, 0.111, 215, 108, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
3503, 3us0B, 0.5119, 4.02, 0.127, 292, 110, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3504, 3opzL, 0.5119, 2.49, 0.159, 102, 88, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
3505, 3mnvC, 0.5119, 3.97, 0.112, 213, 107, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
3506, 3lkfA, 0.5119, 4.11, 0.111, 215, 108, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS WITH PHOSPHOCHOLINE BOUND
3507, 3hr5A, 0.5119, 4.11, 0.111, 213, 108, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3508, 3dsfL, 0.5119, 4.01, 0.093, 214, 107, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE
3509, 2z92B, 0.5119, 4.02, 0.103, 211, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
3510, 2mcpL, 0.5119, 4.05, 0.111, 219, 108, REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
3511, 2j4wL, 0.5119, 4.11, 0.102, 209, 108, STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX
3512, 1yejL, 0.5119, 4.02, 0.093, 210, 107, CATALYTIC ANTIBODY COMPLEX
3513, 1xedB, 0.5119, 3.95, 0.113, 213, 106, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
3514, 1ws8A, 0.5119, 4.11, 0.102, 327, 108, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
3515, 1s5iL, 0.5119, 4.06, 0.111, 212, 108, FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2 CRYSTAL STRUCTURE
3516, 1kn2L, 0.5119, 4.06, 0.111, 211, 108, CATALYTIC ANTIBODY D2.3 COMPLEX
3517, 1kb5L, 0.5119, 4.70, 0.034, 184, 119, MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
3518, 1bqhH, 0.5119, 4.70, 0.034, 184, 119, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
3519, 1ad0C, 0.5119, 4.70, 0.034, 184, 119, FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
3520, 1ad0A, 0.5119, 4.70, 0.034, 184, 119, FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
3521, 6amuE, 0.5118, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE MMWDRGLGMM 
3522, 6a0xB, 0.5118, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3523, 5w23J, 0.5118, 4.71, 0.034, 184, 119, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3524, 5w23I, 0.5118, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3525, 5aooB, 0.5118, 4.08, 0.103, 214, 107, X-RAY STRUCTURE OF A HUMAN KOBUVIRUS: AICHI VIRUS A (AIV)
3526, 4zypO, 0.5118, 3.98, 0.102, 243, 108, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3527, 4v4mG, 0.5118, 3.96, 0.132, 212, 106, 
3528, 4v4mDA, 0.5118, 4.12, 0.120, 218, 108, 
3529, 4s1dF, 0.5118, 3.90, 0.094, 193, 106, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
3530, 4risH, 0.5118, 3.92, 0.132, 212, 106, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
3531, 4nwvA, 0.5118, 4.08, 0.102, 220, 108, CRYSTAL STRUCTURE OF ORSAY VIRUS-LIKE PARTICLE
3532, 4ms8C, 0.5118, 4.05, 0.118, 292, 110, 42F3 TCR PCPB9/H-2LD COMPLEX
3533, 4mqxF, 0.5118, 4.07, 0.102, 219, 108, CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT
3534, 4cniB, 0.5118, 4.05, 0.131, 213, 107, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
3535, 3sgdL, 0.5118, 3.96, 0.142, 210, 106, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3536, 3ri5H, 0.5118, 3.97, 0.112, 220, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3537, 2hrpL, 0.5118, 3.98, 0.113, 212, 106, ANTIGEN-ANTIBODY COMPLEX
3538, 2fx8O, 0.5118, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3539, 2fx7L, 0.5118, 3.31, 0.089, 109, 101, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3540, 1mlcC, 0.5118, 3.02, 0.105, 104, 95, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
3541, 1il1B, 0.5118, 4.10, 0.111, 219, 108, CRYSTAL STRUCTURE OF G3-519 AN ANTI-HIV MONOCLONAL ANTIBODY
3542, 6meiL, 0.5117, 4.08, 0.120, 219, 108, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3543, 6igtD, 0.5117, 4.04, 0.150, 214, 107, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
3544, 6bgtA, 0.5117, 4.13, 0.082, 125, 110, STRUCTURE OF TRASTUZUMAB FAB MUTANT IN COMPLEX WITH HER2 EXTRACELLULAR DOMAIN 
3545, 6b5rH, 0.5117, 3.94, 0.094, 213, 106, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
3546, 5xs7L, 0.5117, 3.94, 0.094, 213, 106, STRUCTURE OF COXSACKIEVIRUS A6 (CVA6) VIRUS A-PARTICLE IN COMPLEX WITH THE NEUTRALIZING ANTIBODY FRAGMENT 1D5
3547, 5xlib, 0.5117, 4.07, 0.101, 241, 109, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
3548, 5x8lO, 0.5117, 4.06, 0.112, 214, 107, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
3549, 5v6lL, 0.5117, 4.12, 0.082, 219, 110, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A37 IN COMPLEX WITH V3 PEPTIDE JR-FL
3550, 4yhiL, 0.5117, 4.00, 0.083, 219, 109, REVERSAL AGENT FOR DABIGATRAN
3551, 4xbpD, 0.5117, 3.91, 0.057, 314, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
3552, 4v4mZA, 0.5117, 3.96, 0.113, 211, 106, 
3553, 4v4mT, 0.5117, 4.69, 0.034, 184, 119, 
3554, 4v4mN, 0.5117, 4.70, 0.034, 184, 119, 
3555, 4rqqL, 0.5117, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3556, 4rgnD, 0.5117, 4.70, 0.034, 184, 119, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3557, 4jm0B, 0.5117, 4.05, 0.131, 213, 107, STRUCTURE OF HUMAN CYTOMEGALOVIRUS IMMUNE MODULATOR UL141
3558, 4hxbL, 0.5117, 4.09, 0.072, 228, 111, CRYSTAL STRUCTURE OF 6B9 FAB
3559, 3v52L, 0.5117, 4.16, 0.037, 355, 108, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
3560, 3ujtL, 0.5117, 3.93, 0.112, 196, 107, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
3561, 3nabH, 0.5117, 3.98, 0.142, 211, 106, CRYSTAL STRUCTURE OF FAB15 MUT6
3562, 3j2zG, 0.5117, 4.08, 0.121, 214, 107, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
3563, 3j2zE, 0.5117, 4.11, 0.111, 218, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
3564, 3j2zC, 0.5117, 3.99, 0.100, 221, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
3565, 3j2zA, 0.5117, 4.09, 0.111, 215, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
3566, 3j2yG, 0.5117, 4.13, 0.074, 214, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
3567, 3j2yE, 0.5117, 4.15, 0.065, 214, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
3568, 3j2yC, 0.5117, 4.01, 0.121, 214, 107, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
3569, 3j2yA, 0.5117, 4.07, 0.157, 219, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
3570, 2xwtA, 0.5117, 4.04, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
3571, 1yeiL, 0.5117, 3.97, 0.100, 116, 110, CATALYTIC ANTIBODY D2.3 COMPLEX
3572, 1yecL, 0.5117, 4.00, 0.103, 211, 107, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)
3573, 1oaxJ, 0.5117, 4.04, 0.073, 211, 110, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
3574, 1lk3L, 0.5117, 3.94, 0.124, 108, 105, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
3575, 1ikfL, 0.5117, 3.93, 0.123, 213, 106, A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX
3576, 1bypA, 0.5117, 4.01, 0.093, 213, 107, E43KD44K DOUBLE MUTANT PLASTOCYANIN FROM SILENE
3577, 1byoB, 0.5117, 4.07, 0.103, 215, 107, WILD-TYPE PLASTOCYANIN FROM SILENE
3578, 6jmrD, 0.5116, 4.12, 0.111, 219, 108, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3579, 6df2A, 0.5116, 4.11, 0.065, 214, 108, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
3580, 6dc7M, 0.5116, 4.67, 0.042, 184, 119, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
3581, 6cdpB, 0.5116, 4.49, 0.052, 184, 116, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3582, 6cbvL, 0.5116, 4.67, 0.042, 184, 119, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
3583, 6bitK, 0.5116, 4.49, 0.052, 184, 116, SIRPALPHA ANTIBODY COMPLEX
3584, 6b5lL, 0.5116, 4.71, 0.034, 184, 119, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3585, 5xbmD, 0.5116, 4.04, 0.103, 215, 107, STRUCTURE OF SCARB2-JL2 COMPLEX 
3586, 5w0pB, 0.5116, 4.08, 0.091, 210, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
3587, 5njdO, 0.5116, 3.95, 0.126, 183, 111, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
3588, 5jo4C, 0.5116, 4.08, 0.120, 219, 108, ANTIBODY FAB FRAGMENT COMPLEX
3589, 4wfgF, 0.5116, 4.12, 0.120, 218, 108, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
3590, 4u6hA, 0.5116, 4.08, 0.120, 217, 108, VACCINIA L1/M12B9-FAB COMPLEX
3591, 4tnvV, 0.5116, 4.08, 0.082, 217, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3592, 4tnvF, 0.5116, 3.96, 0.132, 212, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3593, 4rgnF, 0.5116, 3.96, 0.132, 212, 106, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3594, 4oziF, 0.5116, 3.96, 0.132, 212, 106, S2 PROTEIN COMPLEX
3595, 4okvD, 0.5116, 3.96, 0.132, 212, 106, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
3596, 4k8rL, 0.5116, 3.96, 0.132, 212, 106, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
3597, 4k55A, 0.5116, 3.96, 0.132, 212, 106, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH (E)-4-HYDROXY-3-METHYL-BUT-2-ENYL PYROPHOSPHATE (HMBPP)
3598, 4g82A, 0.5116, 3.96, 0.132, 212, 106, CRYSTAL STRUCTURE OF P73 DNA-BINDING DOMAIN TETRAMER BOUND TO A FULL RESPONSE-ELEMENT
3599, 3uzeA, 0.5116, 3.96, 0.132, 212, 106, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3600, 3uyrL, 0.5116, 4.09, 0.063, 215, 111, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
3601, 3t0vA, 0.5116, 4.08, 0.120, 219, 108, UNLIGANDED FLUOROGEN ACTIVATING PROTEIN M8VL
3602, 3qynB, 0.5116, 4.09, 0.111, 219, 108, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3603, 3opzM, 0.5116, 4.04, 0.099, 122, 111, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
3604, 3o11L, 0.5116, 3.90, 0.132, 210, 106, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
3605, 3lh9A, 0.5116, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
3606, 3kj6H, 0.5116, 2.70, 0.157, 99, 89, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
3607, 3if1C, 0.5116, 2.66, 0.135, 99, 89, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
3608, 3hmxH, 0.5116, 4.05, 0.102, 219, 108, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
3609, 3f58L, 0.5116, 4.01, 0.103, 215, 107, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
3610, 2lkfA, 0.5116, 4.10, 0.111, 218, 108, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS
3611, 2gsiE, 0.5116, 4.07, 0.111, 219, 108, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3612, 2b2xM, 0.5116, 3.99, 0.103, 213, 107, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
3613, 2adiA, 0.5116, 4.04, 0.121, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
3614, 1zanL, 0.5116, 4.09, 0.111, 218, 108, CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
3615, 1u6aL, 0.5116, 3.84, 0.124, 209, 105, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
3616, 1ahwE, 0.5116, 3.95, 0.038, 802, 106, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
3617, 6rcuB, 0.5115, 3.82, 0.094, 213, 106, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
3618, 6n4rK, 0.5115, 3.81, 0.093, 221, 108, CRYOEM STRUCTURE OF NAV1.7 VSD2 (DEACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
3619, 6n4rI, 0.5115, 3.98, 0.104, 211, 106, CRYOEM STRUCTURE OF NAV1.7 VSD2 (DEACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
3620, 6igtA, 0.5115, 3.86, 0.092, 217, 109, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
3621, 6h5nE, 0.5115, 3.97, 0.091, 224, 110, PLASMODIUM FALCIPARUM PFS48/45 C-TERMINAL DOMAIN BOUND TO MONOCLONAL ANTIBODY 85RF45.1 
3622, 5vtaL, 0.5115, 3.97, 0.091, 222, 110, CO-CRYSTAL STRUCTURE OF DPPIV WITH A CHEMIBODY INHIBITOR 
3623, 5nbwL, 0.5115, 4.09, 0.091, 210, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
3624, 5mf7A, 0.5115, 3.99, 0.102, 243, 108, P53-DNA COMPLEX 6 
3625, 5dlmM, 0.5115, 4.09, 0.120, 218, 108, COMPLEX OF INFLUENZA M2E AND ANTIBODY
3626, 4ygvA, 0.5115, 3.95, 0.121, 214, 107, REVERSAL AGENT FOR DABIGATRAN
3627, 4v4mQA, 0.5115, 4.08, 0.119, 118, 109, 
3628, 4tnwH, 0.5115, 3.87, 0.095, 201, 105, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3629, 4tnvU, 0.5115, 3.91, 0.066, 229, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3630, 4tnvI, 0.5115, 4.12, 0.120, 218, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3631, 4f9lC, 0.5115, 4.02, 0.113, 112, 106, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
3632, 4etqL, 0.5115, 3.91, 0.094, 193, 106, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
3633, 4dn4L, 0.5115, 3.93, 0.132, 212, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A
3634, 4aeiN, 0.5115, 4.02, 0.094, 211, 106, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3635, 3u79A, 0.5115, 3.92, 0.087, 286, 103, AL-103 Y32F Y96F
3636, 3qpqF, 0.5115, 4.06, 0.091, 217, 110, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3637, 3j8dD, 0.5115, 4.09, 0.120, 215, 108, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
3638, 3j8dA, 0.5115, 4.09, 0.054, 217, 111, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
3639, 2fx9L, 0.5115, 4.12, 0.111, 215, 108, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3640, 1orqA, 0.5115, 4.06, 0.118, 296, 110, X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
3641, 1oaxH, 0.5115, 4.14, 0.102, 215, 108, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
3642, 1mlcA, 0.5115, 3.96, 0.104, 210, 106, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
3643, 1mieL, 0.5115, 4.00, 0.131, 211, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
3644, 1kn4L, 0.5115, 4.05, 0.131, 213, 107, CATALYTIC ANTIBODY D2.3 COMPLEX
3645, 6mtoH, 0.5114, 4.00, 0.103, 214, 107, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
3646, 6ey0F, 0.5114, 4.11, 0.099, 214, 111, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
3647, 6e14C, 0.5114, 3.89, 0.073, 222, 109, HANDOVER MECHANISM OF THE GROWING PILUS BY THE BACTERIAL OUTER MEMBRANE USHER FIMD 
3648, 5yxuB, 0.5114, 4.04, 0.112, 215, 107, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
3649, 5tudB, 0.5114, 4.04, 0.112, 215, 107, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
3650, 5n09M, 0.5114, 3.99, 0.100, 117, 110, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3651, 5myoC, 0.5114, 4.15, 0.109, 212, 110, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
3652, 5hdqL, 0.5114, 3.95, 0.123, 208, 106, MNTC CO-STRUCTURE WITH MAB 305-78-7
3653, 5girL, 0.5114, 4.06, 0.103, 214, 107, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
3654, 4v4mJ, 0.5114, 3.90, 0.067, 188, 105, 
3655, 4v4mDB, 0.5114, 4.13, 0.120, 217, 108, 
3656, 4tnvY, 0.5114, 3.93, 0.083, 220, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3657, 4tnvJ, 0.5114, 4.70, 0.034, 184, 119, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3658, 4tnvH, 0.5114, 3.99, 0.100, 223, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3659, 4ps4L, 0.5114, 3.98, 0.091, 221, 110, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
3660, 4o51C, 0.5114, 3.98, 0.091, 222, 110, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
3661, 4nwwA, 0.5114, 4.02, 0.113, 232, 106, CRYSTAL STRUCTURE OF AN N-TERMINALLY TRUNCATED CAPSID PROTEIN MUTANT OF ORSAY VIRUS
3662, 4h88H, 0.5114, 3.95, 0.132, 212, 106, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
3663, 4f3fA, 0.5114, 4.07, 0.093, 213, 108, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
3664, 4aeiM, 0.5114, 4.13, 0.111, 217, 108, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3665, 4aeiL, 0.5114, 3.92, 0.095, 111, 105, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3666, 3vg0L, 0.5114, 4.06, 0.100, 220, 110, ANTIBODY FAB FRAGMENT
3667, 3utzA, 0.5114, 4.06, 0.112, 425, 107, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
3668, 3us0C, 0.5114, 4.06, 0.112, 425, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3669, 3rifI, 0.5114, 4.10, 0.065, 214, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
3670, 3qynD, 0.5114, 4.14, 0.120, 215, 108, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3671, 3qynC, 0.5114, 4.04, 0.099, 122, 111, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3672, 3mclL, 0.5114, 4.04, 0.121, 214, 107, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
3673, 3ikcA, 0.5114, 4.09, 0.093, 218, 108, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3674, 3i9gH, 0.5114, 4.08, 0.120, 219, 108, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
3675, 3i50L, 0.5114, 4.13, 0.063, 219, 111, CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
3676, 3hagA, 0.5114, 4.15, 0.109, 131, 110, CRYSTAL STRUCTURE OF THE HEPATITIS E VIRUS-LIKE PARTICLE
3677, 3c09L, 0.5114, 2.93, 0.105, 205, 95, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
3678, 2r8sL, 0.5114, 3.99, 0.102, 242, 108, HIGH RESOLUTION STRUCTURE OF A SPECIFIC SYNTHETIC FAB BOUND TO P4-P6 RNA RIBOZYME DOMAIN
3679, 1yefL, 0.5114, 3.97, 0.104, 211, 106, STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE
3680, 1xf4A, 0.5114, 4.01, 0.074, 213, 108, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
3681, 1wtlB, 0.5114, 4.10, 0.111, 219, 108, COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS
3682, 1eo8L, 0.5114, 4.09, 0.148, 218, 108, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
3683, 1aj7H, 0.5114, 4.09, 0.121, 212, 107, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
3684, 6jmrC, 0.5113, 4.70, 0.034, 184, 119, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3685, 6iuvC, 0.5113, 4.67, 0.042, 184, 119, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3686, 6fy3X, 0.5113, 4.71, 0.034, 184, 119, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
3687, 6cwtB, 0.5113, 3.98, 0.091, 221, 110, HEPATITIS B CORE-ANTIGEN IN COMPLEX WITH FAB E21 
3688, 6a78M, 0.5113, 3.98, 0.091, 223, 110, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE SCFV FRAGMENT OF MURINE MONOCLONAL ANTIBODY B5209B 
3689, 6a3wD, 0.5113, 3.98, 0.091, 223, 110, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3690, 6a3wA, 0.5113, 4.07, 0.103, 213, 107, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3691, 5mvzH, 0.5113, 3.95, 0.103, 214, 107, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
3692, 5i1lL, 0.5113, 4.21, 0.037, 341, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
3693, 5cdcC, 0.5113, 4.14, 0.090, 218, 111, CRYSTAL STRUCTURE OF ISRAEL ACUTE PARALYSIS VIRUS
3694, 4zpvB, 0.5113, 3.96, 0.104, 211, 106, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
3695, 4yhiH, 0.5113, 4.12, 0.111, 217, 108, REVERSAL AGENT FOR DABIGATRAN
3696, 4v4mVA, 0.5113, 4.12, 0.111, 218, 108, 
3697, 4v4mO, 0.5113, 4.07, 0.121, 213, 107, 
3698, 4tnwG, 0.5113, 4.07, 0.111, 215, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3699, 4jn1L, 0.5113, 3.93, 0.094, 196, 106, AN ANTIDOTE FOR DABIGATRAN
3700, 3t2nH, 0.5113, 4.00, 0.100, 192, 110, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3701, 3ri5J, 0.5113, 3.92, 0.094, 190, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3702, 3qeuB, 0.5113, 3.92, 0.094, 196, 106, THE CRYSTAL STRUCTURE OF TCR DMF5
3703, 3opzN, 0.5113, 3.99, 0.094, 209, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
3704, 3naaH, 0.5113, 4.10, 0.120, 217, 108, CRYSTAL STRUCTURE OF FAB15 MUT5
3705, 3j8zM, 0.5113, 4.09, 0.072, 222, 111, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
3706, 3j8zL, 0.5113, 3.95, 0.113, 207, 106, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
3707, 3j8zK, 0.5113, 3.98, 0.065, 468, 108, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
3708, 3j8zJ, 0.5113, 3.98, 0.094, 211, 106, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
3709, 3ietC, 0.5113, 4.02, 0.093, 214, 107, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3710, 3gewB, 0.5113, 4.09, 0.111, 219, 108, FAEE-FAEG CHAPERONE-MAJOR PILIN COMPLEX OF F4 AD FIMBRIAE
3711, 3be1L, 0.5113, 4.07, 0.121, 213, 107, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3712, 2or9L, 0.5113, 3.92, 0.105, 108, 105, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
3713, 2bpa1, 0.5113, 3.95, 0.113, 210, 106, ATOMIC STRUCTURE OF SINGLE-STRANDED DNA BACTERIOPHAGE PHIX174 AND ITS FUNCTIONAL IMPLICATIONS
3714, 2adgA, 0.5113, 4.06, 0.099, 217, 111, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
3715, 1yegL, 0.5113, 4.11, 0.063, 214, 111, STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT
3716, 1rzgC, 0.5113, 4.06, 0.082, 224, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
3717, 1clyL, 0.5113, 4.22, 0.063, 178, 111, IGG FAB (HUMAN IGG1 KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
3718, 1cf8L, 0.5113, 4.06, 0.112, 214, 107, CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
3719, 6ogxL, 0.5112, 3.93, 0.143, 110, 105, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
3720, 6obdA, 0.5112, 3.97, 0.065, 116, 107, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
3721, 6e15C, 0.5112, 3.97, 0.065, 116, 107, HANDOVER MECHANISM OF THE GROWING PILUS BY THE BACTERIAL OUTER MEMBRANE USHER FIMD 
3722, 6c5jL, 0.5112, 4.22, 0.071, 221, 112, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 1) 
3723, 6bitL, 0.5112, 4.10, 0.111, 220, 108, SIRPALPHA ANTIBODY COMPLEX
3724, 6a0xD, 0.5112, 4.10, 0.066, 243, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3725, 5w06H, 0.5112, 4.01, 0.093, 212, 107, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
3726, 5muqH, 0.5112, 3.97, 0.082, 222, 110, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
3727, 5mf7B, 0.5112, 4.68, 0.042, 184, 119, P53-DNA COMPLEX 6 
3728, 5hj3B, 0.5112, 4.67, 0.042, 184, 119, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
3729, 5epmB, 0.5112, 4.69, 0.042, 184, 119, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
3730, 5dmgL, 0.5112, 3.99, 0.100, 222, 110, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
3731, 5b6fA, 0.5112, 4.13, 0.102, 219, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
3732, 4zptB, 0.5112, 3.83, 0.066, 203, 106, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
3733, 4tnvX, 0.5112, 3.98, 0.100, 215, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3734, 4ofyA, 0.5112, 4.11, 0.110, 238, 109, CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4
3735, 4nkoE, 0.5112, 3.92, 0.132, 212, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3736, 4ma7H, 0.5112, 4.09, 0.090, 225, 111, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
3737, 4gmsL, 0.5112, 4.05, 0.112, 115, 107, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
3738, 3x2dG, 0.5112, 4.05, 0.112, 115, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3739, 3u79C, 0.5112, 4.05, 0.112, 115, 107, AL-103 Y32F Y96F
3740, 3t2nI, 0.5112, 4.05, 0.112, 115, 107, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3741, 3rifF, 0.5112, 4.08, 0.111, 217, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
3742, 3riaJ, 0.5112, 3.29, 0.083, 199, 96, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
3743, 3ri5G, 0.5112, 4.08, 0.119, 216, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3744, 3rhwJ, 0.5112, 4.13, 0.120, 216, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
3745, 3gewC, 0.5112, 4.37, 0.096, 426, 115, FAEE-FAEG CHAPERONE-MAJOR PILIN COMPLEX OF F4 AD FIMBRIAE
3746, 1g6rC, 0.5112, 4.07, 0.121, 211, 107, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
3747, 6eiwB, 0.5111, 4.09, 0.111, 219, 108, SACBROOD VIRUS OF HONEYBEE EMPTY PARTICLE 
3748, 5uddQ, 0.5111, 4.01, 0.082, 213, 110, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3749, 5u3dA, 0.5111, 4.03, 0.112, 217, 107, STRUCTURE OF MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT
3750, 5h35B, 0.5111, 4.13, 0.111, 215, 108, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3751, 5dyoL, 0.5111, 4.00, 0.093, 210, 107, FAB43.1 COMPLEX WITH FLOURESCEIN
3752, 4yhiB, 0.5111, 4.07, 0.102, 216, 108, REVERSAL AGENT FOR DABIGATRAN
3753, 4ygvB, 0.5111, 2.94, 0.094, 199, 96, REVERSAL AGENT FOR DABIGATRAN
3754, 4wo4D, 0.5111, 4.10, 0.120, 217, 108, THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.
3755, 4v4mK, 0.5111, 4.03, 0.112, 210, 107, 
3756, 4u6hB, 0.5111, 4.07, 0.112, 214, 107, VACCINIA L1/M12B9-FAB COMPLEX
3757, 4tsbL, 0.5111, 4.13, 0.081, 216, 111, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
3758, 4odvL, 0.5111, 4.09, 0.091, 219, 110, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3759, 4imlL, 0.5111, 3.90, 0.067, 188, 105, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
3760, 4hc1N, 0.5111, 4.13, 0.093, 203, 108, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
3761, 4djmE, 0.5111, 4.05, 0.121, 218, 107, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3762, 3w11D, 0.5111, 4.02, 0.103, 216, 107, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
3763, 3riaG, 0.5111, 4.12, 0.111, 216, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
3764, 3ri5I, 0.5111, 4.03, 0.093, 212, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3765, 3rhwG, 0.5111, 3.98, 0.091, 224, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
3766, 2zahA, 0.5111, 4.03, 0.075, 230, 107, X-RAY STRUCTURE OF MELON NECROTIC SPOT VIRUS
3767, 2ck0L, 0.5111, 4.09, 0.102, 115, 108, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH A SYNTHETIC CYCLIC PEPTIDE
3768, 1yekL, 0.5111, 4.13, 0.090, 218, 111, CATALYTIC ANTIBODY D2.3 COMPLEX
3769, 1wcbA, 0.5111, 4.02, 0.121, 211, 107, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
3770, 1rziL, 0.5111, 4.04, 0.093, 211, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3771, 1rz8C, 0.5111, 3.93, 0.105, 111, 105, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
3772, 1mj7L, 0.5111, 3.94, 0.056, 205, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
3773, 1iaiM, 0.5111, 4.00, 0.100, 171, 110, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
3774, 1forL, 0.5111, 3.99, 0.100, 215, 110, STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX
3775, 1fh5L, 0.5111, 3.98, 0.100, 200, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MONOCLONAL ANTIBODY MAK33
3776, 1dbbH, 0.5111, 3.99, 0.100, 215, 110, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
3777, 6obdL, 0.5110, 3.29, 0.083, 208, 96, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
3778, 6ev1H, 0.5110, 4.05, 0.102, 202, 108, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3779, 6dezL, 0.5110, 4.06, 0.087, 199, 104, ANTI-PHOSPHOTYROSINE ANTIBODY PY20-4D5 FAB COMPLEXED WITH SULFATE 
3780, 6dcaL, 0.5110, 4.02, 0.093, 211, 107, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3781, 6a3wG, 0.5110, 3.99, 0.103, 214, 107, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3782, 6a0xH, 0.5110, 4.10, 0.120, 217, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3783, 5wkoH, 0.5110, 4.14, 0.120, 216, 108, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3784, 5ushE, 0.5110, 4.13, 0.111, 219, 108, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
3785, 5muqA, 0.5110, 4.13, 0.111, 218, 108, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
3786, 5dyoB, 0.5110, 3.89, 0.084, 242, 107, FAB43.1 COMPLEX WITH FLOURESCEIN
3787, 4yueL, 0.5110, 4.49, 0.052, 184, 116, MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT
3788, 4xmkL, 0.5110, 4.71, 0.034, 184, 119, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
3789, 4v4mQ, 0.5110, 4.14, 0.111, 217, 108, 
3790, 4tnwY, 0.5110, 3.98, 0.121, 214, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3791, 4tnwW, 0.5110, 4.05, 0.093, 214, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3792, 4ongL, 0.5110, 3.93, 0.094, 210, 106, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40
3793, 4lriA, 0.5110, 4.09, 0.112, 213, 107, ANTI CMV FAB FRAGMENT
3794, 3v6fF, 0.5110, 3.12, 0.095, 198, 95, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3795, 3v6fD, 0.5110, 3.98, 0.151, 114, 106, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3796, 3riaH, 0.5110, 3.99, 0.100, 200, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
3797, 3rhwH, 0.5110, 4.01, 0.100, 199, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
3798, 3d9aL, 0.5110, 3.99, 0.100, 200, 110, HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME
3799, 2vxvH, 0.5110, 3.97, 0.029, 296, 103, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
3800, 2r4sH, 0.5110, 4.00, 0.150, 216, 107, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
3801, 2ok0H, 0.5110, 4.09, 0.120, 219, 108, FAB ED10-DNA COMPLEX
3802, 1nldL, 0.5110, 4.00, 0.094, 213, 106, FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1
3803, 1mcpL, 0.5110, 4.11, 0.072, 215, 111, PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
3804, 1blnC, 0.5110, 4.02, 0.103, 214, 107, ANTI-P-GLYCOPROTEIN FAB MRK-16
3805, 6my4L, 0.5109, 4.12, 0.093, 218, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
3806, 6bzvH, 0.5109, 4.14, 0.130, 215, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3807, 5uqyC, 0.5109, 3.98, 0.104, 210, 106, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
3808, 5n2kM, 0.5109, 4.07, 0.103, 213, 107, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3809, 5mvzA, 0.5109, 3.83, 0.083, 219, 109, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
3810, 5b6fC, 0.5109, 4.10, 0.102, 216, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
3811, 4zypM, 0.5109, 3.97, 0.094, 211, 106, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3812, 4yhkL, 0.5109, 4.03, 0.084, 206, 107, REVERSAL AGENT FOR DABIGATRAN
3813, 4xmkN, 0.5109, 4.13, 0.102, 215, 108, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
3814, 4uimD, 0.5109, 3.98, 0.065, 116, 107, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
3815, 4u1gC, 0.5109, 4.09, 0.121, 214, 107, PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY QA1
3816, 4tnvG, 0.5109, 4.17, 0.093, 213, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
3817, 4n90G, 0.5109, 3.93, 0.131, 212, 107, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
3818, 4mwfA, 0.5109, 4.09, 0.091, 219, 110, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
3819, 4m6mL, 0.5109, 4.15, 0.111, 218, 108, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
3820, 4djmB, 0.5109, 4.00, 0.112, 214, 107, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3821, 3vi4L, 0.5109, 4.07, 0.120, 215, 108, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
3822, 3o6kL, 0.5109, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB 11H6H1
3823, 3mltB, 0.5109, 4.70, 0.034, 184, 119, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3824, 3ls5L, 0.5109, 4.00, 0.100, 221, 110, ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT FREE FORM
3825, 3inuN, 0.5109, 4.00, 0.100, 224, 110, CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
3826, 3ijyA, 0.5109, 4.11, 0.111, 214, 108, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3827, 3effA, 0.5109, 4.05, 0.093, 217, 108, THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION
3828, 2ygtA, 0.5109, 4.11, 0.120, 219, 108, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
3829, 2r56M, 0.5109, 4.10, 0.120, 219, 108, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
3830, 2igfL, 0.5109, 4.00, 0.100, 221, 110, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
3831, 1xf5A, 0.5109, 4.00, 0.100, 221, 110, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
3832, 1xcqE, 0.5109, 4.05, 0.112, 213, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3833, 1k6qL, 0.5109, 4.20, 0.089, 222, 112, CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
3834, 6ii9N, 0.5108, 4.08, 0.091, 217, 110, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
3835, 6gk7H, 0.5108, 4.07, 0.081, 216, 111, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
3836, 6bzvF, 0.5108, 4.09, 0.111, 219, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3837, 6b9zA, 0.5108, 3.99, 0.112, 220, 107, TRASTUZUMAB FAB V3 
3838, 5xcxB, 0.5108, 4.16, 0.120, 214, 108, CRYSTAL STRUCTURE OF TS2/16 FV-CLASP FRAGMENT
3839, 5vnwD, 0.5108, 4.03, 0.101, 218, 109, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
3840, 5fhcL, 0.5108, 4.14, 0.111, 215, 108, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
3841, 4xcyL, 0.5108, 4.01, 0.103, 210, 107, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3842, 4ut7L, 0.5108, 3.82, 0.094, 212, 106, CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3843, 4tscL, 0.5108, 4.10, 0.073, 221, 110, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
3844, 4r9yM, 0.5108, 4.06, 0.112, 217, 107, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
3845, 4o51A, 0.5108, 4.01, 0.113, 211, 106, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
3846, 4edxL, 0.5108, 4.10, 0.111, 218, 108, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
3847, 4dgiH, 0.5108, 4.07, 0.120, 213, 108, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230
3848, 4am0C, 0.5108, 4.03, 0.093, 214, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3849, 3v6oF, 0.5108, 4.05, 0.112, 215, 107, LEPTIN RECEPTOR-ANTIBODY COMPLEX
3850, 3uo1L, 0.5108, 3.98, 0.091, 224, 110, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
3851, 3ri5F, 0.5108, 4.06, 0.084, 214, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3852, 3ntcL, 0.5108, 4.00, 0.064, 223, 109, CRYSTAL STRUCTURE OF KD-247 FAB AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
3853, 3lhaA, 0.5108, 4.03, 0.120, 216, 108, CRYSTAL STRUCTURE OF MOUSE VPS26B(R240S/G241A/E242S) IN SPACEGROUP P41 21 2
3854, 3h42L, 0.5108, 3.10, 0.084, 202, 95, CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
3855, 2mpaL, 0.5108, 4.16, 0.083, 219, 108, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
3856, 2eh7L, 0.5108, 4.08, 0.111, 217, 108, CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB
3857, 2adjA, 0.5108, 4.11, 0.045, 219, 110, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
3858, 1ymhC, 0.5108, 4.03, 0.112, 215, 107, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
3859, 1yehL, 0.5108, 4.09, 0.093, 217, 108, STRUCTURE OF IGG2A FAB FRAGMENT
3860, 1v7nM, 0.5108, 4.11, 0.148, 215, 108, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3861, 1qblH, 0.5108, 3.98, 0.103, 215, 107, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
3862, 1nd0G, 0.5108, 4.08, 0.120, 282, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3863, 1d5bL, 0.5108, 4.03, 0.103, 211, 107, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
3864, 1a6uH, 0.5108, 4.09, 0.111, 219, 108, B1-8 FV FRAGMENT
3865, 6fgbL, 0.5107, 4.12, 0.102, 220, 108, HUMAN FCRN EXTRA-CELLULAR DOMAIN COMPLEXED WITH FAB FRAGMENT OF ROZANOLIXIZUMAB 
3866, 6b0hA, 0.5107, 4.04, 0.112, 220, 107, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1262
3867, 5t5fL, 0.5107, 4.04, 0.103, 204, 107, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
3868, 5swsE, 0.5107, 3.94, 0.113, 212, 106, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
3869, 5njdS, 0.5107, 4.00, 0.073, 223, 109, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
3870, 5cusN, 0.5107, 4.05, 0.112, 214, 107, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
3871, 5cusM, 0.5107, 3.99, 0.112, 214, 107, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
3872, 4xmkM, 0.5107, 4.05, 0.103, 160, 107, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
3873, 4wuuE, 0.5107, 3.87, 0.103, 120, 107, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
3874, 4tnwI, 0.5107, 4.04, 0.103, 211, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3875, 4s1dD, 0.5107, 4.11, 0.065, 214, 108, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
3876, 4i77L, 0.5107, 3.93, 0.075, 113, 106, LEBRIKIZUMAB FAB BOUND TO IL-13
3877, 3vw3L, 0.5107, 4.09, 0.120, 214, 108, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
3878, 3us0D, 0.5107, 4.04, 0.112, 214, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3879, 3qeuE, 0.5107, 3.96, 0.103, 214, 107, THE CRYSTAL STRUCTURE OF TCR DMF5
3880, 3qdgE, 0.5107, 4.07, 0.093, 214, 107, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3881, 3iglA, 0.5107, 4.16, 0.090, 218, 111, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 1)
3882, 3clfH, 0.5107, 4.14, 0.081, 211, 111, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3883, 3cleH, 0.5107, 4.04, 0.113, 212, 106, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
3884, 2y5tA, 0.5107, 4.13, 0.120, 218, 108, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
3885, 2cgrL, 0.5107, 4.01, 0.100, 188, 110, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
3886, 2b1hL, 0.5107, 4.13, 0.102, 219, 108, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
3887, 1ymhB, 0.5107, 3.84, 0.098, 283, 102, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
3888, 1tzgM, 0.5107, 4.02, 0.111, 214, 108, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
3889, 1mh5L, 0.5107, 4.08, 0.120, 219, 108, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
3890, 1cf1C, 0.5107, 4.13, 0.102, 219, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
3891, 1c5dL, 0.5107, 4.01, 0.131, 211, 107, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
3892, 6iekF, 0.5106, 4.05, 0.103, 220, 107, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
3893, 6higH, 0.5106, 4.09, 0.111, 219, 108, HPD-1/NBO1A FAB COMPLEX 
3894, 6h5nB, 0.5106, 3.98, 0.151, 212, 106, PLASMODIUM FALCIPARUM PFS48/45 C-TERMINAL DOMAIN BOUND TO MONOCLONAL ANTIBODY 85RF45.1 
3895, 6aruB, 0.5106, 4.12, 0.090, 219, 111, STRUCTURE OF CETUXIMAB FAB MUTANT IN COMPLEX WITH EGFR EXTRACELLULAR DOMAIN 
3896, 5cusL, 0.5106, 4.13, 0.102, 219, 108, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
3897, 4yx2H, 0.5106, 4.04, 0.121, 211, 107, CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB
3898, 4ygvL, 0.5106, 3.92, 0.083, 120, 108, REVERSAL AGENT FOR DABIGATRAN
3899, 4tnwX, 0.5106, 4.13, 0.111, 219, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3900, 4qt5A, 0.5106, 4.02, 0.103, 213, 107, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
3901, 4o51L, 0.5106, 4.15, 0.130, 216, 108, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
3902, 4louF, 0.5106, 4.10, 0.130, 239, 108, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
3903, 3ls4L, 0.5106, 3.83, 0.094, 214, 106, CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC
3904, 2r9hF, 0.5106, 3.90, 0.123, 184, 106, CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB
3905, 2ocwA, 0.5106, 3.91, 0.113, 203, 106, SOLUTION STRUCTURE OF HUMAN SECRETORY COMPONENT
3906, 2fbjL, 0.5106, 4.07, 0.120, 215, 108, REFINED CRYSTAL STRUCTURE OF THE GALACTAN-BINDING IMMUNOGLOBULIN FAB J539 AT 1.95-ANGSTROMS RESOLUTION
3907, 2adfL, 0.5106, 4.05, 0.064, 223, 110, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
3908, 1za6C, 0.5106, 3.99, 0.091, 222, 110, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3909, 1mreL, 0.5106, 4.07, 0.131, 211, 107, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
3910, 1m7iA, 0.5106, 4.10, 0.102, 218, 108, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
3911, 1dbaH, 0.5106, 4.09, 0.128, 215, 109, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
3912, 1cicB, 0.5106, 3.92, 0.094, 192, 106, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3913, 6nc2X, 0.5105, 4.08, 0.101, 243, 109, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
3914, 6nc2W, 0.5105, 4.13, 0.101, 242, 109, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
3915, 6nc2V, 0.5105, 3.91, 0.067, 197, 105, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
3916, 6nc2U, 0.5105, 3.96, 0.127, 220, 110, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
3917, 6nc2T, 0.5105, 3.96, 0.118, 218, 110, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
3918, 6nc2L, 0.5105, 4.24, 0.117, 222, 111, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
3919, 6ey0G, 0.5105, 4.07, 0.111, 219, 108, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
3920, 6cwtD, 0.5105, 3.92, 0.085, 215, 106, HEPATITIS B CORE-ANTIGEN IN COMPLEX WITH FAB E21 
3921, 5swzO, 0.5105, 3.95, 0.073, 218, 110, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
3922, 5n2kK, 0.5105, 4.14, 0.065, 214, 108, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3923, 5jrpL, 0.5105, 4.18, 0.111, 212, 108, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MR78 FAB
3924, 5ibuG, 0.5105, 3.58, 0.039, 380, 102, FAB (UNBOUND)
3925, 5b6fG, 0.5105, 4.05, 0.112, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
3926, 4wv1A, 0.5105, 3.96, 0.139, 218, 108, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
3927, 4v4mOA, 0.5105, 4.11, 0.081, 209, 111, 
3928, 4u6hC, 0.5105, 4.16, 0.109, 212, 110, VACCINIA L1/M12B9-FAB COMPLEX
3929, 4kk6F, 0.5105, 4.01, 0.103, 210, 107, STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
3930, 4ibwA, 0.5105, 3.91, 0.113, 185, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3931, 4hqqH, 0.5105, 4.13, 0.090, 214, 111, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
3932, 4fqlL, 0.5105, 4.12, 0.111, 218, 108, INFLUENZA B HA ANTIBODY (FAB) CR8033
3933, 4etqH, 0.5105, 4.01, 0.100, 224, 110, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
3934, 4edxA, 0.5105, 4.15, 0.102, 216, 108, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
3935, 4cmhC, 0.5105, 3.95, 0.103, 214, 107, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
3936, 4al8H, 0.5105, 3.99, 0.142, 211, 106, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
3937, 3qo1A, 0.5105, 4.14, 0.130, 215, 108, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
3938, 3qo0A, 0.5105, 3.99, 0.142, 211, 106, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA
3939, 3qnyC, 0.5105, 3.95, 0.083, 585, 109, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
3940, 3hmwH, 0.5105, 3.94, 0.113, 213, 106, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3941, 3b9kB, 0.5105, 4.02, 0.103, 209, 107, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
3942, 2w9dL, 0.5105, 4.13, 0.102, 220, 108, STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.
3943, 2cdfB, 0.5105, 4.12, 0.111, 218, 108, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
3944, 1xf4L, 0.5105, 4.11, 0.111, 215, 108, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
3945, 1ottF, 0.5105, 3.95, 0.082, 219, 110, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
3946, 1mpaL, 0.5105, 4.12, 0.108, 217, 111, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
3947, 6h2bA, 0.5104, 3.88, 0.086, 108, 105, STRUCTURE OF THE MACROBRACHIUM ROSENBERGII NODAVIRUS 
3948, 6df2L, 0.5104, 3.88, 0.086, 108, 105, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
3949, 6baeA, 0.5104, 3.88, 0.086, 108, 105, TRASTUZUMAB FAB V3 IN COMPLEX WITH CQFDLSTRRLKC 
3950, 5npjB, 0.5104, 3.88, 0.086, 108, 105, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
3951, 5npiB, 0.5104, 3.88, 0.086, 108, 105, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
3952, 5mcvA, 0.5104, 3.88, 0.086, 108, 105, P53-DNA COMPLEX 3 
3953, 4tnwU, 0.5104, 4.18, 0.099, 129, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
3954, 4qt5L, 0.5104, 4.06, 0.112, 208, 107, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
3955, 4eneF, 0.5104, 4.06, 0.130, 241, 108, STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
3956, 3riaI, 0.5104, 3.82, 0.094, 214, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
3957, 3rhwI, 0.5104, 3.91, 0.094, 210, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
3958, 3qnyA, 0.5104, 4.07, 0.064, 225, 110, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
3959, 3kj4L, 0.5104, 4.14, 0.111, 217, 108, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3960, 3iy1A, 0.5104, 4.04, 0.112, 214, 107, VARIABLE DOMAINS OF THE WAM OF FAB B FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB B COMPLEX
3961, 3ejyF, 0.5104, 4.69, 0.042, 184, 119, STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER CLC-EC1
3962, 2z93D, 0.5104, 3.74, 0.093, 217, 108, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD
3963, 2q8bH, 0.5104, 3.96, 0.142, 211, 106, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3964, 2q8aH, 0.5104, 3.91, 0.067, 197, 105, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3965, 2q76C, 0.5104, 4.11, 0.072, 215, 111, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
3966, 2exwF, 0.5104, 4.09, 0.093, 215, 108, CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS
3967, 1zglV, 0.5104, 4.07, 0.090, 215, 111, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
3968, 1ngwB, 0.5104, 4.07, 0.093, 214, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
3969, 1n8zA, 0.5104, 4.11, 0.093, 213, 107, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
3970, 1igcL, 0.5104, 4.01, 0.082, 212, 110, IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS
3971, 1axsL, 0.5104, 4.06, 0.121, 219, 107, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
3972, 1a4kL, 0.5104, 4.15, 0.111, 219, 108, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
3973, 6iekC, 0.5103, 4.07, 0.121, 219, 107, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
3974, 6be2L, 0.5103, 4.11, 0.054, 218, 111, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598)
3975, 6am5E, 0.5103, 4.01, 0.109, 117, 110, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
3976, 5xcqA, 0.5103, 3.97, 0.123, 210, 106, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
3977, 5tz2H, 0.5103, 4.06, 0.110, 244, 109, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
3978, 5ocxL, 0.5103, 4.06, 0.131, 213, 107, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT 
3979, 5npiA, 0.5103, 3.97, 0.151, 211, 106, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
3980, 5mqcB, 0.5103, 4.09, 0.111, 219, 108, STRUCTURE OF BLACK QUEEN CELL VIRUS
3981, 5jorC, 0.5103, 4.20, 0.064, 316, 109, CRYSTAL STRUCTURE OF UNBOUND ANTI-GLYCAN ANTIBODY FAB14.22 AT 2.2 A
3982, 5hj3J, 0.5103, 4.13, 0.102, 215, 108, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
3983, 5d06A, 0.5103, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME
3984, 4yhiA, 0.5103, 4.09, 0.081, 232, 111, REVERSAL AGENT FOR DABIGATRAN
3985, 4plkG, 0.5103, 4.09, 0.081, 233, 111, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3986, 4fqhB, 0.5103, 3.84, 0.067, 200, 104, CRYSTAL STRUCTURE OF FAB CR9114
3987, 4fg6F, 0.5103, 3.99, 0.091, 221, 110, STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
3988, 4d9lL, 0.5103, 4.09, 0.102, 216, 108, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
3989, 3us2B, 0.5103, 3.97, 0.142, 211, 106, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
3990, 3tfkC, 0.5103, 4.01, 0.100, 199, 110, 42F3-P4B10/H2-LD
3991, 3o6fH, 0.5103, 4.01, 0.100, 199, 110, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3992, 3o11A, 0.5103, 4.07, 0.121, 218, 107, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
3993, 3mlvN, 0.5103, 4.13, 0.111, 219, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
3994, 3levL, 0.5103, 3.89, 0.105, 107, 105, HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
3995, 3j30G, 0.5103, 3.97, 0.142, 211, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3996, 3j30E, 0.5103, 3.97, 0.113, 184, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3997, 3j30C, 0.5103, 3.93, 0.085, 199, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3998, 3j30A, 0.5103, 4.04, 0.084, 199, 107, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3999, 3j2xG, 0.5103, 4.02, 0.131, 212, 107, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4000, 3j2xE, 0.5103, 3.96, 0.170, 211, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4001, 3j2xC, 0.5103, 4.04, 0.109, 242, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4002, 3j2xA, 0.5103, 4.13, 0.081, 216, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4003, 3eyvL, 0.5103, 4.02, 0.112, 214, 107, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
4004, 2htlF, 0.5103, 4.00, 0.132, 213, 106, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX
4005, 2htkF, 0.5103, 4.05, 0.112, 211, 107, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX
4006, 2fedF, 0.5103, 4.07, 0.111, 217, 108, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4007, 1xctA, 0.5103, 3.96, 0.139, 218, 108, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
4008, 1wcbL, 0.5103, 4.12, 0.128, 213, 109, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
4009, 1tqcC, 0.5103, 4.05, 0.111, 242, 108, OVINE RECOMBINANT PRP(114-234) ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)
4010, 1oauJ, 0.5103, 4.09, 0.072, 166, 111, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
4011, 1oauH, 0.5103, 4.22, 0.071, 213, 112, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
4012, 1iqwH, 0.5103, 4.08, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
4013, 1dqdL, 0.5103, 4.09, 0.081, 232, 111, CRYSTAL STRUCTURE OF FAB HGR-2 F6 A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
4014, 1bbjL, 0.5103, 3.91, 0.038, 231, 104, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4015, 1bbjA, 0.5103, 4.12, 0.120, 218, 108, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4016, 9pcyA, 0.5102, 4.13, 0.093, 209, 108, HIGH-RESOLUTION SOLUTION STRUCTURE OF REDUCED FRENCH BEAN PLASTOCYANIN AND COMPARISON WITH THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN
4017, 6dcvB, 0.5102, 3.42, 0.059, 1526, 102, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
4018, 6be4L, 0.5102, 3.93, 0.082, 222, 110, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH NONA-N-ACETYL-D-GLUCOSAMINE (9NAC)
4019, 6a3wJ, 0.5102, 4.07, 0.093, 198, 108, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
4020, 5zv3H, 0.5102, 3.92, 0.132, 212, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
4021, 5w23H, 0.5102, 4.00, 0.142, 211, 106, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
4022, 5nhwL, 0.5102, 3.96, 0.112, 214, 107, CRYSTAL STRUCTURE OF THE BIMAGRUMAB FAB
4023, 5j3dB, 0.5102, 3.82, 0.095, 182, 105, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
4024, 5immA, 0.5102, 4.13, 0.120, 201, 108, NANOBODY TARGETING MOUSE VSIG4 IN SPACEGROUP P212121
4025, 5ik3B, 0.5102, 3.88, 0.093, 243, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
4026, 5ifjH, 0.5102, 4.02, 0.094, 211, 106, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
4027, 5bvpL, 0.5102, 4.13, 0.045, 221, 110, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
4028, 4yhnB, 0.5102, 4.05, 0.103, 214, 107, DABIGATRAN REVERSAL AGENT
4029, 4xbpF, 0.5102, 4.12, 0.111, 217, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
4030, 4xbgD, 0.5102, 4.12, 0.111, 217, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4031, 4whyL, 0.5102, 4.12, 0.111, 217, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P21 CRYSTAL FORM
4032, 4r9yL, 0.5102, 4.12, 0.111, 217, 108, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
4033, 4kjqF, 0.5102, 4.12, 0.111, 217, 108, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4034, 4jkwA, 0.5102, 4.12, 0.111, 217, 108, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BUTYROPHILIN BTN3A1 IN COMPLEX WITH ISOPENTENYL PYROPHOSPHATE (IPP)
4035, 4j8rC, 0.5102, 4.12, 0.111, 217, 108, STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT
4036, 4hfwL, 0.5102, 4.12, 0.111, 217, 108, ANTI ROTAVIRUS ANTIBODY
4037, 4ffwL, 0.5102, 4.07, 0.120, 216, 108, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
4038, 3us2D, 0.5102, 3.97, 0.142, 211, 106, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
4039, 3qnzA, 0.5102, 3.98, 0.142, 211, 106, ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA
4040, 3pqyT, 0.5102, 3.97, 0.142, 211, 106, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
4041, 3o6fD, 0.5102, 4.13, 0.139, 220, 108, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
4042, 3lqaL, 0.5102, 4.01, 0.094, 213, 106, CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB
4043, 3iy6A, 0.5102, 4.18, 0.120, 219, 108, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB E FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB E COMPLEX
4044, 2xqyJ, 0.5102, 4.04, 0.099, 122, 111, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
4045, 2vweC, 0.5102, 4.04, 0.099, 122, 111, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
4046, 2jxmA, 0.5102, 4.11, 0.108, 221, 111, ENSEMBLE OF TWENTY STRUCTURES OF THE PROCHLOROTHRIX HOLLANDICA PLASTOCYANIN- CYTOCHROME F COMPLEX
4047, 2feeL, 0.5102, 3.94, 0.123, 214, 106, STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR
4048, 1ws8D, 0.5102, 4.02, 0.121, 211, 107, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
4049, 1ru9L, 0.5102, 4.02, 0.121, 211, 107, CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.
4050, 1ngwH, 0.5102, 2.64, 0.125, 99, 88, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
4051, 1jvkB, 0.5102, 4.05, 0.072, 226, 111, THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
4052, 1b3iA, 0.5102, 4.14, 0.128, 213, 109, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (MINIMIZED AVERAGE STRUCTURE)
4053, 6cdpA, 0.5101, 3.99, 0.065, 116, 107, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4054, 6b9yA, 0.5101, 4.09, 0.072, 219, 111, TRASTUZUMAB FAB V3 IN COMPLEX WITH 5-PHENYL MEDITOPE VARIANT 
4055, 6b5tH, 0.5101, 4.11, 0.082, 219, 110, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
4056, 6awpC, 0.5101, 3.98, 0.084, 215, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
4057, 6apdM, 0.5101, 4.03, 0.093, 215, 107, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4058, 5xrqL, 0.5101, 4.11, 0.071, 120, 112, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
4059, 5ockL, 0.5101, 4.12, 0.102, 220, 108, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CEP1 
4060, 5npjA, 0.5101, 4.10, 0.138, 213, 109, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
4061, 5n7wB, 0.5101, 4.09, 0.093, 213, 107, COMPUTATIONALLY DESIGNED FUNCTIONAL ANTIBODY 
4062, 5fhaL, 0.5101, 4.14, 0.111, 218, 108, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 114
4063, 5f6iC, 0.5101, 4.14, 0.065, 213, 108, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH428 FROM A RHESUS MACAQUE
4064, 4xpgL, 0.5101, 4.14, 0.074, 214, 108, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO BETA-CFT OR WIN35428
4065, 4whtT, 0.5101, 4.15, 0.102, 218, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4066, 4m1gL, 0.5101, 4.06, 0.121, 214, 107, STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS
4067, 4k7pL, 0.5101, 3.98, 0.142, 211, 106, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4068, 4djmG, 0.5101, 4.10, 0.110, 119, 109, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4069, 3w13D, 0.5101, 4.01, 0.142, 210, 106, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHACT PEPTIDE(693-719) AND FAB 83-7
4070, 3us1D, 0.5101, 4.09, 0.093, 212, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR RESPONSE ELEMENT CONTAINING A TWO BASE PAIR GC SPACER BETWEEN HALF SITES
4071, 3tu6A, 0.5101, 3.99, 0.142, 202, 106, THE STRUCTURE OF A PSEUDOAZURIN FROM SINORHIZOBIUM MELILTOI
4072, 3qumL, 0.5101, 3.82, 0.095, 182, 105, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4073, 3i9gL, 0.5101, 4.06, 0.131, 219, 107, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
4074, 3gfuC, 0.5101, 4.19, 0.128, 240, 109, FAEE-FAEG CHAPERONE-MAJOR PILIN COMPLEX OF F4 AC 5/95 FIMBRIAE
4075, 3ejzF, 0.5101, 3.87, 0.093, 245, 107, STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER CLC-EC1
4076, 2po6H, 0.5101, 3.95, 0.121, 213, 107, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
4077, 2pcxA, 0.5101, 3.92, 0.114, 107, 105, CRYSTAL STRUCTURE OF P53DBD(R282Q) AT 1.54-ANGSTROM RESOLUTION
4078, 2geqA, 0.5101, 4.18, 0.099, 216, 111, CRYSTAL STRUCTURE OF A P53 CORE DIMER BOUND TO DNA
4079, 1xf3A, 0.5101, 4.07, 0.103, 214, 107, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4080, 1ws7D, 0.5101, 2.65, 0.144, 97, 90, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
4081, 1v7nO, 0.5101, 3.96, 0.142, 211, 106, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4082, 1pw3A, 0.5101, 2.98, 0.096, 103, 94, CRYSTAL STRUCTURE OF JTOR68S
4083, 1nmcL, 0.5101, 4.09, 0.111, 218, 108, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
4084, 1nmcC, 0.5101, 4.13, 0.081, 216, 111, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
4085, 1mrcL, 0.5101, 4.00, 0.083, 214, 108, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
4086, 1hklH, 0.5101, 2.65, 0.144, 97, 90, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
4087, 1e4xH, 0.5101, 3.96, 0.109, 221, 110, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
4088, 1e4wH, 0.5101, 4.02, 0.112, 214, 107, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
4089, 6dcvH, 0.5100, 4.06, 0.073, 211, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
4090, 6be3L, 0.5100, 4.05, 0.121, 214, 107, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE (GLCNAC)
4091, 6andL, 0.5100, 3.94, 0.103, 213, 107, PINATUZUMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
4092, 5ushL, 0.5100, 4.14, 0.093, 213, 108, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
4093, 5szfL, 0.5100, 4.11, 0.120, 214, 108, 2A10 FAB FRAGMENT 2.54 ANGSTOMS
4094, 5mcvB, 0.5100, 4.09, 0.081, 232, 111, P53-DNA COMPLEX 3 
4095, 5lgyC, 0.5100, 4.04, 0.093, 210, 107, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
4096, 4yxkH, 0.5100, 4.05, 0.103, 212, 107, CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB
4097, 4yhnA, 0.5100, 3.89, 0.086, 210, 105, DABIGATRAN REVERSAL AGENT
4098, 4xcnD, 0.5100, 4.09, 0.121, 214, 107, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4099, 4wffD, 0.5100, 4.13, 0.102, 215, 108, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
4100, 4r4nL, 0.5100, 4.05, 0.121, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4101, 4n0cG, 0.5100, 4.07, 0.140, 214, 107, 42F3 TCR PCPE3/H-2LD COMPLEX
4102, 4hg4M, 0.5100, 3.11, 0.084, 199, 95, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4103, 4am0H, 0.5100, 3.92, 0.124, 114, 105, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4104, 3s62H, 0.5100, 3.82, 0.095, 182, 105, STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN
4105, 3qumA, 0.5100, 2.77, 0.148, 127, 88, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4106, 3qh3B, 0.5100, 4.19, 0.111, 219, 108, THE CRYSTAL STRUCTURE OF TCR A6
4107, 3ncyW, 0.5100, 4.09, 0.093, 213, 107, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
4108, 3ncyS, 0.5100, 3.29, 0.083, 210, 96, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
4109, 3mnvA, 0.5100, 3.97, 0.142, 211, 106, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4110, 2vweJ, 0.5100, 4.06, 0.102, 244, 108, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
4111, 1qfuH, 0.5100, 3.86, 0.067, 205, 105, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
4112, 1hq4C, 0.5100, 3.88, 0.048, 188, 105, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
4113, 1hq4A, 0.5100, 4.03, 0.142, 213, 106, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
4114, 6mqmH, 0.5099, 3.16, 0.104, 105, 96, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
4115, 6cdmA, 0.5099, 3.96, 0.123, 213, 106, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4116, 6c6xD, 0.5099, 4.03, 0.131, 111, 107, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
4117, 6bi2L, 0.5099, 3.97, 0.085, 109, 106, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
4118, 6bdzL, 0.5099, 3.97, 0.085, 109, 106, ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB
4119, 5ocaL, 0.5099, 4.11, 0.111, 216, 108, PCSK9:FAB COMPLEX WITH DEXTRAN SULFATE
4120, 5n4gL, 0.5099, 4.00, 0.100, 217, 110, HUMAN FAB FRAGMENT 12E1 AGAINST NHBA FROM NEISSERIA MENINGITIDIS
4121, 5mhgL, 0.5099, 4.03, 0.100, 216, 110, CRYSTAL STRUCTURE OF ANTI-T4 FAB FRAGMENT WITH TETRAIODOBPA 
4122, 5lvcb, 0.5099, 4.12, 0.108, 213, 111, AICHI VIRUS 1: EMPTY PARTICLE
4123, 5lghL, 0.5099, 4.09, 0.072, 226, 111, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM II SAME AS 5L7X BUT ISOMORPHOUS SETTING INDEXED SAME AS 5L88 5L9D
4124, 5l7xL, 0.5099, 4.12, 0.128, 213, 109, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM II
4125, 5ihzF, 0.5099, 4.01, 0.104, 212, 106, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
4126, 5ig7B, 0.5099, 3.94, 0.131, 212, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
4127, 5e94A, 0.5099, 4.09, 0.103, 212, 107, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
4128, 5cjsL, 0.5099, 3.85, 0.067, 200, 104, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4129, 5buaA, 0.5099, 3.91, 0.067, 196, 105, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH DNA.
4130, 5a3iC, 0.5099, 4.15, 0.090, 218, 111, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
4131, 4tnwJ, 0.5099, 3.95, 0.083, 220, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
4132, 4rzcF, 0.5099, 4.13, 0.065, 214, 108, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
4133, 4py8J, 0.5099, 4.00, 0.113, 211, 106, CRYSTAL STRUCTURE OF FAB 3.1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
4134, 4np4I, 0.5099, 4.10, 0.112, 210, 107, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
4135, 4nghL, 0.5099, 4.04, 0.111, 197, 108, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 AND A TETHERED PHOSPHATE MOIETY.
4136, 4hlzH, 0.5099, 4.03, 0.093, 214, 107, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4137, 4f33C, 0.5099, 4.12, 0.081, 214, 111, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4138, 4d9lM, 0.5099, 3.99, 0.101, 215, 109, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
4139, 3ujtH, 0.5099, 4.06, 0.093, 218, 107, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
4140, 3riaF, 0.5099, 4.01, 0.102, 245, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
4141, 3rhwF, 0.5099, 4.00, 0.123, 211, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
4142, 3o6mL, 0.5099, 4.00, 0.123, 211, 106, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 9-MER TAT PEPTIDE
4143, 3iy2A, 0.5099, 4.09, 0.102, 221, 108, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 6 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 6 COMPLEX
4144, 3gnmH, 0.5099, 4.06, 0.103, 214, 107, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
4145, 3bt2L, 0.5099, 4.10, 0.108, 223, 111, STRUCTURE OF UROKINASE RECEPTOR UROKINASE AND VITRONECTIN COMPLEX
4146, 2ypvH, 0.5099, 4.14, 0.111, 215, 108, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
4147, 2oqjJ, 0.5099, 4.14, 0.111, 215, 108, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4148, 2hrpM, 0.5099, 4.11, 0.083, 217, 108, ANTIGEN-ANTIBODY COMPLEX
4149, 1za6A, 0.5099, 3.97, 0.091, 218, 110, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4150, 1l7tL, 0.5099, 4.02, 0.065, 214, 107, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
4151, 1igfM, 0.5099, 3.99, 0.103, 213, 107, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
4152, 1fbiH, 0.5099, 4.17, 0.139, 215, 108, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
4153, 6ii9Q, 0.5098, 4.03, 0.120, 214, 108, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
4154, 6ii9L, 0.5098, 4.07, 0.112, 216, 107, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
4155, 6e63C, 0.5098, 3.96, 0.142, 213, 106, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
4156, 6cxlK, 0.5098, 3.84, 0.038, 289, 105, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5 
4157, 6b5rL, 0.5098, 4.07, 0.103, 214, 107, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
4158, 5ywoR, 0.5098, 4.07, 0.103, 214, 107, STRUCTURE OF JEV-2F2 FAB COMPLEX
4159, 5ywoN, 0.5098, 4.16, 0.138, 213, 109, STRUCTURE OF JEV-2F2 FAB COMPLEX
4160, 5y11A, 0.5098, 4.11, 0.138, 213, 109, SFTSV GN WITH NEUTRALIZING ANTIBODY MAB4-5
4161, 5uy3L, 0.5098, 4.02, 0.075, 214, 107, CRYSTAL STRUCTURE OF HUMAN FAB PGT144 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4162, 5ibtH, 0.5098, 3.96, 0.123, 211, 106, UCA FAB (UNBOUND) FROM 6515 LINEAGE
4163, 5eocM, 0.5098, 3.85, 0.067, 199, 104, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
4164, 4tnwV, 0.5098, 4.14, 0.063, 226, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
4165, 4tnwF, 0.5098, 4.01, 0.100, 222, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
4166, 4rzcL, 0.5098, 4.04, 0.123, 111, 106, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
4167, 4r97C, 0.5098, 4.09, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
4168, 4fqhL, 0.5098, 4.31, 0.071, 221, 112, CRYSTAL STRUCTURE OF FAB CR9114
4169, 3w12D, 0.5098, 4.14, 0.065, 215, 108, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
4170, 3utzD, 0.5098, 4.07, 0.103, 211, 107, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
4171, 3qjfB, 0.5098, 4.00, 0.104, 211, 106, CRYSTAL STRUCTURE OF THE 2B4 TCR
4172, 3qctL, 0.5098, 3.97, 0.112, 215, 107, CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
4173, 3mlrH, 0.5098, 4.12, 0.100, 207, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
4174, 3lh8A, 0.5098, 4.01, 0.100, 191, 110, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
4175, 3l5wL, 0.5098, 4.01, 0.100, 191, 110, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
4176, 2r4rH, 0.5098, 4.13, 0.111, 216, 108, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
4177, 2qhrL, 0.5098, 3.90, 0.133, 107, 105, CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.
4178, 2p52A, 0.5098, 4.15, 0.099, 218, 111, MOUSE P53 DNA-BINDING DOMAIN IN ZINC-FREE OXIDIZED STATE
4179, 2nr6F, 0.5098, 3.96, 0.113, 211, 106, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
4180, 2b2xL, 0.5098, 4.14, 0.090, 215, 111, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
4181, 1za6E, 0.5098, 4.03, 0.094, 211, 106, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4182, 1tkwA, 0.5098, 4.10, 0.111, 218, 108, THE TRANSIENT COMPLEX OF POPLAR PLASTOCYANIN WITH TURNIP CYTOCHROME F DETERMINED WITH PARAMAGNETIC NMR
4183, 1rjlA, 0.5098, 4.14, 0.120, 220, 108, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
4184, 1mjjH, 0.5098, 4.07, 0.121, 219, 107, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
4185, 1fveC, 0.5098, 4.12, 0.111, 219, 108, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4186, 1ahwB, 0.5098, 4.18, 0.089, 221, 112, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
4187, 6jbtL, 0.5097, 3.97, 0.113, 212, 106, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
4188, 6gv4A, 0.5097, 3.96, 0.113, 212, 106, HIGH-RESOLUTION CRYO-EM OF FAB-LABELED HUMAN PARECHOVIRUS 3 
4189, 6fy2X, 0.5097, 4.14, 0.118, 212, 110, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
4190, 6faxH, 0.5097, 4.04, 0.094, 213, 106, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
4191, 6ev1J, 0.5097, 4.02, 0.092, 212, 109, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
4192, 6bpaF, 0.5097, 4.09, 0.063, 218, 111, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
4193, 5w0kH, 0.5097, 4.09, 0.063, 218, 111, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
4194, 5njdU, 0.5097, 4.22, 0.071, 219, 112, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
4195, 5lgyA, 0.5097, 4.15, 0.093, 216, 108, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
4196, 5j74B, 0.5097, 4.19, 0.072, 218, 111, FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P
4197, 5i1jH, 0.5097, 4.02, 0.123, 215, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
4198, 5gznL, 0.5097, 4.01, 0.100, 224, 110, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
4199, 5cckH, 0.5097, 4.01, 0.100, 221, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
4200, 4xcnB, 0.5097, 4.05, 0.113, 110, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4201, 4r4nG, 0.5097, 4.05, 0.082, 218, 110, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4202, 4qexI, 0.5097, 3.98, 0.123, 212, 106, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
4203, 4qexH, 0.5097, 3.91, 0.124, 114, 105, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
4204, 4nhuC, 0.5097, 4.00, 0.113, 212, 106, THE M33 TCR P3M33L/H-2 LD COMPLEX
4205, 4kk8F, 0.5097, 4.01, 0.083, 240, 109, STRUCTURE OF THE E148Q MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE
4206, 4gq9H, 0.5097, 4.10, 0.111, 218, 108, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
4207, 4f33A, 0.5097, 4.12, 0.045, 226, 110, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4208, 3vwjD, 0.5097, 3.75, 0.099, 283, 101, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
4209, 3vi3E, 0.5097, 4.08, 0.093, 213, 107, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
4210, 3uypA, 0.5097, 4.09, 0.091, 217, 110, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
4211, 3ts8C, 0.5097, 4.00, 0.130, 218, 108, CRYSTAL STRUCTURE OF A MULTIDOMAIN HUMAN P53 TETRAMER BOUND TO THE NATURAL CDKN1A(P21) P53-RESPONSE ELEMENT
4212, 3se9H, 0.5097, 3.90, 0.048, 196, 105, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
4213, 3eyfC, 0.5097, 4.03, 0.091, 213, 110, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE
4214, 2ht4F, 0.5097, 3.98, 0.104, 210, 106, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX
4215, 2g60H, 0.5097, 4.14, 0.102, 220, 108, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
4216, 2cd0A, 0.5097, 2.70, 0.157, 99, 89, STRUCTURE OF HUMAN LAMBDA-6 LIGHT CHAIN DIMER WIL
4217, 1tefA, 0.5097, 4.07, 0.112, 212, 107, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
4218, 1nezG, 0.5097, 4.11, 0.100, 209, 110, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
4219, 1lk3H, 0.5097, 4.02, 0.112, 214, 107, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
4220, 1g6rA, 0.5097, 4.13, 0.099, 214, 111, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
4221, 1fe8M, 0.5097, 4.10, 0.111, 218, 108, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4222, 1bfoA, 0.5097, 4.09, 0.075, 256, 106, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4223, 1ay1L, 0.5097, 4.12, 0.081, 219, 111, ANTI TAQ FAB TP7
4224, 6dwiG, 0.5096, 4.11, 0.090, 216, 111, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4225, 6df0L, 0.5096, 3.98, 0.094, 212, 106, ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 FAB COMPLEXED WITH SULFATE 
4226, 5muqL, 0.5096, 4.06, 0.103, 211, 107, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
4227, 5muqB, 0.5096, 4.19, 0.099, 213, 111, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
4228, 5kg9L, 0.5096, 3.83, 0.094, 215, 106, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
4229, 5d7iF, 0.5096, 3.91, 0.067, 196, 105, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
4230, 5cddC, 0.5096, 3.94, 0.123, 233, 106, CRYSTAL STRUCTURE OF ISRAEL ACUTE PARALYSIS VIRUS PENTAMER
4231, 5b6fE, 0.5096, 4.22, 0.071, 213, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
4232, 4yhnL, 0.5096, 3.98, 0.104, 213, 106, DABIGATRAN REVERSAL AGENT
4233, 4x80L, 0.5096, 4.00, 0.074, 224, 108, CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
4234, 4o5iR, 0.5096, 4.13, 0.065, 214, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4235, 4o51E, 0.5096, 4.01, 0.113, 210, 106, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
4236, 4nwuL, 0.5096, 4.01, 0.092, 210, 109, CRYSTAL STRUCTURE OF APE1551 AN ANTI-HUMAN NGF FAB WITH A NINE AMINO ACID INSERTION IN CDR H1
4237, 4kklF, 0.5096, 4.01, 0.092, 206, 109, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTA NC CONSTRUCT IN 100MM FLUORIDE
4238, 4jm2B, 0.5096, 3.94, 0.112, 199, 107, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4239, 4i3sH, 0.5096, 3.99, 0.142, 211, 106, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
4240, 4hlzL, 0.5096, 4.05, 0.100, 218, 110, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4241, 3vxqA, 0.5096, 4.00, 0.104, 211, 106, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
4242, 3mlvH, 0.5096, 3.90, 0.104, 241, 106, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
4243, 3ixyH, 0.5096, 4.16, 0.083, 219, 108, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4244, 3exjB, 0.5096, 3.88, 0.075, 226, 106, CRYSTAL STRUCTURE OF A P53 CORE TETRAMER BOUND TO DNA
4245, 2zpkH, 0.5096, 3.95, 0.075, 234, 106, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
4246, 2zchL, 0.5096, 3.99, 0.073, 225, 110, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
4247, 2r6pF, 0.5096, 4.07, 0.093, 215, 107, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
4248, 2r6pD, 0.5096, 3.98, 0.142, 211, 106, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
4249, 2r29H, 0.5096, 3.97, 0.082, 208, 110, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
4250, 2pcyA, 0.5096, 4.03, 0.131, 111, 107, THE CRYSTAL STRUCTURE OF POPLAR APOPLASTOCYANIN AT 1.8- ANGSTROMS RESOLUTION. THE GEOMETRY OF THE COPPER-BINDING SITE IS CREATED BY THE POLYPEPTIDE
4251, 2hlfF, 0.5096, 2.75, 0.157, 99, 89, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
4252, 1z3gM, 0.5096, 4.04, 0.083, 122, 109, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
4253, 1qgc4, 0.5096, 4.10, 0.090, 219, 111, STRUCTURE OF THE COMPLEX OF A FAB FRAGMENT OF A NEUTRALIZING ANTIBODY WITH FOOT AND MOUTH DISEASE VIRUS
4254, 1n0lC, 0.5096, 4.06, 0.111, 202, 108, CRYSTAL STRUCTURE OF THE PAPD CHAPERONE (C-TERMINALLY 6X HISTIDINE-TAGGED) BOUND TO THE PAPE PILUS SUBUNIT (N- TERMINAL-DELETED) FROM UROPATHOGENIC E. COLI
4255, 1mrdL, 0.5096, 4.03, 0.075, 211, 107, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
4256, 6o3bE, 0.5095, 4.07, 0.121, 214, 107, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
4257, 6n1vL, 0.5095, 3.97, 0.132, 210, 106, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY A12V163-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4258, 6n1v4, 0.5095, 4.08, 0.084, 211, 107, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY A12V163-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4259, 6n1v2, 0.5095, 4.04, 0.103, 211, 107, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY A12V163-A.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4260, 6msyL, 0.5095, 4.16, 0.157, 219, 108, ANTI-HIV-1 FAB FAB 2G12 + MAN4 RE-REFINEMENT 
4261, 6mb3P, 0.5095, 4.16, 0.157, 219, 108, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4262, 6ewbI, 0.5095, 3.99, 0.130, 218, 108, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
4263, 5vsiL, 0.5095, 4.11, 0.101, 243, 109, CH1/CKAPPA FAB MUTANT 15.1
4264, 5u6aA, 0.5095, 4.21, 0.056, 200, 107, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- PEG3-MEDITOPE
4265, 5n2kI, 0.5095, 4.15, 0.111, 216, 108, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4266, 5mo9L, 0.5095, 4.14, 0.111, 218, 108, STRUCTURE OF HUMAN TRKB RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE FAB FRGMENT OF ANTIBODY AB20
4267, 5lqbL, 0.5095, 4.11, 0.150, 213, 107, COMPLEX STRUCTURE OF HUMAN IL2 MUTANT PROLEUKIN WITH FAB FRAGMENT OF NARA1 ANTIBODY
4268, 5l88L, 0.5095, 3.93, 0.105, 213, 105, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM I NON-PARSIMONIOUS MODEL
4269, 5ecgB, 0.5095, 3.96, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF 53BP1 IN COMPLEX WITH P53 AND H2AX-PSER139 (GAMMAH2AX)
4270, 4xp4L, 0.5095, 4.14, 0.111, 220, 108, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH COCAINE
4271, 4wv1D, 0.5095, 3.99, 0.142, 211, 106, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
4272, 4wfhD, 0.5095, 4.11, 0.103, 214, 107, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4273, 4wfeD, 0.5095, 4.09, 0.072, 222, 111, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
4274, 4ot1L, 0.5095, 4.09, 0.112, 205, 107, STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1
4275, 4orgL, 0.5095, 4.13, 0.112, 204, 107, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4276, 4loeC, 0.5095, 4.13, 0.045, 221, 110, HUMAN P53 CORE DOMAIN MUTANT N239Y
4277, 4kkbF, 0.5095, 3.87, 0.105, 213, 105, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4278, 4ki5C, 0.5095, 3.91, 0.048, 194, 105, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
4279, 4i9wD, 0.5095, 3.96, 0.083, 207, 108, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4280, 4hkzA, 0.5095, 4.12, 0.111, 215, 108, TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
4281, 4hfwA, 0.5095, 4.10, 0.081, 216, 111, ANTI ROTAVIRUS ANTIBODY
4282, 4djmC, 0.5095, 4.10, 0.081, 216, 111, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4283, 4bz1H, 0.5095, 4.10, 0.081, 216, 111, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
4284, 4am0E, 0.5095, 2.71, 0.157, 99, 89, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4285, 3wiiI, 0.5095, 3.98, 0.151, 211, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
4286, 3kz8A, 0.5095, 3.98, 0.113, 213, 106, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 3)
4287, 3dggC, 0.5095, 4.08, 0.111, 217, 108, CRYSTAL STRUCTURE OF FABOX108
4288, 2bmkA, 0.5095, 3.14, 0.144, 212, 97, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
4289, 1ztxL, 0.5095, 4.12, 0.111, 216, 108, WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
4290, 1yntD, 0.5095, 3.98, 0.093, 213, 107, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
4291, 1rukL, 0.5095, 4.01, 0.112, 215, 107, CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1
4292, 1qfuL, 0.5095, 4.01, 0.112, 215, 107, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
4293, 1lhzB, 0.5095, 4.01, 0.112, 215, 107, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
4294, 1a6wH, 0.5095, 4.03, 0.094, 210, 106, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND
4295, 1a4jH, 0.5095, 3.84, 0.114, 112, 105, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
4296, 6mhgW, 0.5094, 3.99, 0.113, 211, 106, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4297, 6b08C, 0.5094, 3.97, 0.104, 212, 106, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1276
4298, 5whzL, 0.5094, 4.03, 0.112, 214, 107, PGDM1400-10E8V4 CODV FAB
4299, 5tljE, 0.5094, 3.85, 0.094, 214, 106, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4300, 5tdpC, 0.5094, 4.13, 0.102, 219, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4301, 5girH, 0.5094, 4.13, 0.111, 217, 108, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4302, 5d93B, 0.5094, 4.07, 0.112, 215, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
4303, 5d1xA, 0.5094, 3.92, 0.067, 183, 105, ISDB NEAT2 BOUND BY D4-30
4304, 5alcL, 0.5094, 4.08, 0.150, 214, 107, TICAGRELOR ANTIDOTE CANDIDATE FAB 72 IN COMPLEX WITH TICAGRELOR
4305, 4xcyD, 0.5094, 4.05, 0.112, 214, 107, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4306, 4r4nU, 0.5094, 4.01, 0.113, 211, 106, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4307, 4nccL, 0.5094, 4.01, 0.113, 211, 106, NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS
4308, 4kjwF, 0.5094, 3.99, 0.093, 214, 107, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4309, 4hjeB, 0.5094, 3.99, 0.086, 211, 105, CRYSTAL STRUCTURE OF P53 CORE DOMAIN IN COMPLEX WITH DNA
4310, 4f33E, 0.5094, 3.93, 0.067, 194, 105, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4311, 4ag4L, 0.5094, 4.00, 0.142, 211, 106, CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
4312, 3wiiH, 0.5094, 4.07, 0.073, 218, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
4313, 3w9dD, 0.5094, 4.01, 0.113, 211, 106, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
4314, 3mlsH, 0.5094, 4.04, 0.103, 213, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4315, 3g04B, 0.5094, 4.10, 0.093, 210, 107, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY
4316, 2r6pE, 0.5094, 3.11, 0.084, 199, 95, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
4317, 2r4sL, 0.5094, 4.12, 0.099, 212, 111, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
4318, 2r29L, 0.5094, 4.15, 0.081, 212, 111, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
4319, 1yntB, 0.5094, 3.96, 0.118, 220, 110, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
4320, 1rupL, 0.5094, 3.81, 0.067, 195, 104, CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID
4321, 1ruaL, 0.5094, 4.20, 0.102, 215, 108, CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
4322, 1qfoC, 0.5094, 3.91, 0.086, 213, 105, N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH 3 SIALYLLACTOSE
4323, 1otsF, 0.5094, 4.02, 0.140, 212, 107, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
4324, 1k6qH, 0.5094, 3.95, 0.109, 218, 110, CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
4325, 6n8dE, 0.5093, 4.11, 0.111, 219, 108, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY A1431 
4326, 6n2xK, 0.5093, 4.13, 0.120, 217, 108, ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT 
4327, 6eyoL, 0.5093, 3.98, 0.083, 213, 108, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
4328, 6c6xF, 0.5093, 4.01, 0.092, 120, 109, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
4329, 6bahA, 0.5093, 4.03, 0.081, 217, 111, TRASTUZUMAB FAB V3 WITH 5-DIPHENYL MEDITOPE VARIANT 
4330, 5y9fQ, 0.5093, 3.79, 0.114, 112, 105, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
4331, 5wtgA, 0.5093, 4.19, 0.080, 221, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HAV ANTIBODY R10
4332, 5wkoL, 0.5093, 4.01, 0.103, 336, 107, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4333, 5vpgC, 0.5093, 4.11, 0.102, 215, 108, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
4334, 5u5fA, 0.5093, 3.98, 0.112, 213, 107, MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (AC) CQFDA(PH)2STRRLRCGGSK
4335, 5ijkC, 0.5093, 4.07, 0.128, 208, 109, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
4336, 5gisH, 0.5093, 3.98, 0.113, 212, 106, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4337, 4xpfL, 0.5093, 4.16, 0.093, 218, 108, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO RTI-55
4338, 4risL, 0.5093, 3.84, 0.095, 210, 105, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
4339, 4r96F, 0.5093, 4.09, 0.065, 214, 108, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4340, 4ky1L, 0.5093, 4.00, 0.113, 210, 106, HUMANIZED HP1/2 FAB
4341, 4i18B, 0.5093, 3.99, 0.113, 211, 106, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
4342, 4hjgA, 0.5093, 4.00, 0.142, 211, 106, MEDITOPE-ENABLED TRASTUZUMAB
4343, 3t0eD, 0.5093, 3.90, 0.067, 200, 105, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
4344, 3rvwC, 0.5093, 4.01, 0.104, 211, 106, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
4345, 3qdjE, 0.5093, 3.99, 0.113, 210, 106, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
4346, 3mlsI, 0.5093, 3.96, 0.118, 220, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4347, 3kj6L, 0.5093, 4.14, 0.083, 213, 108, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
4348, 3fmgL, 0.5093, 4.14, 0.045, 226, 110, STRUCTURE OF ROTAVIRUS OUTER CAPSID PROTEIN VP7 TRIMER IN COMPLEX WITH A NEUTRALIZING FAB
4349, 3fctD, 0.5093, 4.09, 0.072, 215, 111, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
4350, 2znwB, 0.5093, 4.11, 0.111, 206, 108, CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
4351, 2r6pG, 0.5093, 4.03, 0.103, 214, 107, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
4352, 1rumL, 0.5093, 4.11, 0.111, 204, 108, CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
4353, 1rulL, 0.5093, 3.95, 0.109, 218, 110, CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
4354, 1a4kA, 0.5093, 4.11, 0.111, 219, 108, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
4355, 6n8dB, 0.5092, 4.11, 0.111, 218, 108, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY A1431 
4356, 6ewbL, 0.5092, 3.89, 0.056, 114, 108, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
4357, 5yxgB, 0.5092, 3.97, 0.142, 211, 106, CRYSTAL STRUCTURE OF C-TERMINAL FRAGMENT OF SPAD FROM LACTOBACILLUS RHAMNOSUS GG GENERATED BY LIMITED PROTEOLYSIS 
4358, 5wk3T, 0.5092, 4.15, 0.099, 213, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
4359, 5uhyI, 0.5092, 4.07, 0.084, 212, 107, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
4360, 5uhyG, 0.5092, 4.05, 0.094, 213, 106, A HUMAN ANTIBODY AGAINST ZIKA VIRUS CROSSLINKS THE E PROTEIN TO PREVENT INFECTION
4361, 5n2kO, 0.5092, 4.16, 0.093, 210, 108, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4362, 5mx3H, 0.5092, 4.07, 0.075, 214, 107, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4363, 5kvgL, 0.5092, 4.03, 0.112, 214, 107, ZIKA SPECIFIC ANTIBODY ZV-67 BOUND TO ZIKA ENVELOPE DIII
4364, 5kveL, 0.5092, 4.18, 0.111, 217, 108, ZIKA SPECIFIC ANTIBODY ZV-48 BOUND TO ZIKA ENVELOPE DIII
4365, 5j74A, 0.5092, 4.01, 0.123, 212, 106, FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P
4366, 4x0kB, 0.5092, 4.17, 0.093, 213, 108, ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE
4367, 4orgB, 0.5092, 4.04, 0.093, 211, 107, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4368, 4okvA, 0.5092, 4.03, 0.112, 214, 107, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4369, 4m6nL, 0.5092, 4.12, 0.111, 218, 108, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
4370, 4kaqH, 0.5092, 4.18, 0.127, 210, 110, STRUCTURE OF RITUXIMAB FAB
4371, 4g83B, 0.5092, 4.08, 0.150, 214, 107, CRYSTAL STRUCTURE OF P73 DNA-BINDING DOMAIN TETRAMER BOUND TO A FULL RESPONSE-ELEMENT
4372, 3x2dC, 0.5092, 4.08, 0.119, 213, 109, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4373, 3vg9C, 0.5092, 4.15, 0.090, 213, 111, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
4374, 3n85L, 0.5092, 4.08, 0.084, 213, 107, CRYSTALLOGRAPHIC TRIMER OF HER2 EXTRACELLULAR REGIONS IN COMPLEX WITH TRYPTOPHAN-RICH ANTIBODY FRAGMENT
4375, 3fctB, 0.5092, 3.99, 0.103, 215, 107, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
4376, 3d08A, 0.5092, 4.03, 0.103, 214, 107, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATION H168R
4377, 2g2rL, 0.5092, 3.88, 0.083, 245, 108, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
4378, 2ahiC, 0.5092, 4.04, 0.093, 211, 107, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
4379, 1zlsL, 0.5092, 4.02, 0.102, 242, 108, FAB 2G12 + MAN4
4380, 1tegA, 0.5092, 4.14, 0.045, 226, 110, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
4381, 1ggiL, 0.5092, 4.07, 0.103, 214, 107, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
4382, 6furB, 0.5091, 4.10, 0.112, 211, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4383, 6fr6B, 0.5091, 4.13, 0.090, 216, 111, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4384, 6flcA, 0.5091, 3.91, 0.106, 221, 104, 2C8 FAB BOUND TO EDIII OF DENV 2 
4385, 6bpcC, 0.5091, 4.11, 0.111, 206, 108, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
4386, 5xzcE, 0.5091, 4.12, 0.102, 218, 108, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
4387, 5w05H, 0.5091, 4.11, 0.111, 218, 108, ANTI-TISSUE FACTOR ANTIBODY M59 A HUMANIZED VERSION OF 10H10
4388, 5nj3F, 0.5091, 4.09, 0.111, 216, 108, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
4389, 5nj3D, 0.5091, 4.12, 0.084, 212, 107, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
4390, 5mheL, 0.5091, 3.87, 0.114, 210, 105, CRYSTAL STRUCTURE OF ANTI-T4 FAB FRAGMENT WITH T4 
4391, 5l8qB, 0.5091, 3.72, 0.067, 306, 105, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
4392, 5ikcH, 0.5091, 4.15, 0.093, 218, 108, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
4393, 5ibuH, 0.5091, 4.11, 0.121, 214, 107, FAB (UNBOUND)
4394, 5gznD, 0.5091, 4.11, 0.121, 214, 107, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
4395, 5eoqL, 0.5091, 3.84, 0.094, 210, 106, STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40
4396, 5a3iG, 0.5091, 4.06, 0.091, 219, 110, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
4397, 4y1aE, 0.5091, 4.11, 0.121, 214, 107, IMMUNE COMPLEX
4398, 4xcnL, 0.5091, 4.04, 0.123, 115, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4399, 4xccL, 0.5091, 3.92, 0.124, 231, 105, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP
4400, 4xbgL, 0.5091, 4.15, 0.102, 226, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4401, 4r96D, 0.5091, 3.98, 0.086, 208, 105, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4402, 4ogaD, 0.5091, 4.17, 0.118, 214, 110, INSULIN IN COMPLEX WITH SITE 1 OF THE HUMAN INSULIN RECEPTOR
4403, 4o5iT, 0.5091, 3.99, 0.130, 216, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4404, 4n8cH, 0.5091, 3.93, 0.119, 220, 109, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
4405, 4mziA, 0.5091, 3.87, 0.105, 198, 105, CRYSTAL STRUCTURE OF A HUMAN MUTANT P53
4406, 4hfuH, 0.5091, 4.04, 0.093, 211, 107, CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4407, 4f33G, 0.5091, 4.11, 0.099, 224, 111, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4408, 3pqyJ, 0.5091, 4.05, 0.093, 214, 107, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
4409, 3mltI, 0.5091, 4.15, 0.081, 216, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
4410, 3kmdA, 0.5091, 4.02, 0.066, 182, 106, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
4411, 3detF, 0.5091, 4.12, 0.120, 219, 108, STRUCTURE OF THE E148A Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1 CL-/H+ ANTIPORTER
4412, 2zuqB, 0.5091, 4.01, 0.057, 193, 106, CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX
4413, 2ltqB, 0.5091, 4.04, 0.094, 209, 106, HIGH RESOLUTION STRUCTURE OF DSBB C41S BY JOINT CALCULATION WITH SOLID-STATE NMR AND X-RAY DATA
4414, 2htlD, 0.5091, 2.76, 0.157, 99, 89, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX
4415, 2fx9M, 0.5091, 4.05, 0.103, 215, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4416, 2fjfM, 0.5091, 4.02, 0.074, 240, 108, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4417, 1ncwL, 0.5091, 4.08, 0.102, 241, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID
4418, 1mhpL, 0.5091, 4.07, 0.140, 211, 107, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
4419, 1mh5B, 0.5091, 3.94, 0.113, 212, 106, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
4420, 1kfaM, 0.5091, 3.91, 0.067, 232, 105, CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
4421, 1e6jL, 0.5091, 4.16, 0.081, 220, 111, CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
4422, 1bqlL, 0.5091, 4.10, 0.112, 210, 107, STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
4423, 1b0wB, 0.5091, 4.10, 0.112, 210, 107, STRUCTURAL COMPARISON OF AMYLOIDOGENIC LIGHT CHAIN DIMER IN TWO CRYSTAL FORMS WITH NONAMYLOIDOGENIC COUNTERPARTS
4424, 6mv5L, 0.5090, 3.98, 0.142, 212, 106, ANTI-PCSK9 FAB 6E2 BOUND TO THE N-TERMINAL PEPTIDE FROM PCSK9 (E32K) 
4425, 6mjzL, 0.5090, 4.06, 0.048, 250, 105, CRYO-EM STRUCTURE OF HUMAN PARAINFLUENZA VIRUS TYPE 3 (HPIV3) IN COMPLEX WITH ANTIBODY PIA174 
4426, 6bpcF, 0.5090, 3.99, 0.092, 214, 109, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
4427, 6bi0L, 0.5090, 3.97, 0.064, 219, 109, TRASTUZUMAB FAB N158A D185A K190A (LIGHT CHAIN) TRIPLE MUTANT.
4428, 6bhzL, 0.5090, 3.98, 0.104, 214, 106, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT.
4429, 5y2mJ, 0.5090, 4.14, 0.102, 218, 108, CRYSTAL STRUCTURE OF A GROUP 2 HA BINDING ANTIBODY AF4H1K1 FAB IN COMPLEX WITH THE H4N6 DUCK ISOLATE (H4-CZ/56) HEMAGGLUTININ 
4430, 5u5mA, 0.5090, 4.14, 0.063, 226, 111, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- MEDITOPE
4431, 5n2kG, 0.5090, 4.09, 0.092, 240, 109, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4432, 5mhrO, 0.5090, 4.14, 0.065, 214, 108, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4433, 5jqdD, 0.5090, 4.13, 0.065, 214, 108, ANTIBODY FAB FRAGMENT
4434, 5h2bA, 0.5090, 4.14, 0.065, 214, 108, STRUCTURE OF A NOVEL ANTIBODY G196
4435, 4xc3L, 0.5090, 4.09, 0.073, 213, 110, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE
4436, 4r4nR, 0.5090, 4.07, 0.150, 114, 107, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4437, 4o5iN, 0.5090, 3.93, 0.105, 213, 105, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4438, 4hkbC, 0.5090, 4.11, 0.090, 220, 111, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4439, 4grlD, 0.5090, 3.91, 0.076, 193, 105, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
4440, 4djmF, 0.5090, 4.02, 0.073, 224, 110, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4441, 4djmA, 0.5090, 4.02, 0.104, 211, 106, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4442, 3uzeB, 0.5090, 4.19, 0.110, 240, 109, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
4443, 3j2zH, 0.5090, 4.15, 0.045, 219, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4444, 3j2zF, 0.5090, 3.91, 0.067, 200, 105, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4445, 3j2zD, 0.5090, 3.97, 0.151, 211, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4446, 3j2zB, 0.5090, 4.26, 0.111, 218, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
4447, 3j2yH, 0.5090, 4.26, 0.111, 218, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4448, 3j2yF, 0.5090, 4.03, 0.151, 211, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4449, 3j2yD, 0.5090, 4.15, 0.065, 214, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4450, 3j2yB, 0.5090, 4.06, 0.103, 211, 107, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
4451, 2oqjD, 0.5090, 4.12, 0.102, 219, 108, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4452, 2oqjA, 0.5090, 4.00, 0.094, 212, 106, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4453, 1zlwK, 0.5090, 4.10, 0.100, 172, 110, FAB 2G12 + MAN8
4454, 1zluK, 0.5090, 4.02, 0.121, 213, 107, FAB 2G12 + MAN5
4455, 1kfaL, 0.5090, 3.92, 0.113, 210, 106, CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
4456, 1faiL, 0.5090, 4.00, 0.132, 212, 106, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
4457, 1dbjH, 0.5090, 3.97, 0.105, 108, 105, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
4458, 1aj7L, 0.5090, 4.16, 0.074, 218, 108, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
4459, 6fy2H, 0.5089, 3.93, 0.113, 108, 106, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
4460, 6fy0I, 0.5089, 3.94, 0.113, 211, 106, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4461, 6fr9B, 0.5089, 4.00, 0.112, 212, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4462, 6e0cM, 0.5089, 4.01, 0.112, 213, 107, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4463, 6d9gD, 0.5089, 4.16, 0.093, 212, 108, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
4464, 6bi2M, 0.5089, 4.03, 0.112, 214, 107, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
4465, 5tljA, 0.5089, 3.85, 0.094, 212, 106, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4466, 5lapB, 0.5089, 4.09, 0.112, 210, 107, P53 CANCER MUTANT Y220C WITH CYS182 ALKYLATION
4467, 5ijkD, 0.5089, 4.36, 0.061, 214, 114, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
4468, 5ihbD, 0.5089, 4.11, 0.081, 216, 111, STRUCTURE OF THE IMMUNE RECEPTOR CD33
4469, 5ifjB, 0.5089, 4.11, 0.065, 213, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
4470, 5i18L, 0.5089, 4.12, 0.112, 210, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1
4471, 5a3iD, 0.5089, 3.97, 0.105, 213, 105, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
4472, 4xi5C, 0.5089, 4.10, 0.081, 218, 111, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES
4473, 4xbgF, 0.5089, 4.02, 0.165, 257, 109, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4474, 4xbgB, 0.5089, 2.95, 0.074, 202, 94, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4475, 4of3B, 0.5089, 3.14, 0.095, 196, 95, CRYSTAL STRUCTURE OF SYG-1 D1-D2 GLYCOSYLATED
4476, 4kkcF, 0.5089, 4.02, 0.074, 226, 108, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4477, 4fg6D, 0.5089, 4.15, 0.108, 218, 111, STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE
4478, 3ze1H, 0.5089, 4.15, 0.108, 218, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4479, 3u79H, 0.5089, 4.15, 0.108, 218, 111, AL-103 Y32F Y96F
4480, 3qumH, 0.5089, 4.15, 0.108, 218, 111, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4481, 3kmdC, 0.5089, 4.15, 0.108, 218, 111, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
4482, 3hi6L, 0.5089, 4.15, 0.108, 218, 111, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
4483, 2wbjD, 0.5089, 4.15, 0.108, 218, 111, TCR COMPLEX
4484, 2fecL, 0.5089, 4.15, 0.108, 218, 111, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4485, 1rzgA, 0.5089, 4.04, 0.094, 211, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
4486, 1axtL, 0.5089, 4.03, 0.094, 211, 106, IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES
4487, 6oe4C, 0.5088, 4.04, 0.094, 209, 106, PREFUSION RSV F MONOMER BOUND BY NEUTRALIZING ANTIBODY CR9501 
4488, 6n35L, 0.5088, 4.05, 0.094, 209, 106, ANTI-HIV-1 FAB 2G12 + MAN1-2 RE-REFINEMENT 
4489, 6ggdA, 0.5088, 4.14, 0.111, 217, 108, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9324 
4490, 6funA, 0.5088, 4.08, 0.093, 214, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4491, 6cxlL, 0.5088, 3.94, 0.082, 219, 110, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5 
4492, 5xzcC, 0.5088, 4.02, 0.084, 214, 107, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
4493, 5xhvL, 0.5088, 4.13, 0.081, 219, 111, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
4494, 5u68E, 0.5088, 4.16, 0.081, 216, 111, STRUCTURAL BASIS FOR ANTIBODY CROSS-NEUTRALIZATION OF RESPIRATORY SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS
4495, 5o4yC, 0.5088, 4.02, 0.074, 240, 108, STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR
4496, 5n2kA, 0.5088, 3.90, 0.102, 229, 108, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4497, 5lk7B, 0.5088, 4.12, 0.102, 216, 108, SINGLE PARTICLE RECONSTRUCTION OF SLOW BEE PARALYSIS VIRUS VIRION AT PH 5.5
4498, 5ifjE, 0.5088, 4.03, 0.112, 214, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
4499, 5i1lA, 0.5088, 4.06, 0.093, 215, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
4500, 5i1kH, 0.5088, 3.86, 0.057, 196, 105, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
4501, 5eocH, 0.5088, 4.03, 0.103, 218, 107, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
4502, 5bvjG, 0.5088, 3.97, 0.047, 209, 107, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
4503, 4xzuF, 0.5088, 4.10, 0.138, 213, 109, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
4504, 4xp6L, 0.5088, 4.14, 0.102, 219, 108, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT METHAMPHETAMINE
4505, 4r4nK, 0.5088, 4.15, 0.111, 218, 108, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4506, 4r0lL, 0.5088, 4.11, 0.093, 206, 107, ANTI-CANINE CD28 ANTIBODY 1C6 BOUND CANINE CD28
4507, 4oz4H, 0.5088, 4.15, 0.065, 212, 108, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4508, 4oiiL, 0.5088, 4.13, 0.065, 214, 108, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
4509, 4np4H, 0.5088, 3.65, 0.087, 233, 104, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
4510, 4lspL, 0.5088, 4.00, 0.151, 211, 106, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
4511, 4lasL, 0.5088, 4.03, 0.151, 211, 106, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4512, 4kk9F, 0.5088, 4.00, 0.091, 216, 110, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE
4513, 4kk5F, 0.5088, 3.91, 0.114, 111, 105, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE
4514, 4kaqL, 0.5088, 4.13, 0.091, 217, 110, STRUCTURE OF RITUXIMAB FAB
4515, 4janH, 0.5088, 3.91, 0.067, 200, 105, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4516, 4j4pD, 0.5088, 4.07, 0.093, 210, 107, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
4517, 4ioiA, 0.5088, 3.98, 0.093, 270, 108, MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
4518, 3r8bL, 0.5088, 3.96, 0.142, 211, 106, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
4519, 3qh3D, 0.5088, 4.09, 0.081, 223, 111, THE CRYSTAL STRUCTURE OF TCR A6
4520, 3q05A, 0.5088, 4.17, 0.120, 216, 108, AN INDUCED FIT MECHANISM REGULATES P53 DNA BINDING KINETICS TO CONFER SEQUENCE SPECIFICITY
4521, 3mlyM, 0.5088, 4.06, 0.075, 212, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
4522, 3kr3L, 0.5088, 4.04, 0.094, 211, 106, CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
4523, 3iy7A, 0.5088, 3.86, 0.057, 196, 105, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB F FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB F COMPLEX
4524, 2r4rL, 0.5088, 3.99, 0.148, 202, 108, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
4525, 1zlwL, 0.5088, 4.02, 0.094, 213, 106, FAB 2G12 + MAN8
4526, 1xguA, 0.5088, 3.91, 0.067, 232, 105, STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4527, 1mnuL, 0.5088, 4.15, 0.093, 214, 107, UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
4528, 1fn4A, 0.5088, 3.85, 0.096, 233, 104, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
4529, 6oe4F, 0.5087, 3.88, 0.094, 118, 106, PREFUSION RSV F MONOMER BOUND BY NEUTRALIZING ANTIBODY CR9501 
4530, 6mubK, 0.5087, 3.85, 0.094, 216, 106, ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT 
4531, 6iuvH, 0.5087, 4.10, 0.058, 252, 104, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
4532, 6hf1B, 0.5087, 4.11, 0.138, 213, 109, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
4533, 6azmC, 0.5087, 4.17, 0.102, 219, 108, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
4534, 5xzcB, 0.5087, 4.23, 0.071, 211, 112, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
4535, 5xjmL, 0.5087, 4.22, 0.117, 212, 111, COMPLEX STRUCTURE OF ANGIOTENSIN II TYPE 2 RECEPTOR WITH FAB 
4536, 5wkoJ, 0.5087, 4.12, 0.103, 214, 107, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4537, 5w4lE, 0.5087, 4.02, 0.142, 195, 106, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT C11-LIKE ANTIBODY N12-I3 IN COMPLEX WITH HIV-1 CLADE A/E GP120 THE CD4 MIMETIC M48U1 AND THE ANTIBODY N5-I5.
4538, 5uy3B, 0.5087, 4.10, 0.121, 213, 107, CRYSTAL STRUCTURE OF HUMAN FAB PGT144 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4539, 5mvzB, 0.5087, 4.12, 0.112, 210, 107, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
4540, 5l9dL, 0.5087, 4.07, 0.104, 113, 106, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM I PARSIMONIOUS MODEL
4541, 5j98B, 0.5087, 4.06, 0.091, 219, 110, CRYSTAL STRUCTURE OF SLOW BEE PARALYSIS VIRUS AT 2.6A RESOLUTION
4542, 5fhxH, 0.5087, 4.08, 0.140, 213, 107, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
4543, 5f89B, 0.5087, 4.28, 0.071, 215, 112, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALISING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE
4544, 5e6iL, 0.5087, 3.93, 0.105, 208, 105, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
4545, 4xpbL, 0.5087, 4.03, 0.151, 115, 106, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO COCAINE
4546, 4wuuD, 0.5087, 3.99, 0.142, 211, 106, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
4547, 4qo1B, 0.5087, 4.01, 0.151, 211, 106, P53 DNA BINDING DOMAIN IN COMPLEX WITH NB139
4548, 4oiiM, 0.5087, 3.93, 0.124, 211, 105, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
4549, 4nkdD, 0.5087, 4.07, 0.082, 218, 110, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4550, 4nhhQ, 0.5087, 3.95, 0.095, 215, 105, STRUCTURE OF 2G12 IGG DIMER
4551, 4nhhL, 0.5087, 4.04, 0.112, 214, 107, STRUCTURE OF 2G12 IGG DIMER
4552, 4nhhG, 0.5087, 4.06, 0.074, 114, 108, STRUCTURE OF 2G12 IGG DIMER
4553, 4i18L, 0.5087, 4.02, 0.102, 241, 108, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
4554, 4g9fE, 0.5087, 3.78, 0.087, 234, 104, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
4555, 3qeqE, 0.5087, 4.07, 0.112, 214, 107, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
4556, 3kz8B, 0.5087, 4.06, 0.103, 214, 107, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 3)
4557, 2rcsH, 0.5087, 3.95, 0.095, 106, 105, IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
4558, 2p5wE, 0.5087, 4.06, 0.103, 214, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
4559, 2bdnH, 0.5087, 4.05, 0.094, 209, 106, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
4560, 1pkqA, 0.5087, 4.11, 0.112, 214, 107, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
4561, 1op3L, 0.5087, 4.13, 0.111, 219, 108, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
4562, 6qkdO, 0.5086, 4.11, 0.131, 211, 107, CRYSTAL STRUCTURE OF VHH-BASED FAB-FRAGMENT OF ANTIBODY BCD-085 
4563, 6n2xL, 0.5086, 4.05, 0.075, 212, 107, ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT 
4564, 6igoC, 0.5086, 4.06, 0.094, 213, 106, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
4565, 6ieaL, 0.5086, 4.19, 0.081, 228, 111, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R13 
4566, 6eh6B, 0.5086, 3.97, 0.104, 211, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4567, 6e62L, 0.5086, 4.14, 0.130, 219, 108, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
4568, 6e62C, 0.5086, 3.91, 0.067, 232, 105, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
4569, 6dkpE, 0.5086, 3.99, 0.123, 212, 106, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
4570, 6cwdA, 0.5086, 4.19, 0.093, 213, 108, HEPATITIS B CORE-ANTIGEN IN COMPLEX WITH SCFV E13 
4571, 5zwoD, 0.5086, 4.16, 0.083, 213, 108, CRYO-EM STRUCTURE OF THE YEAST B COMPLEX AT AVERAGE RESOLUTION OF 3.9 ANGSTROM 
4572, 5zwmAA, 0.5086, 4.15, 0.083, 216, 108, Cryo-EM structure of the yeast pre-B complex at an average resolution of 3.4~4.6 angstrom (tri-snRNP and U2 snRNP Part)  
4573, 5y2mL, 0.5086, 4.10, 0.075, 214, 107, CRYSTAL STRUCTURE OF A GROUP 2 HA BINDING ANTIBODY AF4H1K1 FAB IN COMPLEX WITH THE H4N6 DUCK ISOLATE (H4-CZ/56) HEMAGGLUTININ 
4574, 5xlia, 0.5086, 4.17, 0.130, 214, 108, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
4575, 5viyJ, 0.5086, 4.07, 0.058, 260, 104, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
4576, 5viyH, 0.5086, 3.95, 0.092, 340, 109, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
4577, 5t0yG, 0.5086, 3.95, 0.095, 222, 105, 2A10 ANTIBODY FAB FRAGMENT
4578, 5i4fA, 0.5086, 4.20, 0.100, 242, 110, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE
4579, 5i30L, 0.5086, 4.11, 0.121, 214, 107, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
4580, 5cjsE, 0.5086, 4.01, 0.112, 212, 107, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4581, 5c0rL, 0.5086, 3.98, 0.057, 199, 105, CRYSTAL STRUCTURE OF A GENERATION 3 INFLUENZA HEMAGGLUTININ STABILIZED STEM COMPLEXED WITH THE BROADLY NEUTRALIZING ANTIBODY C179
4582, 4z7qH, 0.5086, 4.08, 0.140, 213, 107, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
4583, 4xcnF, 0.5086, 4.11, 0.102, 115, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4584, 4xbgI, 0.5086, 4.04, 0.094, 211, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4585, 4wnqD, 0.5086, 4.04, 0.094, 211, 106, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
4586, 4nztH, 0.5086, 4.04, 0.094, 211, 106, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4587, 4kmtL, 0.5086, 4.00, 0.103, 216, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4588, 4kkaF, 0.5086, 4.02, 0.102, 250, 108, STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE
4589, 4i3rH, 0.5086, 4.08, 0.102, 243, 108, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
4590, 4gxuN, 0.5086, 3.93, 0.067, 195, 105, CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ
4591, 3mxvH, 0.5086, 4.06, 0.100, 217, 110, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
4592, 3mlsJ, 0.5086, 4.05, 0.093, 242, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4593, 3cvhL, 0.5086, 4.02, 0.100, 217, 110, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
4594, 3chnS, 0.5086, 4.09, 0.111, 219, 108, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4595, 3axyA, 0.5086, 4.04, 0.094, 211, 106, STRUCTURE OF FLORIGEN ACTIVATION COMPLEX CONSISTING OF RICE FLORIGEN HD3A 14-3-3 PROTEIN GF14 AND RICE FD HOMOLOG OSFD1
4596, 2os7A, 0.5086, 4.12, 0.074, 213, 108, CAF1M PERIPLASMIC CHAPERONE TETRAMER
4597, 1pz5A, 0.5086, 4.04, 0.094, 213, 106, STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
4598, 1pkqF, 0.5086, 4.34, 0.113, 122, 115, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
4599, 1p7kA, 0.5086, 4.29, 0.107, 218, 112, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
4600, 6ff9A, 0.5085, 4.15, 0.073, 240, 109, MUTANT R280K OF HUMAN P53 
4601, 6e4zL, 0.5085, 4.11, 0.119, 213, 109, ANTI-PCSK9 FAB 6E2 BOUND TO THE MODIFIED N-TERMINAL PEPTIDE FROM PCSK9 
4602, 6dezA, 0.5085, 4.12, 0.110, 213, 109, ANTI-PHOSPHOTYROSINE ANTIBODY PY20-4D5 FAB COMPLEXED WITH SULFATE 
4603, 6bb4M, 0.5085, 4.13, 0.101, 242, 109, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
4604, 6b5sL, 0.5085, 4.01, 0.114, 231, 105, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
4605, 5mthA, 0.5085, 3.02, 0.129, 1699, 93, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
4606, 5kanK, 0.5085, 3.02, 0.129, 1699, 93, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4607, 5k9qY, 0.5085, 4.16, 0.083, 212, 108, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4608, 5it2H, 0.5085, 3.94, 0.151, 213, 106, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
4609, 5i1iL, 0.5085, 4.36, 0.088, 223, 114, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV4-1
4610, 5eocJ, 0.5085, 4.36, 0.088, 223, 114, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
4611, 4z7oH, 0.5085, 4.12, 0.103, 211, 107, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
4612, 4ynyB, 0.5085, 4.11, 0.099, 237, 111, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
4613, 4ydlB, 0.5085, 4.06, 0.093, 212, 107, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
4614, 4xzuE, 0.5085, 3.98, 0.123, 211, 106, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
4615, 4ub0L, 0.5085, 4.10, 0.103, 214, 107, NEW DESIGN FOR MONOVALENT BISPECIFIC IGG THROUGH CYSTEINE ENGINEERING OF THE CH1-CL INTERFACE
4616, 4uaoB, 0.5085, 4.00, 0.091, 216, 110, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
4617, 4tw1A, 0.5085, 4.15, 0.065, 214, 108, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
4618, 4r96C, 0.5085, 4.14, 0.074, 214, 108, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4619, 4nkdB, 0.5085, 4.02, 0.093, 242, 108, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4620, 4m1dM, 0.5085, 4.09, 0.073, 222, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
4621, 4hieA, 0.5085, 4.12, 0.093, 214, 107, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102
4622, 4ffvH, 0.5085, 3.99, 0.142, 211, 106, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
4623, 4dw2L, 0.5085, 3.98, 0.073, 228, 110, THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB- 112
4624, 3ze1E, 0.5085, 4.02, 0.104, 213, 106, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4625, 3wxvH, 0.5085, 4.02, 0.100, 220, 110, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1
4626, 3s88L, 0.5085, 4.13, 0.045, 226, 110, CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN GULU) BOUND TO 16F6
4627, 3qhzL, 0.5085, 4.08, 0.084, 209, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
4628, 3exjA, 0.5085, 3.94, 0.083, 585, 109, CRYSTAL STRUCTURE OF A P53 CORE TETRAMER BOUND TO DNA
4629, 3d39E, 0.5085, 3.21, 0.053, 166, 95, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
4630, 2oqjG, 0.5085, 3.29, 0.084, 206, 95, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4631, 2ht3D, 0.5085, 4.12, 0.120, 215, 108, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX
4632, 2fatH, 0.5085, 4.08, 0.111, 216, 108, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
4633, 1zlvL, 0.5085, 4.14, 0.131, 214, 107, FAB 2G12 + MAN7
4634, 1nmaL, 0.5085, 4.00, 0.057, 193, 106, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
4635, 1ndgA, 0.5085, 4.15, 0.102, 218, 108, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME
4636, 1fytD, 0.5085, 4.06, 0.093, 203, 107, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
4637, 6mnfK, 0.5084, 4.03, 0.121, 211, 107, ANTI-HIV-1 FAB 2G12 + MAN8 RE-REFINEMENT 
4638, 6mb3N, 0.5084, 4.00, 0.093, 212, 108, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4639, 6mb3M, 0.5084, 4.05, 0.091, 220, 110, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4640, 6frcA, 0.5084, 4.11, 0.093, 214, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4641, 6e64B, 0.5084, 4.11, 0.093, 214, 107, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
4642, 5xhfA, 0.5084, 4.24, 0.071, 218, 112, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING P-AZIDO-L- PHENYLALANINE
4643, 5vkkL, 0.5084, 4.15, 0.111, 219, 108, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
4644, 5tq2H, 0.5084, 4.14, 0.118, 214, 110, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT GLUN1 AND GLUN2A
4645, 5njdW, 0.5084, 3.98, 0.091, 216, 110, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
4646, 4ydlH, 0.5084, 4.15, 0.128, 209, 109, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
4647, 4xphL, 0.5084, 4.09, 0.081, 223, 111, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO 34DICHLOROPHENETHYLAMINE
4648, 4rzcD, 0.5084, 4.06, 0.073, 208, 110, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
4649, 4r8wL, 0.5084, 4.02, 0.112, 214, 107, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A NEUTRALIZING ANTIBODY CT149
4650, 4r4bL, 0.5084, 4.08, 0.112, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
4651, 4okvC, 0.5084, 4.22, 0.080, 281, 113, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4652, 4ncc1, 0.5084, 4.16, 0.102, 219, 108, NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS
4653, 4kjpF, 0.5084, 4.12, 0.102, 115, 108, STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE
4654, 4jzjB, 0.5084, 4.02, 0.104, 213, 106, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
4655, 4janA, 0.5084, 4.09, 0.084, 212, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4656, 4ijtA, 0.5084, 4.12, 0.090, 209, 111, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM II)
4657, 3t3mH, 0.5084, 4.13, 0.120, 214, 108, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
4658, 3hntL, 0.5084, 4.02, 0.082, 216, 110, CS-35 FAB COMPLEX WITH A LINEAR TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
4659, 3gkzA, 0.5084, 3.99, 0.083, 119, 109, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX METHAMPHETAMINE
4660, 3cmoX, 0.5084, 4.19, 0.140, 212, 107, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
4661, 3bd5B, 0.5084, 4.00, 0.104, 216, 106, CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS
4662, 2qadG, 0.5084, 3.80, 0.048, 194, 104, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
4663, 2ht3F, 0.5084, 4.12, 0.092, 245, 109, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX
4664, 2fx8L, 0.5084, 4.05, 0.094, 211, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4665, 2fecO, 0.5084, 4.04, 0.151, 211, 106, STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC- EC1 FROM E.COLI
4666, 2bipA, 0.5084, 4.23, 0.089, 214, 112, HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-R249S- N268D
4667, 1zeaH, 0.5084, 4.14, 0.103, 211, 107, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
4668, 1xgrA, 0.5084, 3.97, 0.094, 109, 106, STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4669, 1um6L, 0.5084, 4.11, 0.112, 214, 107, CATALYTIC ANTIBODY 21H3
4670, 1tetH, 0.5084, 3.96, 0.139, 198, 108, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
4671, 1mhhB, 0.5084, 4.05, 0.094, 213, 106, ANTIBODY-ANTIGEN COMPLEX
4672, 1ap2D, 0.5084, 3.89, 0.105, 112, 105, SINGLE CHAIN FV OF C219
4673, 6n32M, 0.5083, 3.85, 0.114, 112, 105, ANTI-HIV-1 FAB 2G12 RE-REFINEMENT 
4674, 6mqeL, 0.5083, 3.99, 0.148, 202, 108, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DFPH-A.15 IN COMPLEX WITH FP (RESIDUE 512-519) 
4675, 6mnfL, 0.5083, 4.14, 0.109, 213, 110, ANTI-HIV-1 FAB 2G12 + MAN8 RE-REFINEMENT 
4676, 6e64L, 0.5083, 4.06, 0.112, 212, 107, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
4677, 6e4yL, 0.5083, 4.11, 0.102, 219, 108, ANTI-PCSK9 FAB 6E2 BOUND TO THE N-TERMINAL PEPTIDE FROM PCSK9; UNMODIFIED 
4678, 6df1L, 0.5083, 4.14, 0.081, 205, 111, ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 FAB COMPLEXED WITH SULFATE 
4679, 6cwdG, 0.5083, 3.87, 0.094, 214, 106, HEPATITIS B CORE-ANTIGEN IN COMPLEX WITH SCFV E13 
4680, 6a9kA, 0.5083, 4.09, 0.081, 223, 111, CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 9C10 WITH A TRANSITION-STATE ANALOG 
4681, 5ziaI, 0.5083, 4.10, 0.121, 214, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
4682, 5y2lJ, 0.5083, 4.06, 0.113, 111, 106, CRYSTAL STRUCTURE OF A GROUP 2 HA BINDING ANTIBODY AF4H1K1 FAB IN COMPLEX WITH THE 1968 H3N2 PANDEMIC (H3-AC/68) HEMAGGLUTININ 
4683, 5xhgA, 0.5083, 4.13, 0.084, 110, 107, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING NE-(O- AZIDOBENZYLOXYCARBONYL)-L-LYSINE
4684, 5x2nH, 0.5083, 4.12, 0.112, 210, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
4685, 5wkoD, 0.5083, 4.17, 0.118, 215, 110, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4686, 5gaoB, 0.5083, 4.00, 0.113, 210, 106, HEAD REGION OF THE YEAST SPLICEOSOMAL U4/U6.U5 TRI-SNRNP
4687, 4xcyF, 0.5083, 4.01, 0.142, 211, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4688, 4plkI, 0.5083, 4.15, 0.120, 219, 108, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4689, 4mayD, 0.5083, 4.03, 0.083, 218, 109, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
4690, 4lvhI, 0.5083, 3.93, 0.057, 198, 105, INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ
4691, 4kmtH, 0.5083, 3.99, 0.082, 216, 110, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4692, 4hweH, 0.5083, 4.09, 0.093, 214, 107, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4693, 4ht1L, 0.5083, 4.12, 0.121, 233, 107, HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
4694, 4hlzJ, 0.5083, 4.08, 0.093, 209, 107, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4695, 4hkbE, 0.5083, 4.02, 0.114, 112, 105, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4696, 4gmsN, 0.5083, 4.15, 0.093, 213, 107, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4697, 4ag4H, 0.5083, 3.99, 0.142, 211, 106, CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
4698, 3ze0H, 0.5083, 4.18, 0.065, 214, 108, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4699, 3vi4E, 0.5083, 4.04, 0.151, 211, 106, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
4700, 3u1sL, 0.5083, 3.99, 0.057, 185, 106, CRYSTAL STRUCTURE OF HUMAN FAB PGT145 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4701, 3tt1H, 0.5083, 3.97, 0.082, 209, 110, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4702, 3oazK, 0.5083, 4.11, 0.112, 215, 107, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4703, 3nifE, 0.5083, 4.01, 0.084, 219, 107, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
4704, 3lrgA, 0.5083, 4.02, 0.082, 209, 110, STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN
4705, 3i2cL, 0.5083, 4.10, 0.072, 215, 111, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
4706, 3hnsL, 0.5083, 3.99, 0.065, 123, 107, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
4707, 3fo9L, 0.5083, 4.05, 0.094, 213, 106, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
4708, 3effC, 0.5083, 4.10, 0.084, 212, 107, THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION
4709, 3d0aD, 0.5083, 4.04, 0.094, 213, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND SITE SUPPRESSOR MUTATION H168R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
4710, 3d09A, 0.5083, 4.16, 0.109, 213, 110, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATIONS H168R AND T123A
4711, 3c6sG, 0.5083, 4.16, 0.102, 218, 108, CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE
4712, 3au0A, 0.5083, 4.06, 0.103, 213, 107, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS
4713, 2qadC, 0.5083, 4.02, 0.114, 231, 105, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
4714, 2iamD, 0.5083, 4.21, 0.120, 219, 108, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4715, 2ialB, 0.5083, 4.16, 0.130, 217, 108, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4716, 2cmrL, 0.5083, 4.16, 0.093, 212, 108, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
4717, 1mimL, 0.5083, 4.02, 0.112, 213, 107, IGG FAB FRAGMENT (CD25-BINDING)
4718, 1kenL, 0.5083, 4.10, 0.081, 223, 111, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
4719, 1j5oL, 0.5083, 4.20, 0.093, 213, 108, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
4720, 6n16J, 0.5082, 3.01, 0.129, 1710, 93, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-B.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
4721, 6mh2A, 0.5082, 4.13, 0.065, 214, 108, STRUCTURE OF HERCEPTIN FAB WITHOUT ANTIGEN 
4722, 6frbB, 0.5082, 4.09, 0.110, 218, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4723, 6fj5A, 0.5082, 4.03, 0.165, 255, 109, P53-DNA COMPLEX 5 
4724, 6egxB, 0.5082, 4.00, 0.104, 210, 106, SACBROOD VIRUS OF HONEYBEE - EXPANSION STATE I 
4725, 6dwcL, 0.5082, 4.16, 0.072, 218, 111, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
4726, 6al0L, 0.5082, 4.22, 0.071, 213, 112, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 267 
4727, 5x2qH, 0.5082, 4.09, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
4728, 5wkoF, 0.5082, 4.06, 0.093, 212, 107, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4729, 5wkoB, 0.5082, 4.10, 0.072, 220, 111, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4730, 5t0yB, 0.5082, 4.05, 0.121, 213, 107, 2A10 ANTIBODY FAB FRAGMENT
4731, 5ngvL, 0.5082, 4.21, 0.126, 209, 111, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV ORTHORHOMBIC CRYSTAL FORM
4732, 5mx3A, 0.5082, 4.00, 0.091, 216, 110, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4733, 5mupB, 0.5082, 4.18, 0.083, 219, 108, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
4734, 5ig7H, 0.5082, 4.14, 0.083, 217, 108, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
4735, 5dfvD, 0.5082, 4.12, 0.081, 212, 111, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
4736, 4xnuL, 0.5082, 4.14, 0.093, 213, 107, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH NISOXETINE
4737, 4whtJ, 0.5082, 4.01, 0.091, 216, 110, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4738, 4wfhG, 0.5082, 3.99, 0.094, 114, 106, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4739, 4utbM, 0.5082, 4.06, 0.120, 218, 108, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4740, 4hg4U, 0.5082, 4.09, 0.093, 214, 107, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4741, 4ffvL, 0.5082, 4.15, 0.111, 219, 108, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
4742, 3vi3L, 0.5082, 4.01, 0.093, 215, 107, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
4743, 3sddD, 0.5082, 3.98, 0.066, 194, 106, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
4744, 3r8bH, 0.5082, 4.03, 0.066, 188, 106, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
4745, 3q01B, 0.5082, 4.10, 0.112, 216, 107, AN INDUCED FIT MECHANISM REGULATES P53 DNA BINDING KINETICS TO CONFER SEQUENCE SPECIFICITY
4746, 3lexL, 0.5082, 3.94, 0.074, 339, 108, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
4747, 3dggB, 0.5082, 4.15, 0.093, 213, 107, CRYSTAL STRUCTURE OF FABOX108
4748, 3cvhH, 0.5082, 4.10, 0.093, 239, 108, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
4749, 2zjsH, 0.5082, 4.19, 0.083, 239, 109, CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
4750, 2zckL, 0.5082, 4.14, 0.103, 208, 107, CRYSTAL STRUCTURE OF A TERNARY COMPLEX BETWEEN PSA A SUBSTRAT-ACYL INTERMEDIATE AND AN ACTIVATING ANTIBODY
4751, 2os7C, 0.5082, 4.00, 0.123, 210, 106, CAF1M PERIPLASMIC CHAPERONE TETRAMER
4752, 2iomA, 0.5082, 4.15, 0.120, 213, 108, MOUSE P53 CORE DOMAIN SOAKED WITH 2-PROPANOL
4753, 1ymhD, 0.5082, 4.12, 0.084, 214, 107, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
4754, 1xgpA, 0.5082, 4.13, 0.093, 217, 108, STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4755, 1ggiM, 0.5082, 4.05, 0.112, 214, 107, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
4756, 1dqjA, 0.5082, 4.04, 0.074, 240, 108, CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME
4757, 1bfoG, 0.5082, 3.85, 0.067, 199, 104, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4758, 6q3sD, 0.5081, 4.04, 0.087, 199, 104, ENGINEERED HUMAN HLA_A2 MHC CLASS I MOLECULE IN COMPLEX WITH TCR AND SV9 PEPTIDE 
4759, 6mnrL, 0.5081, 4.14, 0.102, 220, 108, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
4760, 6eh7A, 0.5081, 4.16, 0.118, 213, 110, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4761, 6e0pM, 0.5081, 4.15, 0.081, 219, 111, CRYO-EM STRUCTURE OF THE CENTROMERIC NUCLEOSOME (NATIVE ALPHA SATELLITE DNA) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4762, 6d48G, 0.5081, 4.21, 0.093, 213, 108, CELL SURFACE RECEPTOR 
4763, 6cr1L, 0.5081, 4.20, 0.083, 213, 108, ADALIMUMAB EFAB 
4764, 5umiL, 0.5081, 4.13, 0.103, 212, 107, CLOSTRIDIUM DIFFICILE TCDA-CROPS BOUND TO PA50 FAB
4765, 5u68F, 0.5081, 3.93, 0.095, 111, 105, STRUCTURAL BASIS FOR ANTIBODY CROSS-NEUTRALIZATION OF RESPIRATORY SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS
4766, 5tr8L, 0.5081, 4.06, 0.091, 219, 110, CRYSTAL STRUCTURE OF VACCINE-ELICITED PAN- INFLUENZA H1N1 NEUTRALIZING MURINE ANTIBODY 441D6. 
4767, 5nphH, 0.5081, 4.09, 0.048, 248, 105, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
4768, 5k9qL, 0.5081, 4.09, 0.139, 213, 108, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4769, 4ynyD, 0.5081, 4.17, 0.102, 217, 108, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
4770, 4xnxL, 0.5081, 4.09, 0.121, 214, 107, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH REBOXETINE
4771, 4xcyI, 0.5081, 4.17, 0.102, 215, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4772, 4wfgD, 0.5081, 4.14, 0.090, 210, 111, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
4773, 4rqqB, 0.5081, 4.07, 0.074, 210, 108, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4774, 4odwB, 0.5081, 4.08, 0.093, 211, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6
4775, 4nkmB, 0.5081, 4.02, 0.142, 207, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4776, 4nhcL, 0.5081, 4.18, 0.102, 219, 108, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41.
4777, 4n1eD, 0.5081, 3.70, 0.087, 238, 104, STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION
4778, 4lcwE, 0.5081, 4.16, 0.073, 113, 109, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4779, 4lccB, 0.5081, 3.95, 0.094, 233, 106, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
4780, 4hzlL, 0.5081, 4.10, 0.111, 219, 108, NEUTRALIZING ANTIBODY MAB 8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN
4781, 3r8bB, 0.5081, 4.14, 0.099, 212, 111, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
4782, 3qg7L, 0.5081, 3.89, 0.101, 213, 109, STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY
4783, 3leyL, 0.5081, 4.13, 0.081, 220, 111, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 6A7 IN COMPLEX WITH HIV-1 GP41
4784, 3lexB, 0.5081, 4.12, 0.111, 218, 108, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
4785, 2xqyG, 0.5081, 3.29, 0.095, 205, 95, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
4786, 2ioiA, 0.5081, 3.77, 0.048, 187, 104, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DOMAIN AT 1.55 A
4787, 2exwD, 0.5081, 4.10, 0.072, 218, 111, CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS
4788, 1rihL, 0.5081, 4.14, 0.112, 215, 107, CRYSTAL STRUCTURE OF FAB 14F7 A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
4789, 1p5uA, 0.5081, 4.09, 0.112, 215, 107, X-RAY STRUCTURE OF THE TERNARY CAF1M:CAF1:CAF1 CHAPERONE:SUBUNIT:SUBUNIT COMPLEX
4790, 1it9H, 0.5081, 4.15, 0.112, 214, 107, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A
4791, 1ggcL, 0.5081, 4.08, 0.121, 214, 107, MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
4792, 1dbkH, 0.5081, 4.12, 0.112, 203, 107, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
4793, 6qkdM, 0.5080, 3.94, 0.084, 211, 107, CRYSTAL STRUCTURE OF VHH-BASED FAB-FRAGMENT OF ANTIBODY BCD-085 
4794, 6fuqB, 0.5080, 3.97, 0.148, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4795, 6fumB, 0.5080, 3.89, 0.102, 229, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4796, 6eh7B, 0.5080, 3.95, 0.063, 124, 111, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4797, 6db8L, 0.5080, 4.09, 0.103, 211, 107, STRUCTURAL BASIS FOR PROMISCUOUS BINDING AND ACTIVATION OF FLUOROGENIC DYES BY DIR2S RNA APTAMER 
4798, 6c6zD, 0.5080, 4.05, 0.113, 210, 106, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
4799, 5x2pH, 0.5080, 3.85, 0.096, 233, 104, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4800, 5uk1I, 0.5080, 4.08, 0.093, 212, 107, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 3
4801, 5uk1H, 0.5080, 4.13, 0.090, 214, 111, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 3
4802, 5uk1G, 0.5080, 4.14, 0.093, 214, 107, CRYOEM STRUCTURE OF AN INFLUENZA VIRUS RECEPTOR-BINDING SITE ANTIBODY- ANTIGEN INTERFACE - CLASS 3
4803, 5u72E, 0.5080, 4.15, 0.119, 209, 109, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
4804, 5mo9H, 0.5080, 4.10, 0.150, 214, 107, STRUCTURE OF HUMAN TRKB RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE FAB FRGMENT OF ANTIBODY AB20
4805, 5hdbH, 0.5080, 4.17, 0.065, 211, 108, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
4806, 5girA, 0.5080, 4.03, 0.113, 211, 106, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4807, 5fb8B, 0.5080, 4.14, 0.054, 239, 112, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
4808, 5drwB, 0.5080, 4.10, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL183
4809, 4zypI, 0.5080, 4.02, 0.103, 115, 107, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
4810, 4whyN, 0.5080, 4.19, 0.065, 215, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P21 CRYSTAL FORM
4811, 4whtN, 0.5080, 4.01, 0.104, 109, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4812, 4qxtA, 0.5080, 4.13, 0.092, 243, 109, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30
4813, 4q7gA, 0.5080, 4.13, 0.083, 238, 109, 1.7 ANGSTROM CRYSTAL STRUCTURE OF LEUKOTOXIN LUKD FROM STAPHYLOCOCCUS AUREUS.
4814, 4nkdF, 0.5080, 4.13, 0.120, 217, 108, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4815, 4n8cI, 0.5080, 4.06, 0.074, 114, 108, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
4816, 4m48L, 0.5080, 4.13, 0.111, 216, 108, X-RAY STRUCTURE OF DOPAMINE TRANSPORTER ELUCIDATES ANTIDEPRESSANT MECHANISM
4817, 3ze0E, 0.5080, 4.14, 0.111, 216, 108, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4818, 3zdzE, 0.5080, 4.10, 0.111, 219, 108, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4819, 3ujtI, 0.5080, 4.20, 0.099, 216, 111, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
4820, 3l95A, 0.5080, 3.78, 0.048, 187, 104, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
4821, 2ztnA, 0.5080, 4.00, 0.151, 211, 106, HEPATITIS E VIRUS ORF2 (GENOTYPE 3)
4822, 2zclL, 0.5080, 4.06, 0.104, 212, 106, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
4823, 2wgxB, 0.5080, 3.07, 0.096, 206, 94, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I- N268D
4824, 2fx8N, 0.5080, 4.14, 0.090, 219, 111, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4825, 2ataD, 0.5080, 4.08, 0.103, 215, 107, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
4826, 1z3gI, 0.5080, 3.96, 0.082, 219, 110, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
4827, 1om3M, 0.5080, 4.16, 0.074, 214, 108, FAB 2G12 UNLIGANDED
4828, 1bf8A, 0.5080, 4.02, 0.074, 240, 108, PERIPLASMIC CHAPERONE FIMC NMR 20 STRUCTURES
4829, 6njnM, 0.5079, 4.05, 0.074, 240, 108, STRUCTURE OF A COMPLEX 
4830, 6mb3Q, 0.5079, 4.05, 0.074, 240, 108, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4831, 6igoA, 0.5079, 4.05, 0.093, 212, 107, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
4832, 6ggbA, 0.5079, 4.14, 0.111, 215, 108, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9318 
4833, 6fuoB, 0.5079, 4.12, 0.081, 219, 111, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4834, 6e5pT, 0.5079, 4.08, 0.085, 236, 106, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
4835, 6e5pL, 0.5079, 4.08, 0.085, 236, 106, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
4836, 6e5p4, 0.5079, 4.08, 0.085, 236, 106, BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED; GLYCAN-REACTIVE; NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP; WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03 
4837, 6b0aL, 0.5079, 4.13, 0.092, 243, 109, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1269
4838, 5x2oH, 0.5079, 4.03, 0.109, 212, 110, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
4839, 5v7uL, 0.5079, 4.02, 0.082, 216, 110, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-22.1 FAB
4840, 5nhrL, 0.5079, 4.11, 0.128, 206, 109, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV CUBIC CRYSTAL FORM
4841, 5mevL, 0.5079, 4.03, 0.091, 223, 110, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 21
4842, 5lk8B, 0.5079, 4.16, 0.093, 218, 108, SINGLE PARTICLE RECONSTRUCTION OF SLOW BEE PARALYSIS VIRUS EMPTY PARTICLE
4843, 5kg9B, 0.5079, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
4844, 5ikcL, 0.5079, 4.16, 0.102, 215, 108, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
4845, 5hdbE, 0.5079, 4.17, 0.102, 215, 108, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
4846, 5cszL, 0.5079, 3.75, 0.076, 114, 105, CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11
4847, 5c2bL, 0.5079, 4.05, 0.100, 300, 110, ANTI-CXCL13 PARENTAL SCFV - 3B4
4848, 4z7oE, 0.5079, 4.12, 0.102, 115, 108, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
4849, 4yhmH, 0.5079, 4.09, 0.090, 221, 111, REVERSAL AGENT FOR DABIGATRAN
4850, 4xzuA, 0.5079, 4.10, 0.121, 214, 107, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
4851, 4xcyK, 0.5079, 4.03, 0.082, 216, 110, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4852, 4xcyB, 0.5079, 4.02, 0.082, 216, 110, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4853, 4xakE, 0.5079, 4.18, 0.100, 207, 110, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD
4854, 4wnqB, 0.5079, 4.08, 0.103, 212, 107, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
4855, 4tw1M, 0.5079, 4.23, 0.073, 472, 110, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
4856, 4tw1I, 0.5079, 4.13, 0.111, 218, 108, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
4857, 4o02L, 0.5079, 3.87, 0.067, 194, 105, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
4858, 4nqdE, 0.5079, 4.19, 0.065, 214, 108, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
4859, 4nkdH, 0.5079, 3.97, 0.057, 197, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4860, 4isvB, 0.5079, 4.07, 0.092, 214, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
4861, 4hf5L, 0.5079, 4.05, 0.094, 212, 106, CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4862, 4h0gA, 0.5079, 3.02, 0.125, 205, 96, CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV
4863, 3zdzH, 0.5079, 4.03, 0.000, 213, 107, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4864, 3zdxH, 0.5079, 3.84, 0.114, 112, 105, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4865, 3t3mE, 0.5079, 4.21, 0.115, 120, 113, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
4866, 3qi9D, 0.5079, 3.98, 0.047, 198, 106, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
4867, 3iu3L, 0.5079, 4.05, 0.074, 240, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4868, 3c2aM, 0.5079, 4.02, 0.094, 212, 106, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
4869, 3b9kL, 0.5079, 4.02, 0.094, 212, 106, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
4870, 2fr4A, 0.5079, 4.02, 0.094, 212, 106, STRUCTURE OF FAB DNA-1 COMPLEXED WITH A STEM-LOOP DNA LIGAND
4871, 2ac0C, 0.5079, 4.03, 0.094, 211, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
4872, 2a1wM, 0.5079, 4.14, 0.081, 219, 111, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM I
4873, 1za3L, 0.5079, 4.05, 0.103, 219, 107, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
4874, 1op5L, 0.5079, 3.91, 0.095, 111, 105, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
4875, 1iaiH, 0.5079, 3.94, 0.094, 213, 106, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
4876, 1e4xI, 0.5079, 4.11, 0.077, 215, 104, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
4877, 6njmI, 0.5078, 4.02, 0.130, 218, 108, STRUCTURE OF A COMPLEX 
4878, 6mu3K, 0.5078, 4.17, 0.112, 211, 107, ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT 
4879, 6mqsB, 0.5078, 4.01, 0.091, 214, 110, VACCINE-ELICITED NHP FP-TARGETING HIV NEUTRALIZING ANTIBODY A12V163- A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
4880, 6mhgQ, 0.5078, 4.20, 0.083, 213, 108, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4881, 6mhgO, 0.5078, 3.91, 0.077, 111, 104, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4882, 6e63L, 0.5078, 4.02, 0.082, 216, 110, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
4883, 6d2pL, 0.5078, 4.02, 0.082, 222, 110, CRYSTAL STRUCTURE OF IOMA-CLASS CLK31 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD- GT8 AT 2.6 A 
4884, 6cqrJ, 0.5078, 4.09, 0.073, 213, 110, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
4885, 5x8lL, 0.5078, 4.15, 0.065, 212, 108, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
4886, 5x2nJ, 0.5078, 4.13, 0.065, 214, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
4887, 5w06L, 0.5078, 4.14, 0.075, 207, 107, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
4888, 5vobL, 0.5078, 3.85, 0.094, 241, 106, CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 8I21
4889, 5u72G, 0.5078, 4.24, 0.080, 287, 113, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
4890, 5lwyH, 0.5078, 4.24, 0.071, 290, 113, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID
4891, 5hbvC, 0.5078, 4.12, 0.075, 214, 107, COMPLEX STRUCTURE OF FAB35 AND MOUSE NACHR ALPHA1
4892, 5d0fA, 0.5078, 4.13, 0.092, 243, 109, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME (E564Q) IN COMPLEX WITH MALTOPENTAOSE
4893, 4xpaL, 0.5078, 4.12, 0.102, 115, 108, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO 3 4DICHLOROPHENETHYLAMINE
4894, 4xceL, 0.5078, 4.09, 0.073, 212, 109, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP
4895, 4whtV, 0.5078, 3.93, 0.095, 196, 105, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4896, 4r96A, 0.5078, 4.02, 0.109, 242, 110, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4897, 4oz4A, 0.5078, 4.00, 0.082, 216, 110, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4898, 4lciH, 0.5078, 3.98, 0.091, 216, 110, ANTI CANINE CD28 ANTIBODY 1C6
4899, 4guoD, 0.5078, 3.92, 0.083, 214, 109, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4900, 4g8gE, 0.5078, 3.90, 0.085, 239, 106, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
4901, 4g5zL, 0.5078, 3.99, 0.151, 208, 106, CRYSTAL STRUCTURE OF THE THERAPEUTICAL ANTIBODY FRAGMENT OF CANAKINUMAB IN ITS UNBOUND STATE
4902, 3vgaC, 0.5078, 4.03, 0.113, 216, 106, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
4903, 3pqyO, 0.5078, 4.12, 0.121, 213, 107, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
4904, 3pgfL, 0.5078, 4.15, 0.131, 213, 107, CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
4905, 3of6C, 0.5078, 3.97, 0.057, 195, 105, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
4906, 3oayL, 0.5078, 4.20, 0.111, 216, 108, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4907, 3oayK, 0.5078, 4.09, 0.093, 213, 107, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4908, 3nn8H, 0.5078, 4.02, 0.094, 212, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4909, 3lhpM, 0.5078, 4.07, 0.082, 219, 110, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
4910, 3l1oL, 0.5078, 4.02, 0.109, 217, 110, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
4911, 3exlA, 0.5078, 4.15, 0.000, 218, 111, CRYSTAL STRUCTURE OF A P53 CORE TETRAMER BOUND TO DNA
4912, 2fjfL, 0.5078, 4.04, 0.094, 211, 106, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4913, 2bveA, 0.5078, 4.17, 0.101, 215, 109, STRUCTURE OF THE N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH 2-PHENYL-PROP5AC
4914, 1xf2A, 0.5078, 3.85, 0.114, 112, 105, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
4915, 1xcqF, 0.5078, 3.84, 0.114, 112, 105, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4916, 1wtlA, 0.5078, 4.16, 0.118, 215, 110, COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS
4917, 1otuD, 0.5078, 4.09, 0.093, 210, 107, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
4918, 1ndmA, 0.5078, 4.09, 0.119, 245, 109, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME
4919, 1n0lA, 0.5078, 4.09, 0.093, 202, 107, CRYSTAL STRUCTURE OF THE PAPD CHAPERONE (C-TERMINALLY 6X HISTIDINE-TAGGED) BOUND TO THE PAPE PILUS SUBUNIT (N- TERMINAL-DELETED) FROM UROPATHOGENIC E. COLI
4920, 1fn4C, 0.5078, 4.14, 0.081, 219, 111, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
4921, 1dqqA, 0.5078, 4.17, 0.102, 219, 108, CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63
4922, 1b0wA, 0.5078, 4.14, 0.103, 214, 107, STRUCTURAL COMPARISON OF AMYLOIDOGENIC LIGHT CHAIN DIMER IN TWO CRYSTAL FORMS WITH NONAMYLOIDOGENIC COUNTERPARTS
4923, 6n35K, 0.5077, 4.09, 0.092, 243, 109, ANTI-HIV-1 FAB 2G12 + MAN1-2 RE-REFINEMENT 
4924, 6mu3L, 0.5077, 4.01, 0.083, 119, 109, ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT 
4925, 6d6uL, 0.5077, 4.02, 0.121, 211, 107, HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL; CONFORMATION A 
4926, 6c08A, 0.5077, 3.49, 0.059, 1526, 102, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
4927, 5xqyA, 0.5077, 4.09, 0.121, 214, 107, STRUCTURE OF MONOMERIC MUTANT OF REI IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN CRYSTALLIZED AT PH 8
4928, 5lfrA, 0.5077, 4.14, 0.065, 212, 108, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3
4929, 5hbtC, 0.5077, 4.17, 0.102, 212, 108, COMPLEX STRUCTURE OF FAB35 AND HUMAN NACHR ALPHA1
4930, 5f7eL, 0.5077, 4.17, 0.111, 219, 108, CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF 3BNC60 FAB
4931, 5brzD, 0.5077, 4.06, 0.091, 219, 110, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
4932, 4yo0D, 0.5077, 3.88, 0.075, 120, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
4933, 4xp9L, 0.5077, 4.06, 0.093, 198, 107, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT D-AMPHETAMINE
4934, 4xcnK, 0.5077, 4.09, 0.093, 248, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4935, 4x6cH, 0.5077, 4.16, 0.131, 212, 107, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
4936, 4utbL, 0.5077, 4.13, 0.099, 220, 111, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4937, 4rbpK, 0.5077, 4.09, 0.130, 240, 108, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
4938, 4r4nX, 0.5077, 4.03, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4939, 4r4nO, 0.5077, 3.89, 0.140, 243, 107, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4940, 4r4nD, 0.5077, 4.05, 0.094, 213, 106, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
4941, 4r4bA, 0.5077, 4.06, 0.094, 213, 106, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
4942, 4nhhP, 0.5077, 4.08, 0.102, 116, 108, STRUCTURE OF 2G12 IGG DIMER
4943, 4nhhK, 0.5077, 4.03, 0.065, 110, 107, STRUCTURE OF 2G12 IGG DIMER
4944, 4nhhF, 0.5077, 4.09, 0.103, 214, 107, STRUCTURE OF 2G12 IGG DIMER
4945, 4hihA, 0.5077, 3.81, 0.048, 194, 104, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
4946, 4agnB, 0.5077, 4.10, 0.103, 211, 107, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5116
4947, 3t3pH, 0.5077, 3.92, 0.065, 119, 108, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
4948, 3s35L, 0.5077, 4.12, 0.131, 213, 107, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
4949, 3pl6D, 0.5077, 4.02, 0.073, 218, 110, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
4950, 3oauL, 0.5077, 3.97, 0.095, 108, 105, ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON- DOMAIN-EXCHANGED FORMS BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED
4951, 3kymM, 0.5077, 4.00, 0.170, 211, 106, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
4952, 3gjeL, 0.5077, 4.06, 0.132, 214, 106, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
4953, 2w65A, 0.5077, 3.19, 0.163, 212, 98, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
4954, 2ez0D, 0.5077, 4.13, 0.131, 211, 107, CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC IN COMPLEX WITH A FAB FRAGMENT
4955, 1op3K, 0.5077, 4.15, 0.112, 214, 107, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
4956, 1mh5H, 0.5077, 3.94, 0.105, 108, 105, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
4957, 1a6tA, 0.5077, 4.05, 0.094, 213, 106, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
4958, 6mtoL, 0.5076, 4.06, 0.094, 211, 106, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
4959, 6mehL, 0.5076, 3.91, 0.115, 106, 104, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4960, 6fraB, 0.5076, 3.83, 0.028, 214, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4961, 6cdoA, 0.5076, 3.93, 0.114, 109, 105, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4962, 5ywfB, 0.5076, 3.98, 0.118, 310, 110, CRYSTAL STRUCTURE OF 2H4 FAB
4963, 5xzcD, 0.5076, 4.02, 0.121, 212, 107, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
4964, 5w6gL, 0.5076, 3.90, 0.095, 207, 105, HUMAN ANTIBODY 6649 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS
4965, 5ukoL, 0.5076, 4.15, 0.103, 197, 107, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522IA FAB
4966, 5mhrQ, 0.5076, 4.20, 0.128, 209, 109, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4967, 5mesL, 0.5076, 4.08, 0.150, 213, 107, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 29
4968, 5jueH, 0.5076, 4.20, 0.065, 214, 108, CRYSTAL STRUCTURE OF UIC2 FAB
4969, 5esvD, 0.5076, 4.05, 0.093, 243, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.
4970, 4xcnI, 0.5076, 4.07, 0.074, 213, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4971, 4whtD, 0.5076, 4.06, 0.104, 213, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4972, 4s1dP, 0.5076, 4.12, 0.112, 210, 107, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
4973, 4r96L, 0.5076, 4.14, 0.121, 210, 107, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4974, 4ktdL, 0.5076, 4.04, 0.113, 210, 106, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE136 FROM NON-HUMAN PRIMATE
4975, 4k24L, 0.5076, 4.12, 0.103, 210, 107, STRUCTURE OF ANTI-UPAR FAB ATN-658 IN COMPLEX WITH UPAR
4976, 4guqB, 0.5076, 4.05, 0.094, 211, 106, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
4977, 4ffyL, 0.5076, 4.05, 0.094, 211, 106, CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII STRAIN 16007.
4978, 4elmH, 0.5076, 4.05, 0.094, 211, 106, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
4979, 4c83D, 0.5076, 4.11, 0.084, 212, 107, CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS
4980, 3uzvB, 0.5076, 3.88, 0.057, 197, 105, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
4981, 3tt1I, 0.5076, 3.99, 0.082, 216, 110, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4982, 3r8bD, 0.5076, 4.20, 0.102, 217, 108, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
4983, 3mlxM, 0.5076, 4.04, 0.165, 257, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
4984, 3mlsK, 0.5076, 4.11, 0.093, 212, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4985, 3kmdD, 0.5076, 4.17, 0.075, 208, 107, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
4986, 3ixyJ, 0.5076, 3.97, 0.086, 212, 105, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4987, 3csyH, 0.5076, 4.12, 0.072, 212, 111, CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR
4988, 2ij0C, 0.5076, 4.00, 0.170, 211, 106, STRUCTURAL BASIS OF T CELL SPECIFICITY AND ACTIVATION BY THE BACTERIAL SUPERANTIGEN TOXIC SHOCK SYNDROME TOXIN-1
4989, 2hwzL, 0.5076, 4.05, 0.094, 211, 106, FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM)
4990, 2hh0L, 0.5076, 4.12, 0.100, 190, 110, STRUCTURE OF AN ANTI-PRP FAB P-CLONE IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.
4991, 2fd6L, 0.5076, 4.02, 0.132, 210, 106, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
4992, 2exyD, 0.5076, 4.19, 0.074, 212, 108, CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC FAB COMPLEXED IN ABSENCE OF BOUND IONS
4993, 2ai0N, 0.5076, 4.12, 0.084, 213, 107, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
4994, 1uolB, 0.5076, 4.04, 0.074, 240, 108, CRYSTAL STRUCTURE OF THE HUMAN P53 CORE DOMAIN MUTANT M133L/V203A/N239Y/N268D AT 1.9 A RESOLUTION.
4995, 1pkqE, 0.5076, 4.01, 0.091, 230, 110, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
4996, 6fy1H, 0.5075, 3.95, 0.065, 218, 108, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
4997, 6fy0H, 0.5075, 3.92, 0.067, 232, 105, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4998, 6fuqA, 0.5075, 4.07, 0.093, 214, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4999, 6ddvB, 0.5075, 3.95, 0.086, 211, 105, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
5000, 6d9wL, 0.5075, 4.09, 0.112, 210, 107, CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MNTH; AN NRAMP-FAMILY TRANSITION METAL TRANSPORTER; IN THE INWARD-OPEN APO STATE 
5001, 6cxgL, 0.5075, 3.95, 0.104, 213, 106, ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S 
